#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Classification of multi-site MR images in the presence of heterogeneity using multi-task learning☆
#Text=With the advent of Big Data Imaging Analytics applied to neuroimaging, datasets from multiple sites need to be pooled into larger samples.
1-1	0-14	Classification	_	
1-2	15-17	of	_	
1-3	18-28	multi-site	_	
1-4	29-31	MR	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[1]	
1-5	32-38	images	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[1]	
1-6	39-41	in	_	
1-7	42-45	the	_	
1-8	46-54	presence	_	
1-9	55-57	of	_	
1-10	58-71	heterogeneity	_	
1-11	72-77	using	_	
1-12	78-88	multi-task	_	
1-13	89-97	learning	_	
1-14	97-98	☆	_	
1-15	99-103	With	_	
1-16	104-107	the	_	
1-17	108-114	advent	_	
1-18	115-117	of	_	
1-19	118-121	Big	_	
1-20	122-126	Data	_	
1-21	127-134	Imaging	_	
1-22	135-144	Analytics	_	
1-23	145-152	applied	_	
1-24	153-155	to	_	
1-25	156-168	neuroimaging	_	
1-26	168-169	,	_	
1-27	170-178	datasets	_	
1-28	179-183	from	_	
1-29	184-192	multiple	_	
1-30	193-198	sites	_	
1-31	199-203	need	_	
1-32	204-206	to	_	
1-33	207-209	be	_	
1-34	210-216	pooled	_	
1-35	217-221	into	_	
1-36	222-228	larger	_	
1-37	229-236	samples	_	
1-38	236-237	.	_	

#Text=However, heterogeneity across different scanners, protocols and populations, renders the task of finding underlying disease signatures challenging.
2-1	238-245	However	_	
2-2	245-246	,	_	
2-3	247-260	heterogeneity	_	
2-4	261-267	across	_	
2-5	268-277	different	_	
2-6	278-286	scanners	_	
2-7	286-287	,	_	
2-8	288-297	protocols	_	
2-9	298-301	and	_	
2-10	302-313	populations	_	
2-11	313-314	,	_	
2-12	315-322	renders	_	
2-13	323-326	the	_	
2-14	327-331	task	_	
2-15	332-334	of	_	
2-16	335-342	finding	_	
2-17	343-353	underlying	_	
2-18	354-361	disease	_	
2-19	362-372	signatures	_	
2-20	373-384	challenging	_	
2-21	384-385	.	_	

#Text=The current work investigates the value of multi-task learning in finding disease signatures that generalize across studies and populations.
3-1	386-389	The	_	
3-2	390-397	current	_	
3-3	398-402	work	_	
3-4	403-415	investigates	_	
3-5	416-419	the	_	
3-6	420-425	value	_	
3-7	426-428	of	_	
3-8	429-439	multi-task	_	
3-9	440-448	learning	_	
3-10	449-451	in	_	
3-11	452-459	finding	_	
3-12	460-467	disease	_	
3-13	468-478	signatures	_	
3-14	479-483	that	_	
3-15	484-494	generalize	_	
3-16	495-501	across	_	
3-17	502-509	studies	_	
3-18	510-513	and	_	
3-19	514-525	populations	_	
3-20	525-526	.	_	

#Text=Herein, we present a multi-task learning type of formulation, in which different tasks are from different studies and populations being pooled together.
4-1	527-533	Herein	_	
4-2	533-534	,	_	
4-3	535-537	we	_	
4-4	538-545	present	_	
4-5	546-547	a	_	
4-6	548-558	multi-task	_	
4-7	559-567	learning	_	
4-8	568-572	type	_	
4-9	573-575	of	_	
4-10	576-587	formulation	_	
4-11	587-588	,	_	
4-12	589-591	in	_	
4-13	592-597	which	_	
4-14	598-607	different	_	
4-15	608-613	tasks	_	
4-16	614-617	are	_	
4-17	618-622	from	_	
4-18	623-632	different	_	
4-19	633-640	studies	_	
4-20	641-644	and	_	
4-21	645-656	populations	_	
4-22	657-662	being	_	
4-23	663-669	pooled	_	
4-24	670-678	together	_	
4-25	678-679	.	_	

#Text=We test this approach in an MRI study of the neuroanatomy of schizophrenia (SCZ) by pooling data from 3 different sites and populations: Philadelphia, Sao Paulo and Tianjin (50 controls and 50 patients from each site), which posed integration challenges due to variability in disease chronicity, treatment exposure, and data collection.
5-1	680-682	We	_	
5-2	683-687	test	_	
5-3	688-692	this	_	
5-4	693-701	approach	_	
5-5	702-704	in	_	
5-6	705-707	an	_	
5-7	708-711	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
5-8	712-717	study	_	
5-9	718-720	of	_	
5-10	721-724	the	_	
5-11	725-737	neuroanatomy	_	
5-12	738-740	of	_	
5-13	741-754	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
5-14	755-756	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
5-15	756-759	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
5-16	759-760	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
5-17	761-763	by	_	
5-18	764-771	pooling	_	
5-19	772-776	data	_	
5-20	777-781	from	_	
5-21	782-783	3	_	
5-22	784-793	different	_	
5-23	794-799	sites	_	
5-24	800-803	and	_	
5-25	804-815	populations	_	
5-26	815-816	:	_	
5-27	817-829	Philadelphia	_	
5-28	829-830	,	_	
5-29	831-834	Sao	_	
5-30	835-840	Paulo	_	
5-31	841-844	and	_	
5-32	845-852	Tianjin	_	
5-33	853-854	(	_	
5-34	854-856	50	_	
5-35	857-865	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-36	866-869	and	_	
5-37	870-872	50	_	
5-38	873-881	patients	_	
5-39	882-886	from	_	
5-40	887-891	each	_	
5-41	892-896	site	_	
5-42	896-897	)	_	
5-43	897-898	,	_	
5-44	899-904	which	_	
5-45	905-910	posed	_	
5-46	911-922	integration	_	
5-47	923-933	challenges	_	
5-48	934-937	due	_	
5-49	938-940	to	_	
5-50	941-952	variability	_	
5-51	953-955	in	_	
5-52	956-963	disease	_	
5-53	964-974	chronicity	_	
5-54	974-975	,	_	
5-55	976-985	treatment	_	
5-56	986-994	exposure	_	
5-57	994-995	,	_	
5-58	996-999	and	_	
5-59	1000-1004	data	_	
5-60	1005-1015	collection	_	
5-61	1015-1016	.	_	

#Text=Some existing methods are also tested for comparison purposes.
6-1	1017-1021	Some	_	
6-2	1022-1030	existing	_	
6-3	1031-1038	methods	_	
6-4	1039-1042	are	_	
6-5	1043-1047	also	_	
6-6	1048-1054	tested	_	
6-7	1055-1058	for	_	
6-8	1059-1069	comparison	_	
6-9	1070-1078	purposes	_	
6-10	1078-1079	.	_	

#Text=Experiments show that classification accuracy of multi-site data outperformed that of single-site data and pooled data using multi-task feature learning, and also outperformed other comparison methods.
7-1	1080-1091	Experiments	_	
7-2	1092-1096	show	_	
7-3	1097-1101	that	_	
7-4	1102-1116	classification	_	
7-5	1117-1125	accuracy	_	
7-6	1126-1128	of	_	
7-7	1129-1139	multi-site	_	
7-8	1140-1144	data	_	
7-9	1145-1157	outperformed	_	
7-10	1158-1162	that	_	
7-11	1163-1165	of	_	
7-12	1166-1177	single-site	_	
7-13	1178-1182	data	_	
7-14	1183-1186	and	_	
7-15	1187-1193	pooled	_	
7-16	1194-1198	data	_	
7-17	1199-1204	using	_	
7-18	1205-1215	multi-task	_	
7-19	1216-1223	feature	_	
7-20	1224-1232	learning	_	
7-21	1232-1233	,	_	
7-22	1234-1237	and	_	
7-23	1238-1242	also	_	
7-24	1243-1255	outperformed	_	
7-25	1256-1261	other	_	
7-26	1262-1272	comparison	_	
7-27	1273-1280	methods	_	
7-28	1280-1281	.	_	

#Text=Several anatomical regions were identified to be common discriminant features across sites.
8-1	1282-1289	Several	_	
8-2	1290-1300	anatomical	_	
8-3	1301-1308	regions	_	
8-4	1309-1313	were	_	
8-5	1314-1324	identified	_	
8-6	1325-1327	to	_	
8-7	1328-1330	be	_	
8-8	1331-1337	common	_	
8-9	1338-1350	discriminant	_	
8-10	1351-1359	features	_	
8-11	1360-1366	across	_	
8-12	1367-1372	sites	_	
8-13	1372-1373	.	_	

#Text=These included prefrontal, superior temporal, insular, anterior cingulate cortex, temporo-limbic and striatal regions consistently implicated in the pathophysiology of schizophrenia, as well as the cerebellum, precuneus, and fusiform, middle temporal, inferior parietal, postcentral, angular, lingual and middle occipital gyri.
9-1	1374-1379	These	_	
9-2	1380-1388	included	_	
9-3	1389-1399	prefrontal	_	
9-4	1399-1400	,	_	
9-5	1401-1409	superior	_	
9-6	1410-1418	temporal	_	
9-7	1418-1419	,	_	
9-8	1420-1427	insular	_	
9-9	1427-1428	,	_	
9-10	1429-1437	anterior	_	
9-11	1438-1447	cingulate	_	
9-12	1448-1454	cortex	_	
9-13	1454-1455	,	_	
9-14	1456-1470	temporo-limbic	_	
9-15	1471-1474	and	_	
9-16	1475-1483	striatal	_	
9-17	1484-1491	regions	_	
9-18	1492-1504	consistently	_	
9-19	1505-1515	implicated	_	
9-20	1516-1518	in	_	
9-21	1519-1522	the	_	
9-22	1523-1538	pathophysiology	_	
9-23	1539-1541	of	_	
9-24	1542-1555	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
9-25	1555-1556	,	_	
9-26	1557-1559	as	_	
9-27	1560-1564	well	_	
9-28	1565-1567	as	_	
9-29	1568-1571	the	_	
9-30	1572-1582	cerebellum	_	
9-31	1582-1583	,	_	
9-32	1584-1593	precuneus	_	
9-33	1593-1594	,	_	
9-34	1595-1598	and	_	
9-35	1599-1607	fusiform	_	
9-36	1607-1608	,	_	
9-37	1609-1615	middle	_	
9-38	1616-1624	temporal	_	
9-39	1624-1625	,	_	
9-40	1626-1634	inferior	_	
9-41	1635-1643	parietal	_	
9-42	1643-1644	,	_	
9-43	1645-1656	postcentral	_	
9-44	1656-1657	,	_	
9-45	1658-1665	angular	_	
9-46	1665-1666	,	_	
9-47	1667-1674	lingual	_	
9-48	1675-1678	and	_	
9-49	1679-1685	middle	_	
9-50	1686-1695	occipital	_	
9-51	1696-1700	gyri	_	
9-52	1700-1701	.	_	

#Text=These results indicate that the proposed multi-task learning method is robust in finding consistent and reliable structural brain abnormalities associated with SCZ across different sites, in the presence of multiple sources of heterogeneity.
10-1	1702-1707	These	_	
10-2	1708-1715	results	_	
10-3	1716-1724	indicate	_	
10-4	1725-1729	that	_	
10-5	1730-1733	the	_	
10-6	1734-1742	proposed	_	
10-7	1743-1753	multi-task	_	
10-8	1754-1762	learning	_	
10-9	1763-1769	method	_	
10-10	1770-1772	is	_	
10-11	1773-1779	robust	_	
10-12	1780-1782	in	_	
10-13	1783-1790	finding	_	
10-14	1791-1801	consistent	_	
10-15	1802-1805	and	_	
10-16	1806-1814	reliable	_	
10-17	1815-1825	structural	_	
10-18	1826-1831	brain	_	
10-19	1832-1845	abnormalities	_	
10-20	1846-1856	associated	_	
10-21	1857-1861	with	_	
10-22	1862-1865	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-23	1866-1872	across	_	
10-24	1873-1882	different	_	
10-25	1883-1888	sites	_	
10-26	1888-1889	,	_	
10-27	1890-1892	in	_	
10-28	1893-1896	the	_	
10-29	1897-1905	presence	_	
10-30	1906-1908	of	_	
10-31	1909-1917	multiple	_	
10-32	1918-1925	sources	_	
10-33	1926-1928	of	_	
10-34	1929-1942	heterogeneity	_	
10-35	1942-1943	.	_	

#Text=Highlights
#Text=Multi-task learning is tested to classify MRI data of 3 sites (50 controls and 50 schizophrenia patients from each site).
11-1	1944-1954	Highlights	_	
11-2	1955-1965	Multi-task	_	
11-3	1966-1974	learning	_	
11-4	1975-1977	is	_	
11-5	1978-1984	tested	_	
11-6	1985-1987	to	_	
11-7	1988-1996	classify	_	
11-8	1997-2000	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
11-9	2001-2005	data	_	
11-10	2006-2008	of	_	
11-11	2009-2010	3	_	
11-12	2011-2016	sites	_	
11-13	2017-2018	(	_	
11-14	2018-2020	50	_	
11-15	2021-2029	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
11-16	2030-2033	and	_	
11-17	2034-2036	50	_	
11-18	2037-2050	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]	
11-19	2051-2059	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]	
11-20	2060-2064	from	_	
11-21	2065-2069	each	_	
11-22	2070-2074	site	_	
11-23	2074-2075	)	_	
11-24	2075-2076	.	_	

#Text=Classification accuracy of multi-site data outperformed that of single-site and pooled data.
12-1	2077-2091	Classification	_	
12-2	2092-2100	accuracy	_	
12-3	2101-2103	of	_	
12-4	2104-2114	multi-site	_	
12-5	2115-2119	data	_	
12-6	2120-2132	outperformed	_	
12-7	2133-2137	that	_	
12-8	2138-2140	of	_	
12-9	2141-2152	single-site	_	
12-10	2153-2156	and	_	
12-11	2157-2163	pooled	_	
12-12	2164-2168	data	_	
12-13	2168-2169	.	_	

#Text=Several cortical and subcortical anatomical regions were found to be common discriminant features across different sites.
13-1	2170-2177	Several	_	
13-2	2178-2186	cortical	_	
13-3	2187-2190	and	_	
13-4	2191-2202	subcortical	_	
13-5	2203-2213	anatomical	_	
13-6	2214-2221	regions	_	
13-7	2222-2226	were	_	
13-8	2227-2232	found	_	
13-9	2233-2235	to	_	
13-10	2236-2238	be	_	
13-11	2239-2245	common	_	
13-12	2246-2258	discriminant	_	
13-13	2259-2267	features	_	
13-14	2268-2274	across	_	
13-15	2275-2284	different	_	
13-16	2285-2290	sites	_	
13-17	2290-2291	.	_	

#Text=Multi-task learning is robust in finding reliable structural brain abnormalities of schizophrenia across different sites.
14-1	2292-2302	Multi-task	_	
14-2	2303-2311	learning	_	
14-3	2312-2314	is	_	
14-4	2315-2321	robust	_	
14-5	2322-2324	in	_	
14-6	2325-2332	finding	_	
14-7	2333-2341	reliable	_	
14-8	2342-2352	structural	_	
14-9	2353-2358	brain	_	
14-10	2359-2372	abnormalities	_	
14-11	2373-2375	of	_	
14-12	2376-2389	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
14-13	2390-2396	across	_	
14-14	2397-2406	different	_	
14-15	2407-2412	sites	_	
14-16	2412-2413	.	_	

#Text=Introduction
#Text=Neuroimaging studies have widely explored the clinical value of machine learning methods for differentiating psychiatric patients from healthy controls at the individual level.
15-1	2414-2426	Introduction	_	
15-2	2427-2439	Neuroimaging	_	
15-3	2440-2447	studies	_	
15-4	2448-2452	have	_	
15-5	2453-2459	widely	_	
15-6	2460-2468	explored	_	
15-7	2469-2472	the	_	
15-8	2473-2481	clinical	_	
15-9	2482-2487	value	_	
15-10	2488-2490	of	_	
15-11	2491-2498	machine	_	
15-12	2499-2507	learning	_	
15-13	2508-2515	methods	_	
15-14	2516-2519	for	_	
15-15	2520-2535	differentiating	_	
15-16	2536-2547	psychiatric	_	
15-17	2548-2556	patients	_	
15-18	2557-2561	from	_	
15-19	2562-2569	healthy	_	
15-20	2570-2578	controls	_	
15-21	2579-2581	at	_	
15-22	2582-2585	the	_	
15-23	2586-2596	individual	_	
15-24	2597-2602	level	_	
15-25	2602-2603	.	_	

#Text=In addition to providing individualized indices for diagnostic purposes, machine learning methods may ultimately help identify brain regions affected by disease in subtle ways that can only be elucidated using multi-variate analysis.
16-1	2604-2606	In	_	
16-2	2607-2615	addition	_	
16-3	2616-2618	to	_	
16-4	2619-2628	providing	_	
16-5	2629-2643	individualized	_	
16-6	2644-2651	indices	_	
16-7	2652-2655	for	_	
16-8	2656-2666	diagnostic	_	
16-9	2667-2675	purposes	_	
16-10	2675-2676	,	_	
16-11	2677-2684	machine	_	
16-12	2685-2693	learning	_	
16-13	2694-2701	methods	_	
16-14	2702-2705	may	_	
16-15	2706-2716	ultimately	_	
16-16	2717-2721	help	_	
16-17	2722-2730	identify	_	
16-18	2731-2736	brain	_	
16-19	2737-2744	regions	_	
16-20	2745-2753	affected	_	
16-21	2754-2756	by	_	
16-22	2757-2764	disease	_	
16-23	2765-2767	in	_	
16-24	2768-2774	subtle	_	
16-25	2775-2779	ways	_	
16-26	2780-2784	that	_	
16-27	2785-2788	can	_	
16-28	2789-2793	only	_	
16-29	2794-2796	be	_	
16-30	2797-2807	elucidated	_	
16-31	2808-2813	using	_	
16-32	2814-2827	multi-variate	_	
16-33	2828-2836	analysis	_	
16-34	2836-2837	.	_	

#Text=While most of these neuroimaging studies to date have been performed using single-site datasets, it is essential to integrate multi-site data for two reasons.
17-1	2838-2843	While	_	
17-2	2844-2848	most	_	
17-3	2849-2851	of	_	
17-4	2852-2857	these	_	
17-5	2858-2870	neuroimaging	_	
17-6	2871-2878	studies	_	
17-7	2879-2881	to	_	
17-8	2882-2886	date	_	
17-9	2887-2891	have	_	
17-10	2892-2896	been	_	
17-11	2897-2906	performed	_	
17-12	2907-2912	using	_	
17-13	2913-2924	single-site	_	
17-14	2925-2933	datasets	_	
17-15	2933-2934	,	_	
17-16	2935-2937	it	_	
17-17	2938-2940	is	_	
17-18	2941-2950	essential	_	
17-19	2951-2953	to	_	
17-20	2954-2963	integrate	_	
17-21	2964-2974	multi-site	_	
17-22	2975-2979	data	_	
17-23	2980-2983	for	_	
17-24	2984-2987	two	_	
17-25	2988-2995	reasons	_	
17-26	2995-2996	.	_	

#Text=First, multi-site data provide sufficient statistical power for detecting subtle, but informative patterns of brain structure and function, which may be difficult to unravel with the relative small sample sizes usually acquired in single centers.
18-1	2997-3002	First	_	
18-2	3002-3003	,	_	
18-3	3004-3014	multi-site	_	
18-4	3015-3019	data	_	
18-5	3020-3027	provide	_	
18-6	3028-3038	sufficient	_	
18-7	3039-3050	statistical	_	
18-8	3051-3056	power	_	
18-9	3057-3060	for	_	
18-10	3061-3070	detecting	_	
18-11	3071-3077	subtle	_	
18-12	3077-3078	,	_	
18-13	3079-3082	but	_	
18-14	3083-3094	informative	_	
18-15	3095-3103	patterns	_	
18-16	3104-3106	of	_	
18-17	3107-3112	brain	_	
18-18	3113-3122	structure	_	
18-19	3123-3126	and	_	
18-20	3127-3135	function	_	
18-21	3135-3136	,	_	
18-22	3137-3142	which	_	
18-23	3143-3146	may	_	
18-24	3147-3149	be	_	
18-25	3150-3159	difficult	_	
18-26	3160-3162	to	_	
18-27	3163-3170	unravel	_	
18-28	3171-3175	with	_	
18-29	3176-3179	the	_	
18-30	3180-3188	relative	_	
18-31	3189-3194	small	_	
18-32	3195-3201	sample	_	
18-33	3202-3207	sizes	_	
18-34	3208-3215	usually	_	
18-35	3216-3224	acquired	_	
18-36	3225-3227	in	_	
18-37	3228-3234	single	_	
18-38	3235-3242	centers	_	
18-39	3242-3243	.	_	

#Text=Second, large sample sizes enhance sample generalizability by pooling large patient populations with diverse demographic features and clinical characteristics including disease onset, symptom severity, and types and duration of treatment.
19-1	3244-3250	Second	_	
19-2	3250-3251	,	_	
19-3	3252-3257	large	_	
19-4	3258-3264	sample	_	
19-5	3265-3270	sizes	_	
19-6	3271-3278	enhance	_	
19-7	3279-3285	sample	_	
19-8	3286-3302	generalizability	_	
19-9	3303-3305	by	_	
19-10	3306-3313	pooling	_	
19-11	3314-3319	large	_	
19-12	3320-3327	patient	_	
19-13	3328-3339	populations	_	
19-14	3340-3344	with	_	
19-15	3345-3352	diverse	_	
19-16	3353-3364	demographic	_	
19-17	3365-3373	features	_	
19-18	3374-3377	and	_	
19-19	3378-3386	clinical	_	
19-20	3387-3402	characteristics	_	
19-21	3403-3412	including	_	
19-22	3413-3420	disease	_	
19-23	3421-3426	onset	_	
19-24	3426-3427	,	_	
19-25	3428-3435	symptom	_	
19-26	3436-3444	severity	_	
19-27	3444-3445	,	_	
19-28	3446-3449	and	_	
19-29	3450-3455	types	_	
19-30	3456-3459	and	_	
19-31	3460-3468	duration	_	
19-32	3469-3471	of	_	
19-33	3472-3481	treatment	_	
19-34	3481-3482	.	_	

#Text=Multi-site studies are therefore becoming increasingly the norm in neuroimaging research.
20-1	3483-3493	Multi-site	_	
20-2	3494-3501	studies	_	
20-3	3502-3505	are	_	
20-4	3506-3515	therefore	_	
20-5	3516-3524	becoming	_	
20-6	3525-3537	increasingly	_	
20-7	3538-3541	the	_	
20-8	3542-3546	norm	_	
20-9	3547-3549	in	_	
20-10	3550-3562	neuroimaging	_	
20-11	3563-3571	research	_	
20-12	3571-3572	.	_	

#Text=Multi-site data reflect a more comprehensive abnormal pattern of disease, and therefore may provide a richer understanding of disease signatures than single-site data.
21-1	3573-3583	Multi-site	_	
21-2	3584-3588	data	_	
21-3	3589-3596	reflect	_	
21-4	3597-3598	a	_	
21-5	3599-3603	more	_	
21-6	3604-3617	comprehensive	_	
21-7	3618-3626	abnormal	_	
21-8	3627-3634	pattern	_	
21-9	3635-3637	of	_	
21-10	3638-3645	disease	_	
21-11	3645-3646	,	_	
21-12	3647-3650	and	_	
21-13	3651-3660	therefore	_	
21-14	3661-3664	may	_	
21-15	3665-3672	provide	_	
21-16	3673-3674	a	_	
21-17	3675-3681	richer	_	
21-18	3682-3695	understanding	_	
21-19	3696-3698	of	_	
21-20	3699-3706	disease	_	
21-21	3707-3717	signatures	_	
21-22	3718-3722	than	_	
21-23	3723-3734	single-site	_	
21-24	3735-3739	data	_	
21-25	3739-3740	.	_	

#Text=However, two recent studies found that simple pooling of multi-site data did not outperform single-site disease classification.
22-1	3741-3748	However	_	
22-2	3748-3749	,	_	
22-3	3750-3753	two	_	
22-4	3754-3760	recent	_	
22-5	3761-3768	studies	_	
22-6	3769-3774	found	_	
22-7	3775-3779	that	_	
22-8	3780-3786	simple	_	
22-9	3787-3794	pooling	_	
22-10	3795-3797	of	_	
22-11	3798-3808	multi-site	_	
22-12	3809-3813	data	_	
22-13	3814-3817	did	_	
22-14	3818-3821	not	_	
22-15	3822-3832	outperform	_	
22-16	3833-3844	single-site	_	
22-17	3845-3852	disease	_	
22-18	3853-3867	classification	_	
22-19	3867-3868	.	_	

#Text=Colby and Nielsen pooled multi-site data and trained a common classifier for all data, to identify attention deficit hyperactivity disorder (ADHD) and autism, respectively.
23-1	3869-3874	Colby	_	
23-2	3875-3878	and	_	
23-3	3879-3886	Nielsen	_	
23-4	3887-3893	pooled	_	
23-5	3894-3904	multi-site	_	
23-6	3905-3909	data	_	
23-7	3910-3913	and	_	
23-8	3914-3921	trained	_	
23-9	3922-3923	a	_	
23-10	3924-3930	common	_	
23-11	3931-3941	classifier	_	
23-12	3942-3945	for	_	
23-13	3946-3949	all	_	
23-14	3950-3954	data	_	
23-15	3954-3955	,	_	
23-16	3956-3958	to	_	
23-17	3959-3967	identify	_	
23-18	3968-3977	attention	_	
23-19	3978-3985	deficit	_	
23-20	3986-3999	hyperactivity	_	
23-21	4000-4008	disorder	_	
23-22	4009-4010	(	_	
23-23	4010-4014	ADHD	_	
23-24	4014-4015	)	_	
23-25	4016-4019	and	_	
23-26	4020-4026	autism	_	
23-27	4026-4027	,	_	
23-28	4028-4040	respectively	_	
23-29	4040-4041	.	_	

#Text=Results in these two studies showed that the pooled dataset exhibited lower accuracy than each single-site datasets.
24-1	4042-4049	Results	_	
24-2	4050-4052	in	_	
24-3	4053-4058	these	_	
24-4	4059-4062	two	_	
24-5	4063-4070	studies	_	
24-6	4071-4077	showed	_	
24-7	4078-4082	that	_	
24-8	4083-4086	the	_	
24-9	4087-4093	pooled	_	
24-10	4094-4101	dataset	_	
24-11	4102-4111	exhibited	_	
24-12	4112-4117	lower	_	
24-13	4118-4126	accuracy	_	
24-14	4127-4131	than	_	
24-15	4132-4136	each	_	
24-16	4137-4148	single-site	_	
24-17	4149-4157	datasets	_	
24-18	4157-4158	.	_	

#Text=Here we seek a new approach to synergistically integrating multi-site data, by emphasizing two points.
25-1	4159-4163	Here	_	
25-2	4164-4166	we	_	
25-3	4167-4171	seek	_	
25-4	4172-4173	a	_	
25-5	4174-4177	new	_	
25-6	4178-4186	approach	_	
25-7	4187-4189	to	_	
25-8	4190-4205	synergistically	_	
25-9	4206-4217	integrating	_	
25-10	4218-4228	multi-site	_	
25-11	4229-4233	data	_	
25-12	4233-4234	,	_	
25-13	4235-4237	by	_	
25-14	4238-4249	emphasizing	_	
25-15	4250-4253	two	_	
25-16	4254-4260	points	_	
25-17	4260-4261	.	_	

#Text=First, since datasets collected in multiple imaging centers have a common disorder of interest (e.g. schizophrenia (SCZ), in our experiments herein), the abnormal patterns in each dataset are strongly related and thus, to some extent, may share a common imaging signature.
26-1	4262-4267	First	_	
26-2	4267-4268	,	_	
26-3	4269-4274	since	_	
26-4	4275-4283	datasets	_	
26-5	4284-4293	collected	_	
26-6	4294-4296	in	_	
26-7	4297-4305	multiple	_	
26-8	4306-4313	imaging	_	
26-9	4314-4321	centers	_	
26-10	4322-4326	have	_	
26-11	4327-4328	a	_	
26-12	4329-4335	common	_	
26-13	4336-4344	disorder	_	
26-14	4345-4347	of	_	
26-15	4348-4356	interest	_	
26-16	4357-4358	(	_	
26-17	4358-4361	e.g	_	
26-18	4361-4362	.	_	
26-19	4363-4376	schizophrenia	_	
26-20	4377-4378	(	_	
26-21	4378-4381	SCZ	_	
26-22	4381-4382	)	_	
26-23	4382-4383	,	_	
26-24	4384-4386	in	_	
26-25	4387-4390	our	_	
26-26	4391-4402	experiments	_	
26-27	4403-4409	herein	_	
26-28	4409-4410	)	_	
26-29	4410-4411	,	_	
26-30	4412-4415	the	_	
26-31	4416-4424	abnormal	_	
26-32	4425-4433	patterns	_	
26-33	4434-4436	in	_	
26-34	4437-4441	each	_	
26-35	4442-4449	dataset	_	
26-36	4450-4453	are	_	
26-37	4454-4462	strongly	_	
26-38	4463-4470	related	_	
26-39	4471-4474	and	_	
26-40	4475-4479	thus	_	
26-41	4479-4480	,	_	
26-42	4481-4483	to	_	
26-43	4484-4488	some	_	
26-44	4489-4495	extent	_	
26-45	4495-4496	,	_	
26-46	4497-4500	may	_	
26-47	4501-4506	share	_	
26-48	4507-4508	a	_	
26-49	4509-4515	common	_	
26-50	4516-4523	imaging	_	
26-51	4524-4533	signature	_	
26-52	4533-4534	.	_	

#Text=The pattern reproducibility among multi-site data has been repeatedly demonstrated in several multi-site studies on functional MRI (fMRI), morphometric MRI, and diffusion-tensor imaging (DTI).
27-1	4535-4538	The	_	
27-2	4539-4546	pattern	_	
27-3	4547-4562	reproducibility	_	
27-4	4563-4568	among	_	
27-5	4569-4579	multi-site	_	
27-6	4580-4584	data	_	
27-7	4585-4588	has	_	
27-8	4589-4593	been	_	
27-9	4594-4604	repeatedly	_	
27-10	4605-4617	demonstrated	_	
27-11	4618-4620	in	_	
27-12	4621-4628	several	_	
27-13	4629-4639	multi-site	_	
27-14	4640-4647	studies	_	
27-15	4648-4650	on	_	
27-16	4651-4661	functional	_	
27-17	4662-4665	MRI	_	
27-18	4666-4667	(	_	
27-19	4667-4671	fMRI	_	
27-20	4671-4672	)	_	
27-21	4672-4673	,	_	
27-22	4674-4686	morphometric	_	
27-23	4687-4690	MRI	_	
27-24	4690-4691	,	_	
27-25	4692-4695	and	_	
27-26	4696-4712	diffusion-tensor	_	
27-27	4713-4720	imaging	_	
27-28	4721-4722	(	_	
27-29	4722-4725	DTI	_	
27-30	4725-4726	)	_	
27-31	4726-4727	.	_	

#Text=Most of these studies arrived at similar conclusions, namely that with appropriate multi-site data collection, different data sites shared highly consistent feature patterns.
28-1	4728-4732	Most	_	
28-2	4733-4735	of	_	
28-3	4736-4741	these	_	
28-4	4742-4749	studies	_	
28-5	4750-4757	arrived	_	
28-6	4758-4760	at	_	
28-7	4761-4768	similar	_	
28-8	4769-4780	conclusions	_	
28-9	4780-4781	,	_	
28-10	4782-4788	namely	_	
28-11	4789-4793	that	_	
28-12	4794-4798	with	_	
28-13	4799-4810	appropriate	_	
28-14	4811-4821	multi-site	_	
28-15	4822-4826	data	_	
28-16	4827-4837	collection	_	
28-17	4837-4838	,	_	
28-18	4839-4848	different	_	
28-19	4849-4853	data	_	
28-20	4854-4859	sites	_	
28-21	4860-4866	shared	_	
28-22	4867-4873	highly	_	
28-23	4874-4884	consistent	_	
28-24	4885-4892	feature	_	
28-25	4893-4901	patterns	_	
28-26	4901-4902	.	_	

#Text=With this, the site-shared features reveal consistent brain abnormalities in multi-site data, which can lead to a more accurate neurobiological understanding of the psychiatric disorder under investigation.
29-1	4903-4907	With	_	
29-2	4908-4912	this	_	
29-3	4912-4913	,	_	
29-4	4914-4917	the	_	
29-5	4918-4929	site-shared	_	
29-6	4930-4938	features	_	
29-7	4939-4945	reveal	_	
29-8	4946-4956	consistent	_	
29-9	4957-4962	brain	_	
29-10	4963-4976	abnormalities	_	
29-11	4977-4979	in	_	
29-12	4980-4990	multi-site	_	
29-13	4991-4995	data	_	
29-14	4995-4996	,	_	
29-15	4997-5002	which	_	
29-16	5003-5006	can	_	
29-17	5007-5011	lead	_	
29-18	5012-5014	to	_	
29-19	5015-5016	a	_	
29-20	5017-5021	more	_	
29-21	5022-5030	accurate	_	
29-22	5031-5046	neurobiological	_	
29-23	5047-5060	understanding	_	
29-24	5061-5063	of	_	
29-25	5064-5067	the	_	
29-26	5068-5079	psychiatric	_	
29-27	5080-5088	disorder	_	
29-28	5089-5094	under	_	
29-29	5095-5108	investigation	_	
29-30	5108-5109	.	_	

#Text=On the other hand, though the integration of multiple single-site data is advantageous, the unavoidable presence of site-specific features might decrease the accuracy of a classifier that merely pools data together across studies.
30-1	5110-5112	On	_	
30-2	5113-5116	the	_	
30-3	5117-5122	other	_	
30-4	5123-5127	hand	_	
30-5	5127-5128	,	_	
30-6	5129-5135	though	_	
30-7	5136-5139	the	_	
30-8	5140-5151	integration	_	
30-9	5152-5154	of	_	
30-10	5155-5163	multiple	_	
30-11	5164-5175	single-site	_	
30-12	5176-5180	data	_	
30-13	5181-5183	is	_	
30-14	5184-5196	advantageous	_	
30-15	5196-5197	,	_	
30-16	5198-5201	the	_	
30-17	5202-5213	unavoidable	_	
30-18	5214-5222	presence	_	
30-19	5223-5225	of	_	
30-20	5226-5239	site-specific	_	
30-21	5240-5248	features	_	
30-22	5249-5254	might	_	
30-23	5255-5263	decrease	_	
30-24	5264-5267	the	_	
30-25	5268-5276	accuracy	_	
30-26	5277-5279	of	_	
30-27	5280-5281	a	_	
30-28	5282-5292	classifier	_	
30-29	5293-5297	that	_	
30-30	5298-5304	merely	_	
30-31	5305-5310	pools	_	
30-32	5311-5315	data	_	
30-33	5316-5324	together	_	
30-34	5325-5331	across	_	
30-35	5332-5339	studies	_	
30-36	5339-5340	.	_	

#Text=Heterogeneity can emanate from multiple sources including scanner differences, differences in image acquisition protocols, or ethnic and treatment differences among participating patient populations.
31-1	5341-5354	Heterogeneity	_	
31-2	5355-5358	can	_	
31-3	5359-5366	emanate	_	
31-4	5367-5371	from	_	
31-5	5372-5380	multiple	_	
31-6	5381-5388	sources	_	
31-7	5389-5398	including	_	
31-8	5399-5406	scanner	_	
31-9	5407-5418	differences	_	
31-10	5418-5419	,	_	
31-11	5420-5431	differences	_	
31-12	5432-5434	in	_	
31-13	5435-5440	image	_	
31-14	5441-5452	acquisition	_	
31-15	5453-5462	protocols	_	
31-16	5462-5463	,	_	
31-17	5464-5466	or	_	
31-18	5467-5473	ethnic	_	
31-19	5474-5477	and	_	
31-20	5478-5487	treatment	_	
31-21	5488-5499	differences	_	
31-22	5500-5505	among	_	
31-23	5506-5519	participating	_	
31-24	5520-5527	patient	_	
31-25	5528-5539	populations	_	
31-26	5539-5540	.	_	

#Text=Given such site-related heterogeneity, multi-site datasets should not simply be merged into larger cohorts for further machine learning investigation.
32-1	5541-5546	Given	_	
32-2	5547-5551	such	_	
32-3	5552-5564	site-related	_	
32-4	5565-5578	heterogeneity	_	
32-5	5578-5579	,	_	
32-6	5580-5590	multi-site	_	
32-7	5591-5599	datasets	_	
32-8	5600-5606	should	_	
32-9	5607-5610	not	_	
32-10	5611-5617	simply	_	
32-11	5618-5620	be	_	
32-12	5621-5627	merged	_	
32-13	5628-5632	into	_	
32-14	5633-5639	larger	_	
32-15	5640-5647	cohorts	_	
32-16	5648-5651	for	_	
32-17	5652-5659	further	_	
32-18	5660-5667	machine	_	
32-19	5668-5676	learning	_	
32-20	5677-5690	investigation	_	
32-21	5690-5691	.	_	

#Text=In an attempt to eliminate or reduce the site-specific variability, studies have suggested same scanning protocols, consistent scanner parameters and etc. in data collection, as well as the utilization of smoothness equalization and independent component analysis in data preprocessing.
33-1	5692-5694	In	_	
33-2	5695-5697	an	_	
33-3	5698-5705	attempt	_	
33-4	5706-5708	to	_	
33-5	5709-5718	eliminate	_	
33-6	5719-5721	or	_	
33-7	5722-5728	reduce	_	
33-8	5729-5732	the	_	
33-9	5733-5746	site-specific	_	
33-10	5747-5758	variability	_	
33-11	5758-5759	,	_	
33-12	5760-5767	studies	_	
33-13	5768-5772	have	_	
33-14	5773-5782	suggested	_	
33-15	5783-5787	same	_	
33-16	5788-5796	scanning	_	
33-17	5797-5806	protocols	_	
33-18	5806-5807	,	_	
33-19	5808-5818	consistent	_	
33-20	5819-5826	scanner	_	
33-21	5827-5837	parameters	_	
33-22	5838-5841	and	_	
33-23	5842-5845	etc	_	
33-24	5845-5846	.	_	
33-25	5847-5849	in	_	
33-26	5850-5854	data	_	
33-27	5855-5865	collection	_	
33-28	5865-5866	,	_	
33-29	5867-5869	as	_	
33-30	5870-5874	well	_	
33-31	5875-5877	as	_	
33-32	5878-5881	the	_	
33-33	5882-5893	utilization	_	
33-34	5894-5896	of	_	
33-35	5897-5907	smoothness	_	
33-36	5908-5920	equalization	_	
33-37	5921-5924	and	_	
33-38	5925-5936	independent	_	
33-39	5937-5946	component	_	
33-40	5947-5955	analysis	_	
33-41	5956-5958	in	_	
33-42	5959-5963	data	_	
33-43	5964-5977	preprocessing	_	
33-44	5977-5978	.	_	

#Text=Despite these efforts, site-specific heterogeneities still exist due to their complex causes.
34-1	5979-5986	Despite	_	
34-2	5987-5992	these	_	
34-3	5993-6000	efforts	_	
34-4	6000-6001	,	_	
34-5	6002-6015	site-specific	_	
34-6	6016-6031	heterogeneities	_	
34-7	6032-6037	still	_	
34-8	6038-6043	exist	_	
34-9	6044-6047	due	_	
34-10	6048-6050	to	_	
34-11	6051-6056	their	_	
34-12	6057-6064	complex	_	
34-13	6065-6071	causes	_	
34-14	6071-6072	.	_	

#Text=The above considerations highlight the need for a feature-learning framework in multi-site disease classification that can extract the site-shared features, while also accounting for the site-specific features; this approach generally seeks an overarching signature of disease, whereas it accommodates potential sub-cohort and other differences to be taken into consideration.
35-1	6073-6076	The	_	
35-2	6077-6082	above	_	
35-3	6083-6097	considerations	_	
35-4	6098-6107	highlight	_	
35-5	6108-6111	the	_	
35-6	6112-6116	need	_	
35-7	6117-6120	for	_	
35-8	6121-6122	a	_	
35-9	6123-6139	feature-learning	_	
35-10	6140-6149	framework	_	
35-11	6150-6152	in	_	
35-12	6153-6163	multi-site	_	
35-13	6164-6171	disease	_	
35-14	6172-6186	classification	_	
35-15	6187-6191	that	_	
35-16	6192-6195	can	_	
35-17	6196-6203	extract	_	
35-18	6204-6207	the	_	
35-19	6208-6219	site-shared	_	
35-20	6220-6228	features	_	
35-21	6228-6229	,	_	
35-22	6230-6235	while	_	
35-23	6236-6240	also	_	
35-24	6241-6251	accounting	_	
35-25	6252-6255	for	_	
35-26	6256-6259	the	_	
35-27	6260-6273	site-specific	_	
35-28	6274-6282	features	_	
35-29	6282-6283	;	_	
35-30	6284-6288	this	_	
35-31	6289-6297	approach	_	
35-32	6298-6307	generally	_	
35-33	6308-6313	seeks	_	
35-34	6314-6316	an	_	
35-35	6317-6328	overarching	_	
35-36	6329-6338	signature	_	
35-37	6339-6341	of	_	
35-38	6342-6349	disease	_	
35-39	6349-6350	,	_	
35-40	6351-6358	whereas	_	
35-41	6359-6361	it	_	
35-42	6362-6374	accommodates	_	
35-43	6375-6384	potential	_	
35-44	6385-6395	sub-cohort	_	
35-45	6396-6399	and	_	
35-46	6400-6405	other	_	
35-47	6406-6417	differences	_	
35-48	6418-6420	to	_	
35-49	6421-6423	be	_	
35-50	6424-6429	taken	_	
35-51	6430-6434	into	_	
35-52	6435-6448	consideration	_	
35-53	6448-6449	.	_	

#Text=In recent years, multi-task learning has been successful in learning task-shared and task-specific features simultaneously, which effectively improves generalization compared with traditional machine learning methods.
36-1	6450-6452	In	_	
36-2	6453-6459	recent	_	
36-3	6460-6465	years	_	
36-4	6465-6466	,	_	
36-5	6467-6477	multi-task	_	
36-6	6478-6486	learning	_	
36-7	6487-6490	has	_	
36-8	6491-6495	been	_	
36-9	6496-6506	successful	_	
36-10	6507-6509	in	_	
36-11	6510-6518	learning	_	
36-12	6519-6530	task-shared	_	
36-13	6531-6534	and	_	
36-14	6535-6548	task-specific	_	
36-15	6549-6557	features	_	
36-16	6558-6572	simultaneously	_	
36-17	6572-6573	,	_	
36-18	6574-6579	which	_	
36-19	6580-6591	effectively	_	
36-20	6592-6600	improves	_	
36-21	6601-6615	generalization	_	
36-22	6616-6624	compared	_	
36-23	6625-6629	with	_	
36-24	6630-6641	traditional	_	
36-25	6642-6649	machine	_	
36-26	6650-6658	learning	_	
36-27	6659-6666	methods	_	
36-28	6666-6667	.	_	

#Text=For example, support vector machine (SVM) with single-task learning learns a distinct feature pattern and finds a maximum margin hyperplane to classify two groups, which extracts information within a single learning task.
37-1	6668-6671	For	_	
37-2	6672-6679	example	_	
37-3	6679-6680	,	_	
37-4	6681-6688	support	_	
37-5	6689-6695	vector	_	
37-6	6696-6703	machine	_	
37-7	6704-6705	(	_	
37-8	6705-6708	SVM	_	
37-9	6708-6709	)	_	
37-10	6710-6714	with	_	
37-11	6715-6726	single-task	_	
37-12	6727-6735	learning	_	
37-13	6736-6742	learns	_	
37-14	6743-6744	a	_	
37-15	6745-6753	distinct	_	
37-16	6754-6761	feature	_	
37-17	6762-6769	pattern	_	
37-18	6770-6773	and	_	
37-19	6774-6779	finds	_	
37-20	6780-6781	a	_	
37-21	6782-6789	maximum	_	
37-22	6790-6796	margin	_	
37-23	6797-6807	hyperplane	_	
37-24	6808-6810	to	_	
37-25	6811-6819	classify	_	
37-26	6820-6823	two	_	
37-27	6824-6830	groups	_	
37-28	6830-6831	,	_	
37-29	6832-6837	which	_	
37-30	6838-6846	extracts	_	
37-31	6847-6858	information	_	
37-32	6859-6865	within	_	
37-33	6866-6867	a	_	
37-34	6868-6874	single	_	
37-35	6875-6883	learning	_	
37-36	6884-6888	task	_	
37-37	6888-6889	.	_	

#Text=In contrast, multi-task learning extracts a subset of task-shared features to generate more accurate models on multiple tasks, with the task-specific features learned simultaneously.
38-1	6890-6892	In	_	
38-2	6893-6901	contrast	_	
38-3	6901-6902	,	_	
38-4	6903-6913	multi-task	_	
38-5	6914-6922	learning	_	
38-6	6923-6931	extracts	_	
38-7	6932-6933	a	_	
38-8	6934-6940	subset	_	
38-9	6941-6943	of	_	
38-10	6944-6955	task-shared	_	
38-11	6956-6964	features	_	
38-12	6965-6967	to	_	
38-13	6968-6976	generate	_	
38-14	6977-6981	more	_	
38-15	6982-6990	accurate	_	
38-16	6991-6997	models	_	
38-17	6998-7000	on	_	
38-18	7001-7009	multiple	_	
38-19	7010-7015	tasks	_	
38-20	7015-7016	,	_	
38-21	7017-7021	with	_	
38-22	7022-7025	the	_	
38-23	7026-7039	task-specific	_	
38-24	7040-7048	features	_	
38-25	7049-7056	learned	_	
38-26	7057-7071	simultaneously	_	
38-27	7071-7072	.	_	

#Text=The basic assumption of multi-task learning is that the feature weights of different tasks share similar sparse patterns, which can be learned by imposing sparsity regularization penalties on the task weight matrix. l1-norm and l2,1-norm are two commonly used sparsity regulating terms in multi-task learning, which enforces the weight matrix of different tasks to be sparse across all tasks.
39-1	7073-7076	The	_	
39-2	7077-7082	basic	_	
39-3	7083-7093	assumption	_	
39-4	7094-7096	of	_	
39-5	7097-7107	multi-task	_	
39-6	7108-7116	learning	_	
39-7	7117-7119	is	_	
39-8	7120-7124	that	_	
39-9	7125-7128	the	_	
39-10	7129-7136	feature	_	
39-11	7137-7144	weights	_	
39-12	7145-7147	of	_	
39-13	7148-7157	different	_	
39-14	7158-7163	tasks	_	
39-15	7164-7169	share	_	
39-16	7170-7177	similar	_	
39-17	7178-7184	sparse	_	
39-18	7185-7193	patterns	_	
39-19	7193-7194	,	_	
39-20	7195-7200	which	_	
39-21	7201-7204	can	_	
39-22	7205-7207	be	_	
39-23	7208-7215	learned	_	
39-24	7216-7218	by	_	
39-25	7219-7227	imposing	_	
39-26	7228-7236	sparsity	_	
39-27	7237-7251	regularization	_	
39-28	7252-7261	penalties	_	
39-29	7262-7264	on	_	
39-30	7265-7268	the	_	
39-31	7269-7273	task	_	
39-32	7274-7280	weight	_	
39-33	7281-7287	matrix	_	
39-34	7287-7288	.	_	
39-35	7289-7291	l1	_	
39-36	7291-7292	-	_	
39-37	7292-7296	norm	_	
39-38	7297-7300	and	_	
39-39	7301-7305	l2,1	_	
39-40	7305-7306	-	_	
39-41	7306-7310	norm	_	
39-42	7311-7314	are	_	
39-43	7315-7318	two	_	
39-44	7319-7327	commonly	_	
39-45	7328-7332	used	_	
39-46	7333-7341	sparsity	_	
39-47	7342-7352	regulating	_	
39-48	7353-7358	terms	_	
39-49	7359-7361	in	_	
39-50	7362-7372	multi-task	_	
39-51	7373-7381	learning	_	
39-52	7381-7382	,	_	
39-53	7383-7388	which	_	
39-54	7389-7397	enforces	_	
39-55	7398-7401	the	_	
39-56	7402-7408	weight	_	
39-57	7409-7415	matrix	_	
39-58	7416-7418	of	_	
39-59	7419-7428	different	_	
39-60	7429-7434	tasks	_	
39-61	7435-7437	to	_	
39-62	7438-7440	be	_	
39-63	7441-7447	sparse	_	
39-64	7448-7454	across	_	
39-65	7455-7458	all	_	
39-66	7459-7464	tasks	_	
39-67	7464-7465	.	_	

#Text=Particularly, an l1-norm term highlights task-specific features by encouraging the weights of irrelevant features to be very small, while l2,1-norm introduces group sparsity and enforces task-shared features to have larger weights.
40-1	7466-7478	Particularly	_	
40-2	7478-7479	,	_	
40-3	7480-7482	an	_	
40-4	7483-7485	l1	_	
40-5	7485-7486	-	_	
40-6	7486-7490	norm	_	
40-7	7491-7495	term	_	
40-8	7496-7506	highlights	_	
40-9	7507-7520	task-specific	_	
40-10	7521-7529	features	_	
40-11	7530-7532	by	_	
40-12	7533-7544	encouraging	_	
40-13	7545-7548	the	_	
40-14	7549-7556	weights	_	
40-15	7557-7559	of	_	
40-16	7560-7570	irrelevant	_	
40-17	7571-7579	features	_	
40-18	7580-7582	to	_	
40-19	7583-7585	be	_	
40-20	7586-7590	very	_	
40-21	7591-7596	small	_	
40-22	7596-7597	,	_	
40-23	7598-7603	while	_	
40-24	7604-7608	l2,1	_	
40-25	7608-7609	-	_	
40-26	7609-7613	norm	_	
40-27	7614-7624	introduces	_	
40-28	7625-7630	group	_	
40-29	7631-7639	sparsity	_	
40-30	7640-7643	and	_	
40-31	7644-7652	enforces	_	
40-32	7653-7664	task-shared	_	
40-33	7665-7673	features	_	
40-34	7674-7676	to	_	
40-35	7677-7681	have	_	
40-36	7682-7688	larger	_	
40-37	7689-7696	weights	_	
40-38	7696-7697	.	_	

#Text=The advantage of multi-task learning makes it suitable for multi-site data learning, considering the site as task, and the site-shared and site-specific features as task-shared and task-specific features.
41-1	7698-7701	The	_	
41-2	7702-7711	advantage	_	
41-3	7712-7714	of	_	
41-4	7715-7725	multi-task	_	
41-5	7726-7734	learning	_	
41-6	7735-7740	makes	_	
41-7	7741-7743	it	_	
41-8	7744-7752	suitable	_	
41-9	7753-7756	for	_	
41-10	7757-7767	multi-site	_	
41-11	7768-7772	data	_	
41-12	7773-7781	learning	_	
41-13	7781-7782	,	_	
41-14	7783-7794	considering	_	
41-15	7795-7798	the	_	
41-16	7799-7803	site	_	
41-17	7804-7806	as	_	
41-18	7807-7811	task	_	
41-19	7811-7812	,	_	
41-20	7813-7816	and	_	
41-21	7817-7820	the	_	
41-22	7821-7832	site-shared	_	
41-23	7833-7836	and	_	
41-24	7837-7850	site-specific	_	
41-25	7851-7859	features	_	
41-26	7860-7862	as	_	
41-27	7863-7874	task-shared	_	
41-28	7875-7878	and	_	
41-29	7879-7892	task-specific	_	
41-30	7893-7901	features	_	
41-31	7901-7902	.	_	

#Text=Neuroimaging studies have shown the effectiveness of performing multi-task learning in the brain decoding and disease classification.
42-1	7903-7915	Neuroimaging	_	
42-2	7916-7923	studies	_	
42-3	7924-7928	have	_	
42-4	7929-7934	shown	_	
42-5	7935-7938	the	_	
42-6	7939-7952	effectiveness	_	
42-7	7953-7955	of	_	
42-8	7956-7966	performing	_	
42-9	7967-7977	multi-task	_	
42-10	7978-7986	learning	_	
42-11	7987-7989	in	_	
42-12	7990-7993	the	_	
42-13	7994-7999	brain	_	
42-14	8000-8008	decoding	_	
42-15	8009-8012	and	_	
42-16	8013-8020	disease	_	
42-17	8021-8035	classification	_	
42-18	8035-8036	.	_	

#Text=Specifically, multi-site fMRI data of ADHD was demonstrated better than single-site classification by learning site-shared and site-specific features using multi-task scheme.
43-1	8037-8049	Specifically	_	
43-2	8049-8050	,	_	
43-3	8051-8061	multi-site	_	
43-4	8062-8066	fMRI	_	
43-5	8067-8071	data	_	
43-6	8072-8074	of	_	
43-7	8075-8079	ADHD	_	
43-8	8080-8083	was	_	
43-9	8084-8096	demonstrated	_	
43-10	8097-8103	better	_	
43-11	8104-8108	than	_	
43-12	8109-8120	single-site	_	
43-13	8121-8135	classification	_	
43-14	8136-8138	by	_	
43-15	8139-8147	learning	_	
43-16	8148-8159	site-shared	_	
43-17	8160-8163	and	_	
43-18	8164-8177	site-specific	_	
43-19	8178-8186	features	_	
43-20	8187-8192	using	_	
43-21	8193-8203	multi-task	_	
43-22	8204-8210	scheme	_	
43-23	8210-8211	.	_	

#Text=In this work, though the multi-task learning scheme successfully extracted site-shared and site-specific features in multi-site data, the form of the objective function was rather complex and specific as it included an l2,1-norm group sparsity regularization term and a 6-D spatial structure penalty (generated by the GraphNet, fused Lasso, or the isotropic total variation).
44-1	8212-8214	In	_	
44-2	8215-8219	this	_	
44-3	8220-8224	work	_	
44-4	8224-8225	,	_	
44-5	8226-8232	though	_	
44-6	8233-8236	the	_	
44-7	8237-8247	multi-task	_	
44-8	8248-8256	learning	_	
44-9	8257-8263	scheme	_	
44-10	8264-8276	successfully	_	
44-11	8277-8286	extracted	_	
44-12	8287-8298	site-shared	_	
44-13	8299-8302	and	_	
44-14	8303-8316	site-specific	_	
44-15	8317-8325	features	_	
44-16	8326-8328	in	_	
44-17	8329-8339	multi-site	_	
44-18	8340-8344	data	_	
44-19	8344-8345	,	_	
44-20	8346-8349	the	_	
44-21	8350-8354	form	_	
44-22	8355-8357	of	_	
44-23	8358-8361	the	_	
44-24	8362-8371	objective	_	
44-25	8372-8380	function	_	
44-26	8381-8384	was	_	
44-27	8385-8391	rather	_	
44-28	8392-8399	complex	_	
44-29	8400-8403	and	_	
44-30	8404-8412	specific	_	
44-31	8413-8415	as	_	
44-32	8416-8418	it	_	
44-33	8419-8427	included	_	
44-34	8428-8430	an	_	
44-35	8431-8435	l2,1	_	
44-36	8435-8436	-	_	
44-37	8436-8440	norm	_	
44-38	8441-8446	group	_	
44-39	8447-8455	sparsity	_	
44-40	8456-8470	regularization	_	
44-41	8471-8475	term	_	
44-42	8476-8479	and	_	
44-43	8480-8481	a	_	
44-44	8482-8483	6	_	
44-45	8483-8484	-	_	
44-46	8484-8485	D	_	
44-47	8486-8493	spatial	_	
44-48	8494-8503	structure	_	
44-49	8504-8511	penalty	_	
44-50	8512-8513	(	_	
44-51	8513-8522	generated	_	
44-52	8523-8525	by	_	
44-53	8526-8529	the	_	
44-54	8530-8538	GraphNet	_	
44-55	8538-8539	,	_	
44-56	8540-8545	fused	_	
44-57	8546-8551	Lasso	_	
44-58	8551-8552	,	_	
44-59	8553-8555	or	_	
44-60	8556-8559	the	_	
44-61	8560-8569	isotropic	_	
44-62	8570-8575	total	_	
44-63	8576-8585	variation	_	
44-64	8585-8586	)	_	
44-65	8586-8587	.	_	

#Text=In order to make the multi-task learning scheme more simple and applicable, an objective function including l1-norm and l2,1-norm penalty terms was used in the current study.
45-1	8588-8590	In	_	
45-2	8591-8596	order	_	
45-3	8597-8599	to	_	
45-4	8600-8604	make	_	
45-5	8605-8608	the	_	
45-6	8609-8619	multi-task	_	
45-7	8620-8628	learning	_	
45-8	8629-8635	scheme	_	
45-9	8636-8640	more	_	
45-10	8641-8647	simple	_	
45-11	8648-8651	and	_	
45-12	8652-8662	applicable	_	
45-13	8662-8663	,	_	
45-14	8664-8666	an	_	
45-15	8667-8676	objective	_	
45-16	8677-8685	function	_	
45-17	8686-8695	including	_	
45-18	8696-8698	l1	_	
45-19	8698-8699	-	_	
45-20	8699-8703	norm	_	
45-21	8704-8707	and	_	
45-22	8708-8712	l2,1	_	
45-23	8712-8713	-	_	
45-24	8713-8717	norm	_	
45-25	8718-8725	penalty	_	
45-26	8726-8731	terms	_	
45-27	8732-8735	was	_	
45-28	8736-8740	used	_	
45-29	8741-8743	in	_	
45-30	8744-8747	the	_	
45-31	8748-8755	current	_	
45-32	8756-8761	study	_	
45-33	8761-8762	.	_	

#Text=Building upon this emerging literature, we aim to distinguish SCZ patients from healthy controls across multiple-site MRI data using multi-task learning.
46-1	8763-8771	Building	_	
46-2	8772-8776	upon	_	
46-3	8777-8781	this	_	
46-4	8782-8790	emerging	_	
46-5	8791-8801	literature	_	
46-6	8801-8802	,	_	
46-7	8803-8805	we	_	
46-8	8806-8809	aim	_	
46-9	8810-8812	to	_	
46-10	8813-8824	distinguish	_	
46-11	8825-8828	SCZ	_	
46-12	8829-8837	patients	_	
46-13	8838-8842	from	_	
46-14	8843-8850	healthy	_	
46-15	8851-8859	controls	_	
46-16	8860-8866	across	_	
46-17	8867-8880	multiple-site	_	
46-18	8881-8884	MRI	_	
46-19	8885-8889	data	_	
46-20	8890-8895	using	_	
46-21	8896-8906	multi-task	_	
46-22	8907-8915	learning	_	
46-23	8915-8916	.	_	

#Text=We hypothesized that using multi-task learning framework on multi-site classification would not only have better performance than single-site data classification, but would also identify the abnormalities shared by all sites, and also specific to each site.
47-1	8917-8919	We	_	
47-2	8920-8932	hypothesized	_	
47-3	8933-8937	that	_	
47-4	8938-8943	using	_	
47-5	8944-8954	multi-task	_	
47-6	8955-8963	learning	_	
47-7	8964-8973	framework	_	
47-8	8974-8976	on	_	
47-9	8977-8987	multi-site	_	
47-10	8988-9002	classification	_	
47-11	9003-9008	would	_	
47-12	9009-9012	not	_	
47-13	9013-9017	only	_	
47-14	9018-9022	have	_	
47-15	9023-9029	better	_	
47-16	9030-9041	performance	_	
47-17	9042-9046	than	_	
47-18	9047-9058	single-site	_	
47-19	9059-9063	data	_	
47-20	9064-9078	classification	_	
47-21	9078-9079	,	_	
47-22	9080-9083	but	_	
47-23	9084-9089	would	_	
47-24	9090-9094	also	_	
47-25	9095-9103	identify	_	
47-26	9104-9107	the	_	
47-27	9108-9121	abnormalities	_	
47-28	9122-9128	shared	_	
47-29	9129-9131	by	_	
47-30	9132-9135	all	_	
47-31	9136-9141	sites	_	
47-32	9141-9142	,	_	
47-33	9143-9146	and	_	
47-34	9147-9151	also	_	
47-35	9152-9160	specific	_	
47-36	9161-9163	to	_	
47-37	9164-9168	each	_	
47-38	9169-9173	site	_	
47-39	9173-9174	.	_	

#Text=These site-shared brain structural alterations should be consistent with the previously reported altered regions in SCZ, such as the brain regions involving prefrontal, superior temporal, insular, temporo-limbic regions, among others.
48-1	9175-9180	These	_	
48-2	9181-9192	site-shared	_	
48-3	9193-9198	brain	_	
48-4	9199-9209	structural	_	
48-5	9210-9221	alterations	_	
48-6	9222-9228	should	_	
48-7	9229-9231	be	_	
48-8	9232-9242	consistent	_	
48-9	9243-9247	with	_	
48-10	9248-9251	the	_	
48-11	9252-9262	previously	_	
48-12	9263-9271	reported	_	
48-13	9272-9279	altered	_	
48-14	9280-9287	regions	_	
48-15	9288-9290	in	_	
48-16	9291-9294	SCZ	_	
48-17	9294-9295	,	_	
48-18	9296-9300	such	_	
48-19	9301-9303	as	_	
48-20	9304-9307	the	_	
48-21	9308-9313	brain	_	
48-22	9314-9321	regions	_	
48-23	9322-9331	involving	_	
48-24	9332-9342	prefrontal	_	
48-25	9342-9343	,	_	
48-26	9344-9352	superior	_	
48-27	9353-9361	temporal	_	
48-28	9361-9362	,	_	
48-29	9363-9370	insular	_	
48-30	9370-9371	,	_	
48-31	9372-9386	temporo-limbic	_	
48-32	9387-9394	regions	_	
48-33	9394-9395	,	_	
48-34	9396-9401	among	_	
48-35	9402-9408	others	_	
48-36	9408-9409	.	_	

#Text=Materials and methods
#Text=Participants and MRI acquisitions
#Text=Characteristics of the participants in this study.
49-1	9410-9419	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
49-2	9420-9423	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
49-3	9424-9431	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
49-4	9432-9444	Participants	_	
49-5	9445-9448	and	_	
49-6	9449-9452	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
49-7	9453-9465	acquisitions	_	
49-8	9466-9481	Characteristics	_	
49-9	9482-9484	of	_	
49-10	9485-9488	the	_	
49-11	9489-9501	participants	_	
49-12	9502-9504	in	_	
49-13	9505-9509	this	_	
49-14	9510-9515	study	_	
49-15	9515-9516	.	_	

#Text=Table 1\t \t
#Text=Variable\tSample size\tGender (male/female)\tAge (years) Mean ± SD (range)\t \tSite A\tSCZ\t50\t28/22\t35.38 ± 11.78(19–60)\t \tNC\t50\t25/25\t32.50 ± 12.96(15–65)\t \tp value\t\t0.69a\t0.25b\t \tSite B\tSCZ\t50\t34/16\t27.48 ± 7.89(18–50)\t \tNC\t50\t29/21\t30.60 ± 8.17(18–50)\t \tp value\t\t0.30a\t0.055b\t \tSite C\tSCZ\t50\t25/25\t34.10 ± 8.44(16–56)\t \tNC\t50\t22/28\t32.24 ± 11.42(21–57)\t \tp value\t\t0.55a\t0.36b\t \tSite A + B + C\tSCZ\t150\t87/63\t32.32 ± 10.08(16–60)\t \tNC\t150\t76/74\t31.78 ± 10.99(15–65)\t \tp value\t\t0.20a\t0.66b\t \t
#Text=Note: SCZ: schizophrenia; NC: normal controls.
50-1	9517-9522	Table	_	
50-2	9523-9524	1	_	
50-3	9528-9536	Variable	_	
50-4	9537-9543	Sample	_	
50-5	9544-9548	size	_	
50-6	9549-9555	Gender	_	
50-7	9556-9557	(	_	
50-8	9557-9561	male	_	
50-9	9561-9562	/	_	
50-10	9562-9568	female	_	
50-11	9568-9569	)	_	
50-12	9570-9573	Age	_	
50-13	9574-9575	(	_	
50-14	9575-9580	years	_	
50-15	9580-9581	)	_	
50-16	9582-9586	Mean	_	
50-17	9586-9587	 	_	
50-18	9587-9588	±	_	
50-19	9588-9589	 	_	
50-20	9589-9591	SD	_	
50-21	9592-9593	(	_	
50-22	9593-9598	range	_	
50-23	9598-9599	)	_	
50-24	9602-9606	Site	_	
50-25	9607-9608	A	_	
50-26	9609-9612	SCZ	_	
50-27	9613-9615	50	_	
50-28	9616-9618	28	_	
50-29	9618-9619	/	_	
50-30	9619-9621	22	_	
50-31	9622-9627	35.38	_	
50-32	9627-9628	 	_	
50-33	9628-9629	±	_	
50-34	9629-9630	 	_	
50-35	9630-9635	11.78	_	
50-36	9635-9636	(	_	
50-37	9636-9638	19	_	
50-38	9638-9639	–	_	
50-39	9639-9641	60	_	
50-40	9641-9642	)	_	
50-41	9645-9647	NC	_	
50-42	9648-9650	50	_	
50-43	9651-9653	25	_	
50-44	9653-9654	/	_	
50-45	9654-9656	25	_	
50-46	9657-9662	32.50	_	
50-47	9662-9663	 	_	
50-48	9663-9664	±	_	
50-49	9664-9665	 	_	
50-50	9665-9670	12.96	_	
50-51	9670-9671	(	_	
50-52	9671-9673	15	_	
50-53	9673-9674	–	_	
50-54	9674-9676	65	_	
50-55	9676-9677	)	_	
50-56	9680-9681	p	_	
50-57	9682-9687	value	_	
50-58	9689-9694	0.69a	_	
50-59	9695-9700	0.25b	_	
50-60	9703-9707	Site	_	
50-61	9708-9709	B	_	
50-62	9710-9713	SCZ	_	
50-63	9714-9716	50	_	
50-64	9717-9719	34	_	
50-65	9719-9720	/	_	
50-66	9720-9722	16	_	
50-67	9723-9728	27.48	_	
50-68	9728-9729	 	_	
50-69	9729-9730	±	_	
50-70	9730-9731	 	_	
50-71	9731-9735	7.89	_	
50-72	9735-9736	(	_	
50-73	9736-9738	18	_	
50-74	9738-9739	–	_	
50-75	9739-9741	50	_	
50-76	9741-9742	)	_	
50-77	9745-9747	NC	_	
50-78	9748-9750	50	_	
50-79	9751-9753	29	_	
50-80	9753-9754	/	_	
50-81	9754-9756	21	_	
50-82	9757-9762	30.60	_	
50-83	9762-9763	 	_	
50-84	9763-9764	±	_	
50-85	9764-9765	 	_	
50-86	9765-9769	8.17	_	
50-87	9769-9770	(	_	
50-88	9770-9772	18	_	
50-89	9772-9773	–	_	
50-90	9773-9775	50	_	
50-91	9775-9776	)	_	
50-92	9779-9780	p	_	
50-93	9781-9786	value	_	
50-94	9788-9793	0.30a	_	
50-95	9794-9800	0.055b	_	
50-96	9803-9807	Site	_	
50-97	9808-9809	C	_	
50-98	9810-9813	SCZ	_	
50-99	9814-9816	50	_	
50-100	9817-9819	25	_	
50-101	9819-9820	/	_	
50-102	9820-9822	25	_	
50-103	9823-9828	34.10	_	
50-104	9828-9829	 	_	
50-105	9829-9830	±	_	
50-106	9830-9831	 	_	
50-107	9831-9835	8.44	_	
50-108	9835-9836	(	_	
50-109	9836-9838	16	_	
50-110	9838-9839	–	_	
50-111	9839-9841	56	_	
50-112	9841-9842	)	_	
50-113	9845-9847	NC	_	
50-114	9848-9850	50	_	
50-115	9851-9853	22	_	
50-116	9853-9854	/	_	
50-117	9854-9856	28	_	
50-118	9857-9862	32.24	_	
50-119	9862-9863	 	_	
50-120	9863-9864	±	_	
50-121	9864-9865	 	_	
50-122	9865-9870	11.42	_	
50-123	9870-9871	(	_	
50-124	9871-9873	21	_	
50-125	9873-9874	–	_	
50-126	9874-9876	57	_	
50-127	9876-9877	)	_	
50-128	9880-9881	p	_	
50-129	9882-9887	value	_	
50-130	9889-9894	0.55a	_	
50-131	9895-9900	0.36b	_	
50-132	9903-9907	Site	_	
50-133	9908-9909	A	_	
50-134	9909-9910	 	_	
50-135	9910-9911	+	_	
50-136	9911-9912	 	_	
50-137	9912-9913	B	_	
50-138	9913-9914	 	_	
50-139	9914-9915	+	_	
50-140	9915-9916	 	_	
50-141	9916-9917	C	_	
50-142	9918-9921	SCZ	_	
50-143	9922-9925	150	_	
50-144	9926-9928	87	_	
50-145	9928-9929	/	_	
50-146	9929-9931	63	_	
50-147	9932-9937	32.32	_	
50-148	9937-9938	 	_	
50-149	9938-9939	±	_	
50-150	9939-9940	 	_	
50-151	9940-9945	10.08	_	
50-152	9945-9946	(	_	
50-153	9946-9948	16	_	
50-154	9948-9949	–	_	
50-155	9949-9951	60	_	
50-156	9951-9952	)	_	
50-157	9955-9957	NC	_	
50-158	9958-9961	150	_	
50-159	9962-9964	76	_	
50-160	9964-9965	/	_	
50-161	9965-9967	74	_	
50-162	9968-9973	31.78	_	
50-163	9973-9974	 	_	
50-164	9974-9975	±	_	
50-165	9975-9976	 	_	
50-166	9976-9981	10.99	_	
50-167	9981-9982	(	_	
50-168	9982-9984	15	_	
50-169	9984-9985	–	_	
50-170	9985-9987	65	_	
50-171	9987-9988	)	_	
50-172	9991-9992	p	_	
50-173	9993-9998	value	_	
50-174	10000-10005	0.20a	_	
50-175	10006-10011	0.66b	_	
50-176	10015-10019	Note	_	
50-177	10019-10020	:	_	
50-178	10021-10024	SCZ	_	
50-179	10024-10025	:	_	
50-180	10026-10039	schizophrenia	_	
50-181	10039-10040	;	_	
50-182	10041-10043	NC	_	
50-183	10043-10044	:	_	
50-184	10045-10051	normal	_	
50-185	10052-10060	controls	_	
50-186	10060-10061	.	_	

#Text=Pearson Chi-square test.
51-1	10062-10069	Pearson	_	
51-2	10070-10080	Chi-square	_	
51-3	10081-10085	test	_	
51-4	10085-10086	.	_	

#Text=Two-sample t-test.
52-1	10087-10097	Two-sample	_	
52-2	10098-10104	t-test	_	
52-3	10104-10105	.	_	

#Text=MRI data were collected by three academic centers, including locations in the United States (University of Pennsylvania; site A), Brazil (University of Sao Paulo; site B), and China (Tianjin; site C).
53-1	10106-10109	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
53-2	10110-10114	data	_	
53-3	10115-10119	were	_	
53-4	10120-10129	collected	_	
53-5	10130-10132	by	_	
53-6	10133-10138	three	_	
53-7	10139-10147	academic	_	
53-8	10148-10155	centers	_	
53-9	10155-10156	,	_	
53-10	10157-10166	including	_	
53-11	10167-10176	locations	_	
53-12	10177-10179	in	_	
53-13	10180-10183	the	_	
53-14	10184-10190	United	_	
53-15	10191-10197	States	_	
53-16	10198-10199	(	_	
53-17	10199-10209	University	_	
53-18	10210-10212	of	_	
53-19	10213-10225	Pennsylvania	_	
53-20	10225-10226	;	_	
53-21	10227-10231	site	_	
53-22	10232-10233	A	_	
53-23	10233-10234	)	_	
53-24	10234-10235	,	_	
53-25	10236-10242	Brazil	_	
53-26	10243-10244	(	_	
53-27	10244-10254	University	_	
53-28	10255-10257	of	_	
53-29	10258-10261	Sao	_	
53-30	10262-10267	Paulo	_	
53-31	10267-10268	;	_	
53-32	10269-10273	site	_	
53-33	10274-10275	B	_	
53-34	10275-10276	)	_	
53-35	10276-10277	,	_	
53-36	10278-10281	and	_	
53-37	10282-10287	China	_	
53-38	10288-10289	(	_	
53-39	10289-10296	Tianjin	_	
53-40	10296-10297	;	_	
53-41	10298-10302	site	_	
53-42	10303-10304	C	_	
53-43	10304-10305	)	_	
53-44	10305-10306	.	_	

#Text=From each site, a balanced dataset was obtained with 50 normal controls (NCs) and 50 SCZ patients randomly selected from a larger pool of available subjects.
54-1	10307-10311	From	_	
54-2	10312-10316	each	_	
54-3	10317-10321	site	_	
54-4	10321-10322	,	_	
54-5	10323-10324	a	_	
54-6	10325-10333	balanced	_	
54-7	10334-10341	dataset	_	
54-8	10342-10345	was	_	
54-9	10346-10354	obtained	_	
54-10	10355-10359	with	_	
54-11	10360-10362	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-12	10363-10369	normal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
54-13	10370-10378	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
54-14	10379-10380	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
54-15	10380-10383	NCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
54-16	10383-10384	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
54-17	10385-10388	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-18	10389-10391	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-19	10392-10395	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[7]	
54-20	10396-10404	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[7]	
54-21	10405-10413	randomly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-22	10414-10422	selected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-23	10423-10427	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-24	10428-10429	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-25	10430-10436	larger	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-26	10437-10441	pool	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-27	10442-10444	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-28	10445-10454	available	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-29	10455-10463	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
54-30	10463-10464	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=In total, we had 150 NCs and 150 SCZs, which didn't differ by age and gender significantly (p > 0.05; see Table 1).
55-1	10465-10467	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-2	10468-10473	total	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-3	10473-10474	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-4	10475-10477	we	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-5	10478-10481	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-6	10482-10485	150	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-7	10486-10489	NCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
55-8	10490-10493	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-9	10494-10497	150	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-10	10498-10502	SCZs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
55-11	10502-10503	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-12	10504-10509	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-13	10510-10516	didn't	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-14	10517-10523	differ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-15	10524-10526	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-16	10527-10530	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-17	10531-10534	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-18	10535-10541	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-19	10542-10555	significantly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-20	10556-10557	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-21	10557-10558	p	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-22	10558-10559	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-23	10559-10560	>	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-24	10560-10561	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-25	10561-10565	0.05	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-26	10565-10566	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-27	10567-10570	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-28	10571-10576	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-29	10577-10578	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-30	10578-10579	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
55-31	10579-10580	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=All SCZ patients met DSM-IV criteria.
56-1	10581-10584	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
56-2	10585-10588	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]	
56-3	10589-10597	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]	
56-4	10598-10601	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
56-5	10602-10608	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
56-6	10609-10617	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
56-7	10617-10618	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Written informed consent was obtained from all participants before MRI scanning.
57-1	10619-10626	Written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-2	10627-10635	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-3	10636-10643	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-4	10644-10647	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-5	10648-10656	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-6	10657-10661	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-7	10662-10665	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-8	10666-10678	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-9	10679-10685	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-10	10686-10689	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-11	10690-10698	scanning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
57-12	10698-10699	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=In site A, the 50 SCZ patients had chronic symptoms and were receiving treatment with antipsychotics (mean duration of illness 16.2 ± 12.3 years).
58-1	10700-10702	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-2	10703-10707	site	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-3	10708-10709	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-4	10709-10710	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-5	10711-10714	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-6	10715-10717	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-7	10718-10721	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[14]	
58-8	10722-10730	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[14]	
58-9	10731-10734	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-10	10735-10742	chronic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-11	10743-10751	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-12	10752-10755	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-13	10756-10760	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-14	10761-10770	receiving	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-15	10771-10780	treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-16	10781-10785	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-17	10786-10800	antipsychotics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-18	10801-10802	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-19	10802-10806	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-20	10807-10815	duration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-21	10816-10818	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-22	10819-10826	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-23	10827-10831	16.2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-24	10831-10832	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-25	10832-10833	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-26	10833-10834	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-27	10834-10838	12.3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-28	10838-10839	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-29	10839-10844	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-30	10844-10845	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
58-31	10845-10846	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	

#Text=In site B, all SCZ subjects were recruited shortly after they made their first contact with mental health services due to psychotic symptoms, and their duration of illness was 1.0 ± 1.3 years; 31 patients had been on antipsychotic treatment within 3 weeks of MRI, while the remaining 19 patients were free of antipsychotics at the time of MRI scanning.
59-1	10847-10849	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-2	10850-10854	site	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-3	10855-10856	B	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-4	10856-10857	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-5	10858-10861	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-6	10862-10865	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
59-7	10866-10874	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
59-8	10875-10879	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-9	10880-10889	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-10	10890-10897	shortly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-11	10898-10903	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-12	10904-10908	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-13	10909-10913	made	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-14	10914-10919	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-15	10920-10925	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-16	10926-10933	contact	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-17	10934-10938	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-18	10939-10945	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-19	10946-10952	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-20	10953-10961	services	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-21	10962-10965	due	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-22	10966-10968	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-23	10969-10978	psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-24	10979-10987	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-25	10987-10988	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-26	10989-10992	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-27	10993-10998	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-28	10999-11007	duration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-29	11008-11010	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-30	11011-11018	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-31	11019-11022	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-32	11023-11026	1.0	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-33	11026-11027	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-34	11027-11028	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-35	11028-11029	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-36	11029-11032	1.3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-37	11032-11033	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-38	11033-11038	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-39	11038-11039	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
59-40	11040-11042	31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-41	11043-11051	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-42	11052-11055	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-43	11056-11060	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-44	11061-11063	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-45	11064-11077	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-46	11078-11087	treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-47	11088-11094	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-48	11095-11096	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-49	11096-11097	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-50	11097-11102	weeks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-51	11103-11105	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-52	11106-11109	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[18]	
59-53	11109-11110	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-54	11111-11116	while	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-55	11117-11120	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-56	11121-11130	remaining	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-57	11131-11133	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-58	11134-11142	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-59	11143-11147	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-60	11148-11152	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-61	11153-11155	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-62	11156-11170	antipsychotics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-63	11171-11173	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-64	11174-11177	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-65	11178-11182	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-66	11183-11185	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-67	11186-11189	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[19]	
59-68	11190-11198	scanning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
59-69	11198-11199	.	_	

#Text=Site C contributed 5 first-episode, never-treated SCZ patients and 45 chronic SCZ patients under antipsychotic treatment (mean duration of illness 10.5 ± 7.2 years).
60-1	11200-11204	Site	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-2	11205-11206	C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-3	11207-11218	contributed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-4	11219-11220	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-5	11221-11234	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
60-6	11234-11235	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
60-7	11236-11249	never-treated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
60-8	11250-11253	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
60-9	11254-11262	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
60-10	11263-11266	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-11	11267-11269	45	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-12	11270-11277	chronic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-13	11278-11281	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-14	11282-11290	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-15	11291-11296	under	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-16	11297-11310	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-17	11311-11320	treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[22]	
60-18	11321-11322	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-19	11322-11326	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-20	11327-11335	duration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-21	11336-11338	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-22	11339-11346	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-23	11347-11351	10.5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-24	11351-11352	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-25	11352-11353	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-26	11353-11354	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-27	11354-11357	7.2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-28	11357-11358	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-29	11358-11363	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-30	11363-11364	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
60-31	11364-11365	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	

#Text=In site A, the imaging data were acquired using a Siemens Trio 3-T scanner (Siemens Medical Systems, Erlangen Germany), with the following protocol: slice thickness = 1 mm, TE = 3.51 ms, TR = 18.1 ms, flip angle = 9°, acquisition matrix = 240 × 180, and slice number = 160, no gaps, 1-mm isotropic voxels.
61-1	11366-11368	In	_	
61-2	11369-11373	site	_	
61-3	11374-11375	A	_	
61-4	11375-11376	,	_	
61-5	11377-11380	the	_	
61-6	11381-11388	imaging	_	
61-7	11389-11393	data	_	
61-8	11394-11398	were	_	
61-9	11399-11407	acquired	_	
61-10	11408-11413	using	_	
61-11	11414-11415	a	_	
61-12	11416-11423	Siemens	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-13	11424-11428	Trio	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-14	11429-11430	3	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-15	11430-11431	-	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-16	11431-11432	T	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-17	11433-11440	scanner	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[23]	
61-18	11441-11442	(	_	
61-19	11442-11449	Siemens	_	
61-20	11450-11457	Medical	_	
61-21	11458-11465	Systems	_	
61-22	11465-11466	,	_	
61-23	11467-11475	Erlangen	_	
61-24	11476-11483	Germany	_	
61-25	11483-11484	)	_	
61-26	11484-11485	,	_	
61-27	11486-11490	with	_	
61-28	11491-11494	the	_	
61-29	11495-11504	following	_	
61-30	11505-11513	protocol	_	
61-31	11513-11514	:	_	
61-32	11515-11520	slice	_	
61-33	11521-11530	thickness	_	
61-34	11530-11531	 	_	
61-35	11531-11532	=	_	
61-36	11532-11533	 	_	
61-37	11533-11534	1	_	
61-38	11534-11535	 	_	
61-39	11535-11537	mm	_	
61-40	11537-11538	,	_	
61-41	11539-11541	TE	_	
61-42	11541-11542	 	_	
61-43	11542-11543	=	_	
61-44	11543-11544	 	_	
61-45	11544-11548	3.51	_	
61-46	11548-11549	 	_	
61-47	11549-11551	ms	_	
61-48	11551-11552	,	_	
61-49	11553-11555	TR	_	
61-50	11555-11556	 	_	
61-51	11556-11557	=	_	
61-52	11557-11558	 	_	
61-53	11558-11562	18.1	_	
61-54	11562-11563	 	_	
61-55	11563-11565	ms	_	
61-56	11565-11566	,	_	
61-57	11567-11571	flip	_	
61-58	11572-11577	angle	_	
61-59	11577-11578	 	_	
61-60	11578-11579	=	_	
61-61	11579-11580	 	_	
61-62	11580-11581	9	_	
61-63	11581-11582	°	_	
61-64	11582-11583	,	_	
61-65	11584-11595	acquisition	_	
61-66	11596-11602	matrix	_	
61-67	11602-11603	 	_	
61-68	11603-11604	=	_	
61-69	11604-11605	 	_	
61-70	11605-11608	240	_	
61-71	11608-11609	 	_	
61-72	11609-11610	×	_	
61-73	11610-11611	 	_	
61-74	11611-11614	180	_	
61-75	11614-11615	,	_	
61-76	11616-11619	and	_	
61-77	11620-11625	slice	_	
61-78	11626-11632	number	_	
61-79	11632-11633	 	_	
61-80	11633-11634	=	_	
61-81	11634-11635	 	_	
61-82	11635-11638	160	_	
61-83	11638-11639	,	_	
61-84	11640-11642	no	_	
61-85	11643-11647	gaps	_	
61-86	11647-11648	,	_	
61-87	11649-11650	1	_	
61-88	11650-11651	-	_	
61-89	11651-11653	mm	_	
61-90	11654-11663	isotropic	_	
61-91	11664-11670	voxels	_	
61-92	11670-11671	.	_	

#Text=In site B, the T1 images were acquired using two identical 1.5-T GE Signa scanners (GE Medical Systems, Milwaukee WI, USA) with the following protocol: T1-SPGR sequence providing 124 contiguous slices, TE = 5.2 ms, TR = 21.7 ms, flip angle = 20°, FOV = 22 cm, acquisition matrix = 256 × 192.
62-1	11672-11674	In	_	
62-2	11675-11679	site	_	
62-3	11680-11681	B	_	
62-4	11681-11682	,	_	
62-5	11683-11686	the	_	
62-6	11687-11689	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]	
62-7	11690-11696	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]	
62-8	11697-11701	were	_	
62-9	11702-11710	acquired	_	
62-10	11711-11716	using	_	
62-11	11717-11720	two	_	
62-12	11721-11730	identical	_	
62-13	11731-11734	1.5	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-14	11734-11735	-	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-15	11735-11736	T	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-16	11737-11739	GE	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-17	11740-11745	Signa	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-18	11746-11754	scanners	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[25]	
62-19	11755-11756	(	_	
62-20	11756-11758	GE	_	
62-21	11759-11766	Medical	_	
62-22	11767-11774	Systems	_	
62-23	11774-11775	,	_	
62-24	11776-11785	Milwaukee	_	
62-25	11786-11788	WI	_	
62-26	11788-11789	,	_	
62-27	11790-11793	USA	_	
62-28	11793-11794	)	_	
62-29	11795-11799	with	_	
62-30	11800-11803	the	_	
62-31	11804-11813	following	_	
62-32	11814-11822	protocol	_	
62-33	11822-11823	:	_	
62-34	11824-11826	T1	_	
62-35	11826-11827	-	_	
62-36	11827-11831	SPGR	_	
62-37	11832-11840	sequence	_	
62-38	11841-11850	providing	_	
62-39	11851-11854	124	_	
62-40	11855-11865	contiguous	_	
62-41	11866-11872	slices	_	
62-42	11872-11873	,	_	
62-43	11874-11876	TE	_	
62-44	11876-11877	 	_	
62-45	11877-11878	=	_	
62-46	11878-11879	 	_	
62-47	11879-11882	5.2	_	
62-48	11882-11883	 	_	
62-49	11883-11885	ms	_	
62-50	11885-11886	,	_	
62-51	11887-11889	TR	_	
62-52	11889-11890	 	_	
62-53	11890-11891	=	_	
62-54	11891-11892	 	_	
62-55	11892-11896	21.7	_	
62-56	11896-11897	 	_	
62-57	11897-11899	ms	_	
62-58	11899-11900	,	_	
62-59	11901-11905	flip	_	
62-60	11906-11911	angle	_	
62-61	11911-11912	 	_	
62-62	11912-11913	=	_	
62-63	11913-11914	 	_	
62-64	11914-11916	20	_	
62-65	11916-11917	°	_	
62-66	11917-11918	,	_	
62-67	11919-11922	FOV	_	
62-68	11922-11923	 	_	
62-69	11923-11924	=	_	
62-70	11924-11925	 	_	
62-71	11925-11927	22	_	
62-72	11927-11928	 	_	
62-73	11928-11930	cm	_	
62-74	11930-11931	,	_	
62-75	11932-11943	acquisition	_	
62-76	11944-11950	matrix	_	
62-77	11950-11951	 	_	
62-78	11951-11952	=	_	
62-79	11952-11953	 	_	
62-80	11953-11956	256	_	
62-81	11956-11957	 	_	
62-82	11957-11958	×	_	
62-83	11958-11959	 	_	
62-84	11959-11962	192	_	
62-85	11962-11963	.	_	

#Text=Details of the MRI scanning in site B can be found in.
63-1	11964-11971	Details	_	
63-2	11972-11974	of	_	
63-3	11975-11978	the	_	
63-4	11979-11982	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
63-5	11983-11991	scanning	_	
63-6	11992-11994	in	_	
63-7	11995-11999	site	_	
63-8	12000-12001	B	_	
63-9	12002-12005	can	_	
63-10	12006-12008	be	_	
63-11	12009-12014	found	_	
63-12	12015-12017	in	_	
63-13	12017-12018	.	_	

#Text=In site C, all scans were obtained using a GE 3-T Signa scanner (GE Medical Systems, Milwaukee WI, USA) with the following protocol: slice thickness = 1 mm, TE = 3.2 ms, TR = 8.2 ms, flip angle = 12°, acquisition matrix = 256 × 256, FOV = 25.6 cm.
64-1	12019-12021	In	_	
64-2	12022-12026	site	_	
64-3	12027-12028	C	_	
64-4	12028-12029	,	_	
64-5	12030-12033	all	_	
64-6	12034-12039	scans	_	
64-7	12040-12044	were	_	
64-8	12045-12053	obtained	_	
64-9	12054-12059	using	_	
64-10	12060-12061	a	_	
64-11	12062-12064	GE	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-12	12065-12066	3	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-13	12066-12067	-	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-14	12067-12068	T	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-15	12069-12074	Signa	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-16	12075-12082	scanner	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[26]	
64-17	12083-12084	(	_	
64-18	12084-12086	GE	_	
64-19	12087-12094	Medical	_	
64-20	12095-12102	Systems	_	
64-21	12102-12103	,	_	
64-22	12104-12113	Milwaukee	_	
64-23	12114-12116	WI	_	
64-24	12116-12117	,	_	
64-25	12118-12121	USA	_	
64-26	12121-12122	)	_	
64-27	12123-12127	with	_	
64-28	12128-12131	the	_	
64-29	12132-12141	following	_	
64-30	12142-12150	protocol	_	
64-31	12150-12151	:	_	
64-32	12152-12157	slice	_	
64-33	12158-12167	thickness	_	
64-34	12167-12168	 	_	
64-35	12168-12169	=	_	
64-36	12169-12170	 	_	
64-37	12170-12171	1	_	
64-38	12171-12172	 	_	
64-39	12172-12174	mm	_	
64-40	12174-12175	,	_	
64-41	12176-12178	TE	_	
64-42	12178-12179	 	_	
64-43	12179-12180	=	_	
64-44	12180-12181	 	_	
64-45	12181-12184	3.2	_	
64-46	12184-12185	 	_	
64-47	12185-12187	ms	_	
64-48	12187-12188	,	_	
64-49	12189-12191	TR	_	
64-50	12191-12192	 	_	
64-51	12192-12193	=	_	
64-52	12193-12194	 	_	
64-53	12194-12197	8.2	_	
64-54	12197-12198	 	_	
64-55	12198-12200	ms	_	
64-56	12200-12201	,	_	
64-57	12202-12206	flip	_	
64-58	12207-12212	angle	_	
64-59	12212-12213	 	_	
64-60	12213-12214	=	_	
64-61	12214-12215	 	_	
64-62	12215-12217	12	_	
64-63	12217-12218	°	_	
64-64	12218-12219	,	_	
64-65	12220-12231	acquisition	_	
64-66	12232-12238	matrix	_	
64-67	12238-12239	 	_	
64-68	12239-12240	=	_	
64-69	12240-12241	 	_	
64-70	12241-12244	256	_	
64-71	12244-12245	 	_	
64-72	12245-12246	×	_	
64-73	12246-12247	 	_	
64-74	12247-12250	256	_	
64-75	12250-12251	,	_	
64-76	12252-12255	FOV	_	
64-77	12255-12256	 	_	
64-78	12256-12257	=	_	
64-79	12257-12258	 	_	
64-80	12258-12262	25.6	_	
64-81	12262-12263	 	_	
64-82	12263-12265	cm	_	
64-83	12265-12266	.	_	

#Text=Preprocessing
#Text=The imaging data were preprocessed using the following steps as previously described: (1) skull stripping, (2) bias field correction, (3) brain tissue segmentation into gray matter (GM), white matter (WM), cerebrospinal fluid (CSF), (4) spatial registration to Montreal Neurological Institute (MNI) template, (5) generation of the Regional Analysis of Volumes Examined in Normalized Space (RAVENS) maps of GM, WM, and CSF using deformable registration (DRAMMS), and (6) spatial smoothing of RAVENS maps using a 6-mm Full Width at Half Maximum (FWHM) Gaussian filter.
65-1	12267-12280	Preprocessing	_	
65-2	12281-12284	The	_	
65-3	12285-12292	imaging	_	
65-4	12293-12297	data	_	
65-5	12298-12302	were	_	
65-6	12303-12315	preprocessed	_	
65-7	12316-12321	using	_	
65-8	12322-12325	the	_	
65-9	12326-12335	following	_	
65-10	12336-12341	steps	_	
65-11	12342-12344	as	_	
65-12	12345-12355	previously	_	
65-13	12356-12365	described	_	
65-14	12365-12366	:	_	
65-15	12367-12368	(	_	
65-16	12368-12369	1	_	
65-17	12369-12370	)	_	
65-18	12371-12376	skull	_	
65-19	12377-12386	stripping	_	
65-20	12386-12387	,	_	
65-21	12388-12389	(	_	
65-22	12389-12390	2	_	
65-23	12390-12391	)	_	
65-24	12392-12396	bias	_	
65-25	12397-12402	field	_	
65-26	12403-12413	correction	_	
65-27	12413-12414	,	_	
65-28	12415-12416	(	_	
65-29	12416-12417	3	_	
65-30	12417-12418	)	_	
65-31	12419-12424	brain	_	
65-32	12425-12431	tissue	_	
65-33	12432-12444	segmentation	_	
65-34	12445-12449	into	_	
65-35	12450-12454	gray	_	
65-36	12455-12461	matter	_	
65-37	12462-12463	(	_	
65-38	12463-12465	GM	_	
65-39	12465-12466	)	_	
65-40	12466-12467	,	_	
65-41	12468-12473	white	_	
65-42	12474-12480	matter	_	
65-43	12481-12482	(	_	
65-44	12482-12484	WM	_	
65-45	12484-12485	)	_	
65-46	12485-12486	,	_	
65-47	12487-12500	cerebrospinal	_	
65-48	12501-12506	fluid	_	
65-49	12507-12508	(	_	
65-50	12508-12511	CSF	_	
65-51	12511-12512	)	_	
65-52	12512-12513	,	_	
65-53	12514-12515	(	_	
65-54	12515-12516	4	_	
65-55	12516-12517	)	_	
65-56	12518-12525	spatial	_	
65-57	12526-12538	registration	_	
65-58	12539-12541	to	_	
65-59	12542-12550	Montreal	_	
65-60	12551-12563	Neurological	_	
65-61	12564-12573	Institute	_	
65-62	12574-12575	(	_	
65-63	12575-12578	MNI	_	
65-64	12578-12579	)	_	
65-65	12580-12588	template	_	
65-66	12588-12589	,	_	
65-67	12590-12591	(	_	
65-68	12591-12592	5	_	
65-69	12592-12593	)	_	
65-70	12594-12604	generation	_	
65-71	12605-12607	of	_	
65-72	12608-12611	the	_	
65-73	12612-12620	Regional	_	
65-74	12621-12629	Analysis	_	
65-75	12630-12632	of	_	
65-76	12633-12640	Volumes	_	
65-77	12641-12649	Examined	_	
65-78	12650-12652	in	_	
65-79	12653-12663	Normalized	_	
65-80	12664-12669	Space	_	
65-81	12670-12671	(	_	
65-82	12671-12677	RAVENS	_	
65-83	12677-12678	)	_	
65-84	12679-12683	maps	_	
65-85	12684-12686	of	_	
65-86	12687-12689	GM	_	
65-87	12689-12690	,	_	
65-88	12691-12693	WM	_	
65-89	12693-12694	,	_	
65-90	12695-12698	and	_	
65-91	12699-12702	CSF	_	
65-92	12703-12708	using	_	
65-93	12709-12719	deformable	_	
65-94	12720-12732	registration	_	
65-95	12733-12734	(	_	
65-96	12734-12740	DRAMMS	_	
65-97	12740-12741	)	_	
65-98	12741-12742	,	_	
65-99	12743-12746	and	_	
65-100	12747-12748	(	_	
65-101	12748-12749	6	_	
65-102	12749-12750	)	_	
65-103	12751-12758	spatial	_	
65-104	12759-12768	smoothing	_	
65-105	12769-12771	of	_	
65-106	12772-12778	RAVENS	_	
65-107	12779-12783	maps	_	
65-108	12784-12789	using	_	
65-109	12790-12791	a	_	
65-110	12792-12793	6	_	
65-111	12793-12794	-	_	
65-112	12794-12796	mm	_	
65-113	12797-12801	Full	_	
65-114	12802-12807	Width	_	
65-115	12808-12810	at	_	
65-116	12811-12815	Half	_	
65-117	12816-12823	Maximum	_	
65-118	12824-12825	(	_	
65-119	12825-12829	FWHM	_	
65-120	12829-12830	)	_	
65-121	12831-12839	Gaussian	_	
65-122	12840-12846	filter	_	
65-123	12846-12847	.	_	

#Text=In our study, we investigated the RAVENS value changes in the GM images, which indicated regional GM volumetric alterations in the brain.
66-1	12848-12850	In	_	
66-2	12851-12854	our	_	
66-3	12855-12860	study	_	
66-4	12860-12861	,	_	
66-5	12862-12864	we	_	
66-6	12865-12877	investigated	_	
66-7	12878-12881	the	_	
66-8	12882-12888	RAVENS	_	
66-9	12889-12894	value	_	
66-10	12895-12902	changes	_	
66-11	12903-12905	in	_	
66-12	12906-12909	the	_	
66-13	12910-12912	GM	_	
66-14	12913-12919	images	_	
66-15	12919-12920	,	_	
66-16	12921-12926	which	_	
66-17	12927-12936	indicated	_	
66-18	12937-12945	regional	_	
66-19	12946-12948	GM	_	
66-20	12949-12959	volumetric	_	
66-21	12960-12971	alterations	_	
66-22	12972-12974	in	_	
66-23	12975-12978	the	_	
66-24	12979-12984	brain	_	
66-25	12984-12985	.	_	

#Text=Note that the RAVENS method has been demonstrated to provide more accurate and reliable quantification of volumes of different brain regions.
67-1	12986-12990	Note	_	
67-2	12991-12995	that	_	
67-3	12996-12999	the	_	
67-4	13000-13006	RAVENS	_	
67-5	13007-13013	method	_	
67-6	13014-13017	has	_	
67-7	13018-13022	been	_	
67-8	13023-13035	demonstrated	_	
67-9	13036-13038	to	_	
67-10	13039-13046	provide	_	
67-11	13047-13051	more	_	
67-12	13052-13060	accurate	_	
67-13	13061-13064	and	_	
67-14	13065-13073	reliable	_	
67-15	13074-13088	quantification	_	
67-16	13089-13091	of	_	
67-17	13092-13099	volumes	_	
67-18	13100-13102	of	_	
67-19	13103-13112	different	_	
67-20	13113-13118	brain	_	
67-21	13119-13126	regions	_	
67-22	13126-13127	.	_	

#Text=In order to reduce computational requirements, and since SCZ is not known to be associated with very localized volumetric reductions, the GM RAVENS maps were resampled to have a spatial resolution of 3 × 3 × 3 mm3.
68-1	13128-13130	In	_	
68-2	13131-13136	order	_	
68-3	13137-13139	to	_	
68-4	13140-13146	reduce	_	
68-5	13147-13160	computational	_	
68-6	13161-13173	requirements	_	
68-7	13173-13174	,	_	
68-8	13175-13178	and	_	
68-9	13179-13184	since	_	
68-10	13185-13188	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
68-11	13189-13191	is	_	
68-12	13192-13195	not	_	
68-13	13196-13201	known	_	
68-14	13202-13204	to	_	
68-15	13205-13207	be	_	
68-16	13208-13218	associated	_	
68-17	13219-13223	with	_	
68-18	13224-13228	very	_	
68-19	13229-13238	localized	_	
68-20	13239-13249	volumetric	_	
68-21	13250-13260	reductions	_	
68-22	13260-13261	,	_	
68-23	13262-13265	the	_	
68-24	13266-13268	GM	_	
68-25	13269-13275	RAVENS	_	
68-26	13276-13280	maps	_	
68-27	13281-13285	were	_	
68-28	13286-13295	resampled	_	
68-29	13296-13298	to	_	
68-30	13299-13303	have	_	
68-31	13304-13305	a	_	
68-32	13306-13313	spatial	_	
68-33	13314-13324	resolution	_	
68-34	13325-13327	of	_	
68-35	13328-13329	3	_	
68-36	13329-13330	 	_	
68-37	13330-13331	×	_	
68-38	13331-13332	 	_	
68-39	13332-13333	3	_	
68-40	13333-13334	 	_	
68-41	13334-13335	×	_	
68-42	13335-13336	 	_	
68-43	13336-13337	3	_	
68-44	13337-13338	 	_	
68-45	13338-13341	mm3	_	
68-46	13341-13342	.	_	

#Text=After applying a GM mask, 66,732 voxel-wise features for each subject were extracted.
69-1	13343-13348	After	_	
69-2	13349-13357	applying	_	
69-3	13358-13359	a	_	
69-4	13360-13362	GM	_	
69-5	13363-13367	mask	_	
69-6	13367-13368	,	_	
69-7	13369-13375	66,732	_	
69-8	13375-13376	 	_	
69-9	13376-13386	voxel-wise	_	
69-10	13387-13395	features	_	
69-11	13396-13399	for	_	
69-12	13400-13404	each	_	
69-13	13405-13412	subject	_	
69-14	13413-13417	were	_	
69-15	13418-13427	extracted	_	
69-16	13427-13428	.	_	

#Text=These images yielded a feature matrix of dimensionality of 100 × 66,732 for each site dataset.
70-1	13429-13434	These	_	
70-2	13435-13441	images	_	
70-3	13442-13449	yielded	_	
70-4	13450-13451	a	_	
70-5	13452-13459	feature	_	
70-6	13460-13466	matrix	_	
70-7	13467-13469	of	_	
70-8	13470-13484	dimensionality	_	
70-9	13485-13487	of	_	
70-10	13488-13491	100	_	
70-11	13491-13492	 	_	
70-12	13492-13493	×	_	
70-13	13493-13494	 	_	
70-14	13494-13500	66,732	_	
70-15	13501-13504	for	_	
70-16	13505-13509	each	_	
70-17	13510-13514	site	_	
70-18	13515-13522	dataset	_	
70-19	13522-13523	.	_	

#Text=In order to ensure that features in each site are within the same level and contribute equally in the process of feature weight learning, the feature matrices were then standardized to zero mean and unit variance across all subjects within each site, respectively.
71-1	13524-13526	In	_	
71-2	13527-13532	order	_	
71-3	13533-13535	to	_	
71-4	13536-13542	ensure	_	
71-5	13543-13547	that	_	
71-6	13548-13556	features	_	
71-7	13557-13559	in	_	
71-8	13560-13564	each	_	
71-9	13565-13569	site	_	
71-10	13570-13573	are	_	
71-11	13574-13580	within	_	
71-12	13581-13584	the	_	
71-13	13585-13589	same	_	
71-14	13590-13595	level	_	
71-15	13596-13599	and	_	
71-16	13600-13610	contribute	_	
71-17	13611-13618	equally	_	
71-18	13619-13621	in	_	
71-19	13622-13625	the	_	
71-20	13626-13633	process	_	
71-21	13634-13636	of	_	
71-22	13637-13644	feature	_	
71-23	13645-13651	weight	_	
71-24	13652-13660	learning	_	
71-25	13660-13661	,	_	
71-26	13662-13665	the	_	
71-27	13666-13673	feature	_	
71-28	13674-13682	matrices	_	
71-29	13683-13687	were	_	
71-30	13688-13692	then	_	
71-31	13693-13705	standardized	_	
71-32	13706-13708	to	_	
71-33	13709-13713	zero	_	
71-34	13714-13718	mean	_	
71-35	13719-13722	and	_	
71-36	13723-13727	unit	_	
71-37	13728-13736	variance	_	
71-38	13737-13743	across	_	
71-39	13744-13747	all	_	
71-40	13748-13756	subjects	_	
71-41	13757-13763	within	_	
71-42	13764-13768	each	_	
71-43	13769-13773	site	_	
71-44	13773-13774	,	_	
71-45	13775-13787	respectively	_	
71-46	13787-13788	.	_	

#Text=Multi-site classification using multi-task learning framework
#Text=Workflow of each iteration in multi-site classification (with total 20 repeated experiments). (1) There were three sites in our study (sites A, B, and C).
72-1	13789-13799	Multi-site	_	
72-2	13800-13814	classification	_	
72-3	13815-13820	using	_	
72-4	13821-13831	multi-task	_	
72-5	13832-13840	learning	_	
72-6	13841-13850	framework	_	
72-7	13851-13859	Workflow	_	
72-8	13860-13862	of	_	
72-9	13863-13867	each	_	
72-10	13868-13877	iteration	_	
72-11	13878-13880	in	_	
72-12	13881-13891	multi-site	_	
72-13	13892-13906	classification	_	
72-14	13907-13908	(	_	
72-15	13908-13912	with	_	
72-16	13913-13918	total	_	
72-17	13919-13921	20	_	
72-18	13922-13930	repeated	_	
72-19	13931-13942	experiments	_	
72-20	13942-13943	)	_	
72-21	13943-13944	.	_	
72-22	13945-13946	(	_	
72-23	13946-13947	1	_	
72-24	13947-13948	)	_	
72-25	13949-13954	There	_	
72-26	13955-13959	were	_	
72-27	13960-13965	three	_	
72-28	13966-13971	sites	_	
72-29	13972-13974	in	_	
72-30	13975-13978	our	_	
72-31	13979-13984	study	_	
72-32	13985-13986	(	_	
72-33	13986-13991	sites	_	
72-34	13992-13993	A	_	
72-35	13993-13994	,	_	
72-36	13995-13996	B	_	
72-37	13996-13997	,	_	
72-38	13998-14001	and	_	
72-39	14002-14003	C	_	
72-40	14003-14004	)	_	
72-41	14004-14005	.	_	

#Text=After preprocessing, the N samples in each data site were randomly divided into 5 folds and designated to three sets: one fold for testing, 80% and 20% of the other 4 folds for training and validation, respectively.
73-1	14006-14011	After	_	
73-2	14012-14025	preprocessing	_	
73-3	14025-14026	,	_	
73-4	14027-14030	the	_	
73-5	14031-14032	N	_	
73-6	14033-14040	samples	_	
73-7	14041-14043	in	_	
73-8	14044-14048	each	_	
73-9	14049-14053	data	_	
73-10	14054-14058	site	_	
73-11	14059-14063	were	_	
73-12	14064-14072	randomly	_	
73-13	14073-14080	divided	_	
73-14	14081-14085	into	_	
73-15	14086-14087	5	_	
73-16	14088-14093	folds	_	
73-17	14094-14097	and	_	
73-18	14098-14108	designated	_	
73-19	14109-14111	to	_	
73-20	14112-14117	three	_	
73-21	14118-14122	sets	_	
73-22	14122-14123	:	_	
73-23	14124-14127	one	_	
73-24	14128-14132	fold	_	
73-25	14133-14136	for	_	
73-26	14137-14144	testing	_	
73-27	14144-14145	,	_	
73-28	14146-14149	80%	_	
73-29	14150-14153	and	_	
73-30	14154-14157	20%	_	
73-31	14158-14160	of	_	
73-32	14161-14164	the	_	
73-33	14165-14170	other	_	
73-34	14171-14172	4	_	
73-35	14173-14178	folds	_	
73-36	14179-14182	for	_	
73-37	14183-14191	training	_	
73-38	14192-14195	and	_	
73-39	14196-14206	validation	_	
73-40	14206-14207	,	_	
73-41	14208-14220	respectively	_	
73-42	14220-14221	.	_	

#Text=Each sample had the feature dimension of D. (2) Feature learning.
74-1	14222-14226	Each	_	
74-2	14227-14233	sample	_	
74-3	14234-14237	had	_	
74-4	14238-14241	the	_	
74-5	14242-14249	feature	_	
74-6	14250-14259	dimension	_	
74-7	14260-14262	of	_	
74-8	14263-14264	D	_	
74-9	14264-14265	.	_	
74-10	14266-14267	(	_	
74-11	14267-14268	2	_	
74-12	14268-14269	)	_	
74-13	14270-14277	Feature	_	
74-14	14278-14286	learning	_	
74-15	14286-14287	.	_	

#Text=The training sets from three sites were used in the multi-task learning framework, which generated the feature weights of the three sites W.
75-1	14288-14291	The	_	
75-2	14292-14300	training	_	
75-3	14301-14305	sets	_	
75-4	14306-14310	from	_	
75-5	14311-14316	three	_	
75-6	14317-14322	sites	_	
75-7	14323-14327	were	_	
75-8	14328-14332	used	_	
75-9	14333-14335	in	_	
75-10	14336-14339	the	_	
75-11	14340-14350	multi-task	_	
75-12	14351-14359	learning	_	
75-13	14360-14369	framework	_	
75-14	14369-14370	,	_	
75-15	14371-14376	which	_	
75-16	14377-14386	generated	_	
75-17	14387-14390	the	_	
75-18	14391-14398	feature	_	
75-19	14399-14406	weights	_	
75-20	14407-14409	of	_	
75-21	14410-14413	the	_	
75-22	14414-14419	three	_	
75-23	14420-14425	sites	_	
75-24	14426-14427	W	_	
75-25	14427-14428	.	_	

#Text=The three column vectors in the weight matrix W were then sorted according to their absolute values respectively, while the feature weights of the site-shared features obtained according to the K top ranked feature weights were strengthened.
76-1	14429-14432	The	_	
76-2	14433-14438	three	_	
76-3	14439-14445	column	_	
76-4	14446-14453	vectors	_	
76-5	14454-14456	in	_	
76-6	14457-14460	the	_	
76-7	14461-14467	weight	_	
76-8	14468-14474	matrix	_	
76-9	14475-14476	W	_	
76-10	14477-14481	were	_	
76-11	14482-14486	then	_	
76-12	14487-14493	sorted	_	
76-13	14494-14503	according	_	
76-14	14504-14506	to	_	
76-15	14507-14512	their	_	
76-16	14513-14521	absolute	_	
76-17	14522-14528	values	_	
76-18	14529-14541	respectively	_	
76-19	14541-14542	,	_	
76-20	14543-14548	while	_	
76-21	14549-14552	the	_	
76-22	14553-14560	feature	_	
76-23	14561-14568	weights	_	
76-24	14569-14571	of	_	
76-25	14572-14575	the	_	
76-26	14576-14587	site-shared	_	
76-27	14588-14596	features	_	
76-28	14597-14605	obtained	_	
76-29	14606-14615	according	_	
76-30	14616-14618	to	_	
76-31	14619-14622	the	_	
76-32	14623-14624	K	_	
76-33	14625-14628	top	_	
76-34	14629-14635	ranked	_	
76-35	14636-14643	feature	_	
76-36	14644-14651	weights	_	
76-37	14652-14656	were	_	
76-38	14657-14669	strengthened	_	
76-39	14669-14670	.	_	

#Text=The new feature weights matrix W′ was generated. (3) Parameter tuning.
77-1	14671-14674	The	_	
77-2	14675-14678	new	_	
77-3	14679-14686	feature	_	
77-4	14687-14694	weights	_	
77-5	14695-14701	matrix	_	
77-6	14702-14703	W	_	
77-7	14703-14704	′	_	
77-8	14705-14708	was	_	
77-9	14709-14718	generated	_	
77-10	14718-14719	.	_	
77-11	14720-14721	(	_	
77-12	14721-14722	3	_	
77-13	14722-14723	)	_	
77-14	14724-14733	Parameter	_	
77-15	14734-14740	tuning	_	
77-16	14740-14741	.	_	

#Text=Using the feature weights learned in the last step, the K features and their corresponding weights in the validation samples from three sites were used to classify the validation sets.
78-1	14742-14747	Using	_	
78-2	14748-14751	the	_	
78-3	14752-14759	feature	_	
78-4	14760-14767	weights	_	
78-5	14768-14775	learned	_	
78-6	14776-14778	in	_	
78-7	14779-14782	the	_	
78-8	14783-14787	last	_	
78-9	14788-14792	step	_	
78-10	14792-14793	,	_	
78-11	14794-14797	the	_	
78-12	14798-14799	K	_	
78-13	14800-14808	features	_	
78-14	14809-14812	and	_	
78-15	14813-14818	their	_	
78-16	14819-14832	corresponding	_	
78-17	14833-14840	weights	_	
78-18	14841-14843	in	_	
78-19	14844-14847	the	_	
78-20	14848-14858	validation	_	
78-21	14859-14866	samples	_	
78-22	14867-14871	from	_	
78-23	14872-14877	three	_	
78-24	14878-14883	sites	_	
78-25	14884-14888	were	_	
78-26	14889-14893	used	_	
78-27	14894-14896	to	_	
78-28	14897-14905	classify	_	
78-29	14906-14909	the	_	
78-30	14910-14920	validation	_	
78-31	14921-14925	sets	_	
78-32	14925-14926	.	_	

#Text=The parameter set which contributed to the best classification accuracy was selected. (4) Testing.
79-1	14927-14930	The	_	
79-2	14931-14940	parameter	_	
79-3	14941-14944	set	_	
79-4	14945-14950	which	_	
79-5	14951-14962	contributed	_	
79-6	14963-14965	to	_	
79-7	14966-14969	the	_	
79-8	14970-14974	best	_	
79-9	14975-14989	classification	_	
79-10	14990-14998	accuracy	_	
79-11	14999-15002	was	_	
79-12	15003-15011	selected	_	
79-13	15011-15012	.	_	
79-14	15013-15014	(	_	
79-15	15014-15015	4	_	
79-16	15015-15016	)	_	
79-17	15017-15024	Testing	_	
79-18	15024-15025	.	_	

#Text=The best parameter set was used in testing and the classification accuracy was obtained.
80-1	15026-15029	The	_	
80-2	15030-15034	best	_	
80-3	15035-15044	parameter	_	
80-4	15045-15048	set	_	
80-5	15049-15052	was	_	
80-6	15053-15057	used	_	
80-7	15058-15060	in	_	
80-8	15061-15068	testing	_	
80-9	15069-15072	and	_	
80-10	15073-15076	the	_	
80-11	15077-15091	classification	_	
80-12	15092-15100	accuracy	_	
80-13	15101-15104	was	_	
80-14	15105-15113	obtained	_	
80-15	15113-15114	.	_	

#Text=Fig. 1
#Text=In our study, the multi-task learning framework was used to learn the site-shared and site-specific features in the three data sites.
81-1	15115-15118	Fig	_	
81-2	15118-15119	.	_	
81-3	15120-15121	1	_	
81-4	15122-15124	In	_	
81-5	15125-15128	our	_	
81-6	15129-15134	study	_	
81-7	15134-15135	,	_	
81-8	15136-15139	the	_	
81-9	15140-15150	multi-task	_	
81-10	15151-15159	learning	_	
81-11	15160-15169	framework	_	
81-12	15170-15173	was	_	
81-13	15174-15178	used	_	
81-14	15179-15181	to	_	
81-15	15182-15187	learn	_	
81-16	15188-15191	the	_	
81-17	15192-15203	site-shared	_	
81-18	15204-15207	and	_	
81-19	15208-15221	site-specific	_	
81-20	15222-15230	features	_	
81-21	15231-15233	in	_	
81-22	15234-15237	the	_	
81-23	15238-15243	three	_	
81-24	15244-15248	data	_	
81-25	15249-15254	sites	_	
81-26	15254-15255	.	_	

#Text=These selected features were then used to classify the different data sites respectively.
82-1	15256-15261	These	_	
82-2	15262-15270	selected	_	
82-3	15271-15279	features	_	
82-4	15280-15284	were	_	
82-5	15285-15289	then	_	
82-6	15290-15294	used	_	
82-7	15295-15297	to	_	
82-8	15298-15306	classify	_	
82-9	15307-15310	the	_	
82-10	15311-15320	different	_	
82-11	15321-15325	data	_	
82-12	15326-15331	sites	_	
82-13	15332-15344	respectively	_	
82-14	15344-15345	.	_	

#Text=The workflow of multi-site learning is shown in Fig. 1.
83-1	15346-15349	The	_	
83-2	15350-15358	workflow	_	
83-3	15359-15361	of	_	
83-4	15362-15372	multi-site	_	
83-5	15373-15381	learning	_	
83-6	15382-15384	is	_	
83-7	15385-15390	shown	_	
83-8	15391-15393	in	_	
83-9	15394-15397	Fig	_	
83-10	15397-15398	.	_	
83-11	15399-15400	1	_	
83-12	15400-15401	.	_	

#Text=We model the classification between SCZs and NCs of different sites as a multi-task learning problem with t learning tasks (one task for each site).
84-1	15402-15404	We	_	
84-2	15405-15410	model	_	
84-3	15411-15414	the	_	
84-4	15415-15429	classification	_	
84-5	15430-15437	between	_	
84-6	15438-15442	SCZs	_	
84-7	15443-15446	and	_	
84-8	15447-15450	NCs	_	
84-9	15451-15453	of	_	
84-10	15454-15463	different	_	
84-11	15464-15469	sites	_	
84-12	15470-15472	as	_	
84-13	15473-15474	a	_	
84-14	15475-15485	multi-task	_	
84-15	15486-15494	learning	_	
84-16	15495-15502	problem	_	
84-17	15503-15507	with	_	
84-18	15508-15509	t	_	
84-19	15510-15518	learning	_	
84-20	15519-15524	tasks	_	
84-21	15525-15526	(	_	
84-22	15526-15529	one	_	
84-23	15530-15534	task	_	
84-24	15535-15538	for	_	
84-25	15539-15543	each	_	
84-26	15544-15548	site	_	
84-27	15548-15549	)	_	
84-28	15549-15550	.	_	

#Text=In the ith learning task, Xi = [xi1, xi2, …, xin] ∈ Rd×n is features of training samples, where d is the number of features and n is number of training samples, and their class labels are Yi = [yi1, yi2, …, yin] ∈ Rn, where yj ∈ {+1, −3} stands for NCs and SCZs, respectively.
85-1	15551-15553	In	_	
85-2	15554-15557	the	_	
85-3	15558-15561	ith	_	
85-4	15562-15570	learning	_	
85-5	15571-15575	task	_	
85-6	15575-15576	,	_	
85-7	15577-15579	Xi	_	
85-8	15579-15580	 	_	
85-9	15580-15581	=	_	
85-10	15581-15582	 	_	
85-11	15582-15583	[	_	
85-12	15583-15586	xi1	_	
85-13	15586-15587	,	_	
85-14	15587-15588	 	_	
85-15	15588-15591	xi2	_	
85-16	15591-15592	,	_	
85-17	15592-15593	 	_	
85-18	15593-15594	…	_	
85-19	15594-15595	,	_	
85-20	15595-15596	 	_	
85-21	15596-15599	xin	_	
85-22	15599-15600	]	_	
85-23	15600-15601	 	_	
85-24	15601-15602	∈	_	
85-25	15602-15603	 	_	
85-26	15603-15605	Rd	_	
85-27	15605-15606	×	_	
85-28	15606-15607	n	_	
85-29	15608-15610	is	_	
85-30	15611-15619	features	_	
85-31	15620-15622	of	_	
85-32	15623-15631	training	_	
85-33	15632-15639	samples	_	
85-34	15639-15640	,	_	
85-35	15641-15646	where	_	
85-36	15647-15648	d	_	
85-37	15649-15651	is	_	
85-38	15652-15655	the	_	
85-39	15656-15662	number	_	
85-40	15663-15665	of	_	
85-41	15666-15674	features	_	
85-42	15675-15678	and	_	
85-43	15679-15680	n	_	
85-44	15681-15683	is	_	
85-45	15684-15690	number	_	
85-46	15691-15693	of	_	
85-47	15694-15702	training	_	
85-48	15703-15710	samples	_	
85-49	15710-15711	,	_	
85-50	15712-15715	and	_	
85-51	15716-15721	their	_	
85-52	15722-15727	class	_	
85-53	15728-15734	labels	_	
85-54	15735-15738	are	_	
85-55	15739-15741	Yi	_	
85-56	15741-15742	 	_	
85-57	15742-15743	=	_	
85-58	15743-15744	 	_	
85-59	15744-15745	[	_	
85-60	15745-15748	yi1	_	
85-61	15748-15749	,	_	
85-62	15749-15750	 	_	
85-63	15750-15753	yi2	_	
85-64	15753-15754	,	_	
85-65	15754-15755	 	_	
85-66	15755-15756	…	_	
85-67	15756-15757	,	_	
85-68	15757-15758	 	_	
85-69	15758-15761	yin	_	
85-70	15761-15762	]	_	
85-71	15762-15763	 	_	
85-72	15763-15764	∈	_	
85-73	15764-15765	 	_	
85-74	15765-15767	Rn	_	
85-75	15767-15768	,	_	
85-76	15769-15774	where	_	
85-77	15775-15777	yj	_	
85-78	15777-15778	 	_	
85-79	15778-15779	∈	_	
85-80	15779-15780	 	_	
85-81	15780-15781	{	_	
85-82	15781-15782	+	_	
85-83	15782-15783	1	_	
85-84	15783-15784	,	_	
85-85	15784-15785	 	_	
85-86	15785-15786	−	_	
85-87	15786-15787	3	_	
85-88	15787-15788	}	_	
85-89	15789-15795	stands	_	
85-90	15796-15799	for	_	
85-91	15800-15803	NCs	_	
85-92	15804-15807	and	_	
85-93	15808-15812	SCZs	_	
85-94	15812-15813	,	_	
85-95	15814-15826	respectively	_	
85-96	15826-15827	.	_	

#Text=Let wi ∈ Rd denotes a feature weight vector for the ith learning task, and W = [w1, w2, …, wt] ∈ Rd×t denotes the feature weight matrix of all tasks.
86-1	15828-15831	Let	_	
86-2	15832-15834	wi	_	
86-3	15834-15835	 	_	
86-4	15835-15836	∈	_	
86-5	15836-15837	 	_	
86-6	15837-15839	Rd	_	
86-7	15840-15847	denotes	_	
86-8	15848-15849	a	_	
86-9	15850-15857	feature	_	
86-10	15858-15864	weight	_	
86-11	15865-15871	vector	_	
86-12	15872-15875	for	_	
86-13	15876-15879	the	_	
86-14	15880-15883	ith	_	
86-15	15884-15892	learning	_	
86-16	15893-15897	task	_	
86-17	15897-15898	,	_	
86-18	15899-15902	and	_	
86-19	15903-15904	W	_	
86-20	15904-15905	 	_	
86-21	15905-15906	=	_	
86-22	15906-15907	 	_	
86-23	15907-15908	[	_	
86-24	15908-15910	w1	_	
86-25	15910-15911	,	_	
86-26	15911-15912	 	_	
86-27	15912-15914	w2	_	
86-28	15914-15915	,	_	
86-29	15915-15916	 	_	
86-30	15916-15917	…	_	
86-31	15917-15918	,	_	
86-32	15918-15919	 	_	
86-33	15919-15921	wt	_	
86-34	15921-15922	]	_	
86-35	15922-15923	 	_	
86-36	15923-15924	∈	_	
86-37	15924-15925	 	_	
86-38	15925-15927	Rd	_	
86-39	15927-15928	×	_	
86-40	15928-15929	t	_	
86-41	15930-15937	denotes	_	
86-42	15938-15941	the	_	
86-43	15942-15949	feature	_	
86-44	15950-15956	weight	_	
86-45	15957-15963	matrix	_	
86-46	15964-15966	of	_	
86-47	15967-15970	all	_	
86-48	15971-15976	tasks	_	
86-49	15976-15977	.	_	

#Text=The columns of W (wi ∈ Rd) are the feature weights in each task, and the rows of W (wp ∈ Rt, where p = 1, 2,⋯, d) hold the weight vectors of each feature across all learning tasks.
87-1	15978-15981	The	_	
87-2	15982-15989	columns	_	
87-3	15990-15992	of	_	
87-4	15993-15994	W	_	
87-5	15995-15996	(	_	
87-6	15996-15998	wi	_	
87-7	15998-15999	 	_	
87-8	15999-16000	∈	_	
87-9	16000-16001	 	_	
87-10	16001-16003	Rd	_	
87-11	16003-16004	)	_	
87-12	16005-16008	are	_	
87-13	16009-16012	the	_	
87-14	16013-16020	feature	_	
87-15	16021-16028	weights	_	
87-16	16029-16031	in	_	
87-17	16032-16036	each	_	
87-18	16037-16041	task	_	
87-19	16041-16042	,	_	
87-20	16043-16046	and	_	
87-21	16047-16050	the	_	
87-22	16051-16055	rows	_	
87-23	16056-16058	of	_	
87-24	16059-16060	W	_	
87-25	16061-16062	(	_	
87-26	16062-16064	wp	_	
87-27	16064-16065	 	_	
87-28	16065-16066	∈	_	
87-29	16066-16067	 	_	
87-30	16067-16069	Rt	_	
87-31	16069-16070	,	_	
87-32	16071-16076	where	_	
87-33	16077-16078	p	_	
87-34	16078-16079	 	_	
87-35	16079-16080	=	_	
87-36	16080-16081	 	_	
87-37	16081-16082	1	_	
87-38	16082-16083	,	_	
87-39	16084-16085	2	_	
87-40	16085-16086	,	_	
87-41	16086-16087	⋯	_	
87-42	16087-16088	,	_	
87-43	16089-16090	d	_	
87-44	16090-16091	)	_	
87-45	16092-16096	hold	_	
87-46	16097-16100	the	_	
87-47	16101-16107	weight	_	
87-48	16108-16115	vectors	_	
87-49	16116-16118	of	_	
87-50	16119-16123	each	_	
87-51	16124-16131	feature	_	
87-52	16132-16138	across	_	
87-53	16139-16142	all	_	
87-54	16143-16151	learning	_	
87-55	16152-16157	tasks	_	
87-56	16157-16158	.	_	

#Text=Our goal is to learn the feature weight matrix W by minimizing the following cost function:where  is the dot product of the feature weights and feature values in each training sample, and the first term in the objective function is the hinge loss cost of all training samples in all tasks, the second term ‖W‖1 = ∑i=1t|wi| is l1-norm of W, the last term ‖W‖2, 1 = ∑k=1d‖wk‖2 is a l2,1-norm penalty.
88-1	16159-16162	Our	_	
88-2	16163-16167	goal	_	
88-3	16168-16170	is	_	
88-4	16171-16173	to	_	
88-5	16174-16179	learn	_	
88-6	16180-16183	the	_	
88-7	16184-16191	feature	_	
88-8	16192-16198	weight	_	
88-9	16199-16205	matrix	_	
88-10	16206-16207	W	_	
88-11	16208-16210	by	_	
88-12	16211-16221	minimizing	_	
88-13	16222-16225	the	_	
88-14	16226-16235	following	_	
88-15	16236-16240	cost	_	
88-16	16241-16249	function	_	
88-17	16249-16250	:	_	
88-18	16250-16255	where	_	
88-19	16257-16259	is	_	
88-20	16260-16263	the	_	
88-21	16264-16267	dot	_	
88-22	16268-16275	product	_	
88-23	16276-16278	of	_	
88-24	16279-16282	the	_	
88-25	16283-16290	feature	_	
88-26	16291-16298	weights	_	
88-27	16299-16302	and	_	
88-28	16303-16310	feature	_	
88-29	16311-16317	values	_	
88-30	16318-16320	in	_	
88-31	16321-16325	each	_	
88-32	16326-16334	training	_	
88-33	16335-16341	sample	_	
88-34	16341-16342	,	_	
88-35	16343-16346	and	_	
88-36	16347-16350	the	_	
88-37	16351-16356	first	_	
88-38	16357-16361	term	_	
88-39	16362-16364	in	_	
88-40	16365-16368	the	_	
88-41	16369-16378	objective	_	
88-42	16379-16387	function	_	
88-43	16388-16390	is	_	
88-44	16391-16394	the	_	
88-45	16395-16400	hinge	_	
88-46	16401-16405	loss	_	
88-47	16406-16410	cost	_	
88-48	16411-16413	of	_	
88-49	16414-16417	all	_	
88-50	16418-16426	training	_	
88-51	16427-16434	samples	_	
88-52	16435-16437	in	_	
88-53	16438-16441	all	_	
88-54	16442-16447	tasks	_	
88-55	16447-16448	,	_	
88-56	16449-16452	the	_	
88-57	16453-16459	second	_	
88-58	16460-16464	term	_	
88-59	16465-16466	‖	_	
88-60	16466-16467	W	_	
88-61	16467-16468	‖	_	
88-62	16468-16469	1	_	
88-63	16469-16470	 	_	
88-64	16470-16471	=	_	
88-65	16471-16472	 	_	
88-66	16472-16473	∑	_	
88-67	16473-16474	i	_	
88-68	16474-16475	=	_	
88-69	16475-16477	1t	_	
88-70	16477-16478	|	_	
88-71	16478-16480	wi	_	
88-72	16480-16481	|	_	
88-73	16482-16484	is	_	
88-74	16485-16487	l1	_	
88-75	16487-16488	-	_	
88-76	16488-16492	norm	_	
88-77	16493-16495	of	_	
88-78	16496-16497	W	_	
88-79	16497-16498	,	_	
88-80	16499-16502	the	_	
88-81	16503-16507	last	_	
88-82	16508-16512	term	_	
88-83	16513-16514	‖	_	
88-84	16514-16515	W	_	
88-85	16515-16516	‖	_	
88-86	16516-16517	2	_	
88-87	16517-16518	,	_	
88-88	16519-16520	1	_	
88-89	16520-16521	 	_	
88-90	16521-16522	=	_	
88-91	16522-16523	 	_	
88-92	16523-16524	∑	_	
88-93	16524-16525	k	_	
88-94	16525-16526	=	_	
88-95	16526-16528	1d	_	
88-96	16528-16529	‖	_	
88-97	16529-16531	wk	_	
88-98	16531-16532	‖	_	
88-99	16532-16533	2	_	
88-100	16534-16536	is	_	
88-101	16537-16538	a	_	
88-102	16539-16543	l2,1	_	
88-103	16543-16544	-	_	
88-104	16544-16548	norm	_	
88-105	16549-16556	penalty	_	
88-106	16556-16557	.	_	

#Text=The l1-norm term encourages task-specific sparsity, while l2,1-norm term encourages group sparsity among all tasks to identify task-shared features.
89-1	16558-16561	The	_	
89-2	16562-16564	l1	_	
89-3	16564-16565	-	_	
89-4	16565-16569	norm	_	
89-5	16570-16574	term	_	
89-6	16575-16585	encourages	_	
89-7	16586-16599	task-specific	_	
89-8	16600-16608	sparsity	_	
89-9	16608-16609	,	_	
89-10	16610-16615	while	_	
89-11	16616-16620	l2,1	_	
89-12	16620-16621	-	_	
89-13	16621-16625	norm	_	
89-14	16626-16630	term	_	
89-15	16631-16641	encourages	_	
89-16	16642-16647	group	_	
89-17	16648-16656	sparsity	_	
89-18	16657-16662	among	_	
89-19	16663-16666	all	_	
89-20	16667-16672	tasks	_	
89-21	16673-16675	to	_	
89-22	16676-16684	identify	_	
89-23	16685-16696	task-shared	_	
89-24	16697-16705	features	_	
89-25	16705-16706	.	_	

#Text=The l2,1 + l1 regularization terms consider both the task-specific and task-shared features, which make multi-task learning more suitable in classification of the heterogeneous data.
90-1	16707-16710	The	_	
90-2	16711-16715	l2,1	_	
90-3	16715-16716	 	_	
90-4	16716-16717	+	_	
90-5	16717-16718	 	_	
90-6	16718-16720	l1	_	
90-7	16721-16735	regularization	_	
90-8	16736-16741	terms	_	
90-9	16742-16750	consider	_	
90-10	16751-16755	both	_	
90-11	16756-16759	the	_	
90-12	16760-16773	task-specific	_	
90-13	16774-16777	and	_	
90-14	16778-16789	task-shared	_	
90-15	16790-16798	features	_	
90-16	16798-16799	,	_	
90-17	16800-16805	which	_	
90-18	16806-16810	make	_	
90-19	16811-16821	multi-task	_	
90-20	16822-16830	learning	_	
90-21	16831-16835	more	_	
90-22	16836-16844	suitable	_	
90-23	16845-16847	in	_	
90-24	16848-16862	classification	_	
90-25	16863-16865	of	_	
90-26	16866-16869	the	_	
90-27	16870-16883	heterogeneous	_	
90-28	16884-16888	data	_	
90-29	16888-16889	.	_	

#Text=The optimal stochastic alternating direction method of multipliers (SADMM) was adopted to solve the optimization function.
91-1	16890-16893	The	_	
91-2	16894-16901	optimal	_	
91-3	16902-16912	stochastic	_	
91-4	16913-16924	alternating	_	
91-5	16925-16934	direction	_	
91-6	16935-16941	method	_	
91-7	16942-16944	of	_	
91-8	16945-16956	multipliers	_	
91-9	16957-16958	(	_	
91-10	16958-16963	SADMM	_	
91-11	16963-16964	)	_	
91-12	16965-16968	was	_	
91-13	16969-16976	adopted	_	
91-14	16977-16979	to	_	
91-15	16980-16985	solve	_	
91-16	16986-16989	the	_	
91-17	16990-17002	optimization	_	
91-18	17003-17011	function	_	
91-19	17011-17012	.	_	

#Text=Details in the solution of the optimal problem using SADMM, and the converge prove can be found in.
92-1	17013-17020	Details	_	
92-2	17021-17023	in	_	
92-3	17024-17027	the	_	
92-4	17028-17036	solution	_	
92-5	17037-17039	of	_	
92-6	17040-17043	the	_	
92-7	17044-17051	optimal	_	
92-8	17052-17059	problem	_	
92-9	17060-17065	using	_	
92-10	17066-17071	SADMM	_	
92-11	17071-17072	,	_	
92-12	17073-17076	and	_	
92-13	17077-17080	the	_	
92-14	17081-17089	converge	_	
92-15	17090-17095	prove	_	
92-16	17096-17099	can	_	
92-17	17100-17102	be	_	
92-18	17103-17108	found	_	
92-19	17109-17111	in	_	
92-20	17111-17112	.	_	

#Text=In our study, the learning of feature weights at each data site was considered as a different task.
93-1	17113-17115	In	_	
93-2	17116-17119	our	_	
93-3	17120-17125	study	_	
93-4	17125-17126	,	_	
93-5	17127-17130	the	_	
93-6	17131-17139	learning	_	
93-7	17140-17142	of	_	
93-8	17143-17150	feature	_	
93-9	17151-17158	weights	_	
93-10	17159-17161	at	_	
93-11	17162-17166	each	_	
93-12	17167-17171	data	_	
93-13	17172-17176	site	_	
93-14	17177-17180	was	_	
93-15	17181-17191	considered	_	
93-16	17192-17194	as	_	
93-17	17195-17196	a	_	
93-18	17197-17206	different	_	
93-19	17207-17211	task	_	
93-20	17211-17212	.	_	

#Text=Due to the sparse penalty constrains in the object function of multi-task learning, many elements in the feature weight matrix W were forced to zero, or approximately equal to zero.
94-1	17213-17216	Due	_	
94-2	17217-17219	to	_	
94-3	17220-17223	the	_	
94-4	17224-17230	sparse	_	
94-5	17231-17238	penalty	_	
94-6	17239-17249	constrains	_	
94-7	17250-17252	in	_	
94-8	17253-17256	the	_	
94-9	17257-17263	object	_	
94-10	17264-17272	function	_	
94-11	17273-17275	of	_	
94-12	17276-17286	multi-task	_	
94-13	17287-17295	learning	_	
94-14	17295-17296	,	_	
94-15	17297-17301	many	_	
94-16	17302-17310	elements	_	
94-17	17311-17313	in	_	
94-18	17314-17317	the	_	
94-19	17318-17325	feature	_	
94-20	17326-17332	weight	_	
94-21	17333-17339	matrix	_	
94-22	17340-17341	W	_	
94-23	17342-17346	were	_	
94-24	17347-17353	forced	_	
94-25	17354-17356	to	_	
94-26	17357-17361	zero	_	
94-27	17361-17362	,	_	
94-28	17363-17365	or	_	
94-29	17366-17379	approximately	_	
94-30	17380-17385	equal	_	
94-31	17386-17388	to	_	
94-32	17389-17393	zero	_	
94-33	17393-17394	.	_	

#Text=Weight values reflect the importance levels of different features in learning the classification boundaries between two groups, while weight values that are positive or negative tend to classify the sample into either positive or negative classes, respectively.
95-1	17395-17401	Weight	_	
95-2	17402-17408	values	_	
95-3	17409-17416	reflect	_	
95-4	17417-17420	the	_	
95-5	17421-17431	importance	_	
95-6	17432-17438	levels	_	
95-7	17439-17441	of	_	
95-8	17442-17451	different	_	
95-9	17452-17460	features	_	
95-10	17461-17463	in	_	
95-11	17464-17472	learning	_	
95-12	17473-17476	the	_	
95-13	17477-17491	classification	_	
95-14	17492-17502	boundaries	_	
95-15	17503-17510	between	_	
95-16	17511-17514	two	_	
95-17	17515-17521	groups	_	
95-18	17521-17522	,	_	
95-19	17523-17528	while	_	
95-20	17529-17535	weight	_	
95-21	17536-17542	values	_	
95-22	17543-17547	that	_	
95-23	17548-17551	are	_	
95-24	17552-17560	positive	_	
95-25	17561-17563	or	_	
95-26	17564-17572	negative	_	
95-27	17573-17577	tend	_	
95-28	17578-17580	to	_	
95-29	17581-17589	classify	_	
95-30	17590-17593	the	_	
95-31	17594-17600	sample	_	
95-32	17601-17605	into	_	
95-33	17606-17612	either	_	
95-34	17613-17621	positive	_	
95-35	17622-17624	or	_	
95-36	17625-17633	negative	_	
95-37	17634-17641	classes	_	
95-38	17641-17642	,	_	
95-39	17643-17655	respectively	_	
95-40	17655-17656	.	_	

#Text=We assume that features with larger weight coefficients (in terms of absolute value) contribute more in discriminating SCZ from NCs.
96-1	17657-17659	We	_	
96-2	17660-17666	assume	_	
96-3	17667-17671	that	_	
96-4	17672-17680	features	_	
96-5	17681-17685	with	_	
96-6	17686-17692	larger	_	
96-7	17693-17699	weight	_	
96-8	17700-17712	coefficients	_	
96-9	17713-17714	(	_	
96-10	17714-17716	in	_	
96-11	17717-17722	terms	_	
96-12	17723-17725	of	_	
96-13	17726-17734	absolute	_	
96-14	17735-17740	value	_	
96-15	17740-17741	)	_	
96-16	17742-17752	contribute	_	
96-17	17753-17757	more	_	
96-18	17758-17760	in	_	
96-19	17761-17775	discriminating	_	
96-20	17776-17779	SCZ	_	
96-21	17780-17784	from	_	
96-22	17785-17788	NCs	_	
96-23	17788-17789	.	_	

#Text=Moreover, features with zero and near-zero weights make small contributions in the classification.
97-1	17790-17798	Moreover	_	
97-2	17798-17799	,	_	
97-3	17800-17808	features	_	
97-4	17809-17813	with	_	
97-5	17814-17818	zero	_	
97-6	17819-17822	and	_	
97-7	17823-17832	near-zero	_	
97-8	17833-17840	weights	_	
97-9	17841-17845	make	_	
97-10	17846-17851	small	_	
97-11	17852-17865	contributions	_	
97-12	17866-17868	in	_	
97-13	17869-17872	the	_	
97-14	17873-17887	classification	_	
97-15	17887-17888	.	_	

#Text=Thus, in order to select the more important features for further classification, we sorted the weight vector in each data site according to their absolute values after the weights W were learned.
98-1	17889-17893	Thus	_	
98-2	17893-17894	,	_	
98-3	17895-17897	in	_	
98-4	17898-17903	order	_	
98-5	17904-17906	to	_	
98-6	17907-17913	select	_	
98-7	17914-17917	the	_	
98-8	17918-17922	more	_	
98-9	17923-17932	important	_	
98-10	17933-17941	features	_	
98-11	17942-17945	for	_	
98-12	17946-17953	further	_	
98-13	17954-17968	classification	_	
98-14	17968-17969	,	_	
98-15	17970-17972	we	_	
98-16	17973-17979	sorted	_	
98-17	17980-17983	the	_	
98-18	17984-17990	weight	_	
98-19	17991-17997	vector	_	
98-20	17998-18000	in	_	
98-21	18001-18005	each	_	
98-22	18006-18010	data	_	
98-23	18011-18015	site	_	
98-24	18016-18025	according	_	
98-25	18026-18028	to	_	
98-26	18029-18034	their	_	
98-27	18035-18043	absolute	_	
98-28	18044-18050	values	_	
98-29	18051-18056	after	_	
98-30	18057-18060	the	_	
98-31	18061-18068	weights	_	
98-32	18069-18070	W	_	
98-33	18071-18075	were	_	
98-34	18076-18083	learned	_	
98-35	18083-18084	.	_	

#Text=The consensus features in a small portion of the top-ranked features-which were set to 5% across three data sites, were considered as the site-shared features.
99-1	18085-18088	The	_	
99-2	18089-18098	consensus	_	
99-3	18099-18107	features	_	
99-4	18108-18110	in	_	
99-5	18111-18112	a	_	
99-6	18113-18118	small	_	
99-7	18119-18126	portion	_	
99-8	18127-18129	of	_	
99-9	18130-18133	the	_	
99-10	18134-18144	top-ranked	_	
99-11	18145-18159	features-which	_	
99-12	18160-18164	were	_	
99-13	18165-18168	set	_	
99-14	18169-18171	to	_	
99-15	18172-18174	5%	_	
99-16	18175-18181	across	_	
99-17	18182-18187	three	_	
99-18	18188-18192	data	_	
99-19	18193-18198	sites	_	
99-20	18198-18199	,	_	
99-21	18200-18204	were	_	
99-22	18205-18215	considered	_	
99-23	18216-18218	as	_	
99-24	18219-18222	the	_	
99-25	18223-18234	site-shared	_	
99-26	18235-18243	features	_	
99-27	18243-18244	.	_	

#Text=The threshold of 5% was chosen because in terms of classification performance, it outperformed others in a range of 5%, 10%, and 20%.
100-1	18245-18248	The	_	
100-2	18249-18258	threshold	_	
100-3	18259-18261	of	_	
100-4	18262-18264	5%	_	
100-5	18265-18268	was	_	
100-6	18269-18275	chosen	_	
100-7	18276-18283	because	_	
100-8	18284-18286	in	_	
100-9	18287-18292	terms	_	
100-10	18293-18295	of	_	
100-11	18296-18310	classification	_	
100-12	18311-18322	performance	_	
100-13	18322-18323	,	_	
100-14	18324-18326	it	_	
100-15	18327-18339	outperformed	_	
100-16	18340-18346	others	_	
100-17	18347-18349	in	_	
100-18	18350-18351	a	_	
100-19	18352-18357	range	_	
100-20	18358-18360	of	_	
100-21	18361-18363	5%	_	
100-22	18363-18364	,	_	
100-23	18365-18368	10%	_	
100-24	18368-18369	,	_	
100-25	18370-18373	and	_	
100-26	18374-18377	20%	_	
100-27	18377-18378	.	_	

#Text=For a single data site, the site-specific and site-shared features were mixed together, as well as some irrelevant features.
101-1	18379-18382	For	_	
101-2	18383-18384	a	_	
101-3	18385-18391	single	_	
101-4	18392-18396	data	_	
101-5	18397-18401	site	_	
101-6	18401-18402	,	_	
101-7	18403-18406	the	_	
101-8	18407-18420	site-specific	_	
101-9	18421-18424	and	_	
101-10	18425-18436	site-shared	_	
101-11	18437-18445	features	_	
101-12	18446-18450	were	_	
101-13	18451-18456	mixed	_	
101-14	18457-18465	together	_	
101-15	18465-18466	,	_	
101-16	18467-18469	as	_	
101-17	18470-18474	well	_	
101-18	18475-18477	as	_	
101-19	18478-18482	some	_	
101-20	18483-18493	irrelevant	_	
101-21	18494-18502	features	_	
101-22	18502-18503	.	_	

#Text=Using the multi-task feature learning scheme, the feature weights of the site-specific and site-shared features were obviously greater than the irrelevant features.
102-1	18504-18509	Using	_	
102-2	18510-18513	the	_	
102-3	18514-18524	multi-task	_	
102-4	18525-18532	feature	_	
102-5	18533-18541	learning	_	
102-6	18542-18548	scheme	_	
102-7	18548-18549	,	_	
102-8	18550-18553	the	_	
102-9	18554-18561	feature	_	
102-10	18562-18569	weights	_	
102-11	18570-18572	of	_	
102-12	18573-18576	the	_	
102-13	18577-18590	site-specific	_	
102-14	18591-18594	and	_	
102-15	18595-18606	site-shared	_	
102-16	18607-18615	features	_	
102-17	18616-18620	were	_	
102-18	18621-18630	obviously	_	
102-19	18631-18638	greater	_	
102-20	18639-18643	than	_	
102-21	18644-18647	the	_	
102-22	18648-18658	irrelevant	_	
102-23	18659-18667	features	_	
102-24	18667-18668	.	_	

#Text=Though the site-shared and site-specific features were both very important, the site-shared features were considered underlying the pathology of SCZ and more critical in characterizing disease alterations.
103-1	18669-18675	Though	_	
103-2	18676-18679	the	_	
103-3	18680-18691	site-shared	_	
103-4	18692-18695	and	_	
103-5	18696-18709	site-specific	_	
103-6	18710-18718	features	_	
103-7	18719-18723	were	_	
103-8	18724-18728	both	_	
103-9	18729-18733	very	_	
103-10	18734-18743	important	_	
103-11	18743-18744	,	_	
103-12	18745-18748	the	_	
103-13	18749-18760	site-shared	_	
103-14	18761-18769	features	_	
103-15	18770-18774	were	_	
103-16	18775-18785	considered	_	
103-17	18786-18796	underlying	_	
103-18	18797-18800	the	_	
103-19	18801-18810	pathology	_	
103-20	18811-18813	of	_	
103-21	18814-18817	SCZ	_	
103-22	18818-18821	and	_	
103-23	18822-18826	more	_	
103-24	18827-18835	critical	_	
103-25	18836-18838	in	_	
103-26	18839-18853	characterizing	_	
103-27	18854-18861	disease	_	
103-28	18862-18873	alterations	_	
103-29	18873-18874	.	_	

#Text=Thus, to further emphasize the influence of site-shared features in the classification, we increased the weights of site-shared features using the following equation,where γ ≥ 1.
104-1	18875-18879	Thus	_	
104-2	18879-18880	,	_	
104-3	18881-18883	to	_	
104-4	18884-18891	further	_	
104-5	18892-18901	emphasize	_	
104-6	18902-18905	the	_	
104-7	18906-18915	influence	_	
104-8	18916-18918	of	_	
104-9	18919-18930	site-shared	_	
104-10	18931-18939	features	_	
104-11	18940-18942	in	_	
104-12	18943-18946	the	_	
104-13	18947-18961	classification	_	
104-14	18961-18962	,	_	
104-15	18963-18965	we	_	
104-16	18966-18975	increased	_	
104-17	18976-18979	the	_	
104-18	18980-18987	weights	_	
104-19	18988-18990	of	_	
104-20	18991-19002	site-shared	_	
104-21	19003-19011	features	_	
104-22	19012-19017	using	_	
104-23	19018-19021	the	_	
104-24	19022-19031	following	_	
104-25	19032-19040	equation	_	
104-26	19040-19041	,	_	
104-27	19041-19046	where	_	
104-28	19047-19048	γ	_	
104-29	19048-19049	 	_	
104-30	19049-19050	≥	_	
104-31	19050-19051	 	_	
104-32	19051-19052	1	_	
104-33	19052-19053	.	_	

#Text=Note that the γ was not set to be a free parameter, which was also tuned using the nested-loop cross-validation in our study.
105-1	19054-19058	Note	_	
105-2	19059-19063	that	_	
105-3	19064-19067	the	_	
105-4	19068-19069	γ	_	
105-5	19070-19073	was	_	
105-6	19074-19077	not	_	
105-7	19078-19081	set	_	
105-8	19082-19084	to	_	
105-9	19085-19087	be	_	
105-10	19088-19089	a	_	
105-11	19090-19094	free	_	
105-12	19095-19104	parameter	_	
105-13	19104-19105	,	_	
105-14	19106-19111	which	_	
105-15	19112-19115	was	_	
105-16	19116-19120	also	_	
105-17	19121-19126	tuned	_	
105-18	19127-19132	using	_	
105-19	19133-19136	the	_	
105-20	19137-19148	nested-loop	_	
105-21	19149-19165	cross-validation	_	
105-22	19166-19168	in	_	
105-23	19169-19172	our	_	
105-24	19173-19178	study	_	
105-25	19178-19179	.	_	

#Text=Classification with top ranked features
#Text=The K top ranked features with the new feature weights were used to classify each dataset.
106-1	19180-19194	Classification	_	
106-2	19195-19199	with	_	
106-3	19200-19203	top	_	
106-4	19204-19210	ranked	_	
106-5	19211-19219	features	_	
106-6	19220-19223	The	_	
106-7	19224-19225	K	_	
106-8	19226-19229	top	_	
106-9	19230-19236	ranked	_	
106-10	19237-19245	features	_	
106-11	19246-19250	with	_	
106-12	19251-19254	the	_	
106-13	19255-19258	new	_	
106-14	19259-19266	feature	_	
106-15	19267-19274	weights	_	
106-16	19275-19279	were	_	
106-17	19280-19284	used	_	
106-18	19285-19287	to	_	
106-19	19288-19296	classify	_	
106-20	19297-19301	each	_	
106-21	19302-19309	dataset	_	
106-22	19309-19310	.	_	

#Text=The classifier equation is shown as follows.where wip denotes the new weight value of the pth feature in the ith data site, xp denotes the pth feature value, and y denotes the sample label.
107-1	19311-19314	The	_	
107-2	19315-19325	classifier	_	
107-3	19326-19334	equation	_	
107-4	19335-19337	is	_	
107-5	19338-19343	shown	_	
107-6	19344-19346	as	_	
107-7	19347-19360	follows.where	_	
107-8	19361-19364	wip	_	
107-9	19365-19372	denotes	_	
107-10	19373-19376	the	_	
107-11	19377-19380	new	_	
107-12	19381-19387	weight	_	
107-13	19388-19393	value	_	
107-14	19394-19396	of	_	
107-15	19397-19400	the	_	
107-16	19401-19404	pth	_	
107-17	19405-19412	feature	_	
107-18	19413-19415	in	_	
107-19	19416-19419	the	_	
107-20	19420-19423	ith	_	
107-21	19424-19428	data	_	
107-22	19429-19433	site	_	
107-23	19433-19434	,	_	
107-24	19435-19437	xp	_	
107-25	19438-19445	denotes	_	
107-26	19446-19449	the	_	
107-27	19450-19453	pth	_	
107-28	19454-19461	feature	_	
107-29	19462-19467	value	_	
107-30	19467-19468	,	_	
107-31	19469-19472	and	_	
107-32	19473-19474	y	_	
107-33	19475-19482	denotes	_	
107-34	19483-19486	the	_	
107-35	19487-19493	sample	_	
107-36	19494-19499	label	_	
107-37	19499-19500	.	_	

#Text=Given one testing sample in the ith data site, the dot product of the feature weights, and the feature values of the K selected features were summed up to get the sample label.
108-1	19501-19506	Given	_	
108-2	19507-19510	one	_	
108-3	19511-19518	testing	_	
108-4	19519-19525	sample	_	
108-5	19526-19528	in	_	
108-6	19529-19532	the	_	
108-7	19533-19536	ith	_	
108-8	19537-19541	data	_	
108-9	19542-19546	site	_	
108-10	19546-19547	,	_	
108-11	19548-19551	the	_	
108-12	19552-19555	dot	_	
108-13	19556-19563	product	_	
108-14	19564-19566	of	_	
108-15	19567-19570	the	_	
108-16	19571-19578	feature	_	
108-17	19579-19586	weights	_	
108-18	19586-19587	,	_	
108-19	19588-19591	and	_	
108-20	19592-19595	the	_	
108-21	19596-19603	feature	_	
108-22	19604-19610	values	_	
108-23	19611-19613	of	_	
108-24	19614-19617	the	_	
108-25	19618-19619	K	_	
108-26	19620-19628	selected	_	
108-27	19629-19637	features	_	
108-28	19638-19642	were	_	
108-29	19643-19649	summed	_	
108-30	19650-19652	up	_	
108-31	19653-19655	to	_	
108-32	19656-19659	get	_	
108-33	19660-19663	the	_	
108-34	19664-19670	sample	_	
108-35	19671-19676	label	_	
108-36	19676-19677	.	_	

#Text=Validation experiments
#Text=Summary of the comparison methods.
109-1	19678-19688	Validation	_	
109-2	19689-19700	experiments	_	
109-3	19701-19708	Summary	_	
109-4	19709-19711	of	_	
109-5	19712-19715	the	_	
109-6	19716-19726	comparison	_	
109-7	19727-19734	methods	_	
109-8	19734-19735	.	_	

#Text=Table 2\t \t
#Text=Method\tDescription\t \tl2,1 + l1 (MS)\tThe proposed multi-task classification framework on multi-site data, which contains l2,1 + l1 regularization terms in the feature learning step, and the classifier based on the learned feature weights.
110-1	19736-19741	Table	_	
110-2	19742-19743	2	_	
110-3	19747-19753	Method	_	
110-4	19754-19765	Description	_	
110-5	19768-19772	l2,1	_	
110-6	19772-19773	 	_	
110-7	19773-19774	+	_	
110-8	19774-19775	 	_	
110-9	19775-19777	l1	_	
110-10	19778-19779	(	_	
110-11	19779-19781	MS	_	
110-12	19781-19782	)	_	
110-13	19783-19786	The	_	
110-14	19787-19795	proposed	_	
110-15	19796-19806	multi-task	_	
110-16	19807-19821	classification	_	
110-17	19822-19831	framework	_	
110-18	19832-19834	on	_	
110-19	19835-19845	multi-site	_	
110-20	19846-19850	data	_	
110-21	19850-19851	,	_	
110-22	19852-19857	which	_	
110-23	19858-19866	contains	_	
110-24	19867-19871	l2,1	_	
110-25	19871-19872	 	_	
110-26	19872-19873	+	_	
110-27	19873-19874	 	_	
110-28	19874-19876	l1	_	
110-29	19877-19891	regularization	_	
110-30	19892-19897	terms	_	
110-31	19898-19900	in	_	
110-32	19901-19904	the	_	
110-33	19905-19912	feature	_	
110-34	19913-19921	learning	_	
110-35	19922-19926	step	_	
110-36	19926-19927	,	_	
110-37	19928-19931	and	_	
110-38	19932-19935	the	_	
110-39	19936-19946	classifier	_	
110-40	19947-19952	based	_	
110-41	19953-19955	on	_	
110-42	19956-19959	the	_	
110-43	19960-19967	learned	_	
110-44	19968-19975	feature	_	
110-45	19976-19983	weights	_	
110-46	19983-19984	.	_	

#Text=l1 (SS)\tSingle-task classification on each single site data: the single-task feature learning step uses the l1 regularization term, and the classifier uses the same classifier formula as the multi-task classification framework.
111-1	19987-19989	l1	_	
111-2	19990-19991	(	_	
111-3	19991-19993	SS	_	
111-4	19993-19994	)	_	
111-5	19995-20006	Single-task	_	
111-6	20007-20021	classification	_	
111-7	20022-20024	on	_	
111-8	20025-20029	each	_	
111-9	20030-20036	single	_	
111-10	20037-20041	site	_	
111-11	20042-20046	data	_	
111-12	20046-20047	:	_	
111-13	20048-20051	the	_	
111-14	20052-20063	single-task	_	
111-15	20064-20071	feature	_	
111-16	20072-20080	learning	_	
111-17	20081-20085	step	_	
111-18	20086-20090	uses	_	
111-19	20091-20094	the	_	
111-20	20095-20097	l1	_	
111-21	20098-20112	regularization	_	
111-22	20113-20117	term	_	
111-23	20117-20118	,	_	
111-24	20119-20122	and	_	
111-25	20123-20126	the	_	
111-26	20127-20137	classifier	_	
111-27	20138-20142	uses	_	
111-28	20143-20146	the	_	
111-29	20147-20151	same	_	
111-30	20152-20162	classifier	_	
111-31	20163-20170	formula	_	
111-32	20171-20173	as	_	
111-33	20174-20177	the	_	
111-34	20178-20188	multi-task	_	
111-35	20189-20203	classification	_	
111-36	20204-20213	framework	_	
111-37	20213-20214	.	_	

#Text=l1 (PO)\tData from all the datasets are pooled together as a larger dataset.
112-1	20217-20219	l1	_	
112-2	20220-20221	(	_	
112-3	20221-20223	PO	_	
112-4	20223-20224	)	_	
112-5	20225-20229	Data	_	
112-6	20230-20234	from	_	
112-7	20235-20238	all	_	
112-8	20239-20242	the	_	
112-9	20243-20251	datasets	_	
112-10	20252-20255	are	_	
112-11	20256-20262	pooled	_	
112-12	20263-20271	together	_	
112-13	20272-20274	as	_	
112-14	20275-20276	a	_	
112-15	20277-20283	larger	_	
112-16	20284-20291	dataset	_	
112-17	20291-20292	.	_	

#Text=The classification framework is the same as the single-task classification.
113-1	20293-20296	The	_	
113-2	20297-20311	classification	_	
113-3	20312-20321	framework	_	
113-4	20322-20324	is	_	
113-5	20325-20328	the	_	
113-6	20329-20333	same	_	
113-7	20334-20336	as	_	
113-8	20337-20340	the	_	
113-9	20341-20352	single-task	_	
113-10	20353-20367	classification	_	
113-11	20367-20368	.	_	

#Text=l2,1 + l1 + SVM (MS)\tUsing multi-site data, the feature learning step is multi-task learning, and uses SVM classifier with the linear kernel.
114-1	20371-20375	l2,1	_	
114-2	20375-20376	 	_	
114-3	20376-20377	+	_	
114-4	20377-20378	 	_	
114-5	20378-20380	l1	_	
114-6	20380-20381	 	_	
114-7	20381-20382	+	_	
114-8	20382-20383	 	_	
114-9	20383-20386	SVM	_	
114-10	20387-20388	(	_	
114-11	20388-20390	MS	_	
114-12	20390-20391	)	_	
114-13	20392-20397	Using	_	
114-14	20398-20408	multi-site	_	
114-15	20409-20413	data	_	
114-16	20413-20414	,	_	
114-17	20415-20418	the	_	
114-18	20419-20426	feature	_	
114-19	20427-20435	learning	_	
114-20	20436-20440	step	_	
114-21	20441-20443	is	_	
114-22	20444-20454	multi-task	_	
114-23	20455-20463	learning	_	
114-24	20463-20464	,	_	
114-25	20465-20468	and	_	
114-26	20469-20473	uses	_	
114-27	20474-20477	SVM	_	
114-28	20478-20488	classifier	_	
114-29	20489-20493	with	_	
114-30	20494-20497	the	_	
114-31	20498-20504	linear	_	
114-32	20505-20511	kernel	_	
114-33	20511-20512	.	_	

#Text=l1 + SVM (SS)\tUse single-task feature learning framework and a SVM classifier to classify each single site data.
115-1	20515-20517	l1	_	
115-2	20517-20518	 	_	
115-3	20518-20519	+	_	
115-4	20519-20520	 	_	
115-5	20520-20523	SVM	_	
115-6	20524-20525	(	_	
115-7	20525-20527	SS	_	
115-8	20527-20528	)	_	
115-9	20529-20532	Use	_	
115-10	20533-20544	single-task	_	
115-11	20545-20552	feature	_	
115-12	20553-20561	learning	_	
115-13	20562-20571	framework	_	
115-14	20572-20575	and	_	
115-15	20576-20577	a	_	
115-16	20578-20581	SVM	_	
115-17	20582-20592	classifier	_	
115-18	20593-20595	to	_	
115-19	20596-20604	classify	_	
115-20	20605-20609	each	_	
115-21	20610-20616	single	_	
115-22	20617-20621	site	_	
115-23	20622-20626	data	_	
115-24	20626-20627	.	_	

#Text=l1 + SVM (PO)\tUse single-task feature learning framework and a SVM classifier to classify the pooled data.
116-1	20630-20632	l1	_	
116-2	20632-20633	 	_	
116-3	20633-20634	+	_	
116-4	20634-20635	 	_	
116-5	20635-20638	SVM	_	
116-6	20639-20640	(	_	
116-7	20640-20642	PO	_	
116-8	20642-20643	)	_	
116-9	20644-20647	Use	_	
116-10	20648-20659	single-task	_	
116-11	20660-20667	feature	_	
116-12	20668-20676	learning	_	
116-13	20677-20686	framework	_	
116-14	20687-20690	and	_	
116-15	20691-20692	a	_	
116-16	20693-20696	SVM	_	
116-17	20697-20707	classifier	_	
116-18	20708-20710	to	_	
116-19	20711-20719	classify	_	
116-20	20720-20723	the	_	
116-21	20724-20730	pooled	_	
116-22	20731-20735	data	_	
116-23	20735-20736	.	_	

#Text=PCA + SVM (SS)\tUse principal component analysis (PCA) to learn features in each single site data and a SVM classifier with the linear kernel.
117-1	20739-20742	PCA	_	
117-2	20742-20743	 	_	
117-3	20743-20744	+	_	
117-4	20744-20745	 	_	
117-5	20745-20748	SVM	_	
117-6	20749-20750	(	_	
117-7	20750-20752	SS	_	
117-8	20752-20753	)	_	
117-9	20754-20757	Use	_	
117-10	20758-20767	principal	_	
117-11	20768-20777	component	_	
117-12	20778-20786	analysis	_	
117-13	20787-20788	(	_	
117-14	20788-20791	PCA	_	
117-15	20791-20792	)	_	
117-16	20793-20795	to	_	
117-17	20796-20801	learn	_	
117-18	20802-20810	features	_	
117-19	20811-20813	in	_	
117-20	20814-20818	each	_	
117-21	20819-20825	single	_	
117-22	20826-20830	site	_	
117-23	20831-20835	data	_	
117-24	20836-20839	and	_	
117-25	20840-20841	a	_	
117-26	20842-20845	SVM	_	
117-27	20846-20856	classifier	_	
117-28	20857-20861	with	_	
117-29	20862-20865	the	_	
117-30	20866-20872	linear	_	
117-31	20873-20879	kernel	_	
117-32	20879-20880	.	_	

#Text=PCA + SVM (PO)\tUse principal component analysis (PCA) to learn features on the pooled data and a SVM classifier with the linear kernel.
118-1	20883-20886	PCA	_	
118-2	20886-20887	 	_	
118-3	20887-20888	+	_	
118-4	20888-20889	 	_	
118-5	20889-20892	SVM	_	
118-6	20893-20894	(	_	
118-7	20894-20896	PO	_	
118-8	20896-20897	)	_	
118-9	20898-20901	Use	_	
118-10	20902-20911	principal	_	
118-11	20912-20921	component	_	
118-12	20922-20930	analysis	_	
118-13	20931-20932	(	_	
118-14	20932-20935	PCA	_	
118-15	20935-20936	)	_	
118-16	20937-20939	to	_	
118-17	20940-20945	learn	_	
118-18	20946-20954	features	_	
118-19	20955-20957	on	_	
118-20	20958-20961	the	_	
118-21	20962-20968	pooled	_	
118-22	20969-20973	data	_	
118-23	20974-20977	and	_	
118-24	20978-20979	a	_	
118-25	20980-20983	SVM	_	
118-26	20984-20994	classifier	_	
118-27	20995-20999	with	_	
118-28	21000-21003	the	_	
118-29	21004-21010	linear	_	
118-30	21011-21017	kernel	_	
118-31	21017-21018	.	_	

#Text=ttest2 + SVM (SS)\tUse two-sample t-test (ttest2) to learn features in each single site data and a SVM classifier with the linear kernel.
119-1	21021-21027	ttest2	_	
119-2	21027-21028	 	_	
119-3	21028-21029	+	_	
119-4	21029-21030	 	_	
119-5	21030-21033	SVM	_	
119-6	21034-21035	(	_	
119-7	21035-21037	SS	_	
119-8	21037-21038	)	_	
119-9	21039-21042	Use	_	
119-10	21043-21053	two-sample	_	
119-11	21054-21060	t-test	_	
119-12	21061-21062	(	_	
119-13	21062-21068	ttest2	_	
119-14	21068-21069	)	_	
119-15	21070-21072	to	_	
119-16	21073-21078	learn	_	
119-17	21079-21087	features	_	
119-18	21088-21090	in	_	
119-19	21091-21095	each	_	
119-20	21096-21102	single	_	
119-21	21103-21107	site	_	
119-22	21108-21112	data	_	
119-23	21113-21116	and	_	
119-24	21117-21118	a	_	
119-25	21119-21122	SVM	_	
119-26	21123-21133	classifier	_	
119-27	21134-21138	with	_	
119-28	21139-21142	the	_	
119-29	21143-21149	linear	_	
119-30	21150-21156	kernel	_	
119-31	21156-21157	.	_	

#Text=ttest2 + SVM (PO)\tUsing two-sample t-test (ttest2) to learn features on the pooled data and a SVM classifier with the linear kernel.
120-1	21160-21166	ttest2	_	
120-2	21166-21167	 	_	
120-3	21167-21168	+	_	
120-4	21168-21169	 	_	
120-5	21169-21172	SVM	_	
120-6	21173-21174	(	_	
120-7	21174-21176	PO	_	
120-8	21176-21177	)	_	
120-9	21178-21183	Using	_	
120-10	21184-21194	two-sample	_	
120-11	21195-21201	t-test	_	
120-12	21202-21203	(	_	
120-13	21203-21209	ttest2	_	
120-14	21209-21210	)	_	
120-15	21211-21213	to	_	
120-16	21214-21219	learn	_	
120-17	21220-21228	features	_	
120-18	21229-21231	on	_	
120-19	21232-21235	the	_	
120-20	21236-21242	pooled	_	
120-21	21243-21247	data	_	
120-22	21248-21251	and	_	
120-23	21252-21253	a	_	
120-24	21254-21257	SVM	_	
120-25	21258-21268	classifier	_	
120-26	21269-21273	with	_	
120-27	21274-21277	the	_	
120-28	21278-21284	linear	_	
120-29	21285-21291	kernel	_	
120-30	21291-21292	.	_	

#Text=To evaluate the proposed method, ten comparison experiments were designed in the consideration of three aspects. (1) To show the effectiveness of gathering multi-site data, we reported the classification results of single-site, pooled, and multi-site data, respectively.
121-1	21296-21298	To	_	
121-2	21299-21307	evaluate	_	
121-3	21308-21311	the	_	
121-4	21312-21320	proposed	_	
121-5	21321-21327	method	_	
121-6	21327-21328	,	_	
121-7	21329-21332	ten	_	
121-8	21333-21343	comparison	_	
121-9	21344-21355	experiments	_	
121-10	21356-21360	were	_	
121-11	21361-21369	designed	_	
121-12	21370-21372	in	_	
121-13	21373-21376	the	_	
121-14	21377-21390	consideration	_	
121-15	21391-21393	of	_	
121-16	21394-21399	three	_	
121-17	21400-21407	aspects	_	
121-18	21407-21408	.	_	
121-19	21409-21410	(	_	
121-20	21410-21411	1	_	
121-21	21411-21412	)	_	
121-22	21413-21415	To	_	
121-23	21416-21420	show	_	
121-24	21421-21424	the	_	
121-25	21425-21438	effectiveness	_	
121-26	21439-21441	of	_	
121-27	21442-21451	gathering	_	
121-28	21452-21462	multi-site	_	
121-29	21463-21467	data	_	
121-30	21467-21468	,	_	
121-31	21469-21471	we	_	
121-32	21472-21480	reported	_	
121-33	21481-21484	the	_	
121-34	21485-21499	classification	_	
121-35	21500-21507	results	_	
121-36	21508-21510	of	_	
121-37	21511-21522	single-site	_	
121-38	21522-21523	,	_	
121-39	21524-21530	pooled	_	
121-40	21530-21531	,	_	
121-41	21532-21535	and	_	
121-42	21536-21546	multi-site	_	
121-43	21547-21551	data	_	
121-44	21551-21552	,	_	
121-45	21553-21565	respectively	_	
121-46	21565-21566	.	_	

#Text=Single-site classification learns features of each single-site data separately for classification; pooled classification pools the three data sites together as a larger dataset regardless of the site differences, which contributed to a simple binary classification of 150 controls and 150 patients; and multi-site classification uses multi-task learning to learn the site-specific and site-shared features simultaneously, in the three data sites, and combine the two types of features to classify each dataset separately. (2) To show the effectiveness of using multi-task feature learning framework, two widely used feature learning methods including principal component analysis (PCA) and two-sample t-test (ttest2) were also tested. (3) The proposed classifier based on the learned feature weights was compared to the SVM classifier with a linear kernel.
122-1	21567-21578	Single-site	_	
122-2	21579-21593	classification	_	
122-3	21594-21600	learns	_	
122-4	21601-21609	features	_	
122-5	21610-21612	of	_	
122-6	21613-21617	each	_	
122-7	21618-21629	single-site	_	
122-8	21630-21634	data	_	
122-9	21635-21645	separately	_	
122-10	21646-21649	for	_	
122-11	21650-21664	classification	_	
122-12	21664-21665	;	_	
122-13	21666-21672	pooled	_	
122-14	21673-21687	classification	_	
122-15	21688-21693	pools	_	
122-16	21694-21697	the	_	
122-17	21698-21703	three	_	
122-18	21704-21708	data	_	
122-19	21709-21714	sites	_	
122-20	21715-21723	together	_	
122-21	21724-21726	as	_	
122-22	21727-21728	a	_	
122-23	21729-21735	larger	_	
122-24	21736-21743	dataset	_	
122-25	21744-21754	regardless	_	
122-26	21755-21757	of	_	
122-27	21758-21761	the	_	
122-28	21762-21766	site	_	
122-29	21767-21778	differences	_	
122-30	21778-21779	,	_	
122-31	21780-21785	which	_	
122-32	21786-21797	contributed	_	
122-33	21798-21800	to	_	
122-34	21801-21802	a	_	
122-35	21803-21809	simple	_	
122-36	21810-21816	binary	_	
122-37	21817-21831	classification	_	
122-38	21832-21834	of	_	
122-39	21835-21838	150	_	
122-40	21839-21847	controls	_	
122-41	21848-21851	and	_	
122-42	21852-21855	150	_	
122-43	21856-21864	patients	_	
122-44	21864-21865	;	_	
122-45	21866-21869	and	_	
122-46	21870-21880	multi-site	_	
122-47	21881-21895	classification	_	
122-48	21896-21900	uses	_	
122-49	21901-21911	multi-task	_	
122-50	21912-21920	learning	_	
122-51	21921-21923	to	_	
122-52	21924-21929	learn	_	
122-53	21930-21933	the	_	
122-54	21934-21947	site-specific	_	
122-55	21948-21951	and	_	
122-56	21952-21963	site-shared	_	
122-57	21964-21972	features	_	
122-58	21973-21987	simultaneously	_	
122-59	21987-21988	,	_	
122-60	21989-21991	in	_	
122-61	21992-21995	the	_	
122-62	21996-22001	three	_	
122-63	22002-22006	data	_	
122-64	22007-22012	sites	_	
122-65	22012-22013	,	_	
122-66	22014-22017	and	_	
122-67	22018-22025	combine	_	
122-68	22026-22029	the	_	
122-69	22030-22033	two	_	
122-70	22034-22039	types	_	
122-71	22040-22042	of	_	
122-72	22043-22051	features	_	
122-73	22052-22054	to	_	
122-74	22055-22063	classify	_	
122-75	22064-22068	each	_	
122-76	22069-22076	dataset	_	
122-77	22077-22087	separately	_	
122-78	22087-22088	.	_	
122-79	22089-22090	(	_	
122-80	22090-22091	2	_	
122-81	22091-22092	)	_	
122-82	22093-22095	To	_	
122-83	22096-22100	show	_	
122-84	22101-22104	the	_	
122-85	22105-22118	effectiveness	_	
122-86	22119-22121	of	_	
122-87	22122-22127	using	_	
122-88	22128-22138	multi-task	_	
122-89	22139-22146	feature	_	
122-90	22147-22155	learning	_	
122-91	22156-22165	framework	_	
122-92	22165-22166	,	_	
122-93	22167-22170	two	_	
122-94	22171-22177	widely	_	
122-95	22178-22182	used	_	
122-96	22183-22190	feature	_	
122-97	22191-22199	learning	_	
122-98	22200-22207	methods	_	
122-99	22208-22217	including	_	
122-100	22218-22227	principal	_	
122-101	22228-22237	component	_	
122-102	22238-22246	analysis	_	
122-103	22247-22248	(	_	
122-104	22248-22251	PCA	_	
122-105	22251-22252	)	_	
122-106	22253-22256	and	_	
122-107	22257-22267	two-sample	_	
122-108	22268-22274	t-test	_	
122-109	22275-22276	(	_	
122-110	22276-22282	ttest2	_	
122-111	22282-22283	)	_	
122-112	22284-22288	were	_	
122-113	22289-22293	also	_	
122-114	22294-22300	tested	_	
122-115	22300-22301	.	_	
122-116	22302-22303	(	_	
122-117	22303-22304	3	_	
122-118	22304-22305	)	_	
122-119	22306-22309	The	_	
122-120	22310-22318	proposed	_	
122-121	22319-22329	classifier	_	
122-122	22330-22335	based	_	
122-123	22336-22338	on	_	
122-124	22339-22342	the	_	
122-125	22343-22350	learned	_	
122-126	22351-22358	feature	_	
122-127	22359-22366	weights	_	
122-128	22367-22370	was	_	
122-129	22371-22379	compared	_	
122-130	22380-22382	to	_	
122-131	22383-22386	the	_	
122-132	22387-22390	SVM	_	
122-133	22391-22401	classifier	_	
122-134	22402-22406	with	_	
122-135	22407-22408	a	_	
122-136	22409-22415	linear	_	
122-137	22416-22422	kernel	_	
122-138	22422-22423	.	_	

#Text=Differences between these two classifiers exist as the SVM focuses on the selected features and calculates new feature weights for classification, while our proposed classifier takes advantage of the feature weights obtained in the feature learning step, and then generate the classification label.
123-1	22424-22435	Differences	_	
123-2	22436-22443	between	_	
123-3	22444-22449	these	_	
123-4	22450-22453	two	_	
123-5	22454-22465	classifiers	_	
123-6	22466-22471	exist	_	
123-7	22472-22474	as	_	
123-8	22475-22478	the	_	
123-9	22479-22482	SVM	_	
123-10	22483-22490	focuses	_	
123-11	22491-22493	on	_	
123-12	22494-22497	the	_	
123-13	22498-22506	selected	_	
123-14	22507-22515	features	_	
123-15	22516-22519	and	_	
123-16	22520-22530	calculates	_	
123-17	22531-22534	new	_	
123-18	22535-22542	feature	_	
123-19	22543-22550	weights	_	
123-20	22551-22554	for	_	
123-21	22555-22569	classification	_	
123-22	22569-22570	,	_	
123-23	22571-22576	while	_	
123-24	22577-22580	our	_	
123-25	22581-22589	proposed	_	
123-26	22590-22600	classifier	_	
123-27	22601-22606	takes	_	
123-28	22607-22616	advantage	_	
123-29	22617-22619	of	_	
123-30	22620-22623	the	_	
123-31	22624-22631	feature	_	
123-32	22632-22639	weights	_	
123-33	22640-22648	obtained	_	
123-34	22649-22651	in	_	
123-35	22652-22655	the	_	
123-36	22656-22663	feature	_	
123-37	22664-22672	learning	_	
123-38	22673-22677	step	_	
123-39	22677-22678	,	_	
123-40	22679-22682	and	_	
123-41	22683-22687	then	_	
123-42	22688-22696	generate	_	
123-43	22697-22700	the	_	
123-44	22701-22715	classification	_	
123-45	22716-22721	label	_	
123-46	22721-22722	.	_	

#Text=Table 2 listed the ten comparison methods in the current study.
124-1	22723-22728	Table	_	
124-2	22729-22730	2	_	
124-3	22731-22737	listed	_	
124-4	22738-22741	the	_	
124-5	22742-22745	ten	_	
124-6	22746-22756	comparison	_	
124-7	22757-22764	methods	_	
124-8	22765-22767	in	_	
124-9	22768-22771	the	_	
124-10	22772-22779	current	_	
124-11	22780-22785	study	_	
124-12	22785-22786	.	_	

#Text=In the first three experiments, the same proposed feature learning and classifier framework was applied in the multi-site, single-site and pooled data classification, respectively.
125-1	22787-22789	In	_	
125-2	22790-22793	the	_	
125-3	22794-22799	first	_	
125-4	22800-22805	three	_	
125-5	22806-22817	experiments	_	
125-6	22817-22818	,	_	
125-7	22819-22822	the	_	
125-8	22823-22827	same	_	
125-9	22828-22836	proposed	_	
125-10	22837-22844	feature	_	
125-11	22845-22853	learning	_	
125-12	22854-22857	and	_	
125-13	22858-22868	classifier	_	
125-14	22869-22878	framework	_	
125-15	22879-22882	was	_	
125-16	22883-22890	applied	_	
125-17	22891-22893	in	_	
125-18	22894-22897	the	_	
125-19	22898-22908	multi-site	_	
125-20	22908-22909	,	_	
125-21	22910-22921	single-site	_	
125-22	22922-22925	and	_	
125-23	22926-22932	pooled	_	
125-24	22933-22937	data	_	
125-25	22938-22952	classification	_	
125-26	22952-22953	,	_	
125-27	22954-22966	respectively	_	
125-28	22966-22967	.	_	

#Text=In the single-site data classification, for each data site, we used the l1-norm feature selection, which included the hinge loss function and the l1-norm sparsity regularization term in the cost function.
126-1	22968-22970	In	_	
126-2	22971-22974	the	_	
126-3	22975-22986	single-site	_	
126-4	22987-22991	data	_	
126-5	22992-23006	classification	_	
126-6	23006-23007	,	_	
126-7	23008-23011	for	_	
126-8	23012-23016	each	_	
126-9	23017-23021	data	_	
126-10	23022-23026	site	_	
126-11	23026-23027	,	_	
126-12	23028-23030	we	_	
126-13	23031-23035	used	_	
126-14	23036-23039	the	_	
126-15	23040-23042	l1	_	
126-16	23042-23043	-	_	
126-17	23043-23047	norm	_	
126-18	23048-23055	feature	_	
126-19	23056-23065	selection	_	
126-20	23065-23066	,	_	
126-21	23067-23072	which	_	
126-22	23073-23081	included	_	
126-23	23082-23085	the	_	
126-24	23086-23091	hinge	_	
126-25	23092-23096	loss	_	
126-26	23097-23105	function	_	
126-27	23106-23109	and	_	
126-28	23110-23113	the	_	
126-29	23114-23116	l1	_	
126-30	23116-23117	-	_	
126-31	23117-23121	norm	_	
126-32	23122-23130	sparsity	_	
126-33	23131-23145	regularization	_	
126-34	23146-23150	term	_	
126-35	23151-23153	in	_	
126-36	23154-23157	the	_	
126-37	23158-23162	cost	_	
126-38	23163-23171	function	_	
126-39	23171-23172	.	_	

#Text=In the pooled data classification, the feature learning cost function was similar to the single-site classification, which considered the pooled data as a single cohort.
127-1	23173-23175	In	_	
127-2	23176-23179	the	_	
127-3	23180-23186	pooled	_	
127-4	23187-23191	data	_	
127-5	23192-23206	classification	_	
127-6	23206-23207	,	_	
127-7	23208-23211	the	_	
127-8	23212-23219	feature	_	
127-9	23220-23228	learning	_	
127-10	23229-23233	cost	_	
127-11	23234-23242	function	_	
127-12	23243-23246	was	_	
127-13	23247-23254	similar	_	
127-14	23255-23257	to	_	
127-15	23258-23261	the	_	
127-16	23262-23273	single-site	_	
127-17	23274-23288	classification	_	
127-18	23288-23289	,	_	
127-19	23290-23295	which	_	
127-20	23296-23306	considered	_	
127-21	23307-23310	the	_	
127-22	23311-23317	pooled	_	
127-23	23318-23322	data	_	
127-24	23323-23325	as	_	
127-25	23326-23327	a	_	
127-26	23328-23334	single	_	
127-27	23335-23341	cohort	_	
127-28	23341-23342	.	_	

#Text=Note that the feature learning framework applied in the single-site data classification and the pooled data classification was a special case of the multi-task feature learning framework, with the l2,1 sparsity regularization term disabled.
128-1	23343-23347	Note	_	
128-2	23348-23352	that	_	
128-3	23353-23356	the	_	
128-4	23357-23364	feature	_	
128-5	23365-23373	learning	_	
128-6	23374-23383	framework	_	
128-7	23384-23391	applied	_	
128-8	23392-23394	in	_	
128-9	23395-23398	the	_	
128-10	23399-23410	single-site	_	
128-11	23411-23415	data	_	
128-12	23416-23430	classification	_	
128-13	23431-23434	and	_	
128-14	23435-23438	the	_	
128-15	23439-23445	pooled	_	
128-16	23446-23450	data	_	
128-17	23451-23465	classification	_	
128-18	23466-23469	was	_	
128-19	23470-23471	a	_	
128-20	23472-23479	special	_	
128-21	23480-23484	case	_	
128-22	23485-23487	of	_	
128-23	23488-23491	the	_	
128-24	23492-23502	multi-task	_	
128-25	23503-23510	feature	_	
128-26	23511-23519	learning	_	
128-27	23520-23529	framework	_	
128-28	23529-23530	,	_	
128-29	23531-23535	with	_	
128-30	23536-23539	the	_	
128-31	23540-23544	l2,1	_	
128-32	23545-23553	sparsity	_	
128-33	23554-23568	regularization	_	
128-34	23569-23573	term	_	
128-35	23574-23582	disabled	_	
128-36	23582-23583	.	_	

#Text=The site-specific features were learned in the same way in all three classification experiments, while the site-shared features were only emphasized in multi-site learning, which could show the influence of site-shared features more clearly.
129-1	23584-23587	The	_	
129-2	23588-23601	site-specific	_	
129-3	23602-23610	features	_	
129-4	23611-23615	were	_	
129-5	23616-23623	learned	_	
129-6	23624-23626	in	_	
129-7	23627-23630	the	_	
129-8	23631-23635	same	_	
129-9	23636-23639	way	_	
129-10	23640-23642	in	_	
129-11	23643-23646	all	_	
129-12	23647-23652	three	_	
129-13	23653-23667	classification	_	
129-14	23668-23679	experiments	_	
129-15	23679-23680	,	_	
129-16	23681-23686	while	_	
129-17	23687-23690	the	_	
129-18	23691-23702	site-shared	_	
129-19	23703-23711	features	_	
129-20	23712-23716	were	_	
129-21	23717-23721	only	_	
129-22	23722-23732	emphasized	_	
129-23	23733-23735	in	_	
129-24	23736-23746	multi-site	_	
129-25	23747-23755	learning	_	
129-26	23755-23756	,	_	
129-27	23757-23762	which	_	
129-28	23763-23768	could	_	
129-29	23769-23773	show	_	
129-30	23774-23777	the	_	
129-31	23778-23787	influence	_	
129-32	23788-23790	of	_	
129-33	23791-23802	site-shared	_	
129-34	23803-23811	features	_	
129-35	23812-23816	more	_	
129-36	23817-23824	clearly	_	
129-37	23824-23825	.	_	

#Text=The classifier for single-site data and pooled data classification was the same as Eq. (3), however, increasing weights of site-shared features in Eq. (2) was not applied as we did in multi-site learning, since there were no site-shared features in the single-site and pooled data classification.
130-1	23826-23829	The	_	
130-2	23830-23840	classifier	_	
130-3	23841-23844	for	_	
130-4	23845-23856	single-site	_	
130-5	23857-23861	data	_	
130-6	23862-23865	and	_	
130-7	23866-23872	pooled	_	
130-8	23873-23877	data	_	
130-9	23878-23892	classification	_	
130-10	23893-23896	was	_	
130-11	23897-23900	the	_	
130-12	23901-23905	same	_	
130-13	23906-23908	as	_	
130-14	23909-23911	Eq	_	
130-15	23911-23912	.	_	
130-16	23913-23914	(	_	
130-17	23914-23915	3	_	
130-18	23915-23916	)	_	
130-19	23916-23917	,	_	
130-20	23918-23925	however	_	
130-21	23925-23926	,	_	
130-22	23927-23937	increasing	_	
130-23	23938-23945	weights	_	
130-24	23946-23948	of	_	
130-25	23949-23960	site-shared	_	
130-26	23961-23969	features	_	
130-27	23970-23972	in	_	
130-28	23973-23975	Eq	_	
130-29	23975-23976	.	_	
130-30	23977-23978	(	_	
130-31	23978-23979	2	_	
130-32	23979-23980	)	_	
130-33	23981-23984	was	_	
130-34	23985-23988	not	_	
130-35	23989-23996	applied	_	
130-36	23997-23999	as	_	
130-37	24000-24002	we	_	
130-38	24003-24006	did	_	
130-39	24007-24009	in	_	
130-40	24010-24020	multi-site	_	
130-41	24021-24029	learning	_	
130-42	24029-24030	,	_	
130-43	24031-24036	since	_	
130-44	24037-24042	there	_	
130-45	24043-24047	were	_	
130-46	24048-24050	no	_	
130-47	24051-24062	site-shared	_	
130-48	24063-24071	features	_	
130-49	24072-24074	in	_	
130-50	24075-24078	the	_	
130-51	24079-24090	single-site	_	
130-52	24091-24094	and	_	
130-53	24095-24101	pooled	_	
130-54	24102-24106	data	_	
130-55	24107-24121	classification	_	
130-56	24121-24122	.	_	

#Text=In other seven experiments, the SVM classifier with a linear kernel was used after different feature learning methods.
131-1	24123-24125	In	_	
131-2	24126-24131	other	_	
131-3	24132-24137	seven	_	
131-4	24138-24149	experiments	_	
131-5	24149-24150	,	_	
131-6	24151-24154	the	_	
131-7	24155-24158	SVM	_	
131-8	24159-24169	classifier	_	
131-9	24170-24174	with	_	
131-10	24175-24176	a	_	
131-11	24177-24183	linear	_	
131-12	24184-24190	kernel	_	
131-13	24191-24194	was	_	
131-14	24195-24199	used	_	
131-15	24200-24205	after	_	
131-16	24206-24215	different	_	
131-17	24216-24223	feature	_	
131-18	24224-24232	learning	_	
131-19	24233-24240	methods	_	
131-20	24240-24241	.	_	

#Text=As shown in Table 2, the 4th to 6th experiments used the proposed multi-task feature learning technique, taking the feature learning method in single-site and pooled data as a special case of multi-site feature learning.
132-1	24242-24244	As	_	
132-2	24245-24250	shown	_	
132-3	24251-24253	in	_	
132-4	24254-24259	Table	_	
132-5	24260-24261	2	_	
132-6	24261-24262	,	_	
132-7	24263-24266	the	_	
132-8	24267-24270	4th	_	
132-9	24271-24273	to	_	
132-10	24274-24277	6th	_	
132-11	24278-24289	experiments	_	
132-12	24290-24294	used	_	
132-13	24295-24298	the	_	
132-14	24299-24307	proposed	_	
132-15	24308-24318	multi-task	_	
132-16	24319-24326	feature	_	
132-17	24327-24335	learning	_	
132-18	24336-24345	technique	_	
132-19	24345-24346	,	_	
132-20	24347-24353	taking	_	
132-21	24354-24357	the	_	
132-22	24358-24365	feature	_	
132-23	24366-24374	learning	_	
132-24	24375-24381	method	_	
132-25	24382-24384	in	_	
132-26	24385-24396	single-site	_	
132-27	24397-24400	and	_	
132-28	24401-24407	pooled	_	
132-29	24408-24412	data	_	
132-30	24413-24415	as	_	
132-31	24416-24417	a	_	
132-32	24418-24425	special	_	
132-33	24426-24430	case	_	
132-34	24431-24433	of	_	
132-35	24434-24444	multi-site	_	
132-36	24445-24452	feature	_	
132-37	24453-24461	learning	_	
132-38	24461-24462	.	_	

#Text=In the 7th and 8th experiments, the PCA method was used, while in the 9th and 10th experiments, the ttest2 method was used in the single-site and pooled data classification, respectively.
133-1	24463-24465	In	_	
133-2	24466-24469	the	_	
133-3	24470-24473	7th	_	
133-4	24474-24477	and	_	
133-5	24478-24481	8th	_	
133-6	24482-24493	experiments	_	
133-7	24493-24494	,	_	
133-8	24495-24498	the	_	
133-9	24499-24502	PCA	_	
133-10	24503-24509	method	_	
133-11	24510-24513	was	_	
133-12	24514-24518	used	_	
133-13	24518-24519	,	_	
133-14	24520-24525	while	_	
133-15	24526-24528	in	_	
133-16	24529-24532	the	_	
133-17	24533-24536	9th	_	
133-18	24537-24540	and	_	
133-19	24541-24545	10th	_	
133-20	24546-24557	experiments	_	
133-21	24557-24558	,	_	
133-22	24559-24562	the	_	
133-23	24563-24569	ttest2	_	
133-24	24570-24576	method	_	
133-25	24577-24580	was	_	
133-26	24581-24585	used	_	
133-27	24586-24588	in	_	
133-28	24589-24592	the	_	
133-29	24593-24604	single-site	_	
133-30	24605-24608	and	_	
133-31	24609-24615	pooled	_	
133-32	24616-24620	data	_	
133-33	24621-24635	classification	_	
133-34	24635-24636	,	_	
133-35	24637-24649	respectively	_	
133-36	24649-24650	.	_	

#Text=The nested loop 5-fold cross-validation was used in the ten experiments to evaluate the classification performance.
134-1	24651-24654	The	_	
134-2	24655-24661	nested	_	
134-3	24662-24666	loop	_	
134-4	24667-24668	5	_	
134-5	24668-24669	-	_	
134-6	24669-24673	fold	_	
134-7	24674-24690	cross-validation	_	
134-8	24691-24694	was	_	
134-9	24695-24699	used	_	
134-10	24700-24702	in	_	
134-11	24703-24706	the	_	
134-12	24707-24710	ten	_	
134-13	24711-24722	experiments	_	
134-14	24723-24725	to	_	
134-15	24726-24734	evaluate	_	
134-16	24735-24738	the	_	
134-17	24739-24753	classification	_	
134-18	24754-24765	performance	_	
134-19	24765-24766	.	_	

#Text=In specific, the samples were randomly separated into five subsets: one (20% of all samples) was used for testing, and the other four (80% of all samples) were divided further into two parts with the proportion rates of 80% (64% of all samples) and 20% (16% of all samples), respectively.
135-1	24767-24769	In	_	
135-2	24770-24778	specific	_	
135-3	24778-24779	,	_	
135-4	24780-24783	the	_	
135-5	24784-24791	samples	_	
135-6	24792-24796	were	_	
135-7	24797-24805	randomly	_	
135-8	24806-24815	separated	_	
135-9	24816-24820	into	_	
135-10	24821-24825	five	_	
135-11	24826-24833	subsets	_	
135-12	24833-24834	:	_	
135-13	24835-24838	one	_	
135-14	24839-24840	(	_	
135-15	24840-24843	20%	_	
135-16	24844-24846	of	_	
135-17	24847-24850	all	_	
135-18	24851-24858	samples	_	
135-19	24858-24859	)	_	
135-20	24860-24863	was	_	
135-21	24864-24868	used	_	
135-22	24869-24872	for	_	
135-23	24873-24880	testing	_	
135-24	24880-24881	,	_	
135-25	24882-24885	and	_	
135-26	24886-24889	the	_	
135-27	24890-24895	other	_	
135-28	24896-24900	four	_	
135-29	24901-24902	(	_	
135-30	24902-24905	80%	_	
135-31	24906-24908	of	_	
135-32	24909-24912	all	_	
135-33	24913-24920	samples	_	
135-34	24920-24921	)	_	
135-35	24922-24926	were	_	
135-36	24927-24934	divided	_	
135-37	24935-24942	further	_	
135-38	24943-24947	into	_	
135-39	24948-24951	two	_	
135-40	24952-24957	parts	_	
135-41	24958-24962	with	_	
135-42	24963-24966	the	_	
135-43	24967-24977	proportion	_	
135-44	24978-24983	rates	_	
135-45	24984-24986	of	_	
135-46	24987-24990	80%	_	
135-47	24991-24992	(	_	
135-48	24992-24995	64%	_	
135-49	24996-24998	of	_	
135-50	24999-25002	all	_	
135-51	25003-25010	samples	_	
135-52	25010-25011	)	_	
135-53	25012-25015	and	_	
135-54	25016-25019	20%	_	
135-55	25020-25021	(	_	
135-56	25021-25024	16%	_	
135-57	25025-25027	of	_	
135-58	25028-25031	all	_	
135-59	25032-25039	samples	_	
135-60	25039-25040	)	_	
135-61	25040-25041	,	_	
135-62	25042-25054	respectively	_	
135-63	25054-25055	.	_	

#Text=The larger of the two parts was used as a training set, and the smaller part was used as a validation set, as described previously.
136-1	25056-25059	The	_	
136-2	25060-25066	larger	_	
136-3	25067-25069	of	_	
136-4	25070-25073	the	_	
136-5	25074-25077	two	_	
136-6	25078-25083	parts	_	
136-7	25084-25087	was	_	
136-8	25088-25092	used	_	
136-9	25093-25095	as	_	
136-10	25096-25097	a	_	
136-11	25098-25106	training	_	
136-12	25107-25110	set	_	
136-13	25110-25111	,	_	
136-14	25112-25115	and	_	
136-15	25116-25119	the	_	
136-16	25120-25127	smaller	_	
136-17	25128-25132	part	_	
136-18	25133-25136	was	_	
136-19	25137-25141	used	_	
136-20	25142-25144	as	_	
136-21	25145-25146	a	_	
136-22	25147-25157	validation	_	
136-23	25158-25161	set	_	
136-24	25161-25162	,	_	
136-25	25163-25165	as	_	
136-26	25166-25175	described	_	
136-27	25176-25186	previously	_	
136-28	25186-25187	.	_	

#Text=The training samples were used for feature learning and classifier training, while the validation samples were used to tune all parameters with the trained classifier, and the best parameter set which contributed to the best classification accuracy of the validation samples was selected.
137-1	25188-25191	The	_	
137-2	25192-25200	training	_	
137-3	25201-25208	samples	_	
137-4	25209-25213	were	_	
137-5	25214-25218	used	_	
137-6	25219-25222	for	_	
137-7	25223-25230	feature	_	
137-8	25231-25239	learning	_	
137-9	25240-25243	and	_	
137-10	25244-25254	classifier	_	
137-11	25255-25263	training	_	
137-12	25263-25264	,	_	
137-13	25265-25270	while	_	
137-14	25271-25274	the	_	
137-15	25275-25285	validation	_	
137-16	25286-25293	samples	_	
137-17	25294-25298	were	_	
137-18	25299-25303	used	_	
137-19	25304-25306	to	_	
137-20	25307-25311	tune	_	
137-21	25312-25315	all	_	
137-22	25316-25326	parameters	_	
137-23	25327-25331	with	_	
137-24	25332-25335	the	_	
137-25	25336-25343	trained	_	
137-26	25344-25354	classifier	_	
137-27	25354-25355	,	_	
137-28	25356-25359	and	_	
137-29	25360-25363	the	_	
137-30	25364-25368	best	_	
137-31	25369-25378	parameter	_	
137-32	25379-25382	set	_	
137-33	25383-25388	which	_	
137-34	25389-25400	contributed	_	
137-35	25401-25403	to	_	
137-36	25404-25407	the	_	
137-37	25408-25412	best	_	
137-38	25413-25427	classification	_	
137-39	25428-25436	accuracy	_	
137-40	25437-25439	of	_	
137-41	25440-25443	the	_	
137-42	25444-25454	validation	_	
137-43	25455-25462	samples	_	
137-44	25463-25466	was	_	
137-45	25467-25475	selected	_	
137-46	25475-25476	.	_	

#Text=Finally, the best parameters in the validation step were used to classify the testing samples and obtain the classification result.
138-1	25477-25484	Finally	_	
138-2	25484-25485	,	_	
138-3	25486-25489	the	_	
138-4	25490-25494	best	_	
138-5	25495-25505	parameters	_	
138-6	25506-25508	in	_	
138-7	25509-25512	the	_	
138-8	25513-25523	validation	_	
138-9	25524-25528	step	_	
138-10	25529-25533	were	_	
138-11	25534-25538	used	_	
138-12	25539-25541	to	_	
138-13	25542-25550	classify	_	
138-14	25551-25554	the	_	
138-15	25555-25562	testing	_	
138-16	25563-25570	samples	_	
138-17	25571-25574	and	_	
138-18	25575-25581	obtain	_	
138-19	25582-25585	the	_	
138-20	25586-25600	classification	_	
138-21	25601-25607	result	_	
138-22	25607-25608	.	_	

#Text=The whole process was repeated for 20 repeated experiments.
139-1	25609-25612	The	_	
139-2	25613-25618	whole	_	
139-3	25619-25626	process	_	
139-4	25627-25630	was	_	
139-5	25631-25639	repeated	_	
139-6	25640-25643	for	_	
139-7	25644-25646	20	_	
139-8	25647-25655	repeated	_	
139-9	25656-25667	experiments	_	
139-10	25667-25668	.	_	

#Text=The average accuracies of the 20 iterations for each site was considered as the final classification result.
140-1	25669-25672	The	_	
140-2	25673-25680	average	_	
140-3	25681-25691	accuracies	_	
140-4	25692-25694	of	_	
140-5	25695-25698	the	_	
140-6	25699-25701	20	_	
140-7	25702-25712	iterations	_	
140-8	25713-25716	for	_	
140-9	25717-25721	each	_	
140-10	25722-25726	site	_	
140-11	25727-25730	was	_	
140-12	25731-25741	considered	_	
140-13	25742-25744	as	_	
140-14	25745-25748	the	_	
140-15	25749-25754	final	_	
140-16	25755-25769	classification	_	
140-17	25770-25776	result	_	
140-18	25776-25777	.	_	

#Text=The parameters of the multi-task feature learning framework were tuned by grid searching the regularization factors in the range of α, β ∈ {10−8, 10−6, 10−4, 10−2, 10−1, 0.3, 0.5, 1, 5, 10, 102, 103}, while in the special case of using multi-task feature learning in the single-site and pooled data, the l2,1-norm term was disabled and β was set to 0.
141-1	25778-25781	The	_	
141-2	25782-25792	parameters	_	
141-3	25793-25795	of	_	
141-4	25796-25799	the	_	
141-5	25800-25810	multi-task	_	
141-6	25811-25818	feature	_	
141-7	25819-25827	learning	_	
141-8	25828-25837	framework	_	
141-9	25838-25842	were	_	
141-10	25843-25848	tuned	_	
141-11	25849-25851	by	_	
141-12	25852-25856	grid	_	
141-13	25857-25866	searching	_	
141-14	25867-25870	the	_	
141-15	25871-25885	regularization	_	
141-16	25886-25893	factors	_	
141-17	25894-25896	in	_	
141-18	25897-25900	the	_	
141-19	25901-25906	range	_	
141-20	25907-25909	of	_	
141-21	25910-25911	α	_	
141-22	25911-25912	,	_	
141-23	25913-25914	β	_	
141-24	25914-25915	 	_	
141-25	25915-25916	∈	_	
141-26	25916-25917	 	_	
141-27	25917-25918	{	_	
141-28	25918-25920	10	_	
141-29	25920-25921	−	_	
141-30	25921-25922	8	_	
141-31	25922-25923	,	_	
141-32	25924-25926	10	_	
141-33	25926-25927	−	_	
141-34	25927-25928	6	_	
141-35	25928-25929	,	_	
141-36	25930-25932	10	_	
141-37	25932-25933	−	_	
141-38	25933-25934	4	_	
141-39	25934-25935	,	_	
141-40	25936-25938	10	_	
141-41	25938-25939	−	_	
141-42	25939-25940	2	_	
141-43	25940-25941	,	_	
141-44	25942-25944	10	_	
141-45	25944-25945	−	_	
141-46	25945-25946	1	_	
141-47	25946-25947	,	_	
141-48	25948-25951	0.3	_	
141-49	25951-25952	,	_	
141-50	25953-25956	0.5	_	
141-51	25956-25957	,	_	
141-52	25958-25959	1	_	
141-53	25959-25960	,	_	
141-54	25961-25962	5	_	
141-55	25962-25963	,	_	
141-56	25964-25966	10	_	
141-57	25966-25967	,	_	
141-58	25968-25971	102	_	
141-59	25971-25972	,	_	
141-60	25973-25976	103	_	
141-61	25976-25977	}	_	
141-62	25977-25978	,	_	
141-63	25979-25984	while	_	
141-64	25985-25987	in	_	
141-65	25988-25991	the	_	
141-66	25992-25999	special	_	
141-67	26000-26004	case	_	
141-68	26005-26007	of	_	
141-69	26008-26013	using	_	
141-70	26014-26024	multi-task	_	
141-71	26025-26032	feature	_	
141-72	26033-26041	learning	_	
141-73	26042-26044	in	_	
141-74	26045-26048	the	_	
141-75	26049-26060	single-site	_	
141-76	26061-26064	and	_	
141-77	26065-26071	pooled	_	
141-78	26072-26076	data	_	
141-79	26076-26077	,	_	
141-80	26078-26081	the	_	
141-81	26082-26086	l2,1	_	
141-82	26086-26087	-	_	
141-83	26087-26091	norm	_	
141-84	26092-26096	term	_	
141-85	26097-26100	was	_	
141-86	26101-26109	disabled	_	
141-87	26110-26113	and	_	
141-88	26114-26115	β	_	
141-89	26116-26119	was	_	
141-90	26120-26123	set	_	
141-91	26124-26126	to	_	
141-92	26127-26128	0	_	
141-93	26128-26129	.	_	

#Text=In the proposed classifier in the multi-site classification (the first experiment), the ratio to increase the site-shared feature weights γ was tuned in the range of {1, 2, …, 100}.
142-1	26130-26132	In	_	
142-2	26133-26136	the	_	
142-3	26137-26145	proposed	_	
142-4	26146-26156	classifier	_	
142-5	26157-26159	in	_	
142-6	26160-26163	the	_	
142-7	26164-26174	multi-site	_	
142-8	26175-26189	classification	_	
142-9	26190-26191	(	_	
142-10	26191-26194	the	_	
142-11	26195-26200	first	_	
142-12	26201-26211	experiment	_	
142-13	26211-26212	)	_	
142-14	26212-26213	,	_	
142-15	26214-26217	the	_	
142-16	26218-26223	ratio	_	
142-17	26224-26226	to	_	
142-18	26227-26235	increase	_	
142-19	26236-26239	the	_	
142-20	26240-26251	site-shared	_	
142-21	26252-26259	feature	_	
142-22	26260-26267	weights	_	
142-23	26268-26269	γ	_	
142-24	26270-26273	was	_	
142-25	26274-26279	tuned	_	
142-26	26280-26282	in	_	
142-27	26283-26286	the	_	
142-28	26287-26292	range	_	
142-29	26293-26295	of	_	
142-30	26296-26297	{	_	
142-31	26297-26298	1	_	
142-32	26298-26299	,	_	
142-33	26300-26301	2	_	
142-34	26301-26302	,	_	
142-35	26303-26304	…	_	
142-36	26304-26305	,	_	
142-37	26306-26309	100	_	
142-38	26309-26310	}	_	
142-39	26310-26311	.	_	

#Text=The number of selected features K ranged from {500, …, 20,000}, with the step-size of 100.
143-1	26312-26315	The	_	
143-2	26316-26322	number	_	
143-3	26323-26325	of	_	
143-4	26326-26334	selected	_	
143-5	26335-26343	features	_	
143-6	26344-26345	K	_	
143-7	26346-26352	ranged	_	
143-8	26353-26357	from	_	
143-9	26358-26359	{	_	
143-10	26359-26362	500	_	
143-11	26362-26363	,	_	
143-12	26364-26365	…	_	
143-13	26365-26366	,	_	
143-14	26367-26373	20,000	_	
143-15	26373-26374	}	_	
143-16	26374-26375	,	_	
143-17	26376-26380	with	_	
143-18	26381-26384	the	_	
143-19	26385-26394	step-size	_	
143-20	26395-26397	of	_	
143-21	26398-26401	100	_	
143-22	26401-26402	.	_	

#Text=In the experiments with the SVM classifier, the linear kernel was used and the cost value C was set to 1.
144-1	26403-26405	In	_	
144-2	26406-26409	the	_	
144-3	26410-26421	experiments	_	
144-4	26422-26426	with	_	
144-5	26427-26430	the	_	
144-6	26431-26434	SVM	_	
144-7	26435-26445	classifier	_	
144-8	26445-26446	,	_	
144-9	26447-26450	the	_	
144-10	26451-26457	linear	_	
144-11	26458-26464	kernel	_	
144-12	26465-26468	was	_	
144-13	26469-26473	used	_	
144-14	26474-26477	and	_	
144-15	26478-26481	the	_	
144-16	26482-26486	cost	_	
144-17	26487-26492	value	_	
144-18	26493-26494	C	_	
144-19	26495-26498	was	_	
144-20	26499-26502	set	_	
144-21	26503-26505	to	_	
144-22	26506-26507	1	_	
144-23	26507-26508	.	_	

#Text=The site-shared and site-specific features were obtained in the multi-site classification, which used the proposed multi-task learning framework.
145-1	26509-26512	The	_	
145-2	26513-26524	site-shared	_	
145-3	26525-26528	and	_	
145-4	26529-26542	site-specific	_	
145-5	26543-26551	features	_	
145-6	26552-26556	were	_	
145-7	26557-26565	obtained	_	
145-8	26566-26568	in	_	
145-9	26569-26572	the	_	
145-10	26573-26583	multi-site	_	
145-11	26584-26598	classification	_	
145-12	26598-26599	,	_	
145-13	26600-26605	which	_	
145-14	26606-26610	used	_	
145-15	26611-26614	the	_	
145-16	26615-26623	proposed	_	
145-17	26624-26634	multi-task	_	
145-18	26635-26643	learning	_	
145-19	26644-26653	framework	_	
145-20	26653-26654	.	_	

#Text=After the parameter tuning, the best parameter set of the regulation terms α, β, the number of selected features K, and the site-shared feature increasing ratio γ were obtained.
146-1	26655-26660	After	_	
146-2	26661-26664	the	_	
146-3	26665-26674	parameter	_	
146-4	26675-26681	tuning	_	
146-5	26681-26682	,	_	
146-6	26683-26686	the	_	
146-7	26687-26691	best	_	
146-8	26692-26701	parameter	_	
146-9	26702-26705	set	_	
146-10	26706-26708	of	_	
146-11	26709-26712	the	_	
146-12	26713-26723	regulation	_	
146-13	26724-26729	terms	_	
146-14	26730-26731	α	_	
146-15	26731-26732	,	_	
146-16	26733-26734	β	_	
146-17	26734-26735	,	_	
146-18	26736-26739	the	_	
146-19	26740-26746	number	_	
146-20	26747-26749	of	_	
146-21	26750-26758	selected	_	
146-22	26759-26767	features	_	
146-23	26768-26769	K	_	
146-24	26769-26770	,	_	
146-25	26771-26774	and	_	
146-26	26775-26778	the	_	
146-27	26779-26790	site-shared	_	
146-28	26791-26798	feature	_	
146-29	26799-26809	increasing	_	
146-30	26810-26815	ratio	_	
146-31	26816-26817	γ	_	
146-32	26818-26822	were	_	
146-33	26823-26831	obtained	_	
146-34	26831-26832	.	_	

#Text=In each iteration, the best classification accuracy in each site corresponded to a specific W vector.
147-1	26833-26835	In	_	
147-2	26836-26840	each	_	
147-3	26841-26850	iteration	_	
147-4	26850-26851	,	_	
147-5	26852-26855	the	_	
147-6	26856-26860	best	_	
147-7	26861-26875	classification	_	
147-8	26876-26884	accuracy	_	
147-9	26885-26887	in	_	
147-10	26888-26892	each	_	
147-11	26893-26897	site	_	
147-12	26898-26910	corresponded	_	
147-13	26911-26913	to	_	
147-14	26914-26915	a	_	
147-15	26916-26924	specific	_	
147-16	26925-26926	W	_	
147-17	26927-26933	vector	_	
147-18	26933-26934	.	_	

#Text=We first calculated the mean W vectors of the 20 iterations that were contributed to the best accuracy in all three sites respectively, then the mean W vector of sites A, B, and C was obtained.
148-1	26935-26937	We	_	
148-2	26938-26943	first	_	
148-3	26944-26954	calculated	_	
148-4	26955-26958	the	_	
148-5	26959-26963	mean	_	
148-6	26964-26965	W	_	
148-7	26966-26973	vectors	_	
148-8	26974-26976	of	_	
148-9	26977-26980	the	_	
148-10	26981-26983	20	_	
148-11	26984-26994	iterations	_	
148-12	26995-26999	that	_	
148-13	27000-27004	were	_	
148-14	27005-27016	contributed	_	
148-15	27017-27019	to	_	
148-16	27020-27023	the	_	
148-17	27024-27028	best	_	
148-18	27029-27037	accuracy	_	
148-19	27038-27040	in	_	
148-20	27041-27044	all	_	
148-21	27045-27050	three	_	
148-22	27051-27056	sites	_	
148-23	27057-27069	respectively	_	
148-24	27069-27070	,	_	
148-25	27071-27075	then	_	
148-26	27076-27079	the	_	
148-27	27080-27084	mean	_	
148-28	27085-27086	W	_	
148-29	27087-27093	vector	_	
148-30	27094-27096	of	_	
148-31	27097-27102	sites	_	
148-32	27103-27104	A	_	
148-33	27104-27105	,	_	
148-34	27106-27107	B	_	
148-35	27107-27108	,	_	
148-36	27109-27112	and	_	
148-37	27113-27114	C	_	
148-38	27115-27118	was	_	
148-39	27119-27127	obtained	_	
148-40	27127-27128	.	_	

#Text=The consensus features with weights that ranked the top 5% of the three sites were shown as the site-shared features, and the remaining features were considered as the site-specific features for each site, respectively.
149-1	27129-27132	The	_	
149-2	27133-27142	consensus	_	
149-3	27143-27151	features	_	
149-4	27152-27156	with	_	
149-5	27157-27164	weights	_	
149-6	27165-27169	that	_	
149-7	27170-27176	ranked	_	
149-8	27177-27180	the	_	
149-9	27181-27184	top	_	
149-10	27185-27187	5%	_	
149-11	27188-27190	of	_	
149-12	27191-27194	the	_	
149-13	27195-27200	three	_	
149-14	27201-27206	sites	_	
149-15	27207-27211	were	_	
149-16	27212-27217	shown	_	
149-17	27218-27220	as	_	
149-18	27221-27224	the	_	
149-19	27225-27236	site-shared	_	
149-20	27237-27245	features	_	
149-21	27245-27246	,	_	
149-22	27247-27250	and	_	
149-23	27251-27254	the	_	
149-24	27255-27264	remaining	_	
149-25	27265-27273	features	_	
149-26	27274-27278	were	_	
149-27	27279-27289	considered	_	
149-28	27290-27292	as	_	
149-29	27293-27296	the	_	
149-30	27297-27310	site-specific	_	
149-31	27311-27319	features	_	
149-32	27320-27323	for	_	
149-33	27324-27328	each	_	
149-34	27329-27333	site	_	
149-35	27333-27334	,	_	
149-36	27335-27347	respectively	_	
149-37	27347-27348	.	_	

#Text=The feature weights of the site-shared and site-specific features were displayed using the Caret package, in which the clusters comprising of >50 voxels were shown.
150-1	27349-27352	The	_	
150-2	27353-27360	feature	_	
150-3	27361-27368	weights	_	
150-4	27369-27371	of	_	
150-5	27372-27375	the	_	
150-6	27376-27387	site-shared	_	
150-7	27388-27391	and	_	
150-8	27392-27405	site-specific	_	
150-9	27406-27414	features	_	
150-10	27415-27419	were	_	
150-11	27420-27429	displayed	_	
150-12	27430-27435	using	_	
150-13	27436-27439	the	_	
150-14	27440-27445	Caret	_	
150-15	27446-27453	package	_	
150-16	27453-27454	,	_	
150-17	27455-27457	in	_	
150-18	27458-27463	which	_	
150-19	27464-27467	the	_	
150-20	27468-27476	clusters	_	
150-21	27477-27487	comprising	_	
150-22	27488-27490	of	_	
150-23	27491-27492	>	_	
150-24	27492-27494	50	_	
150-25	27494-27495	 	_	
150-26	27495-27501	voxels	_	
150-27	27502-27506	were	_	
150-28	27507-27512	shown	_	
150-29	27512-27513	.	_	

#Text=Results
#Text=The average accuracy values of multi-site, single-site and pooling classification with 20 repetitions in 10 experiments.
151-1	27514-27521	Results	_	
151-2	27522-27525	The	_	
151-3	27526-27533	average	_	
151-4	27534-27542	accuracy	_	
151-5	27543-27549	values	_	
151-6	27550-27552	of	_	
151-7	27553-27563	multi-site	_	
151-8	27563-27564	,	_	
151-9	27565-27576	single-site	_	
151-10	27577-27580	and	_	
151-11	27581-27588	pooling	_	
151-12	27589-27603	classification	_	
151-13	27604-27608	with	_	
151-14	27609-27611	20	_	
151-15	27612-27623	repetitions	_	
151-16	27624-27626	in	_	
151-17	27627-27629	10	_	
151-18	27630-27641	experiments	_	
151-19	27641-27642	.	_	

#Text=Table 3\t \t
#Text=Method\tSite A\tSite B\tSite C\tAverage of 3 sites\t \tl2,1 + l1 (MS)\t0.785\t0.645\t0.845\t0.758\t \tl1 (SS)\t0.76\t0.56\t0.825\t0.713\t \tl1 (PO)\t0.70\t0.575\t0.753\t0.676\t \tl2,1 + l1 + SVM (MS)\t0.713\t0.648\t0.658\t0.673\t \tl1 + SVM (SS)\t0.728\t0.598\t0.825\t0.690\t \tl1 + SVM (PO)\t0.610\t0.573\t0.668\t0.617\t \tPCA + SVM (SS)\t0.668\t0.474\t0.724\t0.622\t \tPCA + SVM (PO)\t0.646\t0.494\t0.732\t0.624\t \tttest2 + SVM (SS)\t0.562\t0.468\t0.680\t0.570\t \tttest2 + SVM (PO)\t0.672\t0.530\t0.646\t0.616\t \t
#Text=MS: multi-site data; SS: single-site data; PO: pooled data.
152-1	27643-27648	Table	_	
152-2	27649-27650	3	_	
152-3	27654-27660	Method	_	
152-4	27661-27665	Site	_	
152-5	27666-27667	A	_	
152-6	27668-27672	Site	_	
152-7	27673-27674	B	_	
152-8	27675-27679	Site	_	
152-9	27680-27681	C	_	
152-10	27682-27689	Average	_	
152-11	27690-27692	of	_	
152-12	27693-27694	3	_	
152-13	27695-27700	sites	_	
152-14	27703-27707	l2,1	_	
152-15	27707-27708	 	_	
152-16	27708-27709	+	_	
152-17	27709-27710	 	_	
152-18	27710-27712	l1	_	
152-19	27713-27714	(	_	
152-20	27714-27716	MS	_	
152-21	27716-27717	)	_	
152-22	27718-27723	0.785	_	
152-23	27724-27729	0.645	_	
152-24	27730-27735	0.845	_	
152-25	27736-27741	0.758	_	
152-26	27744-27746	l1	_	
152-27	27747-27748	(	_	
152-28	27748-27750	SS	_	
152-29	27750-27751	)	_	
152-30	27752-27756	0.76	_	
152-31	27757-27761	0.56	_	
152-32	27762-27767	0.825	_	
152-33	27768-27773	0.713	_	
152-34	27776-27778	l1	_	
152-35	27779-27780	(	_	
152-36	27780-27782	PO	_	
152-37	27782-27783	)	_	
152-38	27784-27788	0.70	_	
152-39	27789-27794	0.575	_	
152-40	27795-27800	0.753	_	
152-41	27801-27806	0.676	_	
152-42	27809-27813	l2,1	_	
152-43	27813-27814	 	_	
152-44	27814-27815	+	_	
152-45	27815-27816	 	_	
152-46	27816-27818	l1	_	
152-47	27818-27819	 	_	
152-48	27819-27820	+	_	
152-49	27820-27821	 	_	
152-50	27821-27824	SVM	_	
152-51	27825-27826	(	_	
152-52	27826-27828	MS	_	
152-53	27828-27829	)	_	
152-54	27830-27835	0.713	_	
152-55	27836-27841	0.648	_	
152-56	27842-27847	0.658	_	
152-57	27848-27853	0.673	_	
152-58	27856-27858	l1	_	
152-59	27858-27859	 	_	
152-60	27859-27860	+	_	
152-61	27860-27861	 	_	
152-62	27861-27864	SVM	_	
152-63	27865-27866	(	_	
152-64	27866-27868	SS	_	
152-65	27868-27869	)	_	
152-66	27870-27875	0.728	_	
152-67	27876-27881	0.598	_	
152-68	27882-27887	0.825	_	
152-69	27888-27893	0.690	_	
152-70	27896-27898	l1	_	
152-71	27898-27899	 	_	
152-72	27899-27900	+	_	
152-73	27900-27901	 	_	
152-74	27901-27904	SVM	_	
152-75	27905-27906	(	_	
152-76	27906-27908	PO	_	
152-77	27908-27909	)	_	
152-78	27910-27915	0.610	_	
152-79	27916-27921	0.573	_	
152-80	27922-27927	0.668	_	
152-81	27928-27933	0.617	_	
152-82	27936-27939	PCA	_	
152-83	27939-27940	 	_	
152-84	27940-27941	+	_	
152-85	27941-27942	 	_	
152-86	27942-27945	SVM	_	
152-87	27946-27947	(	_	
152-88	27947-27949	SS	_	
152-89	27949-27950	)	_	
152-90	27951-27956	0.668	_	
152-91	27957-27962	0.474	_	
152-92	27963-27968	0.724	_	
152-93	27969-27974	0.622	_	
152-94	27977-27980	PCA	_	
152-95	27980-27981	 	_	
152-96	27981-27982	+	_	
152-97	27982-27983	 	_	
152-98	27983-27986	SVM	_	
152-99	27987-27988	(	_	
152-100	27988-27990	PO	_	
152-101	27990-27991	)	_	
152-102	27992-27997	0.646	_	
152-103	27998-28003	0.494	_	
152-104	28004-28009	0.732	_	
152-105	28010-28015	0.624	_	
152-106	28018-28024	ttest2	_	
152-107	28024-28025	 	_	
152-108	28025-28026	+	_	
152-109	28026-28027	 	_	
152-110	28027-28030	SVM	_	
152-111	28031-28032	(	_	
152-112	28032-28034	SS	_	
152-113	28034-28035	)	_	
152-114	28036-28041	0.562	_	
152-115	28042-28047	0.468	_	
152-116	28048-28053	0.680	_	
152-117	28054-28059	0.570	_	
152-118	28062-28068	ttest2	_	
152-119	28068-28069	 	_	
152-120	28069-28070	+	_	
152-121	28070-28071	 	_	
152-122	28071-28074	SVM	_	
152-123	28075-28076	(	_	
152-124	28076-28078	PO	_	
152-125	28078-28079	)	_	
152-126	28080-28085	0.672	_	
152-127	28086-28091	0.530	_	
152-128	28092-28097	0.646	_	
152-129	28098-28103	0.616	_	
152-130	28107-28109	MS	_	
152-131	28109-28110	:	_	
152-132	28111-28121	multi-site	_	
152-133	28122-28126	data	_	
152-134	28126-28127	;	_	
152-135	28128-28130	SS	_	
152-136	28130-28131	:	_	
152-137	28132-28143	single-site	_	
152-138	28144-28148	data	_	
152-139	28148-28149	;	_	
152-140	28150-28152	PO	_	
152-141	28152-28153	:	_	
152-142	28154-28160	pooled	_	
152-143	28161-28165	data	_	
152-144	28165-28166	.	_	

#Text=The classification results of multi-site, single-site, and pooled data were listed in Table 3.
153-1	28167-28170	The	_	
153-2	28171-28185	classification	_	
153-3	28186-28193	results	_	
153-4	28194-28196	of	_	
153-5	28197-28207	multi-site	_	
153-6	28207-28208	,	_	
153-7	28209-28220	single-site	_	
153-8	28220-28221	,	_	
153-9	28222-28225	and	_	
153-10	28226-28232	pooled	_	
153-11	28233-28237	data	_	
153-12	28238-28242	were	_	
153-13	28243-28249	listed	_	
153-14	28250-28252	in	_	
153-15	28253-28258	Table	_	
153-16	28259-28260	3	_	
153-17	28260-28261	.	_	

#Text=Using the proposed multi-task feature learning framework and the classifier based on the learned feature weights, the average classification accuracies of sites A, B, and C, based on the multi-site data learning, were 78.5%, 64.5%, and 84.5%, which outperformed the accuracies of 76%, 56%, and 82.5% on single-site learning, as well as the accuracies of 70%, 57.5%, and 75.3% on the pooled classification.
154-1	28262-28267	Using	_	
154-2	28268-28271	the	_	
154-3	28272-28280	proposed	_	
154-4	28281-28291	multi-task	_	
154-5	28292-28299	feature	_	
154-6	28300-28308	learning	_	
154-7	28309-28318	framework	_	
154-8	28319-28322	and	_	
154-9	28323-28326	the	_	
154-10	28327-28337	classifier	_	
154-11	28338-28343	based	_	
154-12	28344-28346	on	_	
154-13	28347-28350	the	_	
154-14	28351-28358	learned	_	
154-15	28359-28366	feature	_	
154-16	28367-28374	weights	_	
154-17	28374-28375	,	_	
154-18	28376-28379	the	_	
154-19	28380-28387	average	_	
154-20	28388-28402	classification	_	
154-21	28403-28413	accuracies	_	
154-22	28414-28416	of	_	
154-23	28417-28422	sites	_	
154-24	28423-28424	A	_	
154-25	28424-28425	,	_	
154-26	28426-28427	B	_	
154-27	28427-28428	,	_	
154-28	28429-28432	and	_	
154-29	28433-28434	C	_	
154-30	28434-28435	,	_	
154-31	28436-28441	based	_	
154-32	28442-28444	on	_	
154-33	28445-28448	the	_	
154-34	28449-28459	multi-site	_	
154-35	28460-28464	data	_	
154-36	28465-28473	learning	_	
154-37	28473-28474	,	_	
154-38	28475-28479	were	_	
154-39	28480-28485	78.5%	_	
154-40	28485-28486	,	_	
154-41	28487-28492	64.5%	_	
154-42	28492-28493	,	_	
154-43	28494-28497	and	_	
154-44	28498-28503	84.5%	_	
154-45	28503-28504	,	_	
154-46	28505-28510	which	_	
154-47	28511-28523	outperformed	_	
154-48	28524-28527	the	_	
154-49	28528-28538	accuracies	_	
154-50	28539-28541	of	_	
154-51	28542-28545	76%	_	
154-52	28545-28546	,	_	
154-53	28547-28550	56%	_	
154-54	28550-28551	,	_	
154-55	28552-28555	and	_	
154-56	28556-28561	82.5%	_	
154-57	28562-28564	on	_	
154-58	28565-28576	single-site	_	
154-59	28577-28585	learning	_	
154-60	28585-28586	,	_	
154-61	28587-28589	as	_	
154-62	28590-28594	well	_	
154-63	28595-28597	as	_	
154-64	28598-28601	the	_	
154-65	28602-28612	accuracies	_	
154-66	28613-28615	of	_	
154-67	28616-28619	70%	_	
154-68	28619-28620	,	_	
154-69	28621-28626	57.5%	_	
154-70	28626-28627	,	_	
154-71	28628-28631	and	_	
154-72	28632-28637	75.3%	_	
154-73	28638-28640	on	_	
154-74	28641-28644	the	_	
154-75	28645-28651	pooled	_	
154-76	28652-28666	classification	_	
154-77	28666-28667	.	_	

#Text=Using the multi-task feature learning framework and the SVM classifier, the average accuracies in multi-site (67.3%), single-site (69.0%) and pooled (61.7%) data classification were lower than the results using the proposed classifier (75.8%, 71.3%, and 67.6%), respectively.
155-1	28668-28673	Using	_	
155-2	28674-28677	the	_	
155-3	28678-28688	multi-task	_	
155-4	28689-28696	feature	_	
155-5	28697-28705	learning	_	
155-6	28706-28715	framework	_	
155-7	28716-28719	and	_	
155-8	28720-28723	the	_	
155-9	28724-28727	SVM	_	
155-10	28728-28738	classifier	_	
155-11	28738-28739	,	_	
155-12	28740-28743	the	_	
155-13	28744-28751	average	_	
155-14	28752-28762	accuracies	_	
155-15	28763-28765	in	_	
155-16	28766-28776	multi-site	_	
155-17	28777-28778	(	_	
155-18	28778-28783	67.3%	_	
155-19	28783-28784	)	_	
155-20	28784-28785	,	_	
155-21	28786-28797	single-site	_	
155-22	28798-28799	(	_	
155-23	28799-28804	69.0%	_	
155-24	28804-28805	)	_	
155-25	28806-28809	and	_	
155-26	28810-28816	pooled	_	
155-27	28817-28818	(	_	
155-28	28818-28823	61.7%	_	
155-29	28823-28824	)	_	
155-30	28825-28829	data	_	
155-31	28830-28844	classification	_	
155-32	28845-28849	were	_	
155-33	28850-28855	lower	_	
155-34	28856-28860	than	_	
155-35	28861-28864	the	_	
155-36	28865-28872	results	_	
155-37	28873-28878	using	_	
155-38	28879-28882	the	_	
155-39	28883-28891	proposed	_	
155-40	28892-28902	classifier	_	
155-41	28903-28904	(	_	
155-42	28904-28909	75.8%	_	
155-43	28909-28910	,	_	
155-44	28911-28916	71.3%	_	
155-45	28916-28917	,	_	
155-46	28918-28921	and	_	
155-47	28922-28927	67.6%	_	
155-48	28927-28928	)	_	
155-49	28928-28929	,	_	
155-50	28930-28942	respectively	_	
155-51	28942-28943	.	_	

#Text=However, the average accuracy of multi-site classification was poorer than the single-site classification using multi-task feature learning framework and SVM classifiers.
156-1	28944-28951	However	_	
156-2	28951-28952	,	_	
156-3	28953-28956	the	_	
156-4	28957-28964	average	_	
156-5	28965-28973	accuracy	_	
156-6	28974-28976	of	_	
156-7	28977-28987	multi-site	_	
156-8	28988-29002	classification	_	
156-9	29003-29006	was	_	
156-10	29007-29013	poorer	_	
156-11	29014-29018	than	_	
156-12	29019-29022	the	_	
156-13	29023-29034	single-site	_	
156-14	29035-29049	classification	_	
156-15	29050-29055	using	_	
156-16	29056-29066	multi-task	_	
156-17	29067-29074	feature	_	
156-18	29075-29083	learning	_	
156-19	29084-29093	framework	_	
156-20	29094-29097	and	_	
156-21	29098-29101	SVM	_	
156-22	29102-29113	classifiers	_	
156-23	29113-29114	.	_	

#Text=In the experiments using PCA feature learning method and SVM classifiers, the average results of single-site and pooled data classification were 62.2% and 62.4%.
157-1	29115-29117	In	_	
157-2	29118-29121	the	_	
157-3	29122-29133	experiments	_	
157-4	29134-29139	using	_	
157-5	29140-29143	PCA	_	
157-6	29144-29151	feature	_	
157-7	29152-29160	learning	_	
157-8	29161-29167	method	_	
157-9	29168-29171	and	_	
157-10	29172-29175	SVM	_	
157-11	29176-29187	classifiers	_	
157-12	29187-29188	,	_	
157-13	29189-29192	the	_	
157-14	29193-29200	average	_	
157-15	29201-29208	results	_	
157-16	29209-29211	of	_	
157-17	29212-29223	single-site	_	
157-18	29224-29227	and	_	
157-19	29228-29234	pooled	_	
157-20	29235-29239	data	_	
157-21	29240-29254	classification	_	
157-22	29255-29259	were	_	
157-23	29260-29265	62.2%	_	
157-24	29266-29269	and	_	
157-25	29270-29275	62.4%	_	
157-26	29275-29276	.	_	

#Text=In the experiments using ttest2 feature learning method, the classification accuracies were the lowest comparing to all other methods, which were 57.0% and 61.6%, respectively in single-site and pooled data classification.
158-1	29277-29279	In	_	
158-2	29280-29283	the	_	
158-3	29284-29295	experiments	_	
158-4	29296-29301	using	_	
158-5	29302-29308	ttest2	_	
158-6	29309-29316	feature	_	
158-7	29317-29325	learning	_	
158-8	29326-29332	method	_	
158-9	29332-29333	,	_	
158-10	29334-29337	the	_	
158-11	29338-29352	classification	_	
158-12	29353-29363	accuracies	_	
158-13	29364-29368	were	_	
158-14	29369-29372	the	_	
158-15	29373-29379	lowest	_	
158-16	29380-29389	comparing	_	
158-17	29390-29392	to	_	
158-18	29393-29396	all	_	
158-19	29397-29402	other	_	
158-20	29403-29410	methods	_	
158-21	29410-29411	,	_	
158-22	29412-29417	which	_	
158-23	29418-29422	were	_	
158-24	29423-29428	57.0%	_	
158-25	29429-29432	and	_	
158-26	29433-29438	61.6%	_	
158-27	29438-29439	,	_	
158-28	29440-29452	respectively	_	
158-29	29453-29455	in	_	
158-30	29456-29467	single-site	_	
158-31	29468-29471	and	_	
158-32	29472-29478	pooled	_	
158-33	29479-29483	data	_	
158-34	29484-29498	classification	_	
158-35	29498-29499	.	_	

#Text=The best average accuracy was 75.8% with our proposed multi-task feature learning classification method.
159-1	29500-29503	The	_	
159-2	29504-29508	best	_	
159-3	29509-29516	average	_	
159-4	29517-29525	accuracy	_	
159-5	29526-29529	was	_	
159-6	29530-29535	75.8%	_	
159-7	29536-29540	with	_	
159-8	29541-29544	our	_	
159-9	29545-29553	proposed	_	
159-10	29554-29564	multi-task	_	
159-11	29565-29572	feature	_	
159-12	29573-29581	learning	_	
159-13	29582-29596	classification	_	
159-14	29597-29603	method	_	
159-15	29603-29604	.	_	

#Text=The results indicated that multi-site learning captured more precise feature patterns in revealing the differences between SCZ patients and controls, than using only one single-site data.
160-1	29605-29608	The	_	
160-2	29609-29616	results	_	
160-3	29617-29626	indicated	_	
160-4	29627-29631	that	_	
160-5	29632-29642	multi-site	_	
160-6	29643-29651	learning	_	
160-7	29652-29660	captured	_	
160-8	29661-29665	more	_	
160-9	29666-29673	precise	_	
160-10	29674-29681	feature	_	
160-11	29682-29690	patterns	_	
160-12	29691-29693	in	_	
160-13	29694-29703	revealing	_	
160-14	29704-29707	the	_	
160-15	29708-29719	differences	_	
160-16	29720-29727	between	_	
160-17	29728-29731	SCZ	_	
160-18	29732-29740	patients	_	
160-19	29741-29744	and	_	
160-20	29745-29753	controls	_	
160-21	29753-29754	,	_	
160-22	29755-29759	than	_	
160-23	29760-29765	using	_	
160-24	29766-29770	only	_	
160-25	29771-29774	one	_	
160-26	29775-29786	single-site	_	
160-27	29787-29791	data	_	
160-28	29791-29792	.	_	

#Text=Simply pooling all data sites together did not improve classification performance compared with using single-site data.
161-1	29793-29799	Simply	_	
161-2	29800-29807	pooling	_	
161-3	29808-29811	all	_	
161-4	29812-29816	data	_	
161-5	29817-29822	sites	_	
161-6	29823-29831	together	_	
161-7	29832-29835	did	_	
161-8	29836-29839	not	_	
161-9	29840-29847	improve	_	
161-10	29848-29862	classification	_	
161-11	29863-29874	performance	_	
161-12	29875-29883	compared	_	
161-13	29884-29888	with	_	
161-14	29889-29894	using	_	
161-15	29895-29906	single-site	_	
161-16	29907-29911	data	_	
161-17	29911-29912	.	_	

#Text=Left panel: locations of the site-shared features Right panel: locations of the site-specific features corresponding to each site.
162-1	29913-29917	Left	_	
162-2	29918-29923	panel	_	
162-3	29923-29924	:	_	
162-4	29925-29934	locations	_	
162-5	29935-29937	of	_	
162-6	29938-29941	the	_	
162-7	29942-29953	site-shared	_	
162-8	29954-29962	features	_	
162-9	29963-29968	Right	_	
162-10	29969-29974	panel	_	
162-11	29974-29975	:	_	
162-12	29976-29985	locations	_	
162-13	29986-29988	of	_	
162-14	29989-29992	the	_	
162-15	29993-30006	site-specific	_	
162-16	30007-30015	features	_	
162-17	30016-30029	corresponding	_	
162-18	30030-30032	to	_	
162-19	30033-30037	each	_	
162-20	30038-30042	site	_	
162-21	30042-30043	.	_	

#Text=These site-shared and site-specific features were shown with cluster size of >50 voxels obtained by multi-task learning on multi-site schizophrenia classification.
163-1	30044-30049	These	_	
163-2	30050-30061	site-shared	_	
163-3	30062-30065	and	_	
163-4	30066-30079	site-specific	_	
163-5	30080-30088	features	_	
163-6	30089-30093	were	_	
163-7	30094-30099	shown	_	
163-8	30100-30104	with	_	
163-9	30105-30112	cluster	_	
163-10	30113-30117	size	_	
163-11	30118-30120	of	_	
163-12	30121-30122	>	_	
163-13	30122-30124	50	_	
163-14	30124-30125	 	_	
163-15	30125-30131	voxels	_	
163-16	30132-30140	obtained	_	
163-17	30141-30143	by	_	
163-18	30144-30154	multi-task	_	
163-19	30155-30163	learning	_	
163-20	30164-30166	on	_	
163-21	30167-30177	multi-site	_	
163-22	30178-30191	schizophrenia	_	
163-23	30192-30206	classification	_	
163-24	30206-30207	.	_	

#Text=The colorbar represents the weight values of features.
164-1	30208-30211	The	_	
164-2	30212-30220	colorbar	_	
164-3	30221-30231	represents	_	
164-4	30232-30235	the	_	
164-5	30236-30242	weight	_	
164-6	30243-30249	values	_	
164-7	30250-30252	of	_	
164-8	30253-30261	features	_	
164-9	30261-30262	.	_	

#Text=The warm and hot colors corresponded to negative and positive weight values, respectively.
165-1	30263-30266	The	_	
165-2	30267-30271	warm	_	
165-3	30272-30275	and	_	
165-4	30276-30279	hot	_	
165-5	30280-30286	colors	_	
165-6	30287-30299	corresponded	_	
165-7	30300-30302	to	_	
165-8	30303-30311	negative	_	
165-9	30312-30315	and	_	
165-10	30316-30324	positive	_	
165-11	30325-30331	weight	_	
165-12	30332-30338	values	_	
165-13	30338-30339	,	_	
165-14	30340-30352	respectively	_	
165-15	30352-30353	.	_	

#Text=Fig. 2
#Text=The site-shared gray matter alteration features of brain regions.
166-1	30354-30357	Fig	_	
166-2	30357-30358	.	_	
166-3	30359-30360	2	_	
166-4	30361-30364	The	_	
166-5	30365-30376	site-shared	_	
166-6	30377-30381	gray	_	
166-7	30382-30388	matter	_	
166-8	30389-30399	alteration	_	
166-9	30400-30408	features	_	
166-10	30409-30411	of	_	
166-11	30412-30417	brain	_	
166-12	30418-30425	regions	_	
166-13	30425-30426	.	_	

#Text=Table 4\t \t
#Text=Regions\tSide\tBA\tCluster size (voxels)\tMNI coordinates\t \tCerebellum crus I, fusiform gyrus, lingual gyrus\tL\t18,19\t146\t−32,−86,−17/−29,−74,−3\t \tMiddle temporal gyrus\tL\t38,21,22\t77\t−44,12,−35/−59,−14,−8/−56,−59,−13/−65,−35,−1\t \tSuperior temporal gyrus, middle temporal gyrus, insula\tR\t22,41,13\t77\t52,−41,−10/49,−17,1\t \tAnterior cingulate, superior medial frontal gyrus\tL\t32\t51\t−12,34,1/−12,34,25\t \tMiddle occipital gyrus, angular\tL/R\t39,40\t111\t45,−55,20/33,−76,32/−51,67,39\t \tInsula\tR\t13\t27\t33,16,12\t \tMiddle frontal gyrus, inferior triangular frontal gyrus\tL/R\t9,10,44,45\t162\t−51,26,28/−33,52,16/−42,22,13/39,35,24\t \tPostcentral\tL\t2\t18\t−49,−31,50\t \tPrecuneus\tL/R\t31\t25\t−6,−43,36\t \tInferior parietal gyrus\tL\t40\t15\t−40,−49,51\t \tSuperior parietal gyrus\tL\t7,5\t42\t−28,−51,75\t \tSuperior frontal gyrus, middle frontal gyrus\tR\t9,6\t56\t27,47,32/33,41,35/35,8,42\t \tSuperior frontal gyrus, middle frontal gyrus\tL\t32,6\t63\t−16,23,47/−34,11,52\t \tdlPFC\tL/R\t9,6,32\t119\t−16,23,47/−34,11,52/27,47,32/33,41,35/35,8,42\t \t
#Text=Note: BA = Brodmann area, R = right, L = left.
167-1	30427-30432	Table	_	
167-2	30433-30434	4	_	
167-3	30438-30445	Regions	_	
167-4	30446-30450	Side	_	
167-5	30451-30453	BA	_	
167-6	30454-30461	Cluster	_	
167-7	30462-30466	size	_	
167-8	30467-30468	(	_	
167-9	30468-30474	voxels	_	
167-10	30474-30475	)	_	
167-11	30476-30479	MNI	_	
167-12	30480-30491	coordinates	_	
167-13	30494-30504	Cerebellum	_	
167-14	30505-30509	crus	_	
167-15	30510-30511	I	_	
167-16	30511-30512	,	_	
167-17	30513-30521	fusiform	_	
167-18	30522-30527	gyrus	_	
167-19	30527-30528	,	_	
167-20	30529-30536	lingual	_	
167-21	30537-30542	gyrus	_	
167-22	30543-30544	L	_	
167-23	30545-30550	18,19	_	
167-24	30551-30554	146	_	
167-25	30555-30556	−	_	
167-26	30556-30558	32	_	
167-27	30558-30559	,	_	
167-28	30559-30560	−	_	
167-29	30560-30562	86	_	
167-30	30562-30563	,	_	
167-31	30563-30564	−	_	
167-32	30564-30566	17	_	
167-33	30566-30567	/	_	
167-34	30567-30568	−	_	
167-35	30568-30570	29	_	
167-36	30570-30571	,	_	
167-37	30571-30572	−	_	
167-38	30572-30574	74	_	
167-39	30574-30575	,	_	
167-40	30575-30576	−	_	
167-41	30576-30577	3	_	
167-42	30580-30586	Middle	_	
167-43	30587-30595	temporal	_	
167-44	30596-30601	gyrus	_	
167-45	30602-30603	L	_	
167-46	30604-30612	38,21,22	_	
167-47	30613-30615	77	_	
167-48	30616-30617	−	_	
167-49	30617-30622	44,12	_	
167-50	30622-30623	,	_	
167-51	30623-30624	−	_	
167-52	30624-30626	35	_	
167-53	30626-30627	/	_	
167-54	30627-30628	−	_	
167-55	30628-30630	59	_	
167-56	30630-30631	,	_	
167-57	30631-30632	−	_	
167-58	30632-30634	14	_	
167-59	30634-30635	,	_	
167-60	30635-30636	−	_	
167-61	30636-30637	8	_	
167-62	30637-30638	/	_	
167-63	30638-30639	−	_	
167-64	30639-30641	56	_	
167-65	30641-30642	,	_	
167-66	30642-30643	−	_	
167-67	30643-30645	59	_	
167-68	30645-30646	,	_	
167-69	30646-30647	−	_	
167-70	30647-30649	13	_	
167-71	30649-30650	/	_	
167-72	30650-30651	−	_	
167-73	30651-30653	65	_	
167-74	30653-30654	,	_	
167-75	30654-30655	−	_	
167-76	30655-30657	35	_	
167-77	30657-30658	,	_	
167-78	30658-30659	−	_	
167-79	30659-30660	1	_	
167-80	30663-30671	Superior	_	
167-81	30672-30680	temporal	_	
167-82	30681-30686	gyrus	_	
167-83	30686-30687	,	_	
167-84	30688-30694	middle	_	
167-85	30695-30703	temporal	_	
167-86	30704-30709	gyrus	_	
167-87	30709-30710	,	_	
167-88	30711-30717	insula	_	
167-89	30718-30719	R	_	
167-90	30720-30728	22,41,13	_	
167-91	30729-30731	77	_	
167-92	30732-30734	52	_	
167-93	30734-30735	,	_	
167-94	30735-30736	−	_	
167-95	30736-30738	41	_	
167-96	30738-30739	,	_	
167-97	30739-30740	−	_	
167-98	30740-30742	10	_	
167-99	30742-30743	/	_	
167-100	30743-30745	49	_	
167-101	30745-30746	,	_	
167-102	30746-30747	−	_	
167-103	30747-30751	17,1	_	
167-104	30754-30762	Anterior	_	
167-105	30763-30772	cingulate	_	
167-106	30772-30773	,	_	
167-107	30774-30782	superior	_	
167-108	30783-30789	medial	_	
167-109	30790-30797	frontal	_	
167-110	30798-30803	gyrus	_	
167-111	30804-30805	L	_	
167-112	30806-30808	32	_	
167-113	30809-30811	51	_	
167-114	30812-30813	−	_	
167-115	30813-30820	12,34,1	_	
167-116	30820-30821	/	_	
167-117	30821-30822	−	_	
167-118	30822-30830	12,34,25	_	
167-119	30833-30839	Middle	_	
167-120	30840-30849	occipital	_	
167-121	30850-30855	gyrus	_	
167-122	30855-30856	,	_	
167-123	30857-30864	angular	_	
167-124	30865-30866	L	_	
167-125	30866-30867	/	_	
167-126	30867-30868	R	_	
167-127	30869-30874	39,40	_	
167-128	30875-30878	111	_	
167-129	30879-30881	45	_	
167-130	30881-30882	,	_	
167-131	30882-30883	−	_	
167-132	30883-30888	55,20	_	
167-133	30888-30889	/	_	
167-134	30889-30891	33	_	
167-135	30891-30892	,	_	
167-136	30892-30893	−	_	
167-137	30893-30898	76,32	_	
167-138	30898-30899	/	_	
167-139	30899-30900	−	_	
167-140	30900-30908	51,67,39	_	
167-141	30911-30917	Insula	_	
167-142	30918-30919	R	_	
167-143	30920-30922	13	_	
167-144	30923-30925	27	_	
167-145	30926-30934	33,16,12	_	
167-146	30937-30943	Middle	_	
167-147	30944-30951	frontal	_	
167-148	30952-30957	gyrus	_	
167-149	30957-30958	,	_	
167-150	30959-30967	inferior	_	
167-151	30968-30978	triangular	_	
167-152	30979-30986	frontal	_	
167-153	30987-30992	gyrus	_	
167-154	30993-30994	L	_	
167-155	30994-30995	/	_	
167-156	30995-30996	R	_	
167-157	30997-31007	9,10,44,45	_	
167-158	31008-31011	162	_	
167-159	31012-31013	−	_	
167-160	31013-31021	51,26,28	_	
167-161	31021-31022	/	_	
167-162	31022-31023	−	_	
167-163	31023-31031	33,52,16	_	
167-164	31031-31032	/	_	
167-165	31032-31033	−	_	
167-166	31033-31041	42,22,13	_	
167-167	31041-31042	/	_	
167-168	31042-31050	39,35,24	_	
167-169	31053-31064	Postcentral	_	
167-170	31065-31066	L	_	
167-171	31067-31068	2	_	
167-172	31069-31071	18	_	
167-173	31072-31073	−	_	
167-174	31073-31075	49	_	
167-175	31075-31076	,	_	
167-176	31076-31077	−	_	
167-177	31077-31082	31,50	_	
167-178	31085-31094	Precuneus	_	
167-179	31095-31096	L	_	
167-180	31096-31097	/	_	
167-181	31097-31098	R	_	
167-182	31099-31101	31	_	
167-183	31102-31104	25	_	
167-184	31105-31106	−	_	
167-185	31106-31107	6	_	
167-186	31107-31108	,	_	
167-187	31108-31109	−	_	
167-188	31109-31114	43,36	_	
167-189	31117-31125	Inferior	_	
167-190	31126-31134	parietal	_	
167-191	31135-31140	gyrus	_	
167-192	31141-31142	L	_	
167-193	31143-31145	40	_	
167-194	31146-31148	15	_	
167-195	31149-31150	−	_	
167-196	31150-31152	40	_	
167-197	31152-31153	,	_	
167-198	31153-31154	−	_	
167-199	31154-31159	49,51	_	
167-200	31162-31170	Superior	_	
167-201	31171-31179	parietal	_	
167-202	31180-31185	gyrus	_	
167-203	31186-31187	L	_	
167-204	31188-31191	7,5	_	
167-205	31192-31194	42	_	
167-206	31195-31196	−	_	
167-207	31196-31198	28	_	
167-208	31198-31199	,	_	
167-209	31199-31200	−	_	
167-210	31200-31205	51,75	_	
167-211	31208-31216	Superior	_	
167-212	31217-31224	frontal	_	
167-213	31225-31230	gyrus	_	
167-214	31230-31231	,	_	
167-215	31232-31238	middle	_	
167-216	31239-31246	frontal	_	
167-217	31247-31252	gyrus	_	
167-218	31253-31254	R	_	
167-219	31255-31258	9,6	_	
167-220	31259-31261	56	_	
167-221	31262-31270	27,47,32	_	
167-222	31270-31271	/	_	
167-223	31271-31279	33,41,35	_	
167-224	31279-31280	/	_	
167-225	31280-31287	35,8,42	_	
167-226	31290-31298	Superior	_	
167-227	31299-31306	frontal	_	
167-228	31307-31312	gyrus	_	
167-229	31312-31313	,	_	
167-230	31314-31320	middle	_	
167-231	31321-31328	frontal	_	
167-232	31329-31334	gyrus	_	
167-233	31335-31336	L	_	
167-234	31337-31341	32,6	_	
167-235	31342-31344	63	_	
167-236	31345-31346	−	_	
167-237	31346-31354	16,23,47	_	
167-238	31354-31355	/	_	
167-239	31355-31356	−	_	
167-240	31356-31364	34,11,52	_	
167-241	31367-31372	dlPFC	_	
167-242	31373-31374	L	_	
167-243	31374-31375	/	_	
167-244	31375-31376	R	_	
167-245	31377-31383	9,6,32	_	
167-246	31384-31387	119	_	
167-247	31388-31389	−	_	
167-248	31389-31397	16,23,47	_	
167-249	31397-31398	/	_	
167-250	31398-31399	−	_	
167-251	31399-31407	34,11,52	_	
167-252	31407-31408	/	_	
167-253	31408-31416	27,47,32	_	
167-254	31416-31417	/	_	
167-255	31417-31425	33,41,35	_	
167-256	31425-31426	/	_	
167-257	31426-31433	35,8,42	_	
167-258	31437-31441	Note	_	
167-259	31441-31442	:	_	
167-260	31443-31445	BA	_	
167-261	31445-31446	 	_	
167-262	31446-31447	=	_	
167-263	31447-31448	 	_	
167-264	31448-31456	Brodmann	_	
167-265	31457-31461	area	_	
167-266	31461-31462	,	_	
167-267	31463-31464	R	_	
167-268	31464-31465	 	_	
167-269	31465-31466	=	_	
167-270	31466-31467	 	_	
167-271	31467-31472	right	_	
167-272	31472-31473	,	_	
167-273	31474-31475	L	_	
167-274	31475-31476	 	_	
167-275	31476-31477	=	_	
167-276	31477-31478	 	_	
167-277	31478-31482	left	_	
167-278	31482-31483	.	_	

#Text=The site-shared and site-specific features with the largest weights were mapped onto a brain image template.
168-1	31484-31487	The	_	
168-2	31488-31499	site-shared	_	
168-3	31500-31503	and	_	
168-4	31504-31517	site-specific	_	
168-5	31518-31526	features	_	
168-6	31527-31531	with	_	
168-7	31532-31535	the	_	
168-8	31536-31543	largest	_	
168-9	31544-31551	weights	_	
168-10	31552-31556	were	_	
168-11	31557-31563	mapped	_	
168-12	31564-31568	onto	_	
168-13	31569-31570	a	_	
168-14	31571-31576	brain	_	
168-15	31577-31582	image	_	
168-16	31583-31591	template	_	
168-17	31591-31592	.	_	

#Text=As shown in the left panel of Fig. 2, multi-site learning extracted a series of feature patterns as site-shared features, which revealed gray matter abnormalities in a variety of regions, including the fusiform, middle temporal, superior temporal, inferior parietal, postcentral, angular, inferior frontal, middle occipital and lingual gyri, insular, anterior cingulate cortex, precuneus, the dorsolateral prefrontal cortex, and the cerebellum.
169-1	31593-31595	As	_	
169-2	31596-31601	shown	_	
169-3	31602-31604	in	_	
169-4	31605-31608	the	_	
169-5	31609-31613	left	_	
169-6	31614-31619	panel	_	
169-7	31620-31622	of	_	
169-8	31623-31626	Fig	_	
169-9	31626-31627	.	_	
169-10	31628-31629	2	_	
169-11	31629-31630	,	_	
169-12	31631-31641	multi-site	_	
169-13	31642-31650	learning	_	
169-14	31651-31660	extracted	_	
169-15	31661-31662	a	_	
169-16	31663-31669	series	_	
169-17	31670-31672	of	_	
169-18	31673-31680	feature	_	
169-19	31681-31689	patterns	_	
169-20	31690-31692	as	_	
169-21	31693-31704	site-shared	_	
169-22	31705-31713	features	_	
169-23	31713-31714	,	_	
169-24	31715-31720	which	_	
169-25	31721-31729	revealed	_	
169-26	31730-31734	gray	_	
169-27	31735-31741	matter	_	
169-28	31742-31755	abnormalities	_	
169-29	31756-31758	in	_	
169-30	31759-31760	a	_	
169-31	31761-31768	variety	_	
169-32	31769-31771	of	_	
169-33	31772-31779	regions	_	
169-34	31779-31780	,	_	
169-35	31781-31790	including	_	
169-36	31791-31794	the	_	
169-37	31795-31803	fusiform	_	
169-38	31803-31804	,	_	
169-39	31805-31811	middle	_	
169-40	31812-31820	temporal	_	
169-41	31820-31821	,	_	
169-42	31822-31830	superior	_	
169-43	31831-31839	temporal	_	
169-44	31839-31840	,	_	
169-45	31841-31849	inferior	_	
169-46	31850-31858	parietal	_	
169-47	31858-31859	,	_	
169-48	31860-31871	postcentral	_	
169-49	31871-31872	,	_	
169-50	31873-31880	angular	_	
169-51	31880-31881	,	_	
169-52	31882-31890	inferior	_	
169-53	31891-31898	frontal	_	
169-54	31898-31899	,	_	
169-55	31900-31906	middle	_	
169-56	31907-31916	occipital	_	
169-57	31917-31920	and	_	
169-58	31921-31928	lingual	_	
169-59	31929-31933	gyri	_	
169-60	31933-31934	,	_	
169-61	31935-31942	insular	_	
169-62	31942-31943	,	_	
169-63	31944-31952	anterior	_	
169-64	31953-31962	cingulate	_	
169-65	31963-31969	cortex	_	
169-66	31969-31970	,	_	
169-67	31971-31980	precuneus	_	
169-68	31980-31981	,	_	
169-69	31982-31985	the	_	
169-70	31986-31998	dorsolateral	_	
169-71	31999-32009	prefrontal	_	
169-72	32010-32016	cortex	_	
169-73	32016-32017	,	_	
169-74	32018-32021	and	_	
169-75	32022-32025	the	_	
169-76	32026-32036	cerebellum	_	
169-77	32036-32037	.	_	

#Text=The most discriminative site-shared regions are all listed in Table 4.
170-1	32038-32041	The	_	
170-2	32042-32046	most	_	
170-3	32047-32061	discriminative	_	
170-4	32062-32073	site-shared	_	
170-5	32074-32081	regions	_	
170-6	32082-32085	are	_	
170-7	32086-32089	all	_	
170-8	32090-32096	listed	_	
170-9	32097-32099	in	_	
170-10	32100-32105	Table	_	
170-11	32106-32107	4	_	
170-12	32107-32108	.	_	

#Text=Detailed information including the BA area, side, cluster size and peak MNI coordinates is also shown in Table 4.
171-1	32109-32117	Detailed	_	
171-2	32118-32129	information	_	
171-3	32130-32139	including	_	
171-4	32140-32143	the	_	
171-5	32144-32146	BA	_	
171-6	32147-32151	area	_	
171-7	32151-32152	,	_	
171-8	32153-32157	side	_	
171-9	32157-32158	,	_	
171-10	32159-32166	cluster	_	
171-11	32167-32171	size	_	
171-12	32172-32175	and	_	
171-13	32176-32180	peak	_	
171-14	32181-32184	MNI	_	
171-15	32185-32196	coordinates	_	
171-16	32197-32199	is	_	
171-17	32200-32204	also	_	
171-18	32205-32210	shown	_	
171-19	32211-32213	in	_	
171-20	32214-32219	Table	_	
171-21	32220-32221	4	_	
171-22	32221-32222	.	_	

#Text=The site-specific gray matter alteration features of brain regions in site A.
172-1	32223-32226	The	_	
172-2	32227-32240	site-specific	_	
172-3	32241-32245	gray	_	
172-4	32246-32252	matter	_	
172-5	32253-32263	alteration	_	
172-6	32264-32272	features	_	
172-7	32273-32275	of	_	
172-8	32276-32281	brain	_	
172-9	32282-32289	regions	_	
172-10	32290-32292	in	_	
172-11	32293-32297	site	_	
172-12	32298-32299	A	_	
172-13	32299-32300	.	_	

#Text=Table 5\t \t
#Text=Regions\tSide\tBA\tCluster size (voxels)\tMNI coordinates\t \tFusiform gyrus, cerebellum VI, lingual gyrus\tL\t37,19,18\t135\t−20,−59,−15\t \tInferior temporal gyrus, middle temporal gyrus\tL\t37,20,19,21\t50\t−56,−56,−10\t \tSuperior temporal gyrus, middle temporal gyrus\tL/R\t38,21,41\t148\t−47,9,−32/55,−53,−4\t \tPutamen\tR\t\t69\t30,8,15\t \tMiddle frontal gyrus/superior frontal gyrus\tR\t9,8,10\t114\t29,38,38\t \tPostcentral gyrus, superior parietal gyrus\tR\t3,2,5,40\t236\t−43,−37,65/26,−46,49\t \tSuperior medial frontal gyrus, supplemental motor area, superior frontal gyrus\tL\t8,6\t203\t−19,35,58\t \tSuperior parietal gyrus, postcentral gyrus, precuneus gyrus\tL\t7,5\t92\t−28,−54,75\t \tPrecentral gyrus\tL\t6\t54\t−34,−12,77\t \t
#Text=Note: BA = Brodmann area, R = right, L = left.
173-1	32301-32306	Table	_	
173-2	32307-32308	5	_	
173-3	32312-32319	Regions	_	
173-4	32320-32324	Side	_	
173-5	32325-32327	BA	_	
173-6	32328-32335	Cluster	_	
173-7	32336-32340	size	_	
173-8	32341-32342	(	_	
173-9	32342-32348	voxels	_	
173-10	32348-32349	)	_	
173-11	32350-32353	MNI	_	
173-12	32354-32365	coordinates	_	
173-13	32368-32376	Fusiform	_	
173-14	32377-32382	gyrus	_	
173-15	32382-32383	,	_	
173-16	32384-32394	cerebellum	_	
173-17	32395-32397	VI	_	
173-18	32397-32398	,	_	
173-19	32399-32406	lingual	_	
173-20	32407-32412	gyrus	_	
173-21	32413-32414	L	_	
173-22	32415-32423	37,19,18	_	
173-23	32424-32427	135	_	
173-24	32428-32429	−	_	
173-25	32429-32431	20	_	
173-26	32431-32432	,	_	
173-27	32432-32433	−	_	
173-28	32433-32435	59	_	
173-29	32435-32436	,	_	
173-30	32436-32437	−	_	
173-31	32437-32439	15	_	
173-32	32442-32450	Inferior	_	
173-33	32451-32459	temporal	_	
173-34	32460-32465	gyrus	_	
173-35	32465-32466	,	_	
173-36	32467-32473	middle	_	
173-37	32474-32482	temporal	_	
173-38	32483-32488	gyrus	_	
173-39	32489-32490	L	_	
173-40	32491-32502	37,20,19,21	_	
173-41	32503-32505	50	_	
173-42	32506-32507	−	_	
173-43	32507-32509	56	_	
173-44	32509-32510	,	_	
173-45	32510-32511	−	_	
173-46	32511-32513	56	_	
173-47	32513-32514	,	_	
173-48	32514-32515	−	_	
173-49	32515-32517	10	_	
173-50	32520-32528	Superior	_	
173-51	32529-32537	temporal	_	
173-52	32538-32543	gyrus	_	
173-53	32543-32544	,	_	
173-54	32545-32551	middle	_	
173-55	32552-32560	temporal	_	
173-56	32561-32566	gyrus	_	
173-57	32567-32568	L	_	
173-58	32568-32569	/	_	
173-59	32569-32570	R	_	
173-60	32571-32579	38,21,41	_	
173-61	32580-32583	148	_	
173-62	32584-32585	−	_	
173-63	32585-32589	47,9	_	
173-64	32589-32590	,	_	
173-65	32590-32591	−	_	
173-66	32591-32593	32	_	
173-67	32593-32594	/	_	
173-68	32594-32596	55	_	
173-69	32596-32597	,	_	
173-70	32597-32598	−	_	
173-71	32598-32600	53	_	
173-72	32600-32601	,	_	
173-73	32601-32602	−	_	
173-74	32602-32603	4	_	
173-75	32606-32613	Putamen	_	
173-76	32614-32615	R	_	
173-77	32617-32619	69	_	
173-78	32620-32627	30,8,15	_	
173-79	32630-32636	Middle	_	
173-80	32637-32644	frontal	_	
173-81	32645-32650	gyrus	_	
173-82	32650-32651	/	_	
173-83	32651-32659	superior	_	
173-84	32660-32667	frontal	_	
173-85	32668-32673	gyrus	_	
173-86	32674-32675	R	_	
173-87	32676-32682	9,8,10	_	
173-88	32683-32686	114	_	
173-89	32687-32695	29,38,38	_	
173-90	32698-32709	Postcentral	_	
173-91	32710-32715	gyrus	_	
173-92	32715-32716	,	_	
173-93	32717-32725	superior	_	
173-94	32726-32734	parietal	_	
173-95	32735-32740	gyrus	_	
173-96	32741-32742	R	_	
173-97	32743-32751	3,2,5,40	_	
173-98	32752-32755	236	_	
173-99	32756-32757	−	_	
173-100	32757-32759	43	_	
173-101	32759-32760	,	_	
173-102	32760-32761	−	_	
173-103	32761-32766	37,65	_	
173-104	32766-32767	/	_	
173-105	32767-32769	26	_	
173-106	32769-32770	,	_	
173-107	32770-32771	−	_	
173-108	32771-32776	46,49	_	
173-109	32779-32787	Superior	_	
173-110	32788-32794	medial	_	
173-111	32795-32802	frontal	_	
173-112	32803-32808	gyrus	_	
173-113	32808-32809	,	_	
173-114	32810-32822	supplemental	_	
173-115	32823-32828	motor	_	
173-116	32829-32833	area	_	
173-117	32833-32834	,	_	
173-118	32835-32843	superior	_	
173-119	32844-32851	frontal	_	
173-120	32852-32857	gyrus	_	
173-121	32858-32859	L	_	
173-122	32860-32863	8,6	_	
173-123	32864-32867	203	_	
173-124	32868-32869	−	_	
173-125	32869-32877	19,35,58	_	
173-126	32880-32888	Superior	_	
173-127	32889-32897	parietal	_	
173-128	32898-32903	gyrus	_	
173-129	32903-32904	,	_	
173-130	32905-32916	postcentral	_	
173-131	32917-32922	gyrus	_	
173-132	32922-32923	,	_	
173-133	32924-32933	precuneus	_	
173-134	32934-32939	gyrus	_	
173-135	32940-32941	L	_	
173-136	32942-32945	7,5	_	
173-137	32946-32948	92	_	
173-138	32949-32950	−	_	
173-139	32950-32952	28	_	
173-140	32952-32953	,	_	
173-141	32953-32954	−	_	
173-142	32954-32959	54,75	_	
173-143	32962-32972	Precentral	_	
173-144	32973-32978	gyrus	_	
173-145	32979-32980	L	_	
173-146	32981-32982	6	_	
173-147	32983-32985	54	_	
173-148	32986-32987	−	_	
173-149	32987-32989	34	_	
173-150	32989-32990	,	_	
173-151	32990-32991	−	_	
173-152	32991-32996	12,77	_	
173-153	33000-33004	Note	_	
173-154	33004-33005	:	_	
173-155	33006-33008	BA	_	
173-156	33008-33009	 	_	
173-157	33009-33010	=	_	
173-158	33010-33011	 	_	
173-159	33011-33019	Brodmann	_	
173-160	33020-33024	area	_	
173-161	33024-33025	,	_	
173-162	33026-33027	R	_	
173-163	33027-33028	 	_	
173-164	33028-33029	=	_	
173-165	33029-33030	 	_	
173-166	33030-33035	right	_	
173-167	33035-33036	,	_	
173-168	33037-33038	L	_	
173-169	33038-33039	 	_	
173-170	33039-33040	=	_	
173-171	33040-33041	 	_	
173-172	33041-33045	left	_	
173-173	33045-33046	.	_	

#Text=The site-specific gray matter alteration features of brain regions in site B.
174-1	33047-33050	The	_	
174-2	33051-33064	site-specific	_	
174-3	33065-33069	gray	_	
174-4	33070-33076	matter	_	
174-5	33077-33087	alteration	_	
174-6	33088-33096	features	_	
174-7	33097-33099	of	_	
174-8	33100-33105	brain	_	
174-9	33106-33113	regions	_	
174-10	33114-33116	in	_	
174-11	33117-33121	site	_	
174-12	33122-33123	B	_	
174-13	33123-33124	.	_	

#Text=Table 6\t \t
#Text=Regions\tSide\tBA\tCluster size (voxels)\tMNI coordinates\t \tCerebellum IV, V, fusiform gyrus\tR\t19,36\t51\t22,−35,−20\t \tHippocampus, parahippocampus, fusiform gyrus\tR\t36\t75\t34,−35,−11\t \tAnterior cingulate cortex\tL\t32,9,24,10\t294\t−3,38,23\t \tInferior parietal gyrus, middle occipital gyrus, angular\tR\t40,39,7\t105\t−46,−49,47\t \tPosterior cingulum\tL\t\t65\t−9,−43,36\t \tInferior frontal gyrus\tL\t13,44,47\t38\t−39,22,13\t \tMiddle frontal gyrus\tL\t8,9\t53\t−34,35,37\t \tPrecuneus\tL\t7\t120\t−13,−67,37\t \tPostcentral gyrus, precentral gyrus\tL/R\t6,4,3,40\t180\t−52,−31,53\t \t
#Text=Note: BA = Brodmann area, R = right, L = left, dlPFC = dorsolateral prefrontal cortex.
175-1	33125-33130	Table	_	
175-2	33131-33132	6	_	
175-3	33136-33143	Regions	_	
175-4	33144-33148	Side	_	
175-5	33149-33151	BA	_	
175-6	33152-33159	Cluster	_	
175-7	33160-33164	size	_	
175-8	33165-33166	(	_	
175-9	33166-33172	voxels	_	
175-10	33172-33173	)	_	
175-11	33174-33177	MNI	_	
175-12	33178-33189	coordinates	_	
175-13	33192-33202	Cerebellum	_	
175-14	33203-33205	IV	_	
175-15	33205-33206	,	_	
175-16	33207-33208	V	_	
175-17	33208-33209	,	_	
175-18	33210-33218	fusiform	_	
175-19	33219-33224	gyrus	_	
175-20	33225-33226	R	_	
175-21	33227-33232	19,36	_	
175-22	33233-33235	51	_	
175-23	33236-33238	22	_	
175-24	33238-33239	,	_	
175-25	33239-33240	−	_	
175-26	33240-33242	35	_	
175-27	33242-33243	,	_	
175-28	33243-33244	−	_	
175-29	33244-33246	20	_	
175-30	33249-33260	Hippocampus	_	
175-31	33260-33261	,	_	
175-32	33262-33277	parahippocampus	_	
175-33	33277-33278	,	_	
175-34	33279-33287	fusiform	_	
175-35	33288-33293	gyrus	_	
175-36	33294-33295	R	_	
175-37	33296-33298	36	_	
175-38	33299-33301	75	_	
175-39	33302-33304	34	_	
175-40	33304-33305	,	_	
175-41	33305-33306	−	_	
175-42	33306-33308	35	_	
175-43	33308-33309	,	_	
175-44	33309-33310	−	_	
175-45	33310-33312	11	_	
175-46	33315-33323	Anterior	_	
175-47	33324-33333	cingulate	_	
175-48	33334-33340	cortex	_	
175-49	33341-33342	L	_	
175-50	33343-33353	32,9,24,10	_	
175-51	33354-33357	294	_	
175-52	33358-33359	−	_	
175-53	33359-33366	3,38,23	_	
175-54	33369-33377	Inferior	_	
175-55	33378-33386	parietal	_	
175-56	33387-33392	gyrus	_	
175-57	33392-33393	,	_	
175-58	33394-33400	middle	_	
175-59	33401-33410	occipital	_	
175-60	33411-33416	gyrus	_	
175-61	33416-33417	,	_	
175-62	33418-33425	angular	_	
175-63	33426-33427	R	_	
175-64	33428-33435	40,39,7	_	
175-65	33436-33439	105	_	
175-66	33440-33441	−	_	
175-67	33441-33443	46	_	
175-68	33443-33444	,	_	
175-69	33444-33445	−	_	
175-70	33445-33450	49,47	_	
175-71	33453-33462	Posterior	_	
175-72	33463-33471	cingulum	_	
175-73	33472-33473	L	_	
175-74	33475-33477	65	_	
175-75	33478-33479	−	_	
175-76	33479-33480	9	_	
175-77	33480-33481	,	_	
175-78	33481-33482	−	_	
175-79	33482-33487	43,36	_	
175-80	33490-33498	Inferior	_	
175-81	33499-33506	frontal	_	
175-82	33507-33512	gyrus	_	
175-83	33513-33514	L	_	
175-84	33515-33523	13,44,47	_	
175-85	33524-33526	38	_	
175-86	33527-33528	−	_	
175-87	33528-33536	39,22,13	_	
175-88	33539-33545	Middle	_	
175-89	33546-33553	frontal	_	
175-90	33554-33559	gyrus	_	
175-91	33560-33561	L	_	
175-92	33562-33565	8,9	_	
175-93	33566-33568	53	_	
175-94	33569-33570	−	_	
175-95	33570-33578	34,35,37	_	
175-96	33581-33590	Precuneus	_	
175-97	33591-33592	L	_	
175-98	33593-33594	7	_	
175-99	33595-33598	120	_	
175-100	33599-33600	−	_	
175-101	33600-33602	13	_	
175-102	33602-33603	,	_	
175-103	33603-33604	−	_	
175-104	33604-33609	67,37	_	
175-105	33612-33623	Postcentral	_	
175-106	33624-33629	gyrus	_	
175-107	33629-33630	,	_	
175-108	33631-33641	precentral	_	
175-109	33642-33647	gyrus	_	
175-110	33648-33649	L	_	
175-111	33649-33650	/	_	
175-112	33650-33651	R	_	
175-113	33652-33660	6,4,3,40	_	
175-114	33661-33664	180	_	
175-115	33665-33666	−	_	
175-116	33666-33668	52	_	
175-117	33668-33669	,	_	
175-118	33669-33670	−	_	
175-119	33670-33675	31,53	_	
175-120	33679-33683	Note	_	
175-121	33683-33684	:	_	
175-122	33685-33687	BA	_	
175-123	33687-33688	 	_	
175-124	33688-33689	=	_	
175-125	33689-33690	 	_	
175-126	33690-33698	Brodmann	_	
175-127	33699-33703	area	_	
175-128	33703-33704	,	_	
175-129	33705-33706	R	_	
175-130	33706-33707	 	_	
175-131	33707-33708	=	_	
175-132	33708-33709	 	_	
175-133	33709-33714	right	_	
175-134	33714-33715	,	_	
175-135	33716-33717	L	_	
175-136	33717-33718	 	_	
175-137	33718-33719	=	_	
175-138	33719-33720	 	_	
175-139	33720-33724	left	_	
175-140	33724-33725	,	_	
175-141	33726-33731	dlPFC	_	
175-142	33731-33732	 	_	
175-143	33732-33733	=	_	
175-144	33733-33734	 	_	
175-145	33734-33746	dorsolateral	_	
175-146	33747-33757	prefrontal	_	
175-147	33758-33764	cortex	_	
175-148	33764-33765	.	_	

#Text=The site-specific gray matter alteration features of brain regions in site C.
176-1	33766-33769	The	_	
176-2	33770-33783	site-specific	_	
176-3	33784-33788	gray	_	
176-4	33789-33795	matter	_	
176-5	33796-33806	alteration	_	
176-6	33807-33815	features	_	
176-7	33816-33818	of	_	
176-8	33819-33824	brain	_	
176-9	33825-33832	regions	_	
176-10	33833-33835	in	_	
176-11	33836-33840	site	_	
176-12	33841-33842	C	_	
176-13	33842-33843	.	_	

#Text=Table 7\t \t
#Text=Regions\tSide\tBA\tCluster size (voxels)\tMNI coordinates\t \tCerebellum crus I, crus II, fusiform gyrus, lingual gyrus\tL\t18,19\t209\t−28,−84,−38\t \tMiddle temporal gyrus, inferior temporal gyrus\tL\t21,20,22\t274\t−59,−12,−26\t \tSuperior temporal gyrus, middle temporal gyrus, insula\tR\t22,13,41,21\t112\t46,−14,−2\t \tAnterior cingulate cortex, superior medial frontal gyrus\tL\t10,32,9\t122\t0,46,14\t \tAngular\tR\t39,22,13\t62\t45,−55,23\t \tMiddle frontal gyrus\tL\t9,10\t81\t−28,56,37\t \tSupramarginal gyrus\tL\t40\t80\t−54,−37,29\t \tPostcentral gyrus\tR\t2,40,3\t62\t44,−31,55\t \tPrecuneus\tL/R\t7\t72\t2,−66,67\t \t
#Text=Note: BA = Brodmann area, R = right, L = left.
177-1	33844-33849	Table	_	
177-2	33850-33851	7	_	
177-3	33855-33862	Regions	_	
177-4	33863-33867	Side	_	
177-5	33868-33870	BA	_	
177-6	33871-33878	Cluster	_	
177-7	33879-33883	size	_	
177-8	33884-33885	(	_	
177-9	33885-33891	voxels	_	
177-10	33891-33892	)	_	
177-11	33893-33896	MNI	_	
177-12	33897-33908	coordinates	_	
177-13	33911-33921	Cerebellum	_	
177-14	33922-33926	crus	_	
177-15	33927-33928	I	_	
177-16	33928-33929	,	_	
177-17	33930-33934	crus	_	
177-18	33935-33937	II	_	
177-19	33937-33938	,	_	
177-20	33939-33947	fusiform	_	
177-21	33948-33953	gyrus	_	
177-22	33953-33954	,	_	
177-23	33955-33962	lingual	_	
177-24	33963-33968	gyrus	_	
177-25	33969-33970	L	_	
177-26	33971-33976	18,19	_	
177-27	33977-33980	209	_	
177-28	33981-33982	−	_	
177-29	33982-33984	28	_	
177-30	33984-33985	,	_	
177-31	33985-33986	−	_	
177-32	33986-33988	84	_	
177-33	33988-33989	,	_	
177-34	33989-33990	−	_	
177-35	33990-33992	38	_	
177-36	33995-34001	Middle	_	
177-37	34002-34010	temporal	_	
177-38	34011-34016	gyrus	_	
177-39	34016-34017	,	_	
177-40	34018-34026	inferior	_	
177-41	34027-34035	temporal	_	
177-42	34036-34041	gyrus	_	
177-43	34042-34043	L	_	
177-44	34044-34052	21,20,22	_	
177-45	34053-34056	274	_	
177-46	34057-34058	−	_	
177-47	34058-34060	59	_	
177-48	34060-34061	,	_	
177-49	34061-34062	−	_	
177-50	34062-34064	12	_	
177-51	34064-34065	,	_	
177-52	34065-34066	−	_	
177-53	34066-34068	26	_	
177-54	34071-34079	Superior	_	
177-55	34080-34088	temporal	_	
177-56	34089-34094	gyrus	_	
177-57	34094-34095	,	_	
177-58	34096-34102	middle	_	
177-59	34103-34111	temporal	_	
177-60	34112-34117	gyrus	_	
177-61	34117-34118	,	_	
177-62	34119-34125	insula	_	
177-63	34126-34127	R	_	
177-64	34128-34139	22,13,41,21	_	
177-65	34140-34143	112	_	
177-66	34144-34146	46	_	
177-67	34146-34147	,	_	
177-68	34147-34148	−	_	
177-69	34148-34150	14	_	
177-70	34150-34151	,	_	
177-71	34151-34152	−	_	
177-72	34152-34153	2	_	
177-73	34156-34164	Anterior	_	
177-74	34165-34174	cingulate	_	
177-75	34175-34181	cortex	_	
177-76	34181-34182	,	_	
177-77	34183-34191	superior	_	
177-78	34192-34198	medial	_	
177-79	34199-34206	frontal	_	
177-80	34207-34212	gyrus	_	
177-81	34213-34214	L	_	
177-82	34215-34222	10,32,9	_	
177-83	34223-34226	122	_	
177-84	34227-34234	0,46,14	_	
177-85	34237-34244	Angular	_	
177-86	34245-34246	R	_	
177-87	34247-34255	39,22,13	_	
177-88	34256-34258	62	_	
177-89	34259-34261	45	_	
177-90	34261-34262	,	_	
177-91	34262-34263	−	_	
177-92	34263-34268	55,23	_	
177-93	34271-34277	Middle	_	
177-94	34278-34285	frontal	_	
177-95	34286-34291	gyrus	_	
177-96	34292-34293	L	_	
177-97	34294-34298	9,10	_	
177-98	34299-34301	81	_	
177-99	34302-34303	−	_	
177-100	34303-34311	28,56,37	_	
177-101	34314-34327	Supramarginal	_	
177-102	34328-34333	gyrus	_	
177-103	34334-34335	L	_	
177-104	34336-34338	40	_	
177-105	34339-34341	80	_	
177-106	34342-34343	−	_	
177-107	34343-34345	54	_	
177-108	34345-34346	,	_	
177-109	34346-34347	−	_	
177-110	34347-34352	37,29	_	
177-111	34355-34366	Postcentral	_	
177-112	34367-34372	gyrus	_	
177-113	34373-34374	R	_	
177-114	34375-34381	2,40,3	_	
177-115	34382-34384	62	_	
177-116	34385-34387	44	_	
177-117	34387-34388	,	_	
177-118	34388-34389	−	_	
177-119	34389-34394	31,55	_	
177-120	34397-34406	Precuneus	_	
177-121	34407-34408	L	_	
177-122	34408-34409	/	_	
177-123	34409-34410	R	_	
177-124	34411-34412	7	_	
177-125	34413-34415	72	_	
177-126	34416-34417	2	_	
177-127	34417-34418	,	_	
177-128	34418-34419	−	_	
177-129	34419-34424	66,67	_	
177-130	34428-34432	Note	_	
177-131	34432-34433	:	_	
177-132	34434-34436	BA	_	
177-133	34436-34437	 	_	
177-134	34437-34438	=	_	
177-135	34438-34439	 	_	
177-136	34439-34447	Brodmann	_	
177-137	34448-34452	area	_	
177-138	34452-34453	,	_	
177-139	34454-34455	R	_	
177-140	34455-34456	 	_	
177-141	34456-34457	=	_	
177-142	34457-34458	 	_	
177-143	34458-34463	right	_	
177-144	34463-34464	,	_	
177-145	34465-34466	L	_	
177-146	34466-34467	 	_	
177-147	34467-34468	=	_	
177-148	34468-34469	 	_	
177-149	34469-34473	left	_	
177-150	34473-34474	.	_	

#Text=The site-specific features were displayed in the right panel of Fig. 2.
178-1	34475-34478	The	_	
178-2	34479-34492	site-specific	_	
178-3	34493-34501	features	_	
178-4	34502-34506	were	_	
178-5	34507-34516	displayed	_	
178-6	34517-34519	in	_	
178-7	34520-34523	the	_	
178-8	34524-34529	right	_	
178-9	34530-34535	panel	_	
178-10	34536-34538	of	_	
178-11	34539-34542	Fig	_	
178-12	34542-34543	.	_	
178-13	34544-34545	2	_	
178-14	34545-34546	.	_	

#Text=The site-specific features of site A included regions of the fusiform, lingual, inferior temporal, middle temporal, superior temporal, middle frontal, superior frontal, superior medial frontal, postcentral, superior parietal, precentral gyri, precuneus, putamen, supplemental motor area, and the cerebellum.
179-1	34547-34550	The	_	
179-2	34551-34564	site-specific	_	
179-3	34565-34573	features	_	
179-4	34574-34576	of	_	
179-5	34577-34581	site	_	
179-6	34582-34583	A	_	
179-7	34584-34592	included	_	
179-8	34593-34600	regions	_	
179-9	34601-34603	of	_	
179-10	34604-34607	the	_	
179-11	34608-34616	fusiform	_	
179-12	34616-34617	,	_	
179-13	34618-34625	lingual	_	
179-14	34625-34626	,	_	
179-15	34627-34635	inferior	_	
179-16	34636-34644	temporal	_	
179-17	34644-34645	,	_	
179-18	34646-34652	middle	_	
179-19	34653-34661	temporal	_	
179-20	34661-34662	,	_	
179-21	34663-34671	superior	_	
179-22	34672-34680	temporal	_	
179-23	34680-34681	,	_	
179-24	34682-34688	middle	_	
179-25	34689-34696	frontal	_	
179-26	34696-34697	,	_	
179-27	34698-34706	superior	_	
179-28	34707-34714	frontal	_	
179-29	34714-34715	,	_	
179-30	34716-34724	superior	_	
179-31	34725-34731	medial	_	
179-32	34732-34739	frontal	_	
179-33	34739-34740	,	_	
179-34	34741-34752	postcentral	_	
179-35	34752-34753	,	_	
179-36	34754-34762	superior	_	
179-37	34763-34771	parietal	_	
179-38	34771-34772	,	_	
179-39	34773-34783	precentral	_	
179-40	34784-34788	gyri	_	
179-41	34788-34789	,	_	
179-42	34790-34799	precuneus	_	
179-43	34799-34800	,	_	
179-44	34801-34808	putamen	_	
179-45	34808-34809	,	_	
179-46	34810-34822	supplemental	_	
179-47	34823-34828	motor	_	
179-48	34829-34833	area	_	
179-49	34833-34834	,	_	
179-50	34835-34838	and	_	
179-51	34839-34842	the	_	
179-52	34843-34853	cerebellum	_	
179-53	34853-34854	.	_	

#Text=The site-specific features of site B included regions of the fusiform, anterior cingulate cortex, posterior cingulate cortex, hippocampus, parahippocampus, angular, inferior frontal, middle frontal, postcentral, precentral, inferior parietal, middle occipital gyri, precuneus, and the cerebellum.
180-1	34855-34858	The	_	
180-2	34859-34872	site-specific	_	
180-3	34873-34881	features	_	
180-4	34882-34884	of	_	
180-5	34885-34889	site	_	
180-6	34890-34891	B	_	
180-7	34892-34900	included	_	
180-8	34901-34908	regions	_	
180-9	34909-34911	of	_	
180-10	34912-34915	the	_	
180-11	34916-34924	fusiform	_	
180-12	34924-34925	,	_	
180-13	34926-34934	anterior	_	
180-14	34935-34944	cingulate	_	
180-15	34945-34951	cortex	_	
180-16	34951-34952	,	_	
180-17	34953-34962	posterior	_	
180-18	34963-34972	cingulate	_	
180-19	34973-34979	cortex	_	
180-20	34979-34980	,	_	
180-21	34981-34992	hippocampus	_	
180-22	34992-34993	,	_	
180-23	34994-35009	parahippocampus	_	
180-24	35009-35010	,	_	
180-25	35011-35018	angular	_	
180-26	35018-35019	,	_	
180-27	35020-35028	inferior	_	
180-28	35029-35036	frontal	_	
180-29	35036-35037	,	_	
180-30	35038-35044	middle	_	
180-31	35045-35052	frontal	_	
180-32	35052-35053	,	_	
180-33	35054-35065	postcentral	_	
180-34	35065-35066	,	_	
180-35	35067-35077	precentral	_	
180-36	35077-35078	,	_	
180-37	35079-35087	inferior	_	
180-38	35088-35096	parietal	_	
180-39	35096-35097	,	_	
180-40	35098-35104	middle	_	
180-41	35105-35114	occipital	_	
180-42	35115-35119	gyri	_	
180-43	35119-35120	,	_	
180-44	35121-35130	precuneus	_	
180-45	35130-35131	,	_	
180-46	35132-35135	and	_	
180-47	35136-35139	the	_	
180-48	35140-35150	cerebellum	_	
180-49	35150-35151	.	_	

#Text=The site-specific features of site C included regions of the fusiform, lingual, anterior cingulate cortex, angular, middle temporal, inferior temporal, superior temporal, middle frontal, postcentral, supramarginal, superior medial frontal gyri, precuneus, insular, and the cerebellum.
181-1	35152-35155	The	_	
181-2	35156-35169	site-specific	_	
181-3	35170-35178	features	_	
181-4	35179-35181	of	_	
181-5	35182-35186	site	_	
181-6	35187-35188	C	_	
181-7	35189-35197	included	_	
181-8	35198-35205	regions	_	
181-9	35206-35208	of	_	
181-10	35209-35212	the	_	
181-11	35213-35221	fusiform	_	
181-12	35221-35222	,	_	
181-13	35223-35230	lingual	_	
181-14	35230-35231	,	_	
181-15	35232-35240	anterior	_	
181-16	35241-35250	cingulate	_	
181-17	35251-35257	cortex	_	
181-18	35257-35258	,	_	
181-19	35259-35266	angular	_	
181-20	35266-35267	,	_	
181-21	35268-35274	middle	_	
181-22	35275-35283	temporal	_	
181-23	35283-35284	,	_	
181-24	35285-35293	inferior	_	
181-25	35294-35302	temporal	_	
181-26	35302-35303	,	_	
181-27	35304-35312	superior	_	
181-28	35313-35321	temporal	_	
181-29	35321-35322	,	_	
181-30	35323-35329	middle	_	
181-31	35330-35337	frontal	_	
181-32	35337-35338	,	_	
181-33	35339-35350	postcentral	_	
181-34	35350-35351	,	_	
181-35	35352-35365	supramarginal	_	
181-36	35365-35366	,	_	
181-37	35367-35375	superior	_	
181-38	35376-35382	medial	_	
181-39	35383-35390	frontal	_	
181-40	35391-35395	gyri	_	
181-41	35395-35396	,	_	
181-42	35397-35406	precuneus	_	
181-43	35406-35407	,	_	
181-44	35408-35415	insular	_	
181-45	35415-35416	,	_	
181-46	35417-35420	and	_	
181-47	35421-35424	the	_	
181-48	35425-35435	cerebellum	_	
181-49	35435-35436	.	_	

#Text=As shown, the site-specific patterns in the three sites involved several regions that were located adjacent to the same site-shared regions, including the fusiform, lingual, postcentral, precentral, prefrontal gyri, and the cerebellum.
182-1	35437-35439	As	_	
182-2	35440-35445	shown	_	
182-3	35445-35446	,	_	
182-4	35447-35450	the	_	
182-5	35451-35464	site-specific	_	
182-6	35465-35473	patterns	_	
182-7	35474-35476	in	_	
182-8	35477-35480	the	_	
182-9	35481-35486	three	_	
182-10	35487-35492	sites	_	
182-11	35493-35501	involved	_	
182-12	35502-35509	several	_	
182-13	35510-35517	regions	_	
182-14	35518-35522	that	_	
182-15	35523-35527	were	_	
182-16	35528-35535	located	_	
182-17	35536-35544	adjacent	_	
182-18	35545-35547	to	_	
182-19	35548-35551	the	_	
182-20	35552-35556	same	_	
182-21	35557-35568	site-shared	_	
182-22	35569-35576	regions	_	
182-23	35576-35577	,	_	
182-24	35578-35587	including	_	
182-25	35588-35591	the	_	
182-26	35592-35600	fusiform	_	
182-27	35600-35601	,	_	
182-28	35602-35609	lingual	_	
182-29	35609-35610	,	_	
182-30	35611-35622	postcentral	_	
182-31	35622-35623	,	_	
182-32	35624-35634	precentral	_	
182-33	35634-35635	,	_	
182-34	35636-35646	prefrontal	_	
182-35	35647-35651	gyri	_	
182-36	35651-35652	,	_	
182-37	35653-35656	and	_	
182-38	35657-35660	the	_	
182-39	35661-35671	cerebellum	_	
182-40	35671-35672	.	_	

#Text=Detailed information of the site-specific features are shown in Table 5, Table 6, Table 7.
183-1	35673-35681	Detailed	_	
183-2	35682-35693	information	_	
183-3	35694-35696	of	_	
183-4	35697-35700	the	_	
183-5	35701-35714	site-specific	_	
183-6	35715-35723	features	_	
183-7	35724-35727	are	_	
183-8	35728-35733	shown	_	
183-9	35734-35736	in	_	
183-10	35737-35742	Table	_	
183-11	35743-35744	5	_	
183-12	35744-35745	,	_	
183-13	35746-35751	Table	_	
183-14	35752-35753	6	_	
183-15	35753-35754	,	_	
183-16	35755-35760	Table	_	
183-17	35761-35762	7	_	
183-18	35762-35763	.	_	

#Text=Discussion
#Text=We present a method utilizing multi-task l2,1 + l1-norm learning to simultaneously learn the site-shared and site-specific features, for multi-site classification problems.
184-1	35764-35774	Discussion	_	
184-2	35775-35777	We	_	
184-3	35778-35785	present	_	
184-4	35786-35787	a	_	
184-5	35788-35794	method	_	
184-6	35795-35804	utilizing	_	
184-7	35805-35815	multi-task	_	
184-8	35816-35820	l2,1	_	
184-9	35820-35821	 	_	
184-10	35821-35822	+	_	
184-11	35822-35823	 	_	
184-12	35823-35825	l1	_	
184-13	35825-35826	-	_	
184-14	35826-35830	norm	_	
184-15	35831-35839	learning	_	
184-16	35840-35842	to	_	
184-17	35843-35857	simultaneously	_	
184-18	35858-35863	learn	_	
184-19	35864-35867	the	_	
184-20	35868-35879	site-shared	_	
184-21	35880-35883	and	_	
184-22	35884-35897	site-specific	_	
184-23	35898-35906	features	_	
184-24	35906-35907	,	_	
184-25	35908-35911	for	_	
184-26	35912-35922	multi-site	_	
184-27	35923-35937	classification	_	
184-28	35938-35946	problems	_	
184-29	35946-35947	.	_	

#Text=The method was tested to differentiate SCZ patients from healthy controls in three data sites.
185-1	35948-35951	The	_	
185-2	35952-35958	method	_	
185-3	35959-35962	was	_	
185-4	35963-35969	tested	_	
185-5	35970-35972	to	_	
185-6	35973-35986	differentiate	_	
185-7	35987-35990	SCZ	_	
185-8	35991-35999	patients	_	
185-9	36000-36004	from	_	
185-10	36005-36012	healthy	_	
185-11	36013-36021	controls	_	
185-12	36022-36024	in	_	
185-13	36025-36030	three	_	
185-14	36031-36035	data	_	
185-15	36036-36041	sites	_	
185-16	36041-36042	.	_	

#Text=Compared to single-site and pooled data classification, the multi-site classification performance was significantly higher, which demonstrated that multi-site data can enhance accuracy in identifying brain alterations in SCZ if multi-task learning is applied.
186-1	36043-36051	Compared	_	
186-2	36052-36054	to	_	
186-3	36055-36066	single-site	_	
186-4	36067-36070	and	_	
186-5	36071-36077	pooled	_	
186-6	36078-36082	data	_	
186-7	36083-36097	classification	_	
186-8	36097-36098	,	_	
186-9	36099-36102	the	_	
186-10	36103-36113	multi-site	_	
186-11	36114-36128	classification	_	
186-12	36129-36140	performance	_	
186-13	36141-36144	was	_	
186-14	36145-36158	significantly	_	
186-15	36159-36165	higher	_	
186-16	36165-36166	,	_	
186-17	36167-36172	which	_	
186-18	36173-36185	demonstrated	_	
186-19	36186-36190	that	_	
186-20	36191-36201	multi-site	_	
186-21	36202-36206	data	_	
186-22	36207-36210	can	_	
186-23	36211-36218	enhance	_	
186-24	36219-36227	accuracy	_	
186-25	36228-36230	in	_	
186-26	36231-36242	identifying	_	
186-27	36243-36248	brain	_	
186-28	36249-36260	alterations	_	
186-29	36261-36263	in	_	
186-30	36264-36267	SCZ	_	
186-31	36268-36270	if	_	
186-32	36271-36281	multi-task	_	
186-33	36282-36290	learning	_	
186-34	36291-36293	is	_	
186-35	36294-36301	applied	_	
186-36	36301-36302	.	_	

#Text=The multi-task learning framework thus provides a new way to take advantage of multi-site data to better classify and understand brain diseases.
187-1	36303-36306	The	_	
187-2	36307-36317	multi-task	_	
187-3	36318-36326	learning	_	
187-4	36327-36336	framework	_	
187-5	36337-36341	thus	_	
187-6	36342-36350	provides	_	
187-7	36351-36352	a	_	
187-8	36353-36356	new	_	
187-9	36357-36360	way	_	
187-10	36361-36363	to	_	
187-11	36364-36368	take	_	
187-12	36369-36378	advantage	_	
187-13	36379-36381	of	_	
187-14	36382-36392	multi-site	_	
187-15	36393-36397	data	_	
187-16	36398-36400	to	_	
187-17	36401-36407	better	_	
187-18	36408-36416	classify	_	
187-19	36417-36420	and	_	
187-20	36421-36431	understand	_	
187-21	36432-36437	brain	_	
187-22	36438-36446	diseases	_	
187-23	36446-36447	.	_	

#Text=Reliable identification of multi-site schizophrenia data using multi-task learning
#Text=Single-site data contains information about pathophysiology, but may simultaneously include information related to different scanners or imaging protocols, as well as demographic differences that may influence the pattern investigations across individual subject samples.
188-1	36448-36456	Reliable	_	
188-2	36457-36471	identification	_	
188-3	36472-36474	of	_	
188-4	36475-36485	multi-site	_	
188-5	36486-36499	schizophrenia	_	
188-6	36500-36504	data	_	
188-7	36505-36510	using	_	
188-8	36511-36521	multi-task	_	
188-9	36522-36530	learning	_	
188-10	36531-36542	Single-site	_	
188-11	36543-36547	data	_	
188-12	36548-36556	contains	_	
188-13	36557-36568	information	_	
188-14	36569-36574	about	_	
188-15	36575-36590	pathophysiology	_	
188-16	36590-36591	,	_	
188-17	36592-36595	but	_	
188-18	36596-36599	may	_	
188-19	36600-36614	simultaneously	_	
188-20	36615-36622	include	_	
188-21	36623-36634	information	_	
188-22	36635-36642	related	_	
188-23	36643-36645	to	_	
188-24	36646-36655	different	_	
188-25	36656-36664	scanners	_	
188-26	36665-36667	or	_	
188-27	36668-36675	imaging	_	
188-28	36676-36685	protocols	_	
188-29	36685-36686	,	_	
188-30	36687-36689	as	_	
188-31	36690-36694	well	_	
188-32	36695-36697	as	_	
188-33	36698-36709	demographic	_	
188-34	36710-36721	differences	_	
188-35	36722-36726	that	_	
188-36	36727-36730	may	_	
188-37	36731-36740	influence	_	
188-38	36741-36744	the	_	
188-39	36745-36752	pattern	_	
188-40	36753-36767	investigations	_	
188-41	36768-36774	across	_	
188-42	36775-36785	individual	_	
188-43	36786-36793	subject	_	
188-44	36794-36801	samples	_	
188-45	36801-36802	.	_	

#Text=Using single-site data is limited by smaller sample sizes and smaller diversity in imaging features, both of which often lead to poor generalization performance of classifiers on new patient populations.
189-1	36803-36808	Using	_	
189-2	36809-36820	single-site	_	
189-3	36821-36825	data	_	
189-4	36826-36828	is	_	
189-5	36829-36836	limited	_	
189-6	36837-36839	by	_	
189-7	36840-36847	smaller	_	
189-8	36848-36854	sample	_	
189-9	36855-36860	sizes	_	
189-10	36861-36864	and	_	
189-11	36865-36872	smaller	_	
189-12	36873-36882	diversity	_	
189-13	36883-36885	in	_	
189-14	36886-36893	imaging	_	
189-15	36894-36902	features	_	
189-16	36902-36903	,	_	
189-17	36904-36908	both	_	
189-18	36909-36911	of	_	
189-19	36912-36917	which	_	
189-20	36918-36923	often	_	
189-21	36924-36928	lead	_	
189-22	36929-36931	to	_	
189-23	36932-36936	poor	_	
189-24	36937-36951	generalization	_	
189-25	36952-36963	performance	_	
189-26	36964-36966	of	_	
189-27	36967-36978	classifiers	_	
189-28	36979-36981	on	_	
189-29	36982-36985	new	_	
189-30	36986-36993	patient	_	
189-31	36994-37005	populations	_	
189-32	37005-37006	.	_	

#Text=Data pooled from multiple sites alleviate both of these problems at the expense of introducing confounding heterogeneity in the imaging data, which renders the pooled analysis challenging.
190-1	37007-37011	Data	_	
190-2	37012-37018	pooled	_	
190-3	37019-37023	from	_	
190-4	37024-37032	multiple	_	
190-5	37033-37038	sites	_	
190-6	37039-37048	alleviate	_	
190-7	37049-37053	both	_	
190-8	37054-37056	of	_	
190-9	37057-37062	these	_	
190-10	37063-37071	problems	_	
190-11	37072-37074	at	_	
190-12	37075-37078	the	_	
190-13	37079-37086	expense	_	
190-14	37087-37089	of	_	
190-15	37090-37101	introducing	_	
190-16	37102-37113	confounding	_	
190-17	37114-37127	heterogeneity	_	
190-18	37128-37130	in	_	
190-19	37131-37134	the	_	
190-20	37135-37142	imaging	_	
190-21	37143-37147	data	_	
190-22	37147-37148	,	_	
190-23	37149-37154	which	_	
190-24	37155-37162	renders	_	
190-25	37163-37166	the	_	
190-26	37167-37173	pooled	_	
190-27	37174-37182	analysis	_	
190-28	37183-37194	challenging	_	
190-29	37194-37195	.	_	

#Text=In our study, using the proposed multi-task feature learning scheme, the classification accuracy of using pooled data was no better than using each single site and, in the case of site C data, pooled learning performed worse than single-site classification.
191-1	37196-37198	In	_	
191-2	37199-37202	our	_	
191-3	37203-37208	study	_	
191-4	37208-37209	,	_	
191-5	37210-37215	using	_	
191-6	37216-37219	the	_	
191-7	37220-37228	proposed	_	
191-8	37229-37239	multi-task	_	
191-9	37240-37247	feature	_	
191-10	37248-37256	learning	_	
191-11	37257-37263	scheme	_	
191-12	37263-37264	,	_	
191-13	37265-37268	the	_	
191-14	37269-37283	classification	_	
191-15	37284-37292	accuracy	_	
191-16	37293-37295	of	_	
191-17	37296-37301	using	_	
191-18	37302-37308	pooled	_	
191-19	37309-37313	data	_	
191-20	37314-37317	was	_	
191-21	37318-37320	no	_	
191-22	37321-37327	better	_	
191-23	37328-37332	than	_	
191-24	37333-37338	using	_	
191-25	37339-37343	each	_	
191-26	37344-37350	single	_	
191-27	37351-37355	site	_	
191-28	37356-37359	and	_	
191-29	37359-37360	,	_	
191-30	37361-37363	in	_	
191-31	37364-37367	the	_	
191-32	37368-37372	case	_	
191-33	37373-37375	of	_	
191-34	37376-37380	site	_	
191-35	37381-37382	C	_	
191-36	37383-37387	data	_	
191-37	37387-37388	,	_	
191-38	37389-37395	pooled	_	
191-39	37396-37404	learning	_	
191-40	37405-37414	performed	_	
191-41	37415-37420	worse	_	
191-42	37421-37425	than	_	
191-43	37426-37437	single-site	_	
191-44	37438-37452	classification	_	
191-45	37452-37453	.	_	

#Text=This result might demonstrate that the site-specific features in each data site may not always benefit for the pooled classification.
192-1	37454-37458	This	_	
192-2	37459-37465	result	_	
192-3	37466-37471	might	_	
192-4	37472-37483	demonstrate	_	
192-5	37484-37488	that	_	
192-6	37489-37492	the	_	
192-7	37493-37506	site-specific	_	
192-8	37507-37515	features	_	
192-9	37516-37518	in	_	
192-10	37519-37523	each	_	
192-11	37524-37528	data	_	
192-12	37529-37533	site	_	
192-13	37534-37537	may	_	
192-14	37538-37541	not	_	
192-15	37542-37548	always	_	
192-16	37549-37556	benefit	_	
192-17	37557-37560	for	_	
192-18	37561-37564	the	_	
192-19	37565-37571	pooled	_	
192-20	37572-37586	classification	_	
192-21	37586-37587	.	_	

#Text=The advantage of the multi-task learning frame in our study is that it can simultaneously learn site-shared and site-specific features, which is suitable when combining multi-site data for disease classification.
193-1	37588-37591	The	_	
193-2	37592-37601	advantage	_	
193-3	37602-37604	of	_	
193-4	37605-37608	the	_	
193-5	37609-37619	multi-task	_	
193-6	37620-37628	learning	_	
193-7	37629-37634	frame	_	
193-8	37635-37637	in	_	
193-9	37638-37641	our	_	
193-10	37642-37647	study	_	
193-11	37648-37650	is	_	
193-12	37651-37655	that	_	
193-13	37656-37658	it	_	
193-14	37659-37662	can	_	
193-15	37663-37677	simultaneously	_	
193-16	37678-37683	learn	_	
193-17	37684-37695	site-shared	_	
193-18	37696-37699	and	_	
193-19	37700-37713	site-specific	_	
193-20	37714-37722	features	_	
193-21	37722-37723	,	_	
193-22	37724-37729	which	_	
193-23	37730-37732	is	_	
193-24	37733-37741	suitable	_	
193-25	37742-37746	when	_	
193-26	37747-37756	combining	_	
193-27	37757-37767	multi-site	_	
193-28	37768-37772	data	_	
193-29	37773-37776	for	_	
193-30	37777-37784	disease	_	
193-31	37785-37799	classification	_	
193-32	37799-37800	.	_	

#Text=The l2,1 + l1-norm penalty terms focuses on the group sparsity, and sparsity to maximize weights of site-shared or site-specific features, while setting all other irrelevant features to be very small.
194-1	37801-37804	The	_	
194-2	37805-37809	l2,1	_	
194-3	37809-37810	 	_	
194-4	37810-37811	+	_	
194-5	37811-37812	 	_	
194-6	37812-37814	l1	_	
194-7	37814-37815	-	_	
194-8	37815-37819	norm	_	
194-9	37820-37827	penalty	_	
194-10	37828-37833	terms	_	
194-11	37834-37841	focuses	_	
194-12	37842-37844	on	_	
194-13	37845-37848	the	_	
194-14	37849-37854	group	_	
194-15	37855-37863	sparsity	_	
194-16	37863-37864	,	_	
194-17	37865-37868	and	_	
194-18	37869-37877	sparsity	_	
194-19	37878-37880	to	_	
194-20	37881-37889	maximize	_	
194-21	37890-37897	weights	_	
194-22	37898-37900	of	_	
194-23	37901-37912	site-shared	_	
194-24	37913-37915	or	_	
194-25	37916-37929	site-specific	_	
194-26	37930-37938	features	_	
194-27	37938-37939	,	_	
194-28	37940-37945	while	_	
194-29	37946-37953	setting	_	
194-30	37954-37957	all	_	
194-31	37958-37963	other	_	
194-32	37964-37974	irrelevant	_	
194-33	37975-37983	features	_	
194-34	37984-37986	to	_	
194-35	37987-37989	be	_	
194-36	37990-37994	very	_	
194-37	37995-38000	small	_	
194-38	38000-38001	.	_	

#Text=In addition, the two penalty terms are very common and simple in sparsity regularization and can easily be generalized.
195-1	38002-38004	In	_	
195-2	38005-38013	addition	_	
195-3	38013-38014	,	_	
195-4	38015-38018	the	_	
195-5	38019-38022	two	_	
195-6	38023-38030	penalty	_	
195-7	38031-38036	terms	_	
195-8	38037-38040	are	_	
195-9	38041-38045	very	_	
195-10	38046-38052	common	_	
195-11	38053-38056	and	_	
195-12	38057-38063	simple	_	
195-13	38064-38066	in	_	
195-14	38067-38075	sparsity	_	
195-15	38076-38090	regularization	_	
195-16	38091-38094	and	_	
195-17	38095-38098	can	_	
195-18	38099-38105	easily	_	
195-19	38106-38108	be	_	
195-20	38109-38120	generalized	_	
195-21	38120-38121	.	_	

#Text=The multi-task learning framework has attracted increasingly attention in other fields, such as in data mining, bioinformatics and computer vision.
196-1	38122-38125	The	_	
196-2	38126-38136	multi-task	_	
196-3	38137-38145	learning	_	
196-4	38146-38155	framework	_	
196-5	38156-38159	has	_	
196-6	38160-38169	attracted	_	
196-7	38170-38182	increasingly	_	
196-8	38183-38192	attention	_	
196-9	38193-38195	in	_	
196-10	38196-38201	other	_	
196-11	38202-38208	fields	_	
196-12	38208-38209	,	_	
196-13	38210-38214	such	_	
196-14	38215-38217	as	_	
196-15	38218-38220	in	_	
196-16	38221-38225	data	_	
196-17	38226-38232	mining	_	
196-18	38232-38233	,	_	
196-19	38234-38248	bioinformatics	_	
196-20	38249-38252	and	_	
196-21	38253-38261	computer	_	
196-22	38262-38268	vision	_	
196-23	38268-38269	.	_	

#Text=In the current study, the performance was poor in using the PCA and ttest2 feature learning methods in the single-site and pooled classification.
197-1	38270-38272	In	_	
197-2	38273-38276	the	_	
197-3	38277-38284	current	_	
197-4	38285-38290	study	_	
197-5	38290-38291	,	_	
197-6	38292-38295	the	_	
197-7	38296-38307	performance	_	
197-8	38308-38311	was	_	
197-9	38312-38316	poor	_	
197-10	38317-38319	in	_	
197-11	38320-38325	using	_	
197-12	38326-38329	the	_	
197-13	38330-38333	PCA	_	
197-14	38334-38337	and	_	
197-15	38338-38344	ttest2	_	
197-16	38345-38352	feature	_	
197-17	38353-38361	learning	_	
197-18	38362-38369	methods	_	
197-19	38370-38372	in	_	
197-20	38373-38376	the	_	
197-21	38377-38388	single-site	_	
197-22	38389-38392	and	_	
197-23	38393-38399	pooled	_	
197-24	38400-38414	classification	_	
197-25	38414-38415	.	_	

#Text=PCA is a linear method for dimensionality reduction, which may not consider the nonlinear correlations of different features, while ttest2 is a univariate feature selection method, neglecting the relationship of multiple variables.
198-1	38416-38419	PCA	_	
198-2	38420-38422	is	_	
198-3	38423-38424	a	_	
198-4	38425-38431	linear	_	
198-5	38432-38438	method	_	
198-6	38439-38442	for	_	
198-7	38443-38457	dimensionality	_	
198-8	38458-38467	reduction	_	
198-9	38467-38468	,	_	
198-10	38469-38474	which	_	
198-11	38475-38478	may	_	
198-12	38479-38482	not	_	
198-13	38483-38491	consider	_	
198-14	38492-38495	the	_	
198-15	38496-38505	nonlinear	_	
198-16	38506-38518	correlations	_	
198-17	38519-38521	of	_	
198-18	38522-38531	different	_	
198-19	38532-38540	features	_	
198-20	38540-38541	,	_	
198-21	38542-38547	while	_	
198-22	38548-38554	ttest2	_	
198-23	38555-38557	is	_	
198-24	38558-38559	a	_	
198-25	38560-38570	univariate	_	
198-26	38571-38578	feature	_	
198-27	38579-38588	selection	_	
198-28	38589-38595	method	_	
198-29	38595-38596	,	_	
198-30	38597-38607	neglecting	_	
198-31	38608-38611	the	_	
198-32	38612-38624	relationship	_	
198-33	38625-38627	of	_	
198-34	38628-38636	multiple	_	
198-35	38637-38646	variables	_	
198-36	38646-38647	.	_	

#Text=Thus, the accuracies of using PCA and ttest2 were no better than using the proposed multi-task feature learning framework.
199-1	38648-38652	Thus	_	
199-2	38652-38653	,	_	
199-3	38654-38657	the	_	
199-4	38658-38668	accuracies	_	
199-5	38669-38671	of	_	
199-6	38672-38677	using	_	
199-7	38678-38681	PCA	_	
199-8	38682-38685	and	_	
199-9	38686-38692	ttest2	_	
199-10	38693-38697	were	_	
199-11	38698-38700	no	_	
199-12	38701-38707	better	_	
199-13	38708-38712	than	_	
199-14	38713-38718	using	_	
199-15	38719-38722	the	_	
199-16	38723-38731	proposed	_	
199-17	38732-38742	multi-task	_	
199-18	38743-38750	feature	_	
199-19	38751-38759	learning	_	
199-20	38760-38769	framework	_	
199-21	38769-38770	.	_	

#Text=Results also showed that accuracies using the proposed classifier were much better than using SVM.
200-1	38771-38778	Results	_	
200-2	38779-38783	also	_	
200-3	38784-38790	showed	_	
200-4	38791-38795	that	_	
200-5	38796-38806	accuracies	_	
200-6	38807-38812	using	_	
200-7	38813-38816	the	_	
200-8	38817-38825	proposed	_	
200-9	38826-38836	classifier	_	
200-10	38837-38841	were	_	
200-11	38842-38846	much	_	
200-12	38847-38853	better	_	
200-13	38854-38858	than	_	
200-14	38859-38864	using	_	
200-15	38865-38868	SVM	_	
200-16	38868-38869	.	_	

#Text=In the multi-task feature learning step, the feature weights were calculated based on all features and contained valuable information.
201-1	38870-38872	In	_	
201-2	38873-38876	the	_	
201-3	38877-38887	multi-task	_	
201-4	38888-38895	feature	_	
201-5	38896-38904	learning	_	
201-6	38905-38909	step	_	
201-7	38909-38910	,	_	
201-8	38911-38914	the	_	
201-9	38915-38922	feature	_	
201-10	38923-38930	weights	_	
201-11	38931-38935	were	_	
201-12	38936-38946	calculated	_	
201-13	38947-38952	based	_	
201-14	38953-38955	on	_	
201-15	38956-38959	all	_	
201-16	38960-38968	features	_	
201-17	38969-38972	and	_	
201-18	38973-38982	contained	_	
201-19	38983-38991	valuable	_	
201-20	38992-39003	information	_	
201-21	39003-39004	.	_	

#Text=Those features exhibited the largest weights were selected and used in the classification step.
202-1	39005-39010	Those	_	
202-2	39011-39019	features	_	
202-3	39020-39029	exhibited	_	
202-4	39030-39033	the	_	
202-5	39034-39041	largest	_	
202-6	39042-39049	weights	_	
202-7	39050-39054	were	_	
202-8	39055-39063	selected	_	
202-9	39064-39067	and	_	
202-10	39068-39072	used	_	
202-11	39073-39075	in	_	
202-12	39076-39079	the	_	
202-13	39080-39094	classification	_	
202-14	39095-39099	step	_	
202-15	39099-39100	.	_	

#Text=SVM classifier only used the sequencing information of the feature weights, which had lost some valuable information of these selected features.
203-1	39101-39104	SVM	_	
203-2	39105-39115	classifier	_	
203-3	39116-39120	only	_	
203-4	39121-39125	used	_	
203-5	39126-39129	the	_	
203-6	39130-39140	sequencing	_	
203-7	39141-39152	information	_	
203-8	39153-39155	of	_	
203-9	39156-39159	the	_	
203-10	39160-39167	feature	_	
203-11	39168-39175	weights	_	
203-12	39175-39176	,	_	
203-13	39177-39182	which	_	
203-14	39183-39186	had	_	
203-15	39187-39191	lost	_	
203-16	39192-39196	some	_	
203-17	39197-39205	valuable	_	
203-18	39206-39217	information	_	
203-19	39218-39220	of	_	
203-20	39221-39226	these	_	
203-21	39227-39235	selected	_	
203-22	39236-39244	features	_	
203-23	39244-39245	.	_	

#Text=Therefore, better results using our proposed classifier showed that the feature weights learned by the multi-task feature learning method were accurate.
204-1	39246-39255	Therefore	_	
204-2	39255-39256	,	_	
204-3	39257-39263	better	_	
204-4	39264-39271	results	_	
204-5	39272-39277	using	_	
204-6	39278-39281	our	_	
204-7	39282-39290	proposed	_	
204-8	39291-39301	classifier	_	
204-9	39302-39308	showed	_	
204-10	39309-39313	that	_	
204-11	39314-39317	the	_	
204-12	39318-39325	feature	_	
204-13	39326-39333	weights	_	
204-14	39334-39341	learned	_	
204-15	39342-39344	by	_	
204-16	39345-39348	the	_	
204-17	39349-39359	multi-task	_	
204-18	39360-39367	feature	_	
204-19	39368-39376	learning	_	
204-20	39377-39383	method	_	
204-21	39384-39388	were	_	
204-22	39389-39397	accurate	_	
204-23	39397-39398	.	_	

#Text=Site-shared and site-specific regions of gray matter alterations in schizophrenia
#Text=A pattern of gray matter intensity alterations implicating several brain regions in the SCZ sample was revealed by the site-shared feature analysis of multi-site MRI data in our study.
205-1	39399-39410	Site-shared	_	
205-2	39411-39414	and	_	
205-3	39415-39428	site-specific	_	
205-4	39429-39436	regions	_	
205-5	39437-39439	of	_	
205-6	39440-39444	gray	_	
205-7	39445-39451	matter	_	
205-8	39452-39463	alterations	_	
205-9	39464-39466	in	_	
205-10	39467-39480	schizophrenia	_	
205-11	39481-39482	A	_	
205-12	39483-39490	pattern	_	
205-13	39491-39493	of	_	
205-14	39494-39498	gray	_	
205-15	39499-39505	matter	_	
205-16	39506-39515	intensity	_	
205-17	39516-39527	alterations	_	
205-18	39528-39539	implicating	_	
205-19	39540-39547	several	_	
205-20	39548-39553	brain	_	
205-21	39554-39561	regions	_	
205-22	39562-39564	in	_	
205-23	39565-39568	the	_	
205-24	39569-39572	SCZ	_	
205-25	39573-39579	sample	_	
205-26	39580-39583	was	_	
205-27	39584-39592	revealed	_	
205-28	39593-39595	by	_	
205-29	39596-39599	the	_	
205-30	39600-39611	site-shared	_	
205-31	39612-39619	feature	_	
205-32	39620-39628	analysis	_	
205-33	39629-39631	of	_	
205-34	39632-39642	multi-site	_	
205-35	39643-39646	MRI	_	
205-36	39647-39651	data	_	
205-37	39652-39654	in	_	
205-38	39655-39658	our	_	
205-39	39659-39664	study	_	
205-40	39664-39665	.	_	

#Text=This is consistent with a vast number of large-scale structural MRI investigations of SCZ, including both meta-analyses of MRI results, and mega-group comparisons of mean indices combining data from multiple sites.
206-1	39666-39670	This	_	
206-2	39671-39673	is	_	
206-3	39674-39684	consistent	_	
206-4	39685-39689	with	_	
206-5	39690-39691	a	_	
206-6	39692-39696	vast	_	
206-7	39697-39703	number	_	
206-8	39704-39706	of	_	
206-9	39707-39718	large-scale	_	
206-10	39719-39729	structural	_	
206-11	39730-39733	MRI	_	
206-12	39734-39748	investigations	_	
206-13	39749-39751	of	_	
206-14	39752-39755	SCZ	_	
206-15	39755-39756	,	_	
206-16	39757-39766	including	_	
206-17	39767-39771	both	_	
206-18	39772-39785	meta-analyses	_	
206-19	39786-39788	of	_	
206-20	39789-39792	MRI	_	
206-21	39793-39800	results	_	
206-22	39800-39801	,	_	
206-23	39802-39805	and	_	
206-24	39806-39816	mega-group	_	
206-25	39817-39828	comparisons	_	
206-26	39829-39831	of	_	
206-27	39832-39836	mean	_	
206-28	39837-39844	indices	_	
206-29	39845-39854	combining	_	
206-30	39855-39859	data	_	
206-31	39860-39864	from	_	
206-32	39865-39873	multiple	_	
206-33	39874-39879	sites	_	
206-34	39879-39880	.	_	

#Text=These previous studies have repeatedly highlighted the prefrontal cortex, lateral temporal cortex, insular, striatum, anterior cingulate cortex, hippocampus and other temporo-limbic structures as key components of the network of brain regions showing volumetric deficits relative to healthy controls from early stages of SCZ onwards.
207-1	39881-39886	These	_	
207-2	39887-39895	previous	_	
207-3	39896-39903	studies	_	
207-4	39904-39908	have	_	
207-5	39909-39919	repeatedly	_	
207-6	39920-39931	highlighted	_	
207-7	39932-39935	the	_	
207-8	39936-39946	prefrontal	_	
207-9	39947-39953	cortex	_	
207-10	39953-39954	,	_	
207-11	39955-39962	lateral	_	
207-12	39963-39971	temporal	_	
207-13	39972-39978	cortex	_	
207-14	39978-39979	,	_	
207-15	39980-39987	insular	_	
207-16	39987-39988	,	_	
207-17	39989-39997	striatum	_	
207-18	39997-39998	,	_	
207-19	39999-40007	anterior	_	
207-20	40008-40017	cingulate	_	
207-21	40018-40024	cortex	_	
207-22	40024-40025	,	_	
207-23	40026-40037	hippocampus	_	
207-24	40038-40041	and	_	
207-25	40042-40047	other	_	
207-26	40048-40062	temporo-limbic	_	
207-27	40063-40073	structures	_	
207-28	40074-40076	as	_	
207-29	40077-40080	key	_	
207-30	40081-40091	components	_	
207-31	40092-40094	of	_	
207-32	40095-40098	the	_	
207-33	40099-40106	network	_	
207-34	40107-40109	of	_	
207-35	40110-40115	brain	_	
207-36	40116-40123	regions	_	
207-37	40124-40131	showing	_	
207-38	40132-40142	volumetric	_	
207-39	40143-40151	deficits	_	
207-40	40152-40160	relative	_	
207-41	40161-40163	to	_	
207-42	40164-40171	healthy	_	
207-43	40172-40180	controls	_	
207-44	40181-40185	from	_	
207-45	40186-40191	early	_	
207-46	40192-40198	stages	_	
207-47	40199-40201	of	_	
207-48	40202-40205	SCZ	_	
207-49	40206-40213	onwards	_	
207-50	40213-40214	.	_	

#Text=Most of those brain regions were implicated in our study, indicating a high degree of consistency between the spatial distribution of findings in our site-shared feature analysis and the previous MRI literature on SCZ.
208-1	40215-40219	Most	_	
208-2	40220-40222	of	_	
208-3	40223-40228	those	_	
208-4	40229-40234	brain	_	
208-5	40235-40242	regions	_	
208-6	40243-40247	were	_	
208-7	40248-40258	implicated	_	
208-8	40259-40261	in	_	
208-9	40262-40265	our	_	
208-10	40266-40271	study	_	
208-11	40271-40272	,	_	
208-12	40273-40283	indicating	_	
208-13	40284-40285	a	_	
208-14	40286-40290	high	_	
208-15	40291-40297	degree	_	
208-16	40298-40300	of	_	
208-17	40301-40312	consistency	_	
208-18	40313-40320	between	_	
208-19	40321-40324	the	_	
208-20	40325-40332	spatial	_	
208-21	40333-40345	distribution	_	
208-22	40346-40348	of	_	
208-23	40349-40357	findings	_	
208-24	40358-40360	in	_	
208-25	40361-40364	our	_	
208-26	40365-40376	site-shared	_	
208-27	40377-40384	feature	_	
208-28	40385-40393	analysis	_	
208-29	40394-40397	and	_	
208-30	40398-40401	the	_	
208-31	40402-40410	previous	_	
208-32	40411-40414	MRI	_	
208-33	40415-40425	literature	_	
208-34	40426-40428	on	_	
208-35	40429-40432	SCZ	_	
208-36	40432-40433	.	_	

#Text=The brain regions involved in this network are critical to emotion processing and several cognitive domains known to be affected in schizophrenia, including language processing, working memory and other executive functioning operations, episodic memory, attention, self-monitoring, error detection, and attribution of salience to emotionally relevant stimuli, among others.
209-1	40434-40437	The	_	
209-2	40438-40443	brain	_	
209-3	40444-40451	regions	_	
209-4	40452-40460	involved	_	
209-5	40461-40463	in	_	
209-6	40464-40468	this	_	
209-7	40469-40476	network	_	
209-8	40477-40480	are	_	
209-9	40481-40489	critical	_	
209-10	40490-40492	to	_	
209-11	40493-40500	emotion	_	
209-12	40501-40511	processing	_	
209-13	40512-40515	and	_	
209-14	40516-40523	several	_	
209-15	40524-40533	cognitive	_	
209-16	40534-40541	domains	_	
209-17	40542-40547	known	_	
209-18	40548-40550	to	_	
209-19	40551-40553	be	_	
209-20	40554-40562	affected	_	
209-21	40563-40565	in	_	
209-22	40566-40579	schizophrenia	_	
209-23	40579-40580	,	_	
209-24	40581-40590	including	_	
209-25	40591-40599	language	_	
209-26	40600-40610	processing	_	
209-27	40610-40611	,	_	
209-28	40612-40619	working	_	
209-29	40620-40626	memory	_	
209-30	40627-40630	and	_	
209-31	40631-40636	other	_	
209-32	40637-40646	executive	_	
209-33	40647-40658	functioning	_	
209-34	40659-40669	operations	_	
209-35	40669-40670	,	_	
209-36	40671-40679	episodic	_	
209-37	40680-40686	memory	_	
209-38	40686-40687	,	_	
209-39	40688-40697	attention	_	
209-40	40697-40698	,	_	
209-41	40699-40714	self-monitoring	_	
209-42	40714-40715	,	_	
209-43	40716-40721	error	_	
209-44	40722-40731	detection	_	
209-45	40731-40732	,	_	
209-46	40733-40736	and	_	
209-47	40737-40748	attribution	_	
209-48	40749-40751	of	_	
209-49	40752-40760	salience	_	
209-50	40761-40763	to	_	
209-51	40764-40775	emotionally	_	
209-52	40776-40784	relevant	_	
209-53	40785-40792	stimuli	_	
209-54	40792-40793	,	_	
209-55	40794-40799	among	_	
209-56	40800-40806	others	_	
209-57	40806-40807	.	_	

#Text=Thus, the findings presented herein provide evidence that our method robustly identifies consistent and reliable structural brain abnormalities associated with SCZ across different sites.
210-1	40808-40812	Thus	_	
210-2	40812-40813	,	_	
210-3	40814-40817	the	_	
210-4	40818-40826	findings	_	
210-5	40827-40836	presented	_	
210-6	40837-40843	herein	_	
210-7	40844-40851	provide	_	
210-8	40852-40860	evidence	_	
210-9	40861-40865	that	_	
210-10	40866-40869	our	_	
210-11	40870-40876	method	_	
210-12	40877-40885	robustly	_	
210-13	40886-40896	identifies	_	
210-14	40897-40907	consistent	_	
210-15	40908-40911	and	_	
210-16	40912-40920	reliable	_	
210-17	40921-40931	structural	_	
210-18	40932-40937	brain	_	
210-19	40938-40951	abnormalities	_	
210-20	40952-40962	associated	_	
210-21	40963-40967	with	_	
210-22	40968-40971	SCZ	_	
210-23	40972-40978	across	_	
210-24	40979-40988	different	_	
210-25	40989-40994	sites	_	
210-26	40994-40995	.	_	

#Text=Additional brain regions often implicated in the pathophysiology of SCZ were also highlighted in our site-shared analysis, such as the cerebellum.
211-1	40996-41006	Additional	_	
211-2	41007-41012	brain	_	
211-3	41013-41020	regions	_	
211-4	41021-41026	often	_	
211-5	41027-41037	implicated	_	
211-6	41038-41040	in	_	
211-7	41041-41044	the	_	
211-8	41045-41060	pathophysiology	_	
211-9	41061-41063	of	_	
211-10	41064-41067	SCZ	_	
211-11	41068-41072	were	_	
211-12	41073-41077	also	_	
211-13	41078-41089	highlighted	_	
211-14	41090-41092	in	_	
211-15	41093-41096	our	_	
211-16	41097-41108	site-shared	_	
211-17	41109-41117	analysis	_	
211-18	41117-41118	,	_	
211-19	41119-41123	such	_	
211-20	41124-41126	as	_	
211-21	41127-41130	the	_	
211-22	41131-41141	cerebellum	_	
211-23	41141-41142	.	_	

#Text=Though the cerebellum is traditionally believed to participate in motor function, neuroimaging studies, in both nonhuman primates and humans, have demonstrated that it is also involved in brain cognitive and affective processing.
212-1	41143-41149	Though	_	
212-2	41150-41153	the	_	
212-3	41154-41164	cerebellum	_	
212-4	41165-41167	is	_	
212-5	41168-41181	traditionally	_	
212-6	41182-41190	believed	_	
212-7	41191-41193	to	_	
212-8	41194-41205	participate	_	
212-9	41206-41208	in	_	
212-10	41209-41214	motor	_	
212-11	41215-41223	function	_	
212-12	41223-41224	,	_	
212-13	41225-41237	neuroimaging	_	
212-14	41238-41245	studies	_	
212-15	41245-41246	,	_	
212-16	41247-41249	in	_	
212-17	41250-41254	both	_	
212-18	41255-41263	nonhuman	_	
212-19	41264-41272	primates	_	
212-20	41273-41276	and	_	
212-21	41277-41283	humans	_	
212-22	41283-41284	,	_	
212-23	41285-41289	have	_	
212-24	41290-41302	demonstrated	_	
212-25	41303-41307	that	_	
212-26	41308-41310	it	_	
212-27	41311-41313	is	_	
212-28	41314-41318	also	_	
212-29	41319-41327	involved	_	
212-30	41328-41330	in	_	
212-31	41331-41336	brain	_	
212-32	41337-41346	cognitive	_	
212-33	41347-41350	and	_	
212-34	41351-41360	affective	_	
212-35	41361-41371	processing	_	
212-36	41371-41372	.	_	

#Text=Several structural and functional neuroimaging studies have shown cerebellar abnormalities in SCZ subjects relative to controls.
213-1	41373-41380	Several	_	
213-2	41381-41391	structural	_	
213-3	41392-41395	and	_	
213-4	41396-41406	functional	_	
213-5	41407-41419	neuroimaging	_	
213-6	41420-41427	studies	_	
213-7	41428-41432	have	_	
213-8	41433-41438	shown	_	
213-9	41439-41449	cerebellar	_	
213-10	41450-41463	abnormalities	_	
213-11	41464-41466	in	_	
213-12	41467-41470	SCZ	_	
213-13	41471-41479	subjects	_	
213-14	41480-41488	relative	_	
213-15	41489-41491	to	_	
213-16	41492-41500	controls	_	
213-17	41500-41501	.	_	

#Text=Abnormalities in the cerebellum, through its connections to the prefrontal cortex via thalamus, have been proposed as critical to the state of “cognitive dysmetria” put forward by some authors to explain the behavior manifestations and cognitive deficits of schizophrenia.
214-1	41502-41515	Abnormalities	_	
214-2	41516-41518	in	_	
214-3	41519-41522	the	_	
214-4	41523-41533	cerebellum	_	
214-5	41533-41534	,	_	
214-6	41535-41542	through	_	
214-7	41543-41546	its	_	
214-8	41547-41558	connections	_	
214-9	41559-41561	to	_	
214-10	41562-41565	the	_	
214-11	41566-41576	prefrontal	_	
214-12	41577-41583	cortex	_	
214-13	41584-41587	via	_	
214-14	41588-41596	thalamus	_	
214-15	41596-41597	,	_	
214-16	41598-41602	have	_	
214-17	41603-41607	been	_	
214-18	41608-41616	proposed	_	
214-19	41617-41619	as	_	
214-20	41620-41628	critical	_	
214-21	41629-41631	to	_	
214-22	41632-41635	the	_	
214-23	41636-41641	state	_	
214-24	41642-41644	of	_	
214-25	41645-41646	“	_	
214-26	41646-41655	cognitive	_	
214-27	41656-41665	dysmetria	_	
214-28	41665-41666	”	_	
214-29	41667-41670	put	_	
214-30	41671-41678	forward	_	
214-31	41679-41681	by	_	
214-32	41682-41686	some	_	
214-33	41687-41694	authors	_	
214-34	41695-41697	to	_	
214-35	41698-41705	explain	_	
214-36	41706-41709	the	_	
214-37	41710-41718	behavior	_	
214-38	41719-41733	manifestations	_	
214-39	41734-41737	and	_	
214-40	41738-41747	cognitive	_	
214-41	41748-41756	deficits	_	
214-42	41757-41759	of	_	
214-43	41760-41773	schizophrenia	_	
214-44	41773-41774	.	_	

#Text=However cerebellar findings should be interpreted cautiously, since segmentation between GM and WM in that region is difficult and prone to errors, due to poor contrast at this imaging resolution.
215-1	41775-41782	However	_	
215-2	41783-41793	cerebellar	_	
215-3	41794-41802	findings	_	
215-4	41803-41809	should	_	
215-5	41810-41812	be	_	
215-6	41813-41824	interpreted	_	
215-7	41825-41835	cautiously	_	
215-8	41835-41836	,	_	
215-9	41837-41842	since	_	
215-10	41843-41855	segmentation	_	
215-11	41856-41863	between	_	
215-12	41864-41866	GM	_	
215-13	41867-41870	and	_	
215-14	41871-41873	WM	_	
215-15	41874-41876	in	_	
215-16	41877-41881	that	_	
215-17	41882-41888	region	_	
215-18	41889-41891	is	_	
215-19	41892-41901	difficult	_	
215-20	41902-41905	and	_	
215-21	41906-41911	prone	_	
215-22	41912-41914	to	_	
215-23	41915-41921	errors	_	
215-24	41921-41922	,	_	
215-25	41923-41926	due	_	
215-26	41927-41929	to	_	
215-27	41930-41934	poor	_	
215-28	41935-41943	contrast	_	
215-29	41944-41946	at	_	
215-30	41947-41951	this	_	
215-31	41952-41959	imaging	_	
215-32	41960-41970	resolution	_	
215-33	41970-41971	.	_	

#Text=Finally, other brain sites showing volume abnormalities in our study, including the precuneus and lateral parietal cortical regions, fusiform, lingual and middle occipital gyri, have been variably implicated in previous neuroimaging studies of SCZ.
216-1	41972-41979	Finally	_	
216-2	41979-41980	,	_	
216-3	41981-41986	other	_	
216-4	41987-41992	brain	_	
216-5	41993-41998	sites	_	
216-6	41999-42006	showing	_	
216-7	42007-42013	volume	_	
216-8	42014-42027	abnormalities	_	
216-9	42028-42030	in	_	
216-10	42031-42034	our	_	
216-11	42035-42040	study	_	
216-12	42040-42041	,	_	
216-13	42042-42051	including	_	
216-14	42052-42055	the	_	
216-15	42056-42065	precuneus	_	
216-16	42066-42069	and	_	
216-17	42070-42077	lateral	_	
216-18	42078-42086	parietal	_	
216-19	42087-42095	cortical	_	
216-20	42096-42103	regions	_	
216-21	42103-42104	,	_	
216-22	42105-42113	fusiform	_	
216-23	42113-42114	,	_	
216-24	42115-42122	lingual	_	
216-25	42123-42126	and	_	
216-26	42127-42133	middle	_	
216-27	42134-42143	occipital	_	
216-28	42144-42148	gyri	_	
216-29	42148-42149	,	_	
216-30	42150-42154	have	_	
216-31	42155-42159	been	_	
216-32	42160-42168	variably	_	
216-33	42169-42179	implicated	_	
216-34	42180-42182	in	_	
216-35	42183-42191	previous	_	
216-36	42192-42204	neuroimaging	_	
216-37	42205-42212	studies	_	
216-38	42213-42215	of	_	
216-39	42216-42219	SCZ	_	
216-40	42219-42220	.	_	

#Text=These brain regions are involved in a variety of cognitive operations of relevance to schizophrenia, including language, visual attention and emotional processing.
217-1	42221-42226	These	_	
217-2	42227-42232	brain	_	
217-3	42233-42240	regions	_	
217-4	42241-42244	are	_	
217-5	42245-42253	involved	_	
217-6	42254-42256	in	_	
217-7	42257-42258	a	_	
217-8	42259-42266	variety	_	
217-9	42267-42269	of	_	
217-10	42270-42279	cognitive	_	
217-11	42280-42290	operations	_	
217-12	42291-42293	of	_	
217-13	42294-42303	relevance	_	
217-14	42304-42306	to	_	
217-15	42307-42320	schizophrenia	_	
217-16	42320-42321	,	_	
217-17	42322-42331	including	_	
217-18	42332-42340	language	_	
217-19	42340-42341	,	_	
217-20	42342-42348	visual	_	
217-21	42349-42358	attention	_	
217-22	42359-42362	and	_	
217-23	42363-42372	emotional	_	
217-24	42373-42383	processing	_	
217-25	42383-42384	.	_	

#Text=Findings of structural brain abnormalities in SCZ may be influenced by clinical variables not specifically related to the pathophysiology of the disorder, such as the use of antipsychotic medications.
218-1	42385-42393	Findings	_	
218-2	42394-42396	of	_	
218-3	42397-42407	structural	_	
218-4	42408-42413	brain	_	
218-5	42414-42427	abnormalities	_	
218-6	42428-42430	in	_	
218-7	42431-42434	SCZ	_	
218-8	42435-42438	may	_	
218-9	42439-42441	be	_	
218-10	42442-42452	influenced	_	
218-11	42453-42455	by	_	
218-12	42456-42464	clinical	_	
218-13	42465-42474	variables	_	
218-14	42475-42478	not	_	
218-15	42479-42491	specifically	_	
218-16	42492-42499	related	_	
218-17	42500-42502	to	_	
218-18	42503-42506	the	_	
218-19	42507-42522	pathophysiology	_	
218-20	42523-42525	of	_	
218-21	42526-42529	the	_	
218-22	42530-42538	disorder	_	
218-23	42538-42539	,	_	
218-24	42540-42544	such	_	
218-25	42545-42547	as	_	
218-26	42548-42551	the	_	
218-27	42552-42555	use	_	
218-28	42556-42558	of	_	
218-29	42559-42572	antipsychotic	_	
218-30	42573-42584	medications	_	
218-31	42584-42585	.	_	

#Text=Several recent studies have shown that the continued use of antipsychotics may be significantly associated with some of the neuroanatomical changes detected in MRI studies of SCZ, even after taking into account the influence of other potential moderators such as illness severity and substance abuse.
219-1	42586-42593	Several	_	
219-2	42594-42600	recent	_	
219-3	42601-42608	studies	_	
219-4	42609-42613	have	_	
219-5	42614-42619	shown	_	
219-6	42620-42624	that	_	
219-7	42625-42628	the	_	
219-8	42629-42638	continued	_	
219-9	42639-42642	use	_	
219-10	42643-42645	of	_	
219-11	42646-42660	antipsychotics	_	
219-12	42661-42664	may	_	
219-13	42665-42667	be	_	
219-14	42668-42681	significantly	_	
219-15	42682-42692	associated	_	
219-16	42693-42697	with	_	
219-17	42698-42702	some	_	
219-18	42703-42705	of	_	
219-19	42706-42709	the	_	
219-20	42710-42725	neuroanatomical	_	
219-21	42726-42733	changes	_	
219-22	42734-42742	detected	_	
219-23	42743-42745	in	_	
219-24	42746-42749	MRI	_	
219-25	42750-42757	studies	_	
219-26	42758-42760	of	_	
219-27	42761-42764	SCZ	_	
219-28	42764-42765	,	_	
219-29	42766-42770	even	_	
219-30	42771-42776	after	_	
219-31	42777-42783	taking	_	
219-32	42784-42788	into	_	
219-33	42789-42796	account	_	
219-34	42797-42800	the	_	
219-35	42801-42810	influence	_	
219-36	42811-42813	of	_	
219-37	42814-42819	other	_	
219-38	42820-42829	potential	_	
219-39	42830-42840	moderators	_	
219-40	42841-42845	such	_	
219-41	42846-42848	as	_	
219-42	42849-42856	illness	_	
219-43	42857-42865	severity	_	
219-44	42866-42869	and	_	
219-45	42870-42879	substance	_	
219-46	42880-42885	abuse	_	
219-47	42885-42886	.	_	

#Text=In the present study, participants with SCZ from site B were all in their first psychotic episode and had a relatively shorter duration of illness in comparison to the samples contributed by sites A and C (both of which included a substantial proportion of chronic, medicated SCZ patients).
220-1	42887-42889	In	_	
220-2	42890-42893	the	_	
220-3	42894-42901	present	_	
220-4	42902-42907	study	_	
220-5	42907-42908	,	_	
220-6	42909-42921	participants	_	
220-7	42922-42926	with	_	
220-8	42927-42930	SCZ	_	
220-9	42931-42935	from	_	
220-10	42936-42940	site	_	
220-11	42941-42942	B	_	
220-12	42943-42947	were	_	
220-13	42948-42951	all	_	
220-14	42952-42954	in	_	
220-15	42955-42960	their	_	
220-16	42961-42966	first	_	
220-17	42967-42976	psychotic	_	
220-18	42977-42984	episode	_	
220-19	42985-42988	and	_	
220-20	42989-42992	had	_	
220-21	42993-42994	a	_	
220-22	42995-43005	relatively	_	
220-23	43006-43013	shorter	_	
220-24	43014-43022	duration	_	
220-25	43023-43025	of	_	
220-26	43026-43033	illness	_	
220-27	43034-43036	in	_	
220-28	43037-43047	comparison	_	
220-29	43048-43050	to	_	
220-30	43051-43054	the	_	
220-31	43055-43062	samples	_	
220-32	43063-43074	contributed	_	
220-33	43075-43077	by	_	
220-34	43078-43083	sites	_	
220-35	43084-43085	A	_	
220-36	43086-43089	and	_	
220-37	43090-43091	C	_	
220-38	43092-43093	(	_	
220-39	43093-43097	both	_	
220-40	43098-43100	of	_	
220-41	43101-43106	which	_	
220-42	43107-43115	included	_	
220-43	43116-43117	a	_	
220-44	43118-43129	substantial	_	
220-45	43130-43140	proportion	_	
220-46	43141-43143	of	_	
220-47	43144-43151	chronic	_	
220-48	43151-43152	,	_	
220-49	43153-43162	medicated	_	
220-50	43163-43166	SCZ	_	
220-51	43167-43175	patients	_	
220-52	43175-43176	)	_	
220-53	43176-43177	.	_	

#Text=Thus the overall SCZ sample from site B was less exposed to antipsychotic treatment in comparison to the two other sites.
221-1	43178-43182	Thus	_	
221-2	43183-43186	the	_	
221-3	43187-43194	overall	_	
221-4	43195-43198	SCZ	_	
221-5	43199-43205	sample	_	
221-6	43206-43210	from	_	
221-7	43211-43215	site	_	
221-8	43216-43217	B	_	
221-9	43218-43221	was	_	
221-10	43222-43226	less	_	
221-11	43227-43234	exposed	_	
221-12	43235-43237	to	_	
221-13	43238-43251	antipsychotic	_	
221-14	43252-43261	treatment	_	
221-15	43262-43264	in	_	
221-16	43265-43275	comparison	_	
221-17	43276-43278	to	_	
221-18	43279-43282	the	_	
221-19	43283-43286	two	_	
221-20	43287-43292	other	_	
221-21	43293-43298	sites	_	
221-22	43298-43299	.	_	

#Text=The selection of first-episode SCZ patients in site B may help to explain the more modest diagnostic accuracy figures obtained in the single-site analysis for that center in comparison to the two other sites, given the fact that medicated SCZ patients in chronic disease stages display more widespread brain volumetric abnormalities relative to healthy controls than first-episode SCZ patients.
222-1	43300-43303	The	_	
222-2	43304-43313	selection	_	
222-3	43314-43316	of	_	
222-4	43317-43330	first-episode	_	
222-5	43331-43334	SCZ	_	
222-6	43335-43343	patients	_	
222-7	43344-43346	in	_	
222-8	43347-43351	site	_	
222-9	43352-43353	B	_	
222-10	43354-43357	may	_	
222-11	43358-43362	help	_	
222-12	43363-43365	to	_	
222-13	43366-43373	explain	_	
222-14	43374-43377	the	_	
222-15	43378-43382	more	_	
222-16	43383-43389	modest	_	
222-17	43390-43400	diagnostic	_	
222-18	43401-43409	accuracy	_	
222-19	43410-43417	figures	_	
222-20	43418-43426	obtained	_	
222-21	43427-43429	in	_	
222-22	43430-43433	the	_	
222-23	43434-43445	single-site	_	
222-24	43446-43454	analysis	_	
222-25	43455-43458	for	_	
222-26	43459-43463	that	_	
222-27	43464-43470	center	_	
222-28	43471-43473	in	_	
222-29	43474-43484	comparison	_	
222-30	43485-43487	to	_	
222-31	43488-43491	the	_	
222-32	43492-43495	two	_	
222-33	43496-43501	other	_	
222-34	43502-43507	sites	_	
222-35	43507-43508	,	_	
222-36	43509-43514	given	_	
222-37	43515-43518	the	_	
222-38	43519-43523	fact	_	
222-39	43524-43528	that	_	
222-40	43529-43538	medicated	_	
222-41	43539-43542	SCZ	_	
222-42	43543-43551	patients	_	
222-43	43552-43554	in	_	
222-44	43555-43562	chronic	_	
222-45	43563-43570	disease	_	
222-46	43571-43577	stages	_	
222-47	43578-43585	display	_	
222-48	43586-43590	more	_	
222-49	43591-43601	widespread	_	
222-50	43602-43607	brain	_	
222-51	43608-43618	volumetric	_	
222-52	43619-43632	abnormalities	_	
222-53	43633-43641	relative	_	
222-54	43642-43644	to	_	
222-55	43645-43652	healthy	_	
222-56	43653-43661	controls	_	
222-57	43662-43666	than	_	
222-58	43667-43680	first-episode	_	
222-59	43681-43684	SCZ	_	
222-60	43685-43693	patients	_	
222-61	43693-43694	.	_	

#Text=Since the three imaging sites contributed each an equal number of SCZ patients and controls to the present investigation, disease chronicity and antipsychotic exposure should be taken as clinical variables that increased inter-site variability in our study, instead of representing unifying features present in all sites.
223-1	43695-43700	Since	_	
223-2	43701-43704	the	_	
223-3	43705-43710	three	_	
223-4	43711-43718	imaging	_	
223-5	43719-43724	sites	_	
223-6	43725-43736	contributed	_	
223-7	43737-43741	each	_	
223-8	43742-43744	an	_	
223-9	43745-43750	equal	_	
223-10	43751-43757	number	_	
223-11	43758-43760	of	_	
223-12	43761-43764	SCZ	_	
223-13	43765-43773	patients	_	
223-14	43774-43777	and	_	
223-15	43778-43786	controls	_	
223-16	43787-43789	to	_	
223-17	43790-43793	the	_	
223-18	43794-43801	present	_	
223-19	43802-43815	investigation	_	
223-20	43815-43816	,	_	
223-21	43817-43824	disease	_	
223-22	43825-43835	chronicity	_	
223-23	43836-43839	and	_	
223-24	43840-43853	antipsychotic	_	
223-25	43854-43862	exposure	_	
223-26	43863-43869	should	_	
223-27	43870-43872	be	_	
223-28	43873-43878	taken	_	
223-29	43879-43881	as	_	
223-30	43882-43890	clinical	_	
223-31	43891-43900	variables	_	
223-32	43901-43905	that	_	
223-33	43906-43915	increased	_	
223-34	43916-43926	inter-site	_	
223-35	43927-43938	variability	_	
223-36	43939-43941	in	_	
223-37	43942-43945	our	_	
223-38	43946-43951	study	_	
223-39	43951-43952	,	_	
223-40	43953-43960	instead	_	
223-41	43961-43963	of	_	
223-42	43964-43976	representing	_	
223-43	43977-43985	unifying	_	
223-44	43986-43994	features	_	
223-45	43995-44002	present	_	
223-46	44003-44005	in	_	
223-47	44006-44009	all	_	
223-48	44010-44015	sites	_	
223-49	44015-44016	.	_	

#Text=Therefore, the results of the site-shared analysis presented herein can be more safely assumed to reflect the commonality of SCZ neuropathology across the three sites, rather than the potential influence of confounding clinical variables ubiquitously present in the three centers.
224-1	44017-44026	Therefore	_	
224-2	44026-44027	,	_	
224-3	44028-44031	the	_	
224-4	44032-44039	results	_	
224-5	44040-44042	of	_	
224-6	44043-44046	the	_	
224-7	44047-44058	site-shared	_	
224-8	44059-44067	analysis	_	
224-9	44068-44077	presented	_	
224-10	44078-44084	herein	_	
224-11	44085-44088	can	_	
224-12	44089-44091	be	_	
224-13	44092-44096	more	_	
224-14	44097-44103	safely	_	
224-15	44104-44111	assumed	_	
224-16	44112-44114	to	_	
224-17	44115-44122	reflect	_	
224-18	44123-44126	the	_	
224-19	44127-44138	commonality	_	
224-20	44139-44141	of	_	
224-21	44142-44145	SCZ	_	
224-22	44146-44160	neuropathology	_	
224-23	44161-44167	across	_	
224-24	44168-44171	the	_	
224-25	44172-44177	three	_	
224-26	44178-44183	sites	_	
224-27	44183-44184	,	_	
224-28	44185-44191	rather	_	
224-29	44192-44196	than	_	
224-30	44197-44200	the	_	
224-31	44201-44210	potential	_	
224-32	44211-44220	influence	_	
224-33	44221-44223	of	_	
224-34	44224-44235	confounding	_	
224-35	44236-44244	clinical	_	
224-36	44245-44254	variables	_	
224-37	44255-44267	ubiquitously	_	
224-38	44268-44275	present	_	
224-39	44276-44278	in	_	
224-40	44279-44282	the	_	
224-41	44283-44288	three	_	
224-42	44289-44296	centers	_	
224-43	44296-44297	.	_	

#Text=Disentangling the specific neurobiological features underlying psychiatric disorders from clinically relevant confounders is challenging in neuroimaging research, given the highly prevalent influence of factors such as use of nicotine and other drugs of abuse, cardiovascular risk factors, and exposure to pharmacological treatment, all of which can affect brain structure.
225-1	44298-44311	Disentangling	_	
225-2	44312-44315	the	_	
225-3	44316-44324	specific	_	
225-4	44325-44340	neurobiological	_	
225-5	44341-44349	features	_	
225-6	44350-44360	underlying	_	
225-7	44361-44372	psychiatric	_	
225-8	44373-44382	disorders	_	
225-9	44383-44387	from	_	
225-10	44388-44398	clinically	_	
225-11	44399-44407	relevant	_	
225-12	44408-44419	confounders	_	
225-13	44420-44422	is	_	
225-14	44423-44434	challenging	_	
225-15	44435-44437	in	_	
225-16	44438-44450	neuroimaging	_	
225-17	44451-44459	research	_	
225-18	44459-44460	,	_	
225-19	44461-44466	given	_	
225-20	44467-44470	the	_	
225-21	44471-44477	highly	_	
225-22	44478-44487	prevalent	_	
225-23	44488-44497	influence	_	
225-24	44498-44500	of	_	
225-25	44501-44508	factors	_	
225-26	44509-44513	such	_	
225-27	44514-44516	as	_	
225-28	44517-44520	use	_	
225-29	44521-44523	of	_	
225-30	44524-44532	nicotine	_	
225-31	44533-44536	and	_	
225-32	44537-44542	other	_	
225-33	44543-44548	drugs	_	
225-34	44549-44551	of	_	
225-35	44552-44557	abuse	_	
225-36	44557-44558	,	_	
225-37	44559-44573	cardiovascular	_	
225-38	44574-44578	risk	_	
225-39	44579-44586	factors	_	
225-40	44586-44587	,	_	
225-41	44588-44591	and	_	
225-42	44592-44600	exposure	_	
225-43	44601-44603	to	_	
225-44	44604-44619	pharmacological	_	
225-45	44620-44629	treatment	_	
225-46	44629-44630	,	_	
225-47	44631-44634	all	_	
225-48	44635-44637	of	_	
225-49	44638-44643	which	_	
225-50	44644-44647	can	_	
225-51	44648-44654	affect	_	
225-52	44655-44660	brain	_	
225-53	44661-44670	structure	_	
225-54	44670-44671	.	_	

#Text=The site-specific regions of the three sites revealed in our study consisted of two parts.
226-1	44672-44675	The	_	
226-2	44676-44689	site-specific	_	
226-3	44690-44697	regions	_	
226-4	44698-44700	of	_	
226-5	44701-44704	the	_	
226-6	44705-44710	three	_	
226-7	44711-44716	sites	_	
226-8	44717-44725	revealed	_	
226-9	44726-44728	in	_	
226-10	44729-44732	our	_	
226-11	44733-44738	study	_	
226-12	44739-44748	consisted	_	
226-13	44749-44751	of	_	
226-14	44752-44755	two	_	
226-15	44756-44761	parts	_	
226-16	44761-44762	.	_	

#Text=The larger part of the site-specific features was located in the same regions of the site-shared features, though the coordinates were slightly different.
227-1	44763-44766	The	_	
227-2	44767-44773	larger	_	
227-3	44774-44778	part	_	
227-4	44779-44781	of	_	
227-5	44782-44785	the	_	
227-6	44786-44799	site-specific	_	
227-7	44800-44808	features	_	
227-8	44809-44812	was	_	
227-9	44813-44820	located	_	
227-10	44821-44823	in	_	
227-11	44824-44827	the	_	
227-12	44828-44832	same	_	
227-13	44833-44840	regions	_	
227-14	44841-44843	of	_	
227-15	44844-44847	the	_	
227-16	44848-44859	site-shared	_	
227-17	44860-44868	features	_	
227-18	44868-44869	,	_	
227-19	44870-44876	though	_	
227-20	44877-44880	the	_	
227-21	44881-44892	coordinates	_	
227-22	44893-44897	were	_	
227-23	44898-44906	slightly	_	
227-24	44907-44916	different	_	
227-25	44916-44917	.	_	

#Text=These regions involved most of the site-shared features, including the fusiform, lingual, postcentral, precuneus, prefrontal gyri and the cerebellum.
228-1	44918-44923	These	_	
228-2	44924-44931	regions	_	
228-3	44932-44940	involved	_	
228-4	44941-44945	most	_	
228-5	44946-44948	of	_	
228-6	44949-44952	the	_	
228-7	44953-44964	site-shared	_	
228-8	44965-44973	features	_	
228-9	44973-44974	,	_	
228-10	44975-44984	including	_	
228-11	44985-44988	the	_	
228-12	44989-44997	fusiform	_	
228-13	44997-44998	,	_	
228-14	44999-45006	lingual	_	
228-15	45006-45007	,	_	
228-16	45008-45019	postcentral	_	
228-17	45019-45020	,	_	
228-18	45021-45030	precuneus	_	
228-19	45030-45031	,	_	
228-20	45032-45042	prefrontal	_	
228-21	45043-45047	gyri	_	
228-22	45048-45051	and	_	
228-23	45052-45055	the	_	
228-24	45056-45066	cerebellum	_	
228-25	45066-45067	.	_	

#Text=The findings further implicated that these site-shared and also the site-specific regions revealed the abnormal feature patterns of the SCZ accurately, and multi-task feature learning framework provided a promising method in detecting these features.
229-1	45068-45071	The	_	
229-2	45072-45080	findings	_	
229-3	45081-45088	further	_	
229-4	45089-45099	implicated	_	
229-5	45100-45104	that	_	
229-6	45105-45110	these	_	
229-7	45111-45122	site-shared	_	
229-8	45123-45126	and	_	
229-9	45127-45131	also	_	
229-10	45132-45135	the	_	
229-11	45136-45149	site-specific	_	
229-12	45150-45157	regions	_	
229-13	45158-45166	revealed	_	
229-14	45167-45170	the	_	
229-15	45171-45179	abnormal	_	
229-16	45180-45187	feature	_	
229-17	45188-45196	patterns	_	
229-18	45197-45199	of	_	
229-19	45200-45203	the	_	
229-20	45204-45207	SCZ	_	
229-21	45208-45218	accurately	_	
229-22	45218-45219	,	_	
229-23	45220-45223	and	_	
229-24	45224-45234	multi-task	_	
229-25	45235-45242	feature	_	
229-26	45243-45251	learning	_	
229-27	45252-45261	framework	_	
229-28	45262-45270	provided	_	
229-29	45271-45272	a	_	
229-30	45273-45282	promising	_	
229-31	45283-45289	method	_	
229-32	45290-45292	in	_	
229-33	45293-45302	detecting	_	
229-34	45303-45308	these	_	
229-35	45309-45317	features	_	
229-36	45317-45318	.	_	

#Text=However, though these site-specific features were located in the same regions with the site-shared features, the feature distributed in adjacent areas.
230-1	45319-45326	However	_	
230-2	45326-45327	,	_	
230-3	45328-45334	though	_	
230-4	45335-45340	these	_	
230-5	45341-45354	site-specific	_	
230-6	45355-45363	features	_	
230-7	45364-45368	were	_	
230-8	45369-45376	located	_	
230-9	45377-45379	in	_	
230-10	45380-45383	the	_	
230-11	45384-45388	same	_	
230-12	45389-45396	regions	_	
230-13	45397-45401	with	_	
230-14	45402-45405	the	_	
230-15	45406-45417	site-shared	_	
230-16	45418-45426	features	_	
230-17	45426-45427	,	_	
230-18	45428-45431	the	_	
230-19	45432-45439	feature	_	
230-20	45440-45451	distributed	_	
230-21	45452-45454	in	_	
230-22	45455-45463	adjacent	_	
230-23	45464-45469	areas	_	
230-24	45469-45470	.	_	

#Text=This was reasonable due to the data heterogeneity resulted from each site.
231-1	45471-45475	This	_	
231-2	45476-45479	was	_	
231-3	45480-45490	reasonable	_	
231-4	45491-45494	due	_	
231-5	45495-45497	to	_	
231-6	45498-45501	the	_	
231-7	45502-45506	data	_	
231-8	45507-45520	heterogeneity	_	
231-9	45521-45529	resulted	_	
231-10	45530-45534	from	_	
231-11	45535-45539	each	_	
231-12	45540-45544	site	_	
231-13	45544-45545	.	_	

#Text=Another part of the site-specific regions included some site-specific regions found exclusively in each site, such as putamen and supplemental motor area in site A, hippocampus, parahippocampus, posterior cingulate cortex in site B, and supramarginal gyrus in site C.
232-1	45546-45553	Another	_	
232-2	45554-45558	part	_	
232-3	45559-45561	of	_	
232-4	45562-45565	the	_	
232-5	45566-45579	site-specific	_	
232-6	45580-45587	regions	_	
232-7	45588-45596	included	_	
232-8	45597-45601	some	_	
232-9	45602-45615	site-specific	_	
232-10	45616-45623	regions	_	
232-11	45624-45629	found	_	
232-12	45630-45641	exclusively	_	
232-13	45642-45644	in	_	
232-14	45645-45649	each	_	
232-15	45650-45654	site	_	
232-16	45654-45655	,	_	
232-17	45656-45660	such	_	
232-18	45661-45663	as	_	
232-19	45664-45671	putamen	_	
232-20	45672-45675	and	_	
232-21	45676-45688	supplemental	_	
232-22	45689-45694	motor	_	
232-23	45695-45699	area	_	
232-24	45700-45702	in	_	
232-25	45703-45707	site	_	
232-26	45708-45709	A	_	
232-27	45709-45710	,	_	
232-28	45711-45722	hippocampus	_	
232-29	45722-45723	,	_	
232-30	45724-45739	parahippocampus	_	
232-31	45739-45740	,	_	
232-32	45741-45750	posterior	_	
232-33	45751-45760	cingulate	_	
232-34	45761-45767	cortex	_	
232-35	45768-45770	in	_	
232-36	45771-45775	site	_	
232-37	45776-45777	B	_	
232-38	45777-45778	,	_	
232-39	45779-45782	and	_	
232-40	45783-45796	supramarginal	_	
232-41	45797-45802	gyrus	_	
232-42	45803-45805	in	_	
232-43	45806-45810	site	_	
232-44	45811-45812	C	_	
232-45	45812-45813	.	_	

#Text=Studies have shown that supplemental motor area dysfunction was related to motor disturbances in SCZ patients.
233-1	45814-45821	Studies	_	
233-2	45822-45826	have	_	
233-3	45827-45832	shown	_	
233-4	45833-45837	that	_	
233-5	45838-45850	supplemental	_	
233-6	45851-45856	motor	_	
233-7	45857-45861	area	_	
233-8	45862-45873	dysfunction	_	
233-9	45874-45877	was	_	
233-10	45878-45885	related	_	
233-11	45886-45888	to	_	
233-12	45889-45894	motor	_	
233-13	45895-45907	disturbances	_	
233-14	45908-45910	in	_	
233-15	45911-45914	SCZ	_	
233-16	45915-45923	patients	_	
233-17	45923-45924	.	_	

#Text=The putamen was proposed to be related to the treatment response, and also reflected the deficits of auditory verbal hallucinations of SCZ patients.
234-1	45925-45928	The	_	
234-2	45929-45936	putamen	_	
234-3	45937-45940	was	_	
234-4	45941-45949	proposed	_	
234-5	45950-45952	to	_	
234-6	45953-45955	be	_	
234-7	45956-45963	related	_	
234-8	45964-45966	to	_	
234-9	45967-45970	the	_	
234-10	45971-45980	treatment	_	
234-11	45981-45989	response	_	
234-12	45989-45990	,	_	
234-13	45991-45994	and	_	
234-14	45995-45999	also	_	
234-15	46000-46009	reflected	_	
234-16	46010-46013	the	_	
234-17	46014-46022	deficits	_	
234-18	46023-46025	of	_	
234-19	46026-46034	auditory	_	
234-20	46035-46041	verbal	_	
234-21	46042-46056	hallucinations	_	
234-22	46057-46059	of	_	
234-23	46060-46063	SCZ	_	
234-24	46064-46072	patients	_	
234-25	46072-46073	.	_	

#Text=The gyrus of hippocampus and parahippocampus were reduced, and hippocampus was demonstrated to be associated with the positive symptoms of SCZ patients.
235-1	46074-46077	The	_	
235-2	46078-46083	gyrus	_	
235-3	46084-46086	of	_	
235-4	46087-46098	hippocampus	_	
235-5	46099-46102	and	_	
235-6	46103-46118	parahippocampus	_	
235-7	46119-46123	were	_	
235-8	46124-46131	reduced	_	
235-9	46131-46132	,	_	
235-10	46133-46136	and	_	
235-11	46137-46148	hippocampus	_	
235-12	46149-46152	was	_	
235-13	46153-46165	demonstrated	_	
235-14	46166-46168	to	_	
235-15	46169-46171	be	_	
235-16	46172-46182	associated	_	
235-17	46183-46187	with	_	
235-18	46188-46191	the	_	
235-19	46192-46200	positive	_	
235-20	46201-46209	symptoms	_	
235-21	46210-46212	of	_	
235-22	46213-46216	SCZ	_	
235-23	46217-46225	patients	_	
235-24	46225-46226	.	_	

#Text=Meanwhile, the posterior cingulate cortex has recently been implicated in the pathophysiology of schizophrenia.
236-1	46227-46236	Meanwhile	_	
236-2	46236-46237	,	_	
236-3	46238-46241	the	_	
236-4	46242-46251	posterior	_	
236-5	46252-46261	cingulate	_	
236-6	46262-46268	cortex	_	
236-7	46269-46272	has	_	
236-8	46273-46281	recently	_	
236-9	46282-46286	been	_	
236-10	46287-46297	implicated	_	
236-11	46298-46300	in	_	
236-12	46301-46304	the	_	
236-13	46305-46320	pathophysiology	_	
236-14	46321-46323	of	_	
236-15	46324-46337	schizophrenia	_	
236-16	46337-46338	.	_	

#Text=These site-specific regions may provide potential evidences on interpreting the underlying multisite data heterogeneity introduced by different scanners, subjects, treatment exposure, or disease symptoms or etc.
237-1	46339-46344	These	_	
237-2	46345-46358	site-specific	_	
237-3	46359-46366	regions	_	
237-4	46367-46370	may	_	
237-5	46371-46378	provide	_	
237-6	46379-46388	potential	_	
237-7	46389-46398	evidences	_	
237-8	46399-46401	on	_	
237-9	46402-46414	interpreting	_	
237-10	46415-46418	the	_	
237-11	46419-46429	underlying	_	
237-12	46430-46439	multisite	_	
237-13	46440-46444	data	_	
237-14	46445-46458	heterogeneity	_	
237-15	46459-46469	introduced	_	
237-16	46470-46472	by	_	
237-17	46473-46482	different	_	
237-18	46483-46491	scanners	_	
237-19	46491-46492	,	_	
237-20	46493-46501	subjects	_	
237-21	46501-46502	,	_	
237-22	46503-46512	treatment	_	
237-23	46513-46521	exposure	_	
237-24	46521-46522	,	_	
237-25	46523-46525	or	_	
237-26	46526-46533	disease	_	
237-27	46534-46542	symptoms	_	
237-28	46543-46545	or	_	
237-29	46546-46549	etc	_	
237-30	46549-46550	.	_	

#Text=Limitations and future directions
#Text=Although the classification result of multi-site MRI data using multi-task learning was encouraging, there are limitations in our work.
238-1	46551-46562	Limitations	_	
238-2	46563-46566	and	_	
238-3	46567-46573	future	_	
238-4	46574-46584	directions	_	
238-5	46585-46593	Although	_	
238-6	46594-46597	the	_	
238-7	46598-46612	classification	_	
238-8	46613-46619	result	_	
238-9	46620-46622	of	_	
238-10	46623-46633	multi-site	_	
238-11	46634-46637	MRI	_	
238-12	46638-46642	data	_	
238-13	46643-46648	using	_	
238-14	46649-46659	multi-task	_	
238-15	46660-46668	learning	_	
238-16	46669-46672	was	_	
238-17	46673-46684	encouraging	_	
238-18	46684-46685	,	_	
238-19	46686-46691	there	_	
238-20	46692-46695	are	_	
238-21	46696-46707	limitations	_	
238-22	46708-46710	in	_	
238-23	46711-46714	our	_	
238-24	46715-46719	work	_	
238-25	46719-46720	.	_	

#Text=First, due to the limited sample sizes, small site numbers, and the specific psychiatric disease type and data modality in our study, the effectiveness of using multi-task learning scheme on multi-site classification needs to be further validated in larger datasets.
239-1	46721-46726	First	_	
239-2	46726-46727	,	_	
239-3	46728-46731	due	_	
239-4	46732-46734	to	_	
239-5	46735-46738	the	_	
239-6	46739-46746	limited	_	
239-7	46747-46753	sample	_	
239-8	46754-46759	sizes	_	
239-9	46759-46760	,	_	
239-10	46761-46766	small	_	
239-11	46767-46771	site	_	
239-12	46772-46779	numbers	_	
239-13	46779-46780	,	_	
239-14	46781-46784	and	_	
239-15	46785-46788	the	_	
239-16	46789-46797	specific	_	
239-17	46798-46809	psychiatric	_	
239-18	46810-46817	disease	_	
239-19	46818-46822	type	_	
239-20	46823-46826	and	_	
239-21	46827-46831	data	_	
239-22	46832-46840	modality	_	
239-23	46841-46843	in	_	
239-24	46844-46847	our	_	
239-25	46848-46853	study	_	
239-26	46853-46854	,	_	
239-27	46855-46858	the	_	
239-28	46859-46872	effectiveness	_	
239-29	46873-46875	of	_	
239-30	46876-46881	using	_	
239-31	46882-46892	multi-task	_	
239-32	46893-46901	learning	_	
239-33	46902-46908	scheme	_	
239-34	46909-46911	on	_	
239-35	46912-46922	multi-site	_	
239-36	46923-46937	classification	_	
239-37	46938-46943	needs	_	
239-38	46944-46946	to	_	
239-39	46947-46949	be	_	
239-40	46950-46957	further	_	
239-41	46958-46967	validated	_	
239-42	46968-46970	in	_	
239-43	46971-46977	larger	_	
239-44	46978-46986	datasets	_	
239-45	46986-46987	.	_	

#Text=Moreover, an important challenge in multi-task learning is that when new data is analyzed, the multi-task learner would need to be recalculated.
240-1	46988-46996	Moreover	_	
240-2	46996-46997	,	_	
240-3	46998-47000	an	_	
240-4	47001-47010	important	_	
240-5	47011-47020	challenge	_	
240-6	47021-47023	in	_	
240-7	47024-47034	multi-task	_	
240-8	47035-47043	learning	_	
240-9	47044-47046	is	_	
240-10	47047-47051	that	_	
240-11	47052-47056	when	_	
240-12	47057-47060	new	_	
240-13	47061-47065	data	_	
240-14	47066-47068	is	_	
240-15	47069-47077	analyzed	_	
240-16	47077-47078	,	_	
240-17	47079-47082	the	_	
240-18	47083-47093	multi-task	_	
240-19	47094-47101	learner	_	
240-20	47102-47107	would	_	
240-21	47108-47112	need	_	
240-22	47113-47115	to	_	
240-23	47116-47118	be	_	
240-24	47119-47131	recalculated	_	
240-25	47131-47132	.	_	

#Text=This would obviously limit clinical utility.
241-1	47133-47137	This	_	
241-2	47138-47143	would	_	
241-3	47144-47153	obviously	_	
241-4	47154-47159	limit	_	
241-5	47160-47168	clinical	_	
241-6	47169-47176	utility	_	
241-7	47176-47177	.	_	

#Text=One solution is to apply our approach to obtain a set of t discriminants, each associated with one of our training sites.
242-1	47178-47181	One	_	
242-2	47182-47190	solution	_	
242-3	47191-47193	is	_	
242-4	47194-47196	to	_	
242-5	47197-47202	apply	_	
242-6	47203-47206	our	_	
242-7	47207-47215	approach	_	
242-8	47216-47218	to	_	
242-9	47219-47225	obtain	_	
242-10	47226-47227	a	_	
242-11	47228-47231	set	_	
242-12	47232-47234	of	_	
242-13	47235-47236	t	_	
242-14	47237-47250	discriminants	_	
242-15	47250-47251	,	_	
242-16	47252-47256	each	_	
242-17	47257-47267	associated	_	
242-18	47268-47272	with	_	
242-19	47273-47276	one	_	
242-20	47277-47279	of	_	
242-21	47280-47283	our	_	
242-22	47284-47292	training	_	
242-23	47293-47298	sites	_	
242-24	47298-47299	.	_	

#Text=It is possible that as new data and sites are added to our analyses, one would not need to solve the multi-task learning problem again, but rather could apply all these t vectors and pool the classification results via weighted consensus approaches.
243-1	47300-47302	It	_	
243-2	47303-47305	is	_	
243-3	47306-47314	possible	_	
243-4	47315-47319	that	_	
243-5	47320-47322	as	_	
243-6	47323-47326	new	_	
243-7	47327-47331	data	_	
243-8	47332-47335	and	_	
243-9	47336-47341	sites	_	
243-10	47342-47345	are	_	
243-11	47346-47351	added	_	
243-12	47352-47354	to	_	
243-13	47355-47358	our	_	
243-14	47359-47367	analyses	_	
243-15	47367-47368	,	_	
243-16	47369-47372	one	_	
243-17	47373-47378	would	_	
243-18	47379-47382	not	_	
243-19	47383-47387	need	_	
243-20	47388-47390	to	_	
243-21	47391-47396	solve	_	
243-22	47397-47400	the	_	
243-23	47401-47411	multi-task	_	
243-24	47412-47420	learning	_	
243-25	47421-47428	problem	_	
243-26	47429-47434	again	_	
243-27	47434-47435	,	_	
243-28	47436-47439	but	_	
243-29	47440-47446	rather	_	
243-30	47447-47452	could	_	
243-31	47453-47458	apply	_	
243-32	47459-47462	all	_	
243-33	47463-47468	these	_	
243-34	47469-47470	t	_	
243-35	47471-47478	vectors	_	
243-36	47479-47482	and	_	
243-37	47483-47487	pool	_	
243-38	47488-47491	the	_	
243-39	47492-47506	classification	_	
243-40	47507-47514	results	_	
243-41	47515-47518	via	_	
243-42	47519-47527	weighted	_	
243-43	47528-47537	consensus	_	
243-44	47538-47548	approaches	_	
243-45	47548-47549	.	_	

#Text=Conclusion
#Text=This work proposes a multi-task learning framework for high-dimensional classification, which simultaneously learns the site-specific and site-shared features in multi-site MRI data of brain morphology.
244-1	47550-47560	Conclusion	_	
244-2	47561-47565	This	_	
244-3	47566-47570	work	_	
244-4	47571-47579	proposes	_	
244-5	47580-47581	a	_	
244-6	47582-47592	multi-task	_	
244-7	47593-47601	learning	_	
244-8	47602-47611	framework	_	
244-9	47612-47615	for	_	
244-10	47616-47632	high-dimensional	_	
244-11	47633-47647	classification	_	
244-12	47647-47648	,	_	
244-13	47649-47654	which	_	
244-14	47655-47669	simultaneously	_	
244-15	47670-47676	learns	_	
244-16	47677-47680	the	_	
244-17	47681-47694	site-specific	_	
244-18	47695-47698	and	_	
244-19	47699-47710	site-shared	_	
244-20	47711-47719	features	_	
244-21	47720-47722	in	_	
244-22	47723-47733	multi-site	_	
244-23	47734-47737	MRI	_	
244-24	47738-47742	data	_	
244-25	47743-47745	of	_	
244-26	47746-47751	brain	_	
244-27	47752-47762	morphology	_	
244-28	47762-47763	.	_	

#Text=This method was tested on multi-site anatomical images of SCZ patients.
245-1	47764-47768	This	_	
245-2	47769-47775	method	_	
245-3	47776-47779	was	_	
245-4	47780-47786	tested	_	
245-5	47787-47789	on	_	
245-6	47790-47800	multi-site	_	
245-7	47801-47811	anatomical	_	
245-8	47812-47818	images	_	
245-9	47819-47821	of	_	
245-10	47822-47825	SCZ	_	
245-11	47826-47834	patients	_	
245-12	47834-47835	.	_	

#Text=The classification results of using multi-task learning outperformed single-task learning and the pooled data.
246-1	47836-47839	The	_	
246-2	47840-47854	classification	_	
246-3	47855-47862	results	_	
246-4	47863-47865	of	_	
246-5	47866-47871	using	_	
246-6	47872-47882	multi-task	_	
246-7	47883-47891	learning	_	
246-8	47892-47904	outperformed	_	
246-9	47905-47916	single-task	_	
246-10	47917-47925	learning	_	
246-11	47926-47929	and	_	
246-12	47930-47933	the	_	
246-13	47934-47940	pooled	_	
246-14	47941-47945	data	_	
246-15	47945-47946	.	_	

#Text=The most significant site-shared features revealed brain structural alterations in SCZ consistent with those previously reported in the literature.
247-1	47947-47950	The	_	
247-2	47951-47955	most	_	
247-3	47956-47967	significant	_	
247-4	47968-47979	site-shared	_	
247-5	47980-47988	features	_	
247-6	47989-47997	revealed	_	
247-7	47998-48003	brain	_	
247-8	48004-48014	structural	_	
247-9	48015-48026	alterations	_	
247-10	48027-48029	in	_	
247-11	48030-48033	SCZ	_	
247-12	48034-48044	consistent	_	
247-13	48045-48049	with	_	
247-14	48050-48055	those	_	
247-15	48056-48066	previously	_	
247-16	48067-48075	reported	_	
247-17	48076-48078	in	_	
247-18	48079-48082	the	_	
247-19	48083-48093	literature	_	
247-20	48093-48094	.	_	

#Text=In summary, multi-task learning provides a promising technique to learn the site-shared features in multi-site data study without neglecting site-specific features, which gives a new angle on integrating multiple single-site data together for big data studies.
248-1	48095-48097	In	_	
248-2	48098-48105	summary	_	
248-3	48105-48106	,	_	
248-4	48107-48117	multi-task	_	
248-5	48118-48126	learning	_	
248-6	48127-48135	provides	_	
248-7	48136-48137	a	_	
248-8	48138-48147	promising	_	
248-9	48148-48157	technique	_	
248-10	48158-48160	to	_	
248-11	48161-48166	learn	_	
248-12	48167-48170	the	_	
248-13	48171-48182	site-shared	_	
248-14	48183-48191	features	_	
248-15	48192-48194	in	_	
248-16	48195-48205	multi-site	_	
248-17	48206-48210	data	_	
248-18	48211-48216	study	_	
248-19	48217-48224	without	_	
248-20	48225-48235	neglecting	_	
248-21	48236-48249	site-specific	_	
248-22	48250-48258	features	_	
248-23	48258-48259	,	_	
248-24	48260-48265	which	_	
248-25	48266-48271	gives	_	
248-26	48272-48273	a	_	
248-27	48274-48277	new	_	
248-28	48278-48283	angle	_	
248-29	48284-48286	on	_	
248-30	48287-48298	integrating	_	
248-31	48299-48307	multiple	_	
248-32	48308-48319	single-site	_	
248-33	48320-48324	data	_	
248-34	48325-48333	together	_	
248-35	48334-48337	for	_	
248-36	48338-48341	big	_	
248-37	48342-48346	data	_	
248-38	48347-48354	studies	_	
248-39	48354-48355	.	_	

#Text=References
#Text=The role of the cerebellum in schizophrenia
#Text=Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
#Text=
#Text=Dysconnectivity of the inferior frontal gyrus: implications for an impaired self-other distinction in patients with schizophrenia
#Text=Voice-selective areas in human auditory cortex
#Text=Dysfunctional activation of the cerebellum in schizophrenia: a functional neuroimaging meta-analysis
#Text=Regional gray matter volume in monozygotic twins concordant and discordant for schizophrenia
#Text=Multisite reliability of cognitive BOLD data
#Text=Social brain dysfunctions in schizophrenia: a review of neuroimaging studies
#Text=Caudate and putamen volumes in good and poor outcome patients with schizophrenia
#Text=Imaging cognition II: an empirical review of 275 PET and fMRI studies
#Text=Feature-based fusion of medical imaging data
#Text=Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis
#Text=Multitask learning
#Text=Reproducibility of fMRI results across four institutions using a spatial working memory task
#Text=Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression
#Text=Attribute-based neural substrates in temporal cortex for perceiving and knowing about objects
#Text=Learning incoherent sparse and low-rank patterns from multiple tasks
#Text=Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study
#Text=Changes in cortical activity during mental rotation
#Text=Insights into multimodal imaging classification of ADHD
#Text=Multisite fMRI reproducibility of a motor task using identical MR systems
#Text=Putamen-related regional and network functional deficits in first-episode schizophrenia with auditory verbal hallucinations
#Text=Mapping image data to stereotaxic spaces: applications to brain mapping
#Text=Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy
#Text=Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities
#Text=Reduced neuron density, enlarged minicolumn spacing and altered ageing effects in fusiform cortex in schizophrenia
#Text=Face perception in schizophrenia: a functional magnetic resonance imaging study
#Text=A longitudinal study on intrinsic connectivity of hippocampus associated with positive symptom in first-episode schizophrenia
#Text=An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex
#Text=The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis
#Text=Schizophrenia with preserved insight is associated with increased perfusion of the precuneus
#Text=Reducing inter-scanner variability of activation in a multicenter fMRI study: role of smoothness equalization
#Text=Progressive brain changes in schizophrenia related to antipsychotic treatment?
249-1	48356-48366	References	_	
249-2	48367-48370	The	_	
249-3	48371-48375	role	_	
249-4	48376-48378	of	_	
249-5	48379-48382	the	_	
249-6	48383-48393	cerebellum	_	
249-7	48394-48396	in	_	
249-8	48397-48410	schizophrenia	_	
249-9	48411-48419	Defining	_	
249-10	48420-48423	the	_	
249-11	48424-48433	phenotype	_	
249-12	48434-48436	of	_	
249-13	48437-48450	schizophrenia	_	
249-14	48450-48451	:	_	
249-15	48452-48461	cognitive	_	
249-16	48462-48471	dysmetria	_	
249-17	48472-48475	and	_	
249-18	48476-48479	its	_	
249-19	48480-48486	neural	_	
249-20	48487-48497	mechanisms	_	
249-21	48499-48514	Dysconnectivity	_	
249-22	48515-48517	of	_	
249-23	48518-48521	the	_	
249-24	48522-48530	inferior	_	
249-25	48531-48538	frontal	_	
249-26	48539-48544	gyrus	_	
249-27	48544-48545	:	_	
249-28	48546-48558	implications	_	
249-29	48559-48562	for	_	
249-30	48563-48565	an	_	
249-31	48566-48574	impaired	_	
249-32	48575-48585	self-other	_	
249-33	48586-48597	distinction	_	
249-34	48598-48600	in	_	
249-35	48601-48609	patients	_	
249-36	48610-48614	with	_	
249-37	48615-48628	schizophrenia	_	
249-38	48629-48644	Voice-selective	_	
249-39	48645-48650	areas	_	
249-40	48651-48653	in	_	
249-41	48654-48659	human	_	
249-42	48660-48668	auditory	_	
249-43	48669-48675	cortex	_	
249-44	48676-48689	Dysfunctional	_	
249-45	48690-48700	activation	_	
249-46	48701-48703	of	_	
249-47	48704-48707	the	_	
249-48	48708-48718	cerebellum	_	
249-49	48719-48721	in	_	
249-50	48722-48735	schizophrenia	_	
249-51	48735-48736	:	_	
249-52	48737-48738	a	_	
249-53	48739-48749	functional	_	
249-54	48750-48762	neuroimaging	_	
249-55	48763-48776	meta-analysis	_	
249-56	48777-48785	Regional	_	
249-57	48786-48790	gray	_	
249-58	48791-48797	matter	_	
249-59	48798-48804	volume	_	
249-60	48805-48807	in	_	
249-61	48808-48819	monozygotic	_	
249-62	48820-48825	twins	_	
249-63	48826-48836	concordant	_	
249-64	48837-48840	and	_	
249-65	48841-48851	discordant	_	
249-66	48852-48855	for	_	
249-67	48856-48869	schizophrenia	_	
249-68	48870-48879	Multisite	_	
249-69	48880-48891	reliability	_	
249-70	48892-48894	of	_	
249-71	48895-48904	cognitive	_	
249-72	48905-48909	BOLD	_	
249-73	48910-48914	data	_	
249-74	48915-48921	Social	_	
249-75	48922-48927	brain	_	
249-76	48928-48940	dysfunctions	_	
249-77	48941-48943	in	_	
249-78	48944-48957	schizophrenia	_	
249-79	48957-48958	:	_	
249-80	48959-48960	a	_	
249-81	48961-48967	review	_	
249-82	48968-48970	of	_	
249-83	48971-48983	neuroimaging	_	
249-84	48984-48991	studies	_	
249-85	48992-48999	Caudate	_	
249-86	49000-49003	and	_	
249-87	49004-49011	putamen	_	
249-88	49012-49019	volumes	_	
249-89	49020-49022	in	_	
249-90	49023-49027	good	_	
249-91	49028-49031	and	_	
249-92	49032-49036	poor	_	
249-93	49037-49044	outcome	_	
249-94	49045-49053	patients	_	
249-95	49054-49058	with	_	
249-96	49059-49072	schizophrenia	_	
249-97	49073-49080	Imaging	_	
249-98	49081-49090	cognition	_	
249-99	49091-49093	II	_	
249-100	49093-49094	:	_	
249-101	49095-49097	an	_	
249-102	49098-49107	empirical	_	
249-103	49108-49114	review	_	
249-104	49115-49117	of	_	
249-105	49118-49121	275	_	
249-106	49122-49125	PET	_	
249-107	49126-49129	and	_	
249-108	49130-49134	fMRI	_	
249-109	49135-49142	studies	_	
249-110	49143-49156	Feature-based	_	
249-111	49157-49163	fusion	_	
249-112	49164-49166	of	_	
249-113	49167-49174	medical	_	
249-114	49175-49182	imaging	_	
249-115	49183-49187	data	_	
249-116	49188-49199	Reliability	_	
249-117	49200-49202	of	_	
249-118	49203-49218	neuroanatomical	_	
249-119	49219-49231	measurements	_	
249-120	49232-49234	in	_	
249-121	49235-49236	a	_	
249-122	49237-49246	multisite	_	
249-123	49247-49259	longitudinal	_	
249-124	49260-49265	study	_	
249-125	49266-49268	of	_	
249-126	49269-49274	youth	_	
249-127	49275-49277	at	_	
249-128	49278-49282	risk	_	
249-129	49283-49286	for	_	
249-130	49287-49296	psychosis	_	
249-131	49297-49306	Multitask	_	
249-132	49307-49315	learning	_	
249-133	49316-49331	Reproducibility	_	
249-134	49332-49334	of	_	
249-135	49335-49339	fMRI	_	
249-136	49340-49347	results	_	
249-137	49348-49354	across	_	
249-138	49355-49359	four	_	
249-139	49360-49372	institutions	_	
249-140	49373-49378	using	_	
249-141	49379-49380	a	_	
249-142	49381-49388	spatial	_	
249-143	49389-49396	working	_	
249-144	49397-49403	memory	_	
249-145	49404-49408	task	_	
249-146	49409-49414	Brain	_	
249-147	49415-49425	anatomical	_	
249-148	49426-49439	abnormalities	_	
249-149	49440-49442	in	_	
249-150	49443-49452	high-risk	_	
249-151	49453-49464	individuals	_	
249-152	49464-49465	,	_	
249-153	49466-49479	first-episode	_	
249-154	49479-49480	,	_	
249-155	49481-49484	and	_	
249-156	49485-49492	chronic	_	
249-157	49493-49506	schizophrenia	_	
249-158	49506-49507	:	_	
249-159	49508-49510	an	_	
249-160	49511-49521	activation	_	
249-161	49522-49532	likelihood	_	
249-162	49533-49543	estimation	_	
249-163	49544-49557	meta-analysis	_	
249-164	49558-49560	of	_	
249-165	49561-49568	illness	_	
249-166	49569-49580	progression	_	
249-167	49581-49596	Attribute-based	_	
249-168	49597-49603	neural	_	
249-169	49604-49614	substrates	_	
249-170	49615-49617	in	_	
249-171	49618-49626	temporal	_	
249-172	49627-49633	cortex	_	
249-173	49634-49637	for	_	
249-174	49638-49648	perceiving	_	
249-175	49649-49652	and	_	
249-176	49653-49660	knowing	_	
249-177	49661-49666	about	_	
249-178	49667-49674	objects	_	
249-179	49675-49683	Learning	_	
249-180	49684-49694	incoherent	_	
249-181	49695-49701	sparse	_	
249-182	49702-49705	and	_	
249-183	49706-49714	low-rank	_	
249-184	49715-49723	patterns	_	
249-185	49724-49728	from	_	
249-186	49729-49737	multiple	_	
249-187	49738-49743	tasks	_	
249-188	49744-49752	Distinct	_	
249-189	49753-49760	effects	_	
249-190	49761-49763	of	_	
249-191	49764-49772	duration	_	
249-192	49773-49775	of	_	
249-193	49776-49785	untreated	_	
249-194	49786-49795	psychosis	_	
249-195	49796-49798	on	_	
249-196	49799-49804	brain	_	
249-197	49805-49813	cortical	_	
249-198	49814-49824	activities	_	
249-199	49825-49827	in	_	
249-200	49828-49837	different	_	
249-201	49838-49847	treatment	_	
249-202	49848-49854	phases	_	
249-203	49855-49857	of	_	
249-204	49858-49871	schizophrenia	_	
249-205	49871-49872	:	_	
249-206	49873-49874	a	_	
249-207	49875-49888	multi-channel	_	
249-208	49889-49902	near-infrared	_	
249-209	49903-49915	spectroscopy	_	
249-210	49916-49921	study	_	
249-211	49922-49929	Changes	_	
249-212	49930-49932	in	_	
249-213	49933-49941	cortical	_	
249-214	49942-49950	activity	_	
249-215	49951-49957	during	_	
249-216	49958-49964	mental	_	
249-217	49965-49973	rotation	_	
249-218	49974-49982	Insights	_	
249-219	49983-49987	into	_	
249-220	49988-49998	multimodal	_	
249-221	49999-50006	imaging	_	
249-222	50007-50021	classification	_	
249-223	50022-50024	of	_	
249-224	50025-50029	ADHD	_	
249-225	50030-50039	Multisite	_	
249-226	50040-50044	fMRI	_	
249-227	50045-50060	reproducibility	_	
249-228	50061-50063	of	_	
249-229	50064-50065	a	_	
249-230	50066-50071	motor	_	
249-231	50072-50076	task	_	
249-232	50077-50082	using	_	
249-233	50083-50092	identical	_	
249-234	50093-50095	MR	_	
249-235	50096-50103	systems	_	
249-236	50104-50119	Putamen-related	_	
249-237	50120-50128	regional	_	
249-238	50129-50132	and	_	
249-239	50133-50140	network	_	
249-240	50141-50151	functional	_	
249-241	50152-50160	deficits	_	
249-242	50161-50163	in	_	
249-243	50164-50177	first-episode	_	
249-244	50178-50191	schizophrenia	_	
249-245	50192-50196	with	_	
249-246	50197-50205	auditory	_	
249-247	50206-50212	verbal	_	
249-248	50213-50227	hallucinations	_	
249-249	50228-50235	Mapping	_	
249-250	50236-50241	image	_	
249-251	50242-50246	data	_	
249-252	50247-50249	to	_	
249-253	50250-50261	stereotaxic	_	
249-254	50262-50268	spaces	_	
249-255	50268-50269	:	_	
249-256	50270-50282	applications	_	
249-257	50283-50285	to	_	
249-258	50286-50291	brain	_	
249-259	50292-50299	mapping	_	
249-260	50300-50311	Voxel-based	_	
249-261	50312-50323	morphometry	_	
249-262	50324-50329	using	_	
249-263	50330-50333	the	_	
249-264	50334-50340	RAVENS	_	
249-265	50341-50345	maps	_	
249-266	50345-50346	:	_	
249-267	50347-50354	methods	_	
249-268	50355-50358	and	_	
249-269	50359-50369	validation	_	
249-270	50370-50375	using	_	
249-271	50376-50385	simulated	_	
249-272	50386-50398	longitudinal	_	
249-273	50399-50406	atrophy	_	
249-274	50407-50418	Whole-brain	_	
249-275	50419-50431	morphometric	_	
249-276	50432-50437	study	_	
249-277	50438-50440	of	_	
249-278	50441-50454	schizophrenia	_	
249-279	50455-50464	revealing	_	
249-280	50465-50466	a	_	
249-281	50467-50476	spatially	_	
249-282	50477-50484	complex	_	
249-283	50485-50488	set	_	
249-284	50489-50491	of	_	
249-285	50492-50497	focal	_	
249-286	50498-50511	abnormalities	_	
249-287	50512-50519	Reduced	_	
249-288	50520-50526	neuron	_	
249-289	50527-50534	density	_	
249-290	50534-50535	,	_	
249-291	50536-50544	enlarged	_	
249-292	50545-50555	minicolumn	_	
249-293	50556-50563	spacing	_	
249-294	50564-50567	and	_	
249-295	50568-50575	altered	_	
249-296	50576-50582	ageing	_	
249-297	50583-50590	effects	_	
249-298	50591-50593	in	_	
249-299	50594-50602	fusiform	_	
249-300	50603-50609	cortex	_	
249-301	50610-50612	in	_	
249-302	50613-50626	schizophrenia	_	
249-303	50627-50631	Face	_	
249-304	50632-50642	perception	_	
249-305	50643-50645	in	_	
249-306	50646-50659	schizophrenia	_	
249-307	50659-50660	:	_	
249-308	50661-50662	a	_	
249-309	50663-50673	functional	_	
249-310	50674-50682	magnetic	_	
249-311	50683-50692	resonance	_	
249-312	50693-50700	imaging	_	
249-313	50701-50706	study	_	
249-314	50707-50708	A	_	
249-315	50709-50721	longitudinal	_	
249-316	50722-50727	study	_	
249-317	50728-50730	on	_	
249-318	50731-50740	intrinsic	_	
249-319	50741-50753	connectivity	_	
249-320	50754-50756	of	_	
249-321	50757-50768	hippocampus	_	
249-322	50769-50779	associated	_	
249-323	50780-50784	with	_	
249-324	50785-50793	positive	_	
249-325	50794-50801	symptom	_	
249-326	50802-50804	in	_	
249-327	50805-50818	first-episode	_	
249-328	50819-50832	schizophrenia	_	
249-329	50833-50835	An	_	
249-330	50836-50844	unfolded	_	
249-331	50845-50848	map	_	
249-332	50849-50851	of	_	
249-333	50852-50855	the	_	
249-334	50856-50866	cerebellar	_	
249-335	50867-50874	dentate	_	
249-336	50875-50882	nucleus	_	
249-337	50883-50886	and	_	
249-338	50887-50890	its	_	
249-339	50891-50902	projections	_	
249-340	50903-50905	to	_	
249-341	50906-50909	the	_	
249-342	50910-50918	cerebral	_	
249-343	50919-50925	cortex	_	
249-344	50926-50929	The	_	
249-345	50930-50937	anatomy	_	
249-346	50938-50940	of	_	
249-347	50941-50954	first-episode	_	
249-348	50955-50958	and	_	
249-349	50959-50966	chronic	_	
249-350	50967-50980	schizophrenia	_	
249-351	50980-50981	:	_	
249-352	50982-50984	an	_	
249-353	50985-50995	anatomical	_	
249-354	50996-51006	likelihood	_	
249-355	51007-51017	estimation	_	
249-356	51018-51031	meta-analysis	_	
249-357	51032-51045	Schizophrenia	_	
249-358	51046-51050	with	_	
249-359	51051-51060	preserved	_	
249-360	51061-51068	insight	_	
249-361	51069-51071	is	_	
249-362	51072-51082	associated	_	
249-363	51083-51087	with	_	
249-364	51088-51097	increased	_	
249-365	51098-51107	perfusion	_	
249-366	51108-51110	of	_	
249-367	51111-51114	the	_	
249-368	51115-51124	precuneus	_	
249-369	51125-51133	Reducing	_	
249-370	51134-51147	inter-scanner	_	
249-371	51148-51159	variability	_	
249-372	51160-51162	of	_	
249-373	51163-51173	activation	_	
249-374	51174-51176	in	_	
249-375	51177-51178	a	_	
249-376	51179-51190	multicenter	_	
249-377	51191-51195	fMRI	_	
249-378	51196-51201	study	_	
249-379	51201-51202	:	_	
249-380	51203-51207	role	_	
249-381	51208-51210	of	_	
249-382	51211-51221	smoothness	_	
249-383	51222-51234	equalization	_	
249-384	51235-51246	Progressive	_	
249-385	51247-51252	brain	_	
249-386	51253-51260	changes	_	
249-387	51261-51263	in	_	
249-388	51264-51277	schizophrenia	_	
249-389	51278-51285	related	_	
249-390	51286-51288	to	_	
249-391	51289-51302	antipsychotic	_	
249-392	51303-51312	treatment	_	
249-393	51312-51313	?	_	

#Text=A meta-analysis of longitudinal MRI studies
#Text=Detecting structural changes in whole brain based on nonlinear deformations—application to schizophrenia research
#Text=Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study
#Text=Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies
#Text=An image-processing system for qualitative and quantitative volumetric analysis of brain images
#Text=Patterns of gray matter abnormalities in schizophrenia based on an international mega-analysis
#Text=Gray matter abnormalities in paranoid schizophrenia and their clinical correlations
#Text=
#Text=Facial affect decoding in schizophrenic disorders: a study using event-related potentials
#Text=Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia
#Text=Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies
#Text=Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia
#Text=
#Text=Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates
#Text=Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects
#Text=Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: a multicentric resting-state fMRI study
#Text=Theories of visual cortex organization in primates: areas of the third level
#Text=Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate
#Text=Morphometric abnormality of the insula in schizophrenia: a comparison with obsessive-compulsive disorder and normal control using MRI
#Text=Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study
#Text=Disrupted modular architecture of cerebellum in schizophrenia: a graph theoretic analysis
#Text=Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders
#Text=Learning task grouping and overlap in multi-task learning
#Text=Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study
#Text=Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment
#Text=Bayesian multi-task learning for decoding multi-subject neuroimaging data
#Text=The role of the precuneus in metaphor comprehension: evidence from an fMRI study in people with schizophrenia and healthy participants
#Text=An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients
#Text=Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study
#Text=Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen
#Text=Emotion and theory of mind in schizophrenia-investigating the role of the cerebellum
#Text=Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia
#Text=Multisite functional connectivity MRI classification of autism: ABIDE results
#Text=Reduced left angular gyrus volume in first-episode schizophrenia
#Text=Abnormal angular gyrus asymmetry in schizophrenia
#Text=Retrieval of visual, auditory, and abstract semantics
#Text=Joint covariate selection and joint subspace selection for multiple classification problems
#Text=Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory
#Text=Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia
#Text=Association between reduced extraversion and right posterior fusiform gyrus gray matter reduction in chronic schizophrenia
#Text=Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study
#Text=Does the salience network play a cardinal role in psychosis?
250-1	51314-51315	A	_	
250-2	51316-51329	meta-analysis	_	
250-3	51330-51332	of	_	
250-4	51333-51345	longitudinal	_	
250-5	51346-51349	MRI	_	
250-6	51350-51357	studies	_	
250-7	51358-51367	Detecting	_	
250-8	51368-51378	structural	_	
250-9	51379-51386	changes	_	
250-10	51387-51389	in	_	
250-11	51390-51395	whole	_	
250-12	51396-51401	brain	_	
250-13	51402-51407	based	_	
250-14	51408-51410	on	_	
250-15	51411-51420	nonlinear	_	
250-16	51421-51445	deformations—application	_	
250-17	51446-51448	to	_	
250-18	51449-51462	schizophrenia	_	
250-19	51463-51471	research	_	
250-20	51472-51483	Reliability	_	
250-21	51484-51486	of	_	
250-22	51487-51489	an	_	
250-23	51490-51494	fMRI	_	
250-24	51495-51503	paradigm	_	
250-25	51504-51507	for	_	
250-26	51508-51517	emotional	_	
250-27	51518-51528	processing	_	
250-28	51529-51531	in	_	
250-29	51532-51533	a	_	
250-30	51534-51543	multisite	_	
250-31	51544-51556	longitudinal	_	
250-32	51557-51562	study	_	
250-33	51563-51571	Function	_	
250-34	51572-51582	biomedical	_	
250-35	51583-51594	informatics	_	
250-36	51595-51603	research	_	
250-37	51604-51611	network	_	
250-38	51612-51627	recommendations	_	
250-39	51628-51631	for	_	
250-40	51632-51643	prospective	_	
250-41	51644-51655	multicenter	_	
250-42	51656-51666	functional	_	
250-43	51667-51670	MRI	_	
250-44	51671-51678	studies	_	
250-45	51679-51681	An	_	
250-46	51682-51698	image-processing	_	
250-47	51699-51705	system	_	
250-48	51706-51709	for	_	
250-49	51710-51721	qualitative	_	
250-50	51722-51725	and	_	
250-51	51726-51738	quantitative	_	
250-52	51739-51749	volumetric	_	
250-53	51750-51758	analysis	_	
250-54	51759-51761	of	_	
250-55	51762-51767	brain	_	
250-56	51768-51774	images	_	
250-57	51775-51783	Patterns	_	
250-58	51784-51786	of	_	
250-59	51787-51791	gray	_	
250-60	51792-51798	matter	_	
250-61	51799-51812	abnormalities	_	
250-62	51813-51815	in	_	
250-63	51816-51829	schizophrenia	_	
250-64	51830-51835	based	_	
250-65	51836-51838	on	_	
250-66	51839-51841	an	_	
250-67	51842-51855	international	_	
250-68	51856-51869	mega-analysis	_	
250-69	51870-51874	Gray	_	
250-70	51875-51881	matter	_	
250-71	51882-51895	abnormalities	_	
250-72	51896-51898	in	_	
250-73	51899-51907	paranoid	_	
250-74	51908-51921	schizophrenia	_	
250-75	51922-51925	and	_	
250-76	51926-51931	their	_	
250-77	51932-51940	clinical	_	
250-78	51941-51953	correlations	_	
250-79	51955-51961	Facial	_	
250-80	51962-51968	affect	_	
250-81	51969-51977	decoding	_	
250-82	51978-51980	in	_	
250-83	51981-51994	schizophrenic	_	
250-84	51995-52004	disorders	_	
250-85	52004-52005	:	_	
250-86	52006-52007	a	_	
250-87	52008-52013	study	_	
250-88	52014-52019	using	_	
250-89	52020-52033	event-related	_	
250-90	52034-52044	potentials	_	
250-91	52045-52054	Long-term	_	
250-92	52055-52068	antipsychotic	_	
250-93	52069-52078	treatment	_	
250-94	52079-52082	and	_	
250-95	52083-52088	brain	_	
250-96	52089-52096	volumes	_	
250-97	52096-52097	:	_	
250-98	52098-52099	a	_	
250-99	52100-52112	longitudinal	_	
250-100	52113-52118	study	_	
250-101	52119-52121	of	_	
250-102	52122-52135	first-episode	_	
250-103	52136-52149	schizophrenia	_	
250-104	52150-52158	Regional	_	
250-105	52159-52167	deficits	_	
250-106	52168-52170	in	_	
250-107	52171-52176	brain	_	
250-108	52177-52183	volume	_	
250-109	52184-52186	in	_	
250-110	52187-52200	schizophrenia	_	
250-111	52200-52201	:	_	
250-112	52202-52203	a	_	
250-113	52204-52217	meta-analysis	_	
250-114	52218-52220	of	_	
250-115	52221-52232	voxel-based	_	
250-116	52233-52244	morphometry	_	
250-117	52245-52252	studies	_	
250-118	52253-52263	Functional	_	
250-119	52264-52267	and	_	
250-120	52268-52278	anatomical	_	
250-121	52279-52291	connectivity	_	
250-122	52292-52305	abnormalities	_	
250-123	52306-52308	in	_	
250-124	52309-52313	left	_	
250-125	52314-52322	inferior	_	
250-126	52323-52330	frontal	_	
250-127	52331-52336	gyrus	_	
250-128	52337-52339	in	_	
250-129	52340-52353	schizophrenia	_	
250-130	52355-52365	Functional	_	
250-131	52366-52369	MRI	_	
250-132	52370-52372	of	_	
250-133	52373-52379	facial	_	
250-134	52380-52387	emotion	_	
250-135	52388-52399	recognition	_	
250-136	52400-52408	deficits	_	
250-137	52409-52411	in	_	
250-138	52412-52425	schizophrenia	_	
250-139	52426-52429	and	_	
250-140	52430-52435	their	_	
250-141	52436-52456	electrophysiological	_	
250-142	52457-52467	correlates	_	
250-143	52468-52477	Multisite	_	
250-144	52478-52490	longitudinal	_	
250-145	52491-52502	reliability	_	
250-146	52503-52505	of	_	
250-147	52506-52517	tract-based	_	
250-148	52518-52525	spatial	_	
250-149	52526-52536	statistics	_	
250-150	52537-52539	in	_	
250-151	52540-52549	diffusion	_	
250-152	52550-52556	tensor	_	
250-153	52557-52564	imaging	_	
250-154	52565-52567	of	_	
250-155	52568-52575	healthy	_	
250-156	52576-52583	elderly	_	
250-157	52584-52592	subjects	_	
250-158	52593-52605	Longitudinal	_	
250-159	52606-52621	reproducibility	_	
250-160	52622-52624	of	_	
250-161	52625-52637	default-mode	_	
250-162	52638-52645	network	_	
250-163	52646-52658	connectivity	_	
250-164	52659-52661	in	_	
250-165	52662-52669	healthy	_	
250-166	52670-52677	elderly	_	
250-167	52678-52690	participants	_	
250-168	52690-52691	:	_	
250-169	52692-52693	a	_	
250-170	52694-52706	multicentric	_	
250-171	52707-52720	resting-state	_	
250-172	52721-52725	fMRI	_	
250-173	52726-52731	study	_	
250-174	52732-52740	Theories	_	
250-175	52741-52743	of	_	
250-176	52744-52750	visual	_	
250-177	52751-52757	cortex	_	
250-178	52758-52770	organization	_	
250-179	52771-52773	in	_	
250-180	52774-52782	primates	_	
250-181	52782-52783	:	_	
250-182	52784-52789	areas	_	
250-183	52790-52792	of	_	
250-184	52793-52796	the	_	
250-185	52797-52802	third	_	
250-186	52803-52808	level	_	
250-187	52809-52819	Cerebellar	_	
250-188	52820-52825	loops	_	
250-189	52826-52830	with	_	
250-190	52831-52836	motor	_	
250-191	52837-52843	cortex	_	
250-192	52844-52847	and	_	
250-193	52848-52858	prefrontal	_	
250-194	52859-52865	cortex	_	
250-195	52866-52868	of	_	
250-196	52869-52870	a	_	
250-197	52871-52879	nonhuman	_	
250-198	52880-52887	primate	_	
250-199	52888-52900	Morphometric	_	
250-200	52901-52912	abnormality	_	
250-201	52913-52915	of	_	
250-202	52916-52919	the	_	
250-203	52920-52926	insula	_	
250-204	52927-52929	in	_	
250-205	52930-52943	schizophrenia	_	
250-206	52943-52944	:	_	
250-207	52945-52946	a	_	
250-208	52947-52957	comparison	_	
250-209	52958-52962	with	_	
250-210	52963-52983	obsessive-compulsive	_	
250-211	52984-52992	disorder	_	
250-212	52993-52996	and	_	
250-213	52997-53003	normal	_	
250-214	53004-53011	control	_	
250-215	53012-53017	using	_	
250-216	53018-53021	MRI	_	
250-217	53022-53035	Dysregulation	_	
250-218	53036-53038	of	_	
250-219	53039-53046	working	_	
250-220	53047-53053	memory	_	
250-221	53054-53057	and	_	
250-222	53058-53070	default-mode	_	
250-223	53071-53079	networks	_	
250-224	53080-53082	in	_	
250-225	53083-53096	schizophrenia	_	
250-226	53097-53102	using	_	
250-227	53103-53114	independent	_	
250-228	53115-53124	component	_	
250-229	53125-53133	analysis	_	
250-230	53133-53134	,	_	
250-231	53135-53137	an	_	
250-232	53138-53143	fBIRN	_	
250-233	53144-53147	and	_	
250-234	53148-53152	MCIC	_	
250-235	53153-53158	study	_	
250-236	53159-53168	Disrupted	_	
250-237	53169-53176	modular	_	
250-238	53177-53189	architecture	_	
250-239	53190-53192	of	_	
250-240	53193-53203	cerebellum	_	
250-241	53204-53206	in	_	
250-242	53207-53220	schizophrenia	_	
250-243	53220-53221	:	_	
250-244	53222-53223	a	_	
250-245	53224-53229	graph	_	
250-246	53230-53239	theoretic	_	
250-247	53240-53248	analysis	_	
250-248	53249-53260	Accelerated	_	
250-249	53261-53266	brain	_	
250-250	53267-53272	aging	_	
250-251	53273-53275	in	_	
250-252	53276-53289	schizophrenia	_	
250-253	53290-53293	and	_	
250-254	53294-53300	beyond	_	
250-255	53300-53301	:	_	
250-256	53302-53303	a	_	
250-257	53304-53319	neuroanatomical	_	
250-258	53320-53326	marker	_	
250-259	53327-53329	of	_	
250-260	53330-53341	psychiatric	_	
250-261	53342-53351	disorders	_	
250-262	53352-53360	Learning	_	
250-263	53361-53365	task	_	
250-264	53366-53374	grouping	_	
250-265	53375-53378	and	_	
250-266	53379-53386	overlap	_	
250-267	53387-53389	in	_	
250-268	53390-53400	multi-task	_	
250-269	53401-53409	learning	_	
250-270	53410-53418	Fusiform	_	
250-271	53419-53424	gyrus	_	
250-272	53425-53431	volume	_	
250-273	53432-53441	reduction	_	
250-274	53442-53444	in	_	
250-275	53445-53458	first-episode	_	
250-276	53459-53472	schizophrenia	_	
250-277	53472-53473	:	_	
250-278	53474-53475	a	_	
250-279	53476-53484	magnetic	_	
250-280	53485-53494	resonance	_	
250-281	53495-53502	imaging	_	
250-282	53503-53508	study	_	
250-283	53509-53515	Volume	_	
250-284	53516-53525	increases	_	
250-285	53526-53528	in	_	
250-286	53529-53536	putamen	_	
250-287	53537-53547	associated	_	
250-288	53548-53552	with	_	
250-289	53553-53561	positive	_	
250-290	53562-53569	symptom	_	
250-291	53570-53579	reduction	_	
250-292	53580-53582	in	_	
250-293	53583-53593	previously	_	
250-294	53594-53604	drug-naive	_	
250-295	53605-53618	schizophrenia	_	
250-296	53619-53624	after	_	
250-297	53625-53626	6	_	
250-298	53626-53627	 	_	
250-299	53627-53632	weeks	_	
250-300	53633-53646	antipsychotic	_	
250-301	53647-53656	treatment	_	
250-302	53657-53665	Bayesian	_	
250-303	53666-53676	multi-task	_	
250-304	53677-53685	learning	_	
250-305	53686-53689	for	_	
250-306	53690-53698	decoding	_	
250-307	53699-53712	multi-subject	_	
250-308	53713-53725	neuroimaging	_	
250-309	53726-53730	data	_	
250-310	53731-53734	The	_	
250-311	53735-53739	role	_	
250-312	53740-53742	of	_	
250-313	53743-53746	the	_	
250-314	53747-53756	precuneus	_	
250-315	53757-53759	in	_	
250-316	53760-53768	metaphor	_	
250-317	53769-53782	comprehension	_	
250-318	53782-53783	:	_	
250-319	53784-53792	evidence	_	
250-320	53793-53797	from	_	
250-321	53798-53800	an	_	
250-322	53801-53805	fMRI	_	
250-323	53806-53811	study	_	
250-324	53812-53814	in	_	
250-325	53815-53821	people	_	
250-326	53822-53826	with	_	
250-327	53827-53840	schizophrenia	_	
250-328	53841-53844	and	_	
250-329	53845-53852	healthy	_	
250-330	53853-53865	participants	_	
250-331	53866-53868	An	_	
250-332	53869-53873	fMRI	_	
250-333	53874-53879	study	_	
250-334	53880-53882	of	_	
250-335	53883-53890	working	_	
250-336	53891-53897	memory	_	
250-337	53898-53900	in	_	
250-338	53901-53913	first-degree	_	
250-339	53914-53924	unaffected	_	
250-340	53925-53934	relatives	_	
250-341	53935-53937	of	_	
250-342	53938-53951	schizophrenia	_	
250-343	53952-53960	patients	_	
250-344	53961-53971	Structural	_	
250-345	53972-53977	brain	_	
250-346	53978-53989	alterations	_	
250-347	53990-53992	at	_	
250-348	53993-54002	different	_	
250-349	54003-54009	stages	_	
250-350	54010-54012	of	_	
250-351	54013-54026	schizophrenia	_	
250-352	54026-54027	:	_	
250-353	54028-54029	a	_	
250-354	54030-54041	voxel-based	_	
250-355	54042-54054	morphometric	_	
250-356	54055-54060	study	_	
250-357	54061-54065	Poor	_	
250-358	54066-54073	outcome	_	
250-359	54074-54076	in	_	
250-360	54077-54084	chronic	_	
250-361	54085-54098	schizophrenia	_	
250-362	54099-54101	is	_	
250-363	54102-54112	associated	_	
250-364	54113-54117	with	_	
250-365	54118-54129	progressive	_	
250-366	54130-54134	loss	_	
250-367	54135-54137	of	_	
250-368	54138-54144	volume	_	
250-369	54145-54147	of	_	
250-370	54148-54151	the	_	
250-371	54152-54159	putamen	_	
250-372	54160-54167	Emotion	_	
250-373	54168-54171	and	_	
250-374	54172-54178	theory	_	
250-375	54179-54181	of	_	
250-376	54182-54186	mind	_	
250-377	54187-54189	in	_	
250-378	54190-54217	schizophrenia-investigating	_	
250-379	54218-54221	the	_	
250-380	54222-54226	role	_	
250-381	54227-54229	of	_	
250-382	54230-54233	the	_	
250-383	54234-54244	cerebellum	_	
250-384	54245-54254	Increased	_	
250-385	54255-54266	cannabinoid	_	
250-386	54267-54275	receptor	_	
250-387	54276-54283	density	_	
250-388	54284-54286	in	_	
250-389	54287-54290	the	_	
250-390	54291-54300	posterior	_	
250-391	54301-54310	cingulate	_	
250-392	54311-54317	cortex	_	
250-393	54318-54320	in	_	
250-394	54321-54334	schizophrenia	_	
250-395	54335-54344	Multisite	_	
250-396	54345-54355	functional	_	
250-397	54356-54368	connectivity	_	
250-398	54369-54372	MRI	_	
250-399	54373-54387	classification	_	
250-400	54388-54390	of	_	
250-401	54391-54397	autism	_	
250-402	54397-54398	:	_	
250-403	54399-54404	ABIDE	_	
250-404	54405-54412	results	_	
250-405	54413-54420	Reduced	_	
250-406	54421-54425	left	_	
250-407	54426-54433	angular	_	
250-408	54434-54439	gyrus	_	
250-409	54440-54446	volume	_	
250-410	54447-54449	in	_	
250-411	54450-54463	first-episode	_	
250-412	54464-54477	schizophrenia	_	
250-413	54478-54486	Abnormal	_	
250-414	54487-54494	angular	_	
250-415	54495-54500	gyrus	_	
250-416	54501-54510	asymmetry	_	
250-417	54511-54513	in	_	
250-418	54514-54527	schizophrenia	_	
250-419	54528-54537	Retrieval	_	
250-420	54538-54540	of	_	
250-421	54541-54547	visual	_	
250-422	54547-54548	,	_	
250-423	54549-54557	auditory	_	
250-424	54557-54558	,	_	
250-425	54559-54562	and	_	
250-426	54563-54571	abstract	_	
250-427	54572-54581	semantics	_	
250-428	54582-54587	Joint	_	
250-429	54588-54597	covariate	_	
250-430	54598-54607	selection	_	
250-431	54608-54611	and	_	
250-432	54612-54617	joint	_	
250-433	54618-54626	subspace	_	
250-434	54627-54636	selection	_	
250-435	54637-54640	for	_	
250-436	54641-54649	multiple	_	
250-437	54650-54664	classification	_	
250-438	54665-54673	problems	_	
250-439	54674-54682	Anatomic	_	
250-440	54683-54695	subdivisions	_	
250-441	54696-54698	in	_	
250-442	54699-54704	human	_	
250-443	54705-54713	temporal	_	
250-444	54714-54722	cortical	_	
250-445	54723-54731	neuronal	_	
250-446	54732-54740	activity	_	
250-447	54741-54748	related	_	
250-448	54749-54751	to	_	
250-449	54752-54758	recent	_	
250-450	54759-54765	verbal	_	
250-451	54766-54772	memory	_	
250-452	54773-54781	Fusiform	_	
250-453	54782-54787	gyrus	_	
250-454	54788-54794	volume	_	
250-455	54795-54804	reduction	_	
250-456	54805-54808	and	_	
250-457	54809-54815	facial	_	
250-458	54816-54827	recognition	_	
250-459	54828-54830	in	_	
250-460	54831-54838	chronic	_	
250-461	54839-54852	schizophrenia	_	
250-462	54853-54864	Association	_	
250-463	54865-54872	between	_	
250-464	54873-54880	reduced	_	
250-465	54881-54893	extraversion	_	
250-466	54894-54897	and	_	
250-467	54898-54903	right	_	
250-468	54904-54913	posterior	_	
250-469	54914-54922	fusiform	_	
250-470	54923-54928	gyrus	_	
250-471	54929-54933	gray	_	
250-472	54934-54940	matter	_	
250-473	54941-54950	reduction	_	
250-474	54951-54953	in	_	
250-475	54954-54961	chronic	_	
250-476	54962-54975	schizophrenia	_	
250-477	54976-54984	Aberrant	_	
250-478	54985-54993	cortical	_	
250-479	54994-55006	gyrification	_	
250-480	55007-55009	in	_	
250-481	55010-55023	schizophrenia	_	
250-482	55023-55024	:	_	
250-483	55025-55026	a	_	
250-484	55027-55040	surface-based	_	
250-485	55041-55052	morphometry	_	
250-486	55053-55058	study	_	
250-487	55059-55063	Does	_	
250-488	55064-55067	the	_	
250-489	55068-55076	salience	_	
250-490	55077-55084	network	_	
250-491	55085-55089	play	_	
250-492	55090-55091	a	_	
250-493	55092-55100	cardinal	_	
250-494	55101-55105	role	_	
250-495	55106-55108	in	_	
250-496	55109-55118	psychosis	_	
250-497	55118-55119	?	_	

#Text=An emerging hypothesis of insular dysfunction
#Text=Structural correlates of auditory hallucinations in schizophrenia: a meta-analysis
#Text=A survey on transfer learning
#Text=Multisite collaborations and large databases in psychiatric neuroimaging: advantages, problems, and challenges
#Text=Replicability of diffusion tensor imaging measurements of fractional anisotropy and trace in brain
#Text=Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study
#Text=The anatomy of language: a review of 100 fMRI studies published in 2009
#Text=Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia
#Text=
#Text=Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia
#Text=Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia
#Text=Grey matter abnormalities in Brazilians with first-episode psychosis
#Text=Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness
#Text=Sensorimotor cortex and supplementary motor area changes in schizophrenia.
251-1	55120-55122	An	_	
251-2	55123-55131	emerging	_	
251-3	55132-55142	hypothesis	_	
251-4	55143-55145	of	_	
251-5	55146-55153	insular	_	
251-6	55154-55165	dysfunction	_	
251-7	55166-55176	Structural	_	
251-8	55177-55187	correlates	_	
251-9	55188-55190	of	_	
251-10	55191-55199	auditory	_	
251-11	55200-55214	hallucinations	_	
251-12	55215-55217	in	_	
251-13	55218-55231	schizophrenia	_	
251-14	55231-55232	:	_	
251-15	55233-55234	a	_	
251-16	55235-55248	meta-analysis	_	
251-17	55249-55250	A	_	
251-18	55251-55257	survey	_	
251-19	55258-55260	on	_	
251-20	55261-55269	transfer	_	
251-21	55270-55278	learning	_	
251-22	55279-55288	Multisite	_	
251-23	55289-55303	collaborations	_	
251-24	55304-55307	and	_	
251-25	55308-55313	large	_	
251-26	55314-55323	databases	_	
251-27	55324-55326	in	_	
251-28	55327-55338	psychiatric	_	
251-29	55339-55351	neuroimaging	_	
251-30	55351-55352	:	_	
251-31	55353-55363	advantages	_	
251-32	55363-55364	,	_	
251-33	55365-55373	problems	_	
251-34	55373-55374	,	_	
251-35	55375-55378	and	_	
251-36	55379-55389	challenges	_	
251-37	55390-55403	Replicability	_	
251-38	55404-55406	of	_	
251-39	55407-55416	diffusion	_	
251-40	55417-55423	tensor	_	
251-41	55424-55431	imaging	_	
251-42	55432-55444	measurements	_	
251-43	55445-55447	of	_	
251-44	55448-55458	fractional	_	
251-45	55459-55469	anisotropy	_	
251-46	55470-55473	and	_	
251-47	55474-55479	trace	_	
251-48	55480-55482	in	_	
251-49	55483-55488	brain	_	
251-50	55489-55496	Working	_	
251-51	55497-55503	memory	_	
251-52	55504-55507	and	_	
251-53	55508-55513	DLPFC	_	
251-54	55514-55526	inefficiency	_	
251-55	55527-55529	in	_	
251-56	55530-55543	schizophrenia	_	
251-57	55543-55544	:	_	
251-58	55545-55548	the	_	
251-59	55549-55554	FBIRN	_	
251-60	55555-55560	study	_	
251-61	55561-55564	The	_	
251-62	55565-55572	anatomy	_	
251-63	55573-55575	of	_	
251-64	55576-55584	language	_	
251-65	55584-55585	:	_	
251-66	55586-55587	a	_	
251-67	55588-55594	review	_	
251-68	55595-55597	of	_	
251-69	55598-55601	100	_	
251-70	55602-55606	fMRI	_	
251-71	55607-55614	studies	_	
251-72	55615-55624	published	_	
251-73	55625-55627	in	_	
251-74	55628-55632	2009	_	
251-75	55633-55641	Patients	_	
251-76	55642-55646	with	_	
251-77	55647-55651	poor	_	
251-78	55652-55660	response	_	
251-79	55661-55663	to	_	
251-80	55664-55678	antipsychotics	_	
251-81	55679-55683	have	_	
251-82	55684-55685	a	_	
251-83	55686-55690	more	_	
251-84	55691-55697	severe	_	
251-85	55698-55705	pattern	_	
251-86	55706-55708	of	_	
251-87	55709-55716	frontal	_	
251-88	55717-55724	atrophy	_	
251-89	55724-55725	:	_	
251-90	55726-55727	a	_	
251-91	55728-55739	voxel-based	_	
251-92	55740-55751	morphometry	_	
251-93	55752-55757	study	_	
251-94	55758-55760	of	_	
251-95	55761-55770	treatment	_	
251-96	55771-55781	resistance	_	
251-97	55782-55784	in	_	
251-98	55785-55798	schizophrenia	_	
251-99	55800-55809	Reduction	_	
251-100	55810-55812	of	_	
251-101	55813-55816	the	_	
251-102	55817-55832	parahippocampal	_	
251-103	55833-55838	gyrus	_	
251-104	55839-55842	and	_	
251-105	55843-55846	the	_	
251-106	55847-55858	hippocampus	_	
251-107	55859-55861	in	_	
251-108	55862-55870	patients	_	
251-109	55871-55875	with	_	
251-110	55876-55883	chronic	_	
251-111	55884-55897	schizophrenia	_	
251-112	55898-55928	Prefrontal-thalamic-cerebellar	_	
251-113	55929-55933	gray	_	
251-114	55934-55940	matter	_	
251-115	55941-55949	networks	_	
251-116	55950-55953	and	_	
251-117	55954-55963	executive	_	
251-118	55964-55975	functioning	_	
251-119	55976-55978	in	_	
251-120	55979-55992	schizophrenia	_	
251-121	55993-55997	Grey	_	
251-122	55998-56004	matter	_	
251-123	56005-56018	abnormalities	_	
251-124	56019-56021	in	_	
251-125	56022-56032	Brazilians	_	
251-126	56033-56037	with	_	
251-127	56038-56051	first-episode	_	
251-128	56052-56061	psychosis	_	
251-129	56062-56069	Mapping	_	
251-130	56070-56081	reliability	_	
251-131	56082-56084	in	_	
251-132	56085-56096	multicenter	_	
251-133	56097-56100	MRI	_	
251-134	56100-56101	:	_	
251-135	56102-56113	voxel-based	_	
251-136	56114-56125	morphometry	_	
251-137	56126-56129	and	_	
251-138	56130-56138	cortical	_	
251-139	56139-56148	thickness	_	
251-140	56149-56161	Sensorimotor	_	
251-141	56162-56168	cortex	_	
251-142	56169-56172	and	_	
251-143	56173-56186	supplementary	_	
251-144	56187-56192	motor	_	
251-145	56193-56197	area	_	
251-146	56198-56205	changes	_	
251-147	56206-56208	in	_	
251-148	56209-56222	schizophrenia	_	
251-149	56222-56223	.	_	

#Text=A study with functional magnetic resonance imaging
#Text=Increased parahippocampal and lingual gyrification in first-episode schizophrenia
#Text=Voxel-based morphometric multisite collaborative study on schizophrenia
#Text=Increased neural response related to neutral faces in individuals at risk for psychosis
#Text=Very high-resolution morphometry using mass-preserving deformations and HAMMER elastic registration
#Text=Functional asymmetry in the cerebellum: a brief review
#Text=Discriminative analysis of resting-state functional connectivity patterns of schizophrenia using low dimensional embedding of fMRI
#Text=A review of MRI findings in schizophrenia
#Text=Motor function deficits in schizophrenia: an fMRI and VBM study
#Text=DRAMMS: deformable registration via attribute matching and mutual-saliency weighting
#Text=Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies
#Text=Investigation and validation of intersite fMRI studies using the same imaging hardware
#Text=A follow-up MRI study of the fusiform gyrus and middle and inferior temporal gyri in schizophrenia spectrum
#Text=Combined analysis of sMRI and fMRI imaging data provides accurate disease markers for hearing impairment
#Text=Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness
#Text=Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness
#Text=A neural basis for the retrieval of conceptual knowledge
#Text=A population-average, landmark- and surface-based (PALS) atlas of human cerebral cortex
#Text=Multisite neuroimaging trials
#Text=Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies
#Text=Cognitive correlates of gray matter abnormalities in adolescent siblings of patients with childhood-onset schizophrenia
#Text=Encoding deficit during face processing within the right fusiform face area in schizophrenia
#Text=Wang, H., Nie, F., Huang, H., Risacher, S., Ding, C., Saykin, A.J., Shen, L.
252-1	56224-56225	A	_	
252-2	56226-56231	study	_	
252-3	56232-56236	with	_	
252-4	56237-56247	functional	_	
252-5	56248-56256	magnetic	_	
252-6	56257-56266	resonance	_	
252-7	56267-56274	imaging	_	
252-8	56275-56284	Increased	_	
252-9	56285-56300	parahippocampal	_	
252-10	56301-56304	and	_	
252-11	56305-56312	lingual	_	
252-12	56313-56325	gyrification	_	
252-13	56326-56328	in	_	
252-14	56329-56342	first-episode	_	
252-15	56343-56356	schizophrenia	_	
252-16	56357-56368	Voxel-based	_	
252-17	56369-56381	morphometric	_	
252-18	56382-56391	multisite	_	
252-19	56392-56405	collaborative	_	
252-20	56406-56411	study	_	
252-21	56412-56414	on	_	
252-22	56415-56428	schizophrenia	_	
252-23	56429-56438	Increased	_	
252-24	56439-56445	neural	_	
252-25	56446-56454	response	_	
252-26	56455-56462	related	_	
252-27	56463-56465	to	_	
252-28	56466-56473	neutral	_	
252-29	56474-56479	faces	_	
252-30	56480-56482	in	_	
252-31	56483-56494	individuals	_	
252-32	56495-56497	at	_	
252-33	56498-56502	risk	_	
252-34	56503-56506	for	_	
252-35	56507-56516	psychosis	_	
252-36	56517-56521	Very	_	
252-37	56522-56537	high-resolution	_	
252-38	56538-56549	morphometry	_	
252-39	56550-56555	using	_	
252-40	56556-56571	mass-preserving	_	
252-41	56572-56584	deformations	_	
252-42	56585-56588	and	_	
252-43	56589-56595	HAMMER	_	
252-44	56596-56603	elastic	_	
252-45	56604-56616	registration	_	
252-46	56617-56627	Functional	_	
252-47	56628-56637	asymmetry	_	
252-48	56638-56640	in	_	
252-49	56641-56644	the	_	
252-50	56645-56655	cerebellum	_	
252-51	56655-56656	:	_	
252-52	56657-56658	a	_	
252-53	56659-56664	brief	_	
252-54	56665-56671	review	_	
252-55	56672-56686	Discriminative	_	
252-56	56687-56695	analysis	_	
252-57	56696-56698	of	_	
252-58	56699-56712	resting-state	_	
252-59	56713-56723	functional	_	
252-60	56724-56736	connectivity	_	
252-61	56737-56745	patterns	_	
252-62	56746-56748	of	_	
252-63	56749-56762	schizophrenia	_	
252-64	56763-56768	using	_	
252-65	56769-56772	low	_	
252-66	56773-56784	dimensional	_	
252-67	56785-56794	embedding	_	
252-68	56795-56797	of	_	
252-69	56798-56802	fMRI	_	
252-70	56803-56804	A	_	
252-71	56805-56811	review	_	
252-72	56812-56814	of	_	
252-73	56815-56818	MRI	_	
252-74	56819-56827	findings	_	
252-75	56828-56830	in	_	
252-76	56831-56844	schizophrenia	_	
252-77	56845-56850	Motor	_	
252-78	56851-56859	function	_	
252-79	56860-56868	deficits	_	
252-80	56869-56871	in	_	
252-81	56872-56885	schizophrenia	_	
252-82	56885-56886	:	_	
252-83	56887-56889	an	_	
252-84	56890-56894	fMRI	_	
252-85	56895-56898	and	_	
252-86	56899-56902	VBM	_	
252-87	56903-56908	study	_	
252-88	56909-56915	DRAMMS	_	
252-89	56915-56916	:	_	
252-90	56917-56927	deformable	_	
252-91	56928-56940	registration	_	
252-92	56941-56944	via	_	
252-93	56945-56954	attribute	_	
252-94	56955-56963	matching	_	
252-95	56964-56967	and	_	
252-96	56968-56983	mutual-saliency	_	
252-97	56984-56993	weighting	_	
252-98	56994-56999	Brain	_	
252-99	57000-57006	volume	_	
252-100	57007-57009	in	_	
252-101	57010-57023	first-episode	_	
252-102	57024-57037	schizophrenia	_	
252-103	57037-57038	:	_	
252-104	57039-57049	systematic	_	
252-105	57050-57056	review	_	
252-106	57057-57060	and	_	
252-107	57061-57074	meta-analysis	_	
252-108	57075-57077	of	_	
252-109	57078-57086	magnetic	_	
252-110	57087-57096	resonance	_	
252-111	57097-57104	imaging	_	
252-112	57105-57112	studies	_	
252-113	57113-57126	Investigation	_	
252-114	57127-57130	and	_	
252-115	57131-57141	validation	_	
252-116	57142-57144	of	_	
252-117	57145-57154	intersite	_	
252-118	57155-57159	fMRI	_	
252-119	57160-57167	studies	_	
252-120	57168-57173	using	_	
252-121	57174-57177	the	_	
252-122	57178-57182	same	_	
252-123	57183-57190	imaging	_	
252-124	57191-57199	hardware	_	
252-125	57200-57201	A	_	
252-126	57202-57211	follow-up	_	
252-127	57212-57215	MRI	_	
252-128	57216-57221	study	_	
252-129	57222-57224	of	_	
252-130	57225-57228	the	_	
252-131	57229-57237	fusiform	_	
252-132	57238-57243	gyrus	_	
252-133	57244-57247	and	_	
252-134	57248-57254	middle	_	
252-135	57255-57258	and	_	
252-136	57259-57267	inferior	_	
252-137	57268-57276	temporal	_	
252-138	57277-57281	gyri	_	
252-139	57282-57284	in	_	
252-140	57285-57298	schizophrenia	_	
252-141	57299-57307	spectrum	_	
252-142	57308-57316	Combined	_	
252-143	57317-57325	analysis	_	
252-144	57326-57328	of	_	
252-145	57329-57333	sMRI	_	
252-146	57334-57337	and	_	
252-147	57338-57342	fMRI	_	
252-148	57343-57350	imaging	_	
252-149	57351-57355	data	_	
252-150	57356-57364	provides	_	
252-151	57365-57373	accurate	_	
252-152	57374-57381	disease	_	
252-153	57382-57389	markers	_	
252-154	57390-57393	for	_	
252-155	57394-57401	hearing	_	
252-156	57402-57412	impairment	_	
252-157	57413-57425	Morphometric	_	
252-158	57426-57431	brain	_	
252-159	57432-57445	abnormalities	_	
252-160	57446-57448	in	_	
252-161	57449-57462	schizophrenia	_	
252-162	57463-57465	in	_	
252-163	57466-57467	a	_	
252-164	57468-57484	population-based	_	
252-165	57485-57491	sample	_	
252-166	57491-57492	:	_	
252-167	57493-57505	relationship	_	
252-168	57506-57508	to	_	
252-169	57509-57517	duration	_	
252-170	57518-57520	of	_	
252-171	57521-57528	illness	_	
252-172	57529-57537	Patterns	_	
252-173	57538-57540	of	_	
252-174	57541-57549	regional	_	
252-175	57550-57554	gray	_	
252-176	57555-57561	matter	_	
252-177	57562-57566	loss	_	
252-178	57567-57569	at	_	
252-179	57570-57579	different	_	
252-180	57580-57586	stages	_	
252-181	57587-57589	of	_	
252-182	57590-57603	schizophrenia	_	
252-183	57603-57604	:	_	
252-184	57605-57606	a	_	
252-185	57607-57616	multisite	_	
252-186	57616-57617	,	_	
252-187	57618-57633	cross-sectional	_	
252-188	57634-57637	VBM	_	
252-189	57638-57643	study	_	
252-190	57644-57646	in	_	
252-191	57647-57660	first-episode	_	
252-192	57661-57664	and	_	
252-193	57665-57672	chronic	_	
252-194	57673-57680	illness	_	
252-195	57681-57682	A	_	
252-196	57683-57689	neural	_	
252-197	57690-57695	basis	_	
252-198	57696-57699	for	_	
252-199	57700-57703	the	_	
252-200	57704-57713	retrieval	_	
252-201	57714-57716	of	_	
252-202	57717-57727	conceptual	_	
252-203	57728-57737	knowledge	_	
252-204	57738-57739	A	_	
252-205	57740-57758	population-average	_	
252-206	57758-57759	,	_	
252-207	57760-57768	landmark	_	
252-208	57768-57769	-	_	
252-209	57770-57773	and	_	
252-210	57774-57787	surface-based	_	
252-211	57788-57789	(	_	
252-212	57789-57793	PALS	_	
252-213	57793-57794	)	_	
252-214	57795-57800	atlas	_	
252-215	57801-57803	of	_	
252-216	57804-57809	human	_	
252-217	57810-57818	cerebral	_	
252-218	57819-57825	cortex	_	
252-219	57826-57835	Multisite	_	
252-220	57836-57848	neuroimaging	_	
252-221	57849-57855	trials	_	
252-222	57856-57867	Progressive	_	
252-223	57868-57872	loss	_	
252-224	57873-57875	of	_	
252-225	57876-57884	cortical	_	
252-226	57885-57889	gray	_	
252-227	57890-57896	matter	_	
252-228	57897-57899	in	_	
252-229	57900-57913	schizophrenia	_	
252-230	57913-57914	:	_	
252-231	57915-57916	a	_	
252-232	57917-57930	meta-analysis	_	
252-233	57931-57934	and	_	
252-234	57935-57950	meta-regression	_	
252-235	57951-57953	of	_	
252-236	57954-57966	longitudinal	_	
252-237	57967-57970	MRI	_	
252-238	57971-57978	studies	_	
252-239	57979-57988	Cognitive	_	
252-240	57989-57999	correlates	_	
252-241	58000-58002	of	_	
252-242	58003-58007	gray	_	
252-243	58008-58014	matter	_	
252-244	58015-58028	abnormalities	_	
252-245	58029-58031	in	_	
252-246	58032-58042	adolescent	_	
252-247	58043-58051	siblings	_	
252-248	58052-58054	of	_	
252-249	58055-58063	patients	_	
252-250	58064-58068	with	_	
252-251	58069-58084	childhood-onset	_	
252-252	58085-58098	schizophrenia	_	
252-253	58099-58107	Encoding	_	
252-254	58108-58115	deficit	_	
252-255	58116-58122	during	_	
252-256	58123-58127	face	_	
252-257	58128-58138	processing	_	
252-258	58139-58145	within	_	
252-259	58146-58149	the	_	
252-260	58150-58155	right	_	
252-261	58156-58164	fusiform	_	
252-262	58165-58169	face	_	
252-263	58170-58174	area	_	
252-264	58175-58177	in	_	
252-265	58178-58191	schizophrenia	_	
252-266	58192-58196	Wang	_	
252-267	58196-58197	,	_	
252-268	58198-58199	H	_	
252-269	58199-58200	.	_	
252-270	58200-58201	,	_	
252-271	58202-58205	Nie	_	
252-272	58205-58206	,	_	
252-273	58207-58208	F	_	
252-274	58208-58209	.	_	
252-275	58209-58210	,	_	
252-276	58211-58216	Huang	_	
252-277	58216-58217	,	_	
252-278	58218-58219	H	_	
252-279	58219-58220	.	_	
252-280	58220-58221	,	_	
252-281	58222-58230	Risacher	_	
252-282	58230-58231	,	_	
252-283	58232-58233	S	_	
252-284	58233-58234	.	_	
252-285	58234-58235	,	_	
252-286	58236-58240	Ding	_	
252-287	58240-58241	,	_	
252-288	58242-58243	C	_	
252-289	58243-58244	.	_	
252-290	58244-58245	,	_	
252-291	58246-58252	Saykin	_	
252-292	58252-58253	,	_	
252-293	58254-58257	A.J	_	
252-294	58257-58258	.	_	
252-295	58258-58259	,	_	
252-296	58260-58264	Shen	_	
252-297	58264-58265	,	_	
252-298	58266-58267	L	_	
252-299	58267-58268	.	_	

#Text=(Sparse multi-task regression and feature selection to identify brain imaging predictors for memory performance).
253-1	58269-58270	(	_	
253-2	58270-58276	Sparse	_	
253-3	58277-58287	multi-task	_	
253-4	58288-58298	regression	_	
253-5	58299-58302	and	_	
253-6	58303-58310	feature	_	
253-7	58311-58320	selection	_	
253-8	58321-58323	to	_	
253-9	58324-58332	identify	_	
253-10	58333-58338	brain	_	
253-11	58339-58346	imaging	_	
253-12	58347-58357	predictors	_	
253-13	58358-58361	for	_	
253-14	58362-58368	memory	_	
253-15	58369-58380	performance	_	
253-16	58380-58381	)	_	
253-17	58381-58382	.	_	

#Text=In; 2011. p 557–562.
254-1	58383-58385	In	_	
254-2	58385-58386	;	_	
254-3	58387-58391	2011	_	
254-4	58391-58392	.	_	
254-5	58393-58394	p	_	
254-6	58395-58398	557	_	
254-7	58398-58399	–	_	
254-8	58399-58402	562	_	
254-9	58402-58403	.	_	

#Text=Finding the elusive psychiatric “lesion” with 21st-century neuroanatomy: a note of caution
#Text=Functional imaging as a predictor of schizophrenia
#Text=Meta-analysis of regional brain volumes in schizophrenia
#Text=Polysensory interactions along lateral temporal regions evoked by audiovisual speech
#Text=Multi-task learning for classification with Dirichlet process priors
#Text=Cortical surface biomarkers for predicting cognitive outcomes using group l2,1 norm
#Text=Preserved function of the fusiform face area in schizophrenia as revealed by fMRI
#Text=Sub-patterns of language network reorganization in pediatric localization related epilepsy: a multisite study
#Text=Neuroanatomical pattern classification in a population-based sample of first-episode schizophrenia
#Text=There are no conflicts of interest.
255-1	58406-58413	Finding	_	
255-2	58414-58417	the	_	
255-3	58418-58425	elusive	_	
255-4	58426-58437	psychiatric	_	
255-5	58438-58439	“	_	
255-6	58439-58445	lesion	_	
255-7	58445-58446	”	_	
255-8	58447-58451	with	_	
255-9	58452-58464	21st-century	_	
255-10	58465-58477	neuroanatomy	_	
255-11	58477-58478	:	_	
255-12	58479-58480	a	_	
255-13	58481-58485	note	_	
255-14	58486-58488	of	_	
255-15	58489-58496	caution	_	
255-16	58497-58507	Functional	_	
255-17	58508-58515	imaging	_	
255-18	58516-58518	as	_	
255-19	58519-58520	a	_	
255-20	58521-58530	predictor	_	
255-21	58531-58533	of	_	
255-22	58534-58547	schizophrenia	_	
255-23	58548-58561	Meta-analysis	_	
255-24	58562-58564	of	_	
255-25	58565-58573	regional	_	
255-26	58574-58579	brain	_	
255-27	58580-58587	volumes	_	
255-28	58588-58590	in	_	
255-29	58591-58604	schizophrenia	_	
255-30	58605-58616	Polysensory	_	
255-31	58617-58629	interactions	_	
255-32	58630-58635	along	_	
255-33	58636-58643	lateral	_	
255-34	58644-58652	temporal	_	
255-35	58653-58660	regions	_	
255-36	58661-58667	evoked	_	
255-37	58668-58670	by	_	
255-38	58671-58682	audiovisual	_	
255-39	58683-58689	speech	_	
255-40	58690-58700	Multi-task	_	
255-41	58701-58709	learning	_	
255-42	58710-58713	for	_	
255-43	58714-58728	classification	_	
255-44	58729-58733	with	_	
255-45	58734-58743	Dirichlet	_	
255-46	58744-58751	process	_	
255-47	58752-58758	priors	_	
255-48	58759-58767	Cortical	_	
255-49	58768-58775	surface	_	
255-50	58776-58786	biomarkers	_	
255-51	58787-58790	for	_	
255-52	58791-58801	predicting	_	
255-53	58802-58811	cognitive	_	
255-54	58812-58820	outcomes	_	
255-55	58821-58826	using	_	
255-56	58827-58832	group	_	
255-57	58833-58837	l2,1	_	
255-58	58838-58842	norm	_	
255-59	58843-58852	Preserved	_	
255-60	58853-58861	function	_	
255-61	58862-58864	of	_	
255-62	58865-58868	the	_	
255-63	58869-58877	fusiform	_	
255-64	58878-58882	face	_	
255-65	58883-58887	area	_	
255-66	58888-58890	in	_	
255-67	58891-58904	schizophrenia	_	
255-68	58905-58907	as	_	
255-69	58908-58916	revealed	_	
255-70	58917-58919	by	_	
255-71	58920-58924	fMRI	_	
255-72	58925-58937	Sub-patterns	_	
255-73	58938-58940	of	_	
255-74	58941-58949	language	_	
255-75	58950-58957	network	_	
255-76	58958-58972	reorganization	_	
255-77	58973-58975	in	_	
255-78	58976-58985	pediatric	_	
255-79	58986-58998	localization	_	
255-80	58999-59006	related	_	
255-81	59007-59015	epilepsy	_	
255-82	59015-59016	:	_	
255-83	59017-59018	a	_	
255-84	59019-59028	multisite	_	
255-85	59029-59034	study	_	
255-86	59035-59050	Neuroanatomical	_	
255-87	59051-59058	pattern	_	
255-88	59059-59073	classification	_	
255-89	59074-59076	in	_	
255-90	59077-59078	a	_	
255-91	59079-59095	population-based	_	
255-92	59096-59102	sample	_	
255-93	59103-59105	of	_	
255-94	59106-59119	first-episode	_	
255-95	59120-59133	schizophrenia	_	
255-96	59134-59139	There	_	
255-97	59140-59143	are	_	
255-98	59144-59146	no	_	
255-99	59147-59156	conflicts	_	
255-100	59157-59159	of	_	
255-101	59160-59168	interest	_	
255-102	59168-59169	.	_	
